0001643848-17-000028.txt : 20170609 0001643848-17-000028.hdr.sgml : 20170609 20170609135656 ACCESSION NUMBER: 0001643848-17-000028 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 106 CONFORMED PERIOD OF REPORT: 20170430 FILED AS OF DATE: 20170609 DATE AS OF CHANGE: 20170609 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Patheon N.V. CENTRAL INDEX KEY: 0001643848 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981153534 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37837 FILM NUMBER: 17902303 BUSINESS ADDRESS: STREET 1: EVERT VAN DE BEEKSTRAAT 104 CITY: AMSTERDAM SCHIPHOL STATE: P7 ZIP: 1118 CN BUSINESS PHONE: 31 (20) 622-3243 MAIL ADDRESS: STREET 1: EVERT VAN DE BEEKSTRAAT 104 CITY: AMSTERDAM SCHIPHOL STATE: P7 ZIP: 1118 CN FORMER COMPANY: FORMER CONFORMED NAME: Patheon Holdings Cooperatief U.A. DATE OF NAME CHANGE: 20150601 10-Q 1 q22017-10qdocument.htm 10-Q Document



SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 ________________________________________
FORM 10-Q
 _________________________________________
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended April 30, 2017
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             
Commission File Number: 001-37837
________________________________________ 
PATHEON N.V.
(Exact name of registrant as specified in its charter)
 _______________________________________
The Netherlands
98-1153534
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
Evert van de Beekstraat 104
1118 CN, Amsterdam Schiphol
The Netherlands
(Address of Registrant’s Principal Executive Offices and Zip Code)
+31 (0) 20 622 3243
Registrant's Telephone Number, including Area Code
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☐
 
Accelerated filer
☐
Non-accelerated filer
☒
 (Do not check if a smaller reporting company)
Smaller reporting company
☐
 
 
 
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes  ☐    No  ☒
As of May 31, 2017, the registrant had 145,144,742 ordinary shares issued and 145,136,214 ordinary shares outstanding.





Patheon N.V.

TABLE OF CONTENTS






Part I.    Financial Information
Item 1.    Financial Statements (Unaudited)






Patheon N.V.
CONSOLIDATED BALANCE SHEETS
(unaudited)
 
As of April 30, 2017
 
As of October 31, 2016
(in millions of U.S. dollars, except share data)
$
 
$
Assets
 
 
 
Current
 
 
 
Cash and cash equivalents
92.7

 
165.0

Accounts receivable, net
420.9

 
401.0

Inventories, net
451.6

 
395.2

Income taxes receivable
14.3

 
8.7

Prepaid expenses and other
24.1

 
21.5

Total current assets
1,003.6

 
991.4

Capital assets
1,169.3

 
983.6

Intangible assets
235.2

 
247.6

Deferred tax assets
30.2

 
29.8

Goodwill
281.4

 
281.6

Investments
11.2

 
11.5

Other long-term assets
39.2

 
44.1

Total assets
2,770.1

 
2,589.6

Liabilities and shareholders' deficit
 
 
 
Current
 
 
 
Accounts payable and accrued liabilities
382.2

 
393.6

Income taxes payable
9.3

 
6.6

Deferred revenues - current
195.5

 
154.2

Current portion of long-term debt
19.4

 
19.5

Total current liabilities
606.4

 
573.9

Long-term debt
2,069.4

 
2,049.2

Deferred revenues
132.4

 
102.3

Deferred tax liabilities
96.7

 
67.1

Other long-term liabilities
147.7

 
145.5

Total liabilities
3,052.6

 
2,938.0

Commitments and contingencies

 

Shareholders' deficit:
 
 
 
Ordinary shares (par value of €0.01 per share, 500,000,000 shares authorized, 145,144,742 and 145,074,042 shares issued as of April 30, 2017 and October 31, 2016, respectively)
1.6

 
1.6

Additional paid in capital
602.4

 
591.4

Treasury shares (at cost, 8,528 ordinary shares as of April 30, 2017)
(0.2
)
 
—

Accumulated deficit
(786.2
)
 
(842.1
)
Accumulated other comprehensive loss
(100.1
)
 
(99.3
)
Total shareholders' deficit
(282.5
)
 
(348.4
)
Total liabilities and shareholders' deficit
2,770.1

 
2,589.6

See accompanying notes

2



Patheon N.V.
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
 
  
Three months ended April 30,
 
Six months ended April 30,
  
2017
 
2016
 
2017
 
2016
(in millions of U.S. dollars, except share data)
$
 
$
 
$
 
$
Revenues
483.4

 
468.6

 
940.8

 
874.5

Cost of goods sold
342.7

 
330.3

 
670.4

 
637.3

Gross profit
140.7

 
138.3

 
270.4

 
237.2

Selling, general and administrative expenses
92.1

 
74.8

 
173.2

 
148.5

Research and development
0.4

 
0.6

 
1.1

 
1.3

Repositioning expenses
1.8

 
1.3

 
2.4

 
2.5

Acquisition and integration costs
8.1

 
7.6

 
11.6

 
10.2

Other operating expense (income)
0.5

 
1.2

 
4.1

 
(3.7
)
Operating income
37.8

 
52.8

 
78.0

 
78.4

Interest expense, net
30.8

 
42.6

 
59.0

 
86.4

Foreign exchange loss, net
0.7

 
7.1

 
5.5

 
11.4

Refinancing expenses
6.3

 
—

 
6.3

 
—

Bargain purchase gain
(26.4
)
 
—

 
(26.4
)
 
—

Other loss (income), net
0.3

 
0.5

 
0.5

 
(1.3
)
Income (loss) before income taxes
26.1

 
2.6

 
33.1

 
(18.1
)
(Benefit from) provision for income taxes
(1.5
)
 
0.7

 
(22.8
)
 
—

Net income (loss) from continuing operations
27.6

 
1.9

 
55.9

 
(18.1
)
Net loss from discontinued operations
—

 
(1.0
)
 
—

 
(3.1
)
Net income (loss)
27.6

 
0.9

 
55.9

 
(21.2
)
 
 
 
 
 
 
 
 
Basic earnings (loss) per ordinary share
 
 
 
 
 
 
 
From continuing operations
$
0.19

 
$
0.02

 
$
0.39

 
$
(0.16
)
From discontinued operations
$
—

 
$
(0.01
)
 
$
—

 
$
(0.03
)
 
 
 
 
 
 
 
 
Diluted earnings (loss) per ordinary share
 
 
 
 
 
 
 
From continuing operations
$
0.19

 
$
0.02

 
$
0.38

 
$
(0.16
)
From discontinued operations
$
—

 
$
(0.01
)
 
$
—

 
$
(0.03
)
 
 
 
 
 
 
 
 
Average number of ordinary shares outstanding (in thousands)
 
 
 
 
 
 
 
      Basic
145,136

 
115,610

 
145,132

 
115,610

      Diluted
146,267

 
115,610

 
146,276

 
115,610

See accompanying notes

3



Patheon N.V.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(unaudited)
  
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
(in millions of U.S. dollars)
$
 
$
 
$
 
$
Net income (loss)
27.6

 
0.9

 
55.9

 
(21.2
)
Other comprehensive income (loss), net of income taxes:
 
 
 
 
 
 
 
Foreign currency translation adjustments
(4.7
)
 
14.3

 
(7.3
)
 
5.0

Net (loss) gain related to net investment hedge
(4.6
)
 
(25.8
)
 
4.0

 
(18.9
)
Net gain on intra-entity foreign currency transactions
—

 
3.8

 
—

 
3.0

Change in value of derivatives designated as foreign currency cash flow hedges
(3.4
)
 
6.9

 
(1.1
)
 
(1.0
)
Losses from foreign currency hedges reclassified to consolidated statement of operations (1)
0.7

 
3.5

 
2.2

 
8.1

Net change in minimum pension liability (2)
0.7

 
0.4

 
1.4

 
0.8

Comprehensive income (loss)
16.3

 
4.0

 
55.1

 
(24.2
)
1 Net of an income tax benefit of $0.1 million for the three and six months ended April 30, 2017. Income tax expense is not applicable for the six months ended April 30, 2016 as these amounts are from the Company's Canadian operations which were under a full valuation allowance in the prior period. The valuation allowance was released during the fourth quarter of fiscal 2016. Amounts, gross of tax, have been reclassified to foreign exchange loss, net on the consolidated statements of operations.
2 Net of an income tax expense of $0.0 million for the three and six months ended April 30, 2017 and 2016, which is included as a component of provision for income taxes on the consolidated statements of operations. Amounts, gross of tax, have been reclassified to cost of goods sold and selling, general and administrative expenses in the consolidated statements of operations. See Note 7 for further information.
See accompanying notes

4



Patheon N.V.
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' DEFICIT
(unaudited)
 
Shares Outstanding
 
Ordinary Shares
 
Additional Paid-in Capital
 
Treasury Shares
 
Accumulated Deficit
 
Accumulated Other Comprehensive Loss
 
Shareholders' Deficit
(in millions of U.S. dollars, except share data)
 
 
$
 
$
 
$
 
$
 
$
 
$
Balance at October 31, 2016
145,074,042

 
1.6

 
591.4

 
—

 
(842.1
)
 
(99.3
)
 
(348.4
)
Ordinary share issuances related to stock based compensation
70,700

 
—

 
—

 
—

 
—

 
—

 
—

Stock based compensation
 
 
—

 
11.0

 
—

 
—

 
—

 
11.0

Treasury shares acquired, at cost
(8,528
)
 
—

 
—

 
(0.2
)
 
—

 
—

 
(0.2
)
Comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
 
 

Net income
 
 
 
 
 
 
 
 
55.9

 
—

 
55.9

Foreign currency translation adjustments
 
 
 
 
 
 
 
 
 
 
(7.3
)
 
(7.3
)
Net gain related to net investment hedge
 
 
 
 
 
 
 
 
 
 
4.0

 
4.0

Change in value of derivatives designated as foreign currency cash flow hedges
 
 
 
 
 
 
 
 
 
 
(1.1
)
 
(1.1
)
Losses from foreign currency hedges reclassified to consolidated statement of operations
 
 
 
 
 
 
 
 
 
 
2.2

 
2.2

Net change in minimum pension liability
 
 
 
 
 
 
 
 
 
 
1.4

 
1.4

Total comprehensive income (loss)
 
 
 
 
 
 
 
 
55.9

 
(0.8
)
 
55.1

Balance at April 30, 2017
145,136,214

 
1.6

 
602.4

 
(0.2
)
 
(786.2
)
 
(100.1
)
 
(282.5
)
See accompanying notes

5



Patheon N.V.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
  
Six months ended April 30,
  
2017
 
2016
(in millions of U.S. dollars)
$
 
$
Operating activities
 
 
 
Net income (loss) from continuing operations
55.9

 
(18.1
)
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
 
 
 
Depreciation and amortization
61.9

 
53.5

Increase in deferred revenues
141.1

 
172.9

Amortization of deferred revenues
(137.2
)
 
(101.3
)
Non-cash interest
9.5

 
7.6

Change in other long-term assets and liabilities
4.0

 
2.9

Deferred income taxes
(29.7
)
 
(0.9
)
Stock based compensation expense
11.0

 
3.0

Gain on bargain purchase
(26.4
)
 
—

Payment of original issue discount
(4.1
)
 
—

Return on capital from equity investment
—

 
1.3

Foreign exchange loss on debt
—

 
2.2

Other
4.4

 
(5.1
)
Net change in non-cash working capital balances
(69.5
)
 
(161.0
)
Cash provided by (used in) operating activities of continuing operations
20.9

 
(43.0
)
Cash used in operating activities of discontinued operations
—

 
(2.9
)
Cash provided by (used in) operating activities
20.9

 
(45.9
)
Investing activities
 
 
 
Additions to capital assets
(99.2
)
 
(95.1
)
Acquisitions
(10.3
)
 
—

Proceeds from sale of capital assets
—

 
0.1

Return of capital from equity investment
—

 
2.3

Cash used in investing activities of continuing operations
(109.5
)
 
(92.7
)
Cash used in investing activities of discontinued operations
—

 
(3.3
)
Cash used in investing activities
(109.5
)
 
(96.0
)
Financing activities
 
 
 
Proceeds from borrowings
30.0


0.7

Repayment of debt
(9.6
)
 
(9.9
)
Increase in deferred financing costs
(2.7
)

—

Treasury share purchases to satisfy certain tax withholdings
(0.1
)
 
—

Cash provided by (used in) financing activities
17.6

 
(9.2
)
Effect of exchange rate changes on cash and cash equivalents
(1.3
)
 
7.1

Net change in cash and cash equivalents during the period
(72.3
)
 
(144.0
)
Cash and cash equivalents, beginning of period
165.0

 
328.7

Cash and cash equivalents, end of period
92.7

 
184.7

See accompanying notes

6

Patheon N.V.
NOTES TO CONSOLIDATED FINACIAL STATEMENTS


7

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

1.    THE COMPANY
Patheon N.V. (“Patheon” or "the Company") was formed on December 24, 2013, as Patheon Coöperatief U.A., a Dutch cooperative with excluded liability for its members (coöperative met uitgesloten aansparkelijkheid) and a wholly owned indirect subsidiary of JLL/Delta Patheon Holdings, L.P. (the “Partnership”), which in turn is owned 51% by JLL Patheon Co-Investment Fund L.P. ("JLL") and 49% by Koninklijke DSM N.V. ("DSM"). On June 3, 2016, the Company was converted into a Dutch limited liability company (naamloze vennootschap) and changed its name to Patheon N.V.
On July 21, 2016, the Company amended its articles of association, resulting in a split of the Company's ordinary shares and a $1.2 million contribution by the Partnership to the Company's equity capital in connection with the share split. This share split and capital contribution resulted in a total of 115,609,756 ordinary shares outstanding at a par value of €0.01 per share.
On July 21, 2016, the Company commenced an initial public offering ("IPO") of an additional 29,464,286 ordinary shares at a public offering price of $21.00 per share, which included 4,464,286 ordinary shares sold pursuant to the option granted to the underwriters to purchase additional ordinary shares from the Company. As part of the IPO, DSM sold 4,761,905 ordinary shares to the public that were distributed to them in connection to their ownership in the Partnership. A total of 34,226,191 ordinary shares were sold in connection to the IPO. The Company did not receive any proceeds from the ordinary shares sold by DSM. The IPO was completed on July 26, 2016.
The Company received total net proceeds of approximately $584.8 million from the IPO, after deducting underwriting discounts and commissions, but before deducting estimated offering expenses. The shares offered and sold in the IPO were registered under the Securities Act pursuant to the Company's Registration Statement on Form S-1, which was declared effective by the SEC on July 18, 2016. The Company's ordinary shares began trading on the New York Stock Exchange under the symbol "PTHN" as of July 21, 2016.
As of April 30, 2017, the Company had 145,136,214 ordinary shares outstanding with a par value of €0.01 per share. Ordinary shares owned by the public constitute approximately 24% of the outstanding ordinary shares. JLL, DSM and the Partnership own approximately 38%, 34% and 4% of the Company through their ownership of outstanding ordinary shares, respectively. In accordance with the Company's articles of association, each ordinary share shall have one vote in the Company's general meeting. The Partnership's ownership comprises of shares held for the benefit of certain employees. See Note 9 for further discussion.
2.    BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of presentation
Patheon consists of three reportable segments: Drug Product Services ("DPS"), Pharmaceutical Development Services ("PDS"), and Drug Substance Services ("DSS"). Drug Product Services provides manufacturing and packaging for approved prescription, over-the-counter, and nutritional products. Pharmaceutical Development Services provides a wide spectrum of advanced formulation, production, and technical services from the early stages of a product's development to regulatory approval and beyond, as well as for new formulations of approved products for life cycle extension. Drug Substance Services provides development and manufacturing for the biologically active component of a pharmaceutical product from early development through commercial production.
The accompanying unaudited consolidated financial statements have been prepared by the Company in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). Operating results for the three and six months ended April 30, 2017 are not necessarily indicative of the results that may be expected for the fiscal year ending October 31, 2017 ("fiscal 2017"). These consolidated financial statements do not include all the information and footnotes required by U.S. GAAP for annual financial statements and therefore should be read in conjunction with the audited consolidated financial statements and notes for the fiscal year ended October 31, 2016 ("fiscal 2016").
The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions have been eliminated.
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect: the reported amounts of assets and liabilities; the disclosure of contingent assets and liabilities at the date of the consolidated financial statements; and the reported amounts of revenue and expenses in the reporting period. Management believes that the estimates and assumptions used in preparing its consolidated financial statements are reasonable and prudent; however, actual results could differ from those estimates.

8

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

Changes in significant accounting policies
As a result of early adopting Accounting Standards Update 2016-09, 'Improvements to Employee Share-Based Payment Accounting', the Company is electing to account for forfeitures on stock based compensation awards as they occur. No adjustment is required to comply with the early adoption. The Company was previously not estimating forfeitures on stock based compensation awards since the impact of potential forfeiture was immaterial to the consolidated financial statements.
Segment information
U.S. GAAP requires segmentation based on an entity’s internal organization and reporting of revenue and operating income (loss) based upon internal accounting methods commonly referred to as the “management approach.” Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (“CODM”), or decision making group, in deciding how to allocate resources and in assessing performance. The Company’s CODM is its Chief Executive Officer.
The Company’s four operating segments are: North America Drug Product Services, or North America DPS, Europe Drug Product Services, or Europe DPS, Pharmaceutical Development Services, or PDS and Drug Substance Services, or DSS. The North America DPS and Europe DPS operating segments meet the aggregation criteria to be presented as one reportable segment referred to as DPS. As a result, the Company has determined it has three reportable segments: DPS, PDS, and DSS. Corporate is not an individually reportable segment because the quantitative thresholds have not been met and as such has been reported in Other.
Recently adopted accounting pronouncements
Accounting Standards Update ("ASU")
Description
Date Adopted
Improvements to Employee Share-Based Payment Accounting (ASU 2016-09)
This update simplifies several aspects of the accounting for
share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities,
and classification on the statement of cash flows.

The Company early-adopted ASU 2016-09 during the second quarter of fiscal 2017, which had no effect on the Company's financial statements.
February 1, 2017
Simplifying the Accounting for Measurement-Period Adjustment (ASU 2015-16)
This update eliminated the requirement to an acquirer in a business combination to retrospectively adjust provisional amounts recognized at the acquisition date with a corresponding adjustment to goodwill. Instead, the update requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The impact will be dependent on future transactions.
November 1, 2016
Simplifying the Presentation of Debt Issuance Costs (ASU 2015-03)
The pronouncement requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of the debt liability, consistent
with that of debt discounts. The pronouncement is being applied retrospectively and the Company's October 31, 2016 balance sheet has been adjusted. The April 30, 2017 and October 31, 2016 balance sheets were adjusted to decrease the deferred financing cost asset and decrease the long term debt liability by $45.2 million and $50.3 million, respectively.
November 1, 2016
Recently issued accounting pronouncements

9

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

Accounting Standards Update ("ASU")
Description
Expected Impact
Effective Date
Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (ASU 2017-07)
This update requires that an employer disaggregate the service cost component from the other components of net periodic benefit cost. In addition, only the service cost component will be eligible for capitalization. The amendment is applied retrospectively with earlier application permitted.

We are assessing the impact to the individual line items to the Statements of Operations. The Company does not expect there to be a material impact to net income.
November 1, 2018
Simplifying the Test for Goodwill Impairment (ASU 2017-04)
This update simplified the subsequent measurement of goodwill by eliminating Step 2 of the goodwill impairment test. Instead, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The amendment also eliminated the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. The amendment is applied prospectively with earlier application permitted.
We do not expect to have a material impact on the Company’s financial statements.
November 1, 2020
Clarifying the Definition of a Business (ASU 2017-01)
This update narrows the definition of outputs and aligns it with how outputs are described in Topic 606. The amendment also provides a more robust framework to use in determining when a set of assets and activities is a business. The amendment is applied prospectively with earlier application permitted.
The impact on the consolidated financial statements from the adoption of this guidance is dependent on future business combinations.

November 1, 2018
Revenue from Contracts with Customers and related standards (ASU's 2014-09, 2016-08, 2016-10, 2016-12, 2016-20)
This update supersedes the existing revenue recognition guidance and provides a new framework for recognizing revenue. These updates identified practical expedients and clarified various aspects of the new revenue recognition standard outlined in Accounting Standards Update 2014-09. This standard may be adopted using either a retrospective or modified retrospective method. Early adoption is permitted.
We are currently in the process of evaluating the impact of this standard. It is still too early in our process to determine the magnitude of the potential impact. However, based on our preliminary assessment, we believe the timing of revenue recognition for commercial and development contracts may differ from our current revenue recognition policies. The Company is determining the magnitude of this potential change. We plan to adopt the standard on November 1, 2018, and we have not yet selected a transition method.
November 1, 2018
From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date or, in some cases where early adoption is permitted, in advance of the specified effective date. The Company has assessed the recently issued standards that are not yet effective and, unless otherwise discussed above or in our audited consolidated financial statements and notes for fiscal 2016, believes these standards will not have a material impact on the Company’s results of operations, cash flows, or financial position. A more detailed listing of recently issued accounting pronouncements are included in our audited consolidated financial statements and notes for fiscal 2016.
3.    BUSINESS COMBINATIONS
The acquisition activity referenced below has been accounted for using the acquisition method of accounting in accordance with ASC Subtopic 805-10, "Business Combinations," and the fair value concepts set forth in ASC Subtopic 820-10, "Fair Value Measurements and Disclosures". The total purchase price for each acquisition was allocated to the assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The allocation of the purchase price is based

10

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

on estimates and assumptions that are subject to change within the measurement period. The excess of the fair values of the assets acquired and liabilities assumed over the consideration transferred was recorded as a bargain purchase gain.
RCI Acquisition
Background
On February 1, 2017, the Company acquired the Roche Carolin, Inc. active pharmaceutical ingredients (API) facility located in Florence, South Carolina ("RCI Acquisition") from Roche Holdings, Inc. (Roche). Through the acquisition, the Company entered into a stock purchase agreement in which Roche provided amounts to satisfy certain capital expenditures and other liabilities of the facility and the Company provided an upfront payment of $1.0 million to acquire the stock of Roche Carolina Inc. (RCI) and approximately $9.3 million to acquire inventory, spare parts, prepaid expense and accounts payable and certain transaction expenses of Roche. The RCI Acquisition is included in the DSS segment.
As part of the transaction, the parties entered into (i) a supply agreement for the production of certain pharmaceutical intermediates by the Company for Roche and (ii) a toll manufacturing agreement where the Company will assume the manufacturing of certain products produced by the facility.
The toll manufacturing agreement has a five-year initial term. During the first four years of the term, Roche is subject to a minimum annual purchasing commitment. The Company will manufacture certain existing Roche products and sell the products back to Roche at fiscal year 2016 standard costs. Annual volumes above the minimum annual commitment will be rolled into the subsequent year. If applicable, Roche will pay true-up payments for amounts below the minimum purchase requirement. A liability from this unfavorable product supply contract has been recognized as deferred revenue in order to reflect this liability at fair value as of the acquisition date.
Purchase Price Allocation
The preliminary purchase price allocation for the RCI Acquisition is as follows:
 
$
Assets
 
Inventories
9.4

Prepaid expenses and other
0.1

Capital assets
155.6

Total assets acquired
165.1

 
 
Liabilities
 
Accounts payable and accrued liabilities
2.0

Deferred revenue
67.0

Deferred tax liabilities
59.4

Total liabilities assumed
128.4

 
 
Total net assets
36.7

Bargain purchase gain
(26.4
)
Total purchase price
10.3

The bargain purchase gain, net of taxes, is reflected in income before taxes in the statements of operations. In late 2015, Roche analyzed strategic alternatives for the facility, including potentially closing or divesting the facility. The cost to close the facility or continue operating an under utilized facility contributed to the bargain purchase gain noted above.
Financial results
The revenues and net income from continuing operations from the RCI Acquisition for the period from February 1, 2017 to April 30, 2017 included in the consolidated statement of operations are as follows:

11

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

 
February 1, 2017 to April 30, 2017
 
$
Revenues
8.1

Net income from continuing operations (1)
25.9

(1) Net income from continuing operations includes the $26.4 million of the bargain purchase gain.
Pro forma financial information
The following unaudited supplemental pro forma information presents the financial results as if the acquisition had occurred on November 1, 2015. The unaudited supplemental pro forma information does not purport to be indicative of what would have occurred had the acquisition been completed on November 1, 2015, nor is it indicative of any future results.
 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Revenues
483.4

 
484.0

 
999.1

 
904.9

Net income from continuing operations
1.2

 
(6.0
)
 
11.4

 
(258.8
)
(1) Net income from continuing operations for the six months ended April 30, 2016 includes $257.8 million of impairment expense related to Roche's strategic realignment of the facility. This is not part of the acquisition transaction and as such is not removed from the pro forma financial information.
The unaudited pro forma financial information was prepared using the acquisition method of accounting and is based on the historical financial information of the Company and RCI, reflecting the Company's and RCI's combined results of operations for the three and six months ended April 30, 2017 and 2016. The historical financial information has been adjusted to give effect to the pro forma events that are (i) directly attributable to the RCI Acquisition, (ii) factually supportable and (iii) expected to have a continuing impact on the combined results of the Company and RCI. The unaudited pro forma consolidated results reflect primarily the following pro forma adjustments:
•
additional revenue related to the amortization of deferred revenue on the unfavorable product supply contract;
•
additional cost of goods sold resulting from increases in depreciation expense relating to the fair values of acquired property and equipment;
•
removal of repositioning costs related to the acquisition; and
•
the effect of the bargain purchase gain
4.    DISCONTINUED OPERATIONS
Banner Pharmacaps
On May 12, 2015, the Company sold its Banner Pharmacaps entity in Mexico, previously included within the DPS and BLS segments, to the Perrigo Company plc for approximately $36.4 million in cash. The Banner Pharmacaps entity in Mexico produced over-the-counter and nutritional products for consumption in Mexico. The Company acquired the entity in fiscal 2012 and subsequent to this acquisition, the Company shifted its business strategy, focusing more on technological innovation and R&D. The Company recognized a gain on sale of $2.6 million, which included adjustments in the second quarter of 2016 primarily related to working capital adjustments.
Biosolutions Operations in Capua, Italy
On July 31, 2015, the Company sold its Biosolutions facility in Capua, Italy, previously included within the Biosolutions segment, for approximately €0.3 million in cash. The sale occurred as a result of a strategic shift in the Company’s long term business strategy. The Company recognized a loss on sale of $24.0 million, which included an adjustment in the second quarter of 2016 for future retention bonuses at the facility.
DPx Fine Chemicals
On August 31, 2015, the Company sold its DPx Fine Chemicals ("DFC") division, which previously comprised the DFC operating segment. DFC was sold for a cash purchase price of €179.0 million, which included a €3.0 million working capital payment made in the first quarter of 2016. The Company recognized a gain on sale of $107.0 million, which included an

12

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

adjustment in the first quarter of 2016 for estimated taxes on the sale. The DPx Fine Chemicals division, which was acquired through the DPP Acquisition, developed chemicals that are not in line with the Company’s long term business strategy.
The results of the above dispositions have been presented as discontinued operations, the results of which for the three and six months ended April 30, 2016 are as follows:
 
Three months ended April 30,
 
Six months ended April 30,
 
2016
 
2016
 
$
 
$
Revenues
—

 
2.1

Cost of goods sold
—

 
1.9

Gross profit
—

 
0.2

Selling, general and administrative expenses
—

 
0.4

Loss on disposals, net
0.9

 
2.8

Operating loss
(0.9
)
 
(3.0
)
Foreign exchange income, net
(0.1
)
 
(0.1
)
Loss before income taxes
(0.8
)
 
(2.9
)
Provision for income taxes
0.2

 
0.2

Net loss
(1.0
)
 
(3.1
)
The Company did not record any discontinued operations activity for the three and six months ended April 30, 2017.
5.    SUPPLEMENTAL BALANCE SHEET INFORMATION
Inventories
Inventories consisted of the following:
 
April 30, 2017
 
October 31, 2016
 
$
 
$
Raw materials, packaging components and spare parts
228.7

 
192.1

Work-in-process
92.3

 
80.9

Finished goods
130.6

 
122.2

Balance, end of period
451.6

 
395.2

Accounts payable and accrued liabilities
Accounts payable and accrued liabilities consisted of the following:
 
April 30, 2017
 
October 31, 2016
 
$
 
$
Trade payables
277.1

 
279.3

Interest payable
9.8

 
14.0

Accrued salaries and related expenses
78.8

 
81.8

Customer deposits
4.1

 
4.3

Repositioning
4.9

 
5.4

Other accruals
7.5

 
8.8

Balance, end of period
382.2

 
393.6

Intangible assets
The following table summarizes gross carrying amounts, accumulated amortization, and accumulated impairments related to the Company's identifiable intangible assets as of April 30, 2017:

13

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

Definite-lived intangible assets
Gross carrying value
 
Accumulated amortization
 
Net carrying value
 
Weighted Average Useful Life (in Years)
 
$
 
$
 
$
 
 
Favorable agreements
1.0

 
(1.0
)
 
—

 
—

Trade names
1.6

 
(0.9
)
 
0.7

 
5.6

Developed technology
54.1

 
(19.4
)
 
34.7

 
10.8

Trade secrets and patents
2.5

 
(0.4
)
 
2.1

 
14.5

Customer relationships
248.8

 
(49.5
)
 
199.3

 
14.2

Non-compete agreements
2.6

 
(2.2
)
 
0.4

 
3.0

Subtotal
310.6

 
(73.4
)
 
237.2

 
 
Foreign exchange
 
 
 
 
(3.3
)
 
 
Balance, end of period
 
 
 
 
233.9

 
 

Indefinite-lived intangible assets
Gross carrying value
 
Accumulated impairment
 
Net carrying value
 
$
 
$
 
$
In-process research and development
2.2

 
(0.9
)
 
1.3

Regulatory permits
0.2

 
—

 
0.2

Subtotal
2.4

 
(0.9
)
 
1.5

Foreign exchange
 
 
 
 
(0.2
)
Balance, end of period
 
 
 
 
1.3

In-process research and development (“IPR&D”) is classified as definite-lived or indefinite-lived depending on whether the product has been approved and if commercialization has begun. IPR&D for products that have been approved is classified as a definite-lived intangible asset and is amortized over the life of the asset. IPR&D for products that have not been approved is classified as an indefinite-lived intangible asset and either begins to be amortized upon approval and product commercialization or is written-off if the product is not approved.
In the first quarter of fiscal 2016, the Company sold an IPR&D asset to Banner Life Sciences for cash consideration equal to its net carrying value of $3.6 million. At the time of the sale, the asset had a gross carrying value of $7.9 million and had incurred $4.3 million in impairments.
Goodwill
The following table summarizes the changes in the carrying amount of goodwill for the six months ended April 30, 2017:
 
Total
 
$
Balance at October 31, 2016 (1)
281.6

Foreign currency translation adjustments
(0.2
)
Balance at April 30, 2017
281.4

(1) The opening cumulative goodwill balance is reflective of historical impairment charges of the full value of goodwill.

6.    LONG-TERM DEBT
Long-term debt in the accompanying consolidated balance sheets at April 30, 2017 and October 31, 2016 consists of the following:

14

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

 
As of April 30, 2017
 
As of October 31, 2016
 
$
 
$
USD Term Loan at LIBOR with a floor of 1% plus 3.25% rate and maturity date of April 20, 2024 (the "Credit Agreement")
1,133.1

 
—

Euro Term Loan at LIBOR with a floor of 1% plus 3.00% rate and maturity date of April 20, 2024 (the "Credit Agreement")
504.5

 
—

USD Term Loan with a base rate plus 2.25% or LIBOR with a floor of 1% plus 3.25% rate and maturity date of March 10, 2021 (the "Credit Agreement")
—

 
1,138.9

Euro Term Loan with a base rate plus 2.50% or LIBOR with a floor of 1% plus 3.50% rate and maturity date of March 10, 2021 (the "Credit Agreement")
—

 
511.0

7.50% Senior Notes due February 1, 2022 (the "Notes")
450.0

 
450.0

Secured Revolving Facility balance at LIBOR plus 3.25% rate and maturity terms on a rolling basis
50.0

 
20.0

Government of Austria research and development loans with annual interest rates ranging from 1.56% to 2.00% and maturities through March 2020
2.7

 
3.5

Italian subsidized loan with annual interest rate of 0.5%, and maturity date of June 30, 2020
3.6

 
4.1

Italian bank loan with Euribor 6-month + 7.1% rate, and maturity date of June 30, 2020
0.7

 
0.7

Capital lease obligations
1.6

 
0.7

Total long-term debt outstanding
2,146.2

 
2,128.9

Less original issue discount, net of accumulated amortization of $7.1 million and $6.2 million, respectively
(12.2
)
 
(9.9
)
Less deferred financing costs
(45.2
)
 
(50.3
)
Less current portion
(19.4
)
 
(19.5
)
Balance, end of the period
2,069.4

 
2,049.2

2017 Term Loans and Revolving Line
On April 20, 2017, the Company completed the refinancing of its term loans and amended the existing revolving credit facility (the "Refinancing'") by entering into Amendment No. 4 of the original credit facility agreement dated as of March 11, 2014 (the "Credit Facility"). Under Amendment No. 4, the existing term loans were refinanced with new term loans ("Tranche B Term Loans"). The Tranche B Term Loans consisted of (i) Tranche B US Dollar Term Loans in the amount of $1.133 billion and (ii) Tranche B Euro Term Loans in the amount of €463.1 million, or $496.3 million. The Tranche B Term Loans will mature on April 20, 2024.
Under Amendment No. 4, the Company increased the size of the revolver facility (the "Revolving Facility") to $250.0 million, of which up to $75.0 million is available for letters of credit. Of the total revolving commitments, $87.1 million will terminate on March 11, 2019 (the "Tranche A Commitments") and the remaining commitments (the "Tranche B Commitments") will terminate on April 20, 2022.
The US Dollar denominated Tranche B Term Loans bear interest at a rate per annum equal to, at the option of the Company, a base rate plus 2.25% or LIBOR with a floor of 1% plus 3.25%. The margin applied to the base rate will be reduced to 2.0% and the margin applied to LIBOR will be reduced to 3.0% if the Company achieves, and as long as the Company maintains, a B2/Stable credit rating or better from Moody's Inventors Service, Inc.
The Euro denominated Tranche B Term Loans bear interest at a rate per annum equal to LIBOR with a floor of 1% plus 3.00%.
Borrowings under the Revolving Facility bear interest at a rate per annum equal to, at the option of the Company, a base rate plus 2.25% or LIBOR plus an applicable margin of 3.25%. The Company will also pay a commitment fee of 0.50% per annum on the unused portion of the Revolving Facility with a step down to 0.375% when the First Lien Leverage Ratio (as defined below) is less than or equal to 3.00 to 1.00.
As of April 30, 2017, the Company borrowed $50.0 million against the Revolving Facility, which will renew until paid.
Under the Revolving Facility, the Company is required to maintain a First Lien Leverage Ratio below a certain amount for each of the Testing Periods as set forth in the Credit Agreement if the Company has borrowed 25% of the available credit on the Revolving Facility, or $62.5 million. For purposes of the Credit Agreement, a Testing Period means a single period consisting of the most recent four consecutive fiscal quarters ending on the covenant determination date. As of April 30, 2017, the

15

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

Company was not required to calculate the First Lien Leverage Ratio as the Company has not borrowed 25% or $62.5 million under the Secured Revolving Facility. The following table discloses the maximum First Lien Leverage Ratios permitted under the Credit Agreement:
Testing Period Ending
Maximum Ratio
April 30, 2014 through October 31, 2014
6.75 to 1.00
November 1, 2014 through October 31, 2015
6.50 to 1.00
November 1, 2015 through October 31, 2016
6.25 to 1.00
November 1, 2016 through October 31, 2017
6.00 to 1.00
November 1, 2017 and thereafter
5.75 to 1.00
"First Lien Leverage Ratio" is generally defined in the Credit Agreement as the ratio of (i) the sum of the aggregate principal amount of the Company's and its restricted subsidiaries' indebtedness for borrowed money, principal amount of capital lease obligations and debt obligations evidenced by bonds, promissory notes, debentures or debt securities that is secured by a first priority lien on the collateral minus unrestricted cash and cash equivalents held by the Company and its restricted subsidiaries in each case set forth in the Credit Agreement to (ii) Consolidated EBITDA. Consolidated EBITDA is generally defined in the Credit Agreement as income (loss) from continuing operations before repositioning expenses, interest expense, foreign exchange losses reclassified from other comprehensive income (loss), refinancing expenses, acquisition-related costs, gains and losses on sale of capital assets, income taxes, asset impairment charges, depreciation and amortization, stock-based compensation expense, consulting costs related to the Company's operational initiatives, purchase accounting adjustments, other income and expenses, non-cash charges, expenses related to the DPP Acquisition, pro forma cost savings from operational excellence initiatives and plant consolidations, pro forma synergies from the DPP Acquisition, and proceeds from business interruption insurance, among other adjustments. Consolidated EBITDA is not equivalent to Adjusted EBITDA, which as discussed in Note 11, is the Company's measure of segment performance.
The Company is required to make the following mandatory prepayments in respect of the Tranche B Term Loans: (i) 50% of Excess Cash Flow (as defined in the Credit Agreement) when the Company maintains a First Lien Leverage Ratio of greater than 4.00 to 1.00, with step downs to (a) 25% when the Company maintains a First Lien Leverage Ratio of less than or equal to 4.00 to 1.00 but greater than 3.50 to 1.00 and (b) 0% when the Company maintains a First Lien Leverage Ratio of less than or equal to 3.50 to 1.00; (ii) 100% of the net cash proceeds of certain asset sales (including insurance and condemnation proceeds), subject to thresholds, reinvestment rights and certain other exceptions; and (iii) 100% of the net cash proceeds of issuances of debt obligations, subject to certain exceptions and thresholds. "Excess Cash Flow" is generally defined as Consolidated EBITDA (as defined in the Credit Agreement) plus, (i) decreases in working capital, (ii) extraordinary or nonrecurring income or gains and (iii) certain other adjustments, minus, (a) increases in working capital, (b) cash interest, (c) cash taxes, (d) cash capital expenditures (e) scheduled debt amortization and (f) certain other adjustments. As the Excess Cash Flow calculation is performed annually, no payment is due for the six months ended April 30, 2017. No Excess Cash Flow payment was required for fiscal 2016. The Company may voluntarily repay borrowings under the Credit Facility at any time.
If the Company has failed to maintain the applicable First Lien Leverage Ratio, it may nevertheless avoid a default by (i) repaying outstanding borrowings under the Revolving Facility in an amount sufficient to avoid triggering the First Lien Leverage Ratio for that fiscal quarter or (ii) accepting a cash contribution of qualified equity in an amount which, if treated as Consolidated EBITDA, would bring the Company into compliance with the applicable First Lien Leverage Ratio for that fiscal quarter, in each case during the 11 business days following the deadline for delivery of the Company’s compliance certificate for that fiscal quarter. In addition, maintenance of the First Lien Leverage Ratio is required only with respect to the Revolving Line; the Term Loans do not directly benefit from the financial covenant and, until the Revolving Line is terminated and all outstanding borrowings thereunder are accelerated, will remain unaffected by a default under the Revolving Line that arises from the Company’s failure to maintain the applicable First Lien Coverage Ratio.
The Credit Agreement contains other customary terms, including (i) representations, warranties and affirmative covenants, (ii) negative covenants (in addition to the limitation on distributions and the requirement to maintain the First Lien Leverage Ratio levels as described above), such as limitations on indebtedness, liens, mergers, acquisitions, asset sales, investments, prepayments of subordinated debt, and transactions with affiliates, in each case subject to baskets, thresholds and other exceptions, and (iii) events of default, such as for non-payment, breach of other covenants, misrepresentations, cross default to other debt, change in control, bankruptcy events, ERISA events, unsatisfied judgments and actual or asserted invalidity of guarantees or security documents.
As of April 30, 2017, the Company was in compliance with the covenants in the Credit Facility.

16

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

Provided that the Company is in compliance with the First Lien Leverage Ratio test and no default under the Credit Agreement is continuing or would result therefrom, the covenant in the Credit Agreement that limits the Company's ability to pay dividends or make other distributions to its shareholders generally permits (with certain exceptions and qualifications) the Company to pay dividends or make such distributions in an aggregate amount, when taken together with the aggregate amount of any prepayment, repurchase, redemption or defeasance of subordinated indebtedness, not to exceed the greater of (x) 3.00% of Consolidated Total Assets and (y) $65.0 million and (ii) in aggregate amount not to exceed the available amount (as defined in the Credit Agreement) at such time.
The Credit Facility is guaranteed by the Company and certain subsidiaries, and is secured by a first priority pledge on substantially all of the assets of the Company and the subsidiary guarantors, in each case subject to certain exceptions.
2014 Senior Unsecured Notes
In February 2014, the Company issued $450.0 million in aggregate principal amount of 7.50% senior unsecured notes due February 1, 2022 (the "Notes") in a private placement, pursuant to which it entered into an indenture (the “Indenture”) with a commercial bank acting as trustee.
Interest on the Notes accrues at a rate of 7.50% per annum and is payable semiannually in arrears on each February 1 and August 1, commencing on August 1, 2014. Interest is computed on the basis of a 360-day year comprised of twelve 30-day months. The Notes are generally required to be guaranteed by each of the Company’s restricted subsidiaries that guarantees the Credit Facility or that guarantees other material indebtedness of the Company or other Note guarantors.
Except for offers to purchase Notes upon certain asset sales or a change in control of the Company, no mandatory redemption or sinking fund payment is required with respect to the Notes.
On and after February 1, 2017, the Company may redeem all or a portion of the Notes at the applicable redemption prices set forth below (expressed as percentages of principal amount redeemed), plus unpaid interest accruing on the principal amount redeemed to the Redemption Date:
Year
%
2017
105.625
2018
103.750
2019
101.875
2020 and thereafter
100.000
In addition, we may redeem all of the Notes at a redemption price equal to the principal amount redeemed, plus unpaid interest accruing to the Redemption Date, upon certain adverse changes in applicable tax laws.
The Notes are guaranteed by the Company and the Indenture does not require the Company to maintain compliance with any financial covenants. The Indenture does contain customary affirmative and negative covenants, including with respect to mergers, asset sales, restricted payments, restricted investments, issuance of debt and equity, liens, and affiliate transactions, subject to baskets and other exceptions. However, the Company will be exempt from many of the negative covenants if the Notes receive investment grade ratings from both Moody’s and S&P. The Indenture also contains customary events of default, such as for non-payment, breach of other covenants, misrepresentation, cross default to other material debt, bankruptcy events, unsatisfied judgments, and actual or asserted invalidity of guarantees.
As of April 30, 2017, the Company was in compliance with the covenants in the Indenture.
Other Financing Arrangements
During the third quarter of fiscal 2013, the Company received assistance from the Italian government in the form of two loans. One loan is a subsidized loan for approximately €6.0 million, of which the Company received €5.4 million during the third quarter of 2013 and the remaining €0.6 million in the second quarter of 2016. The subsidized loan has an annual interest rate of 0.5%, a maturity date of June 30, 2020 and amortizes in fixed semi-annual installments. The second loan is a bank loan of approximately €0.7 million, of which the Company received €0.6 million during the third quarter of 2013 and the remaining €0.1 million in the second quarter of 2016. The bank loan bears interest at a 6-month Euribor rate plus 7.1%, has a maturity date of June 30, 2020 and amortizes in six variable semi-annual installments beginning in December 2017.

17

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

The Company receives research and development loans from the Austrian government. The loans hold various interest rates and have maturity dates through March 31, 2020. The aggregate current balance of these loans as of April 30, 2017 is $2.7 million.
In May 2011, Gallus entered into an agreement with St. Louis County under the county's Chapter 100 program. Under the program, Gallus transferred title of the St. Louis location's buildings and property to St. Louis County in exchange for St. Louis County, Missouri Taxable Industrial Revenue Bonds (Chapter 100 Bonds) of equal value. Gallus then simultaneously leased back the land and facility from St. Louis County. The proceeds of principal and interest on the Chapter 100 Bonds are equal to the lease payment obligations on the Loan. This arrangement was acquired by the Company through the acquisition of Gallus Pharmaceuticals in September 2014.
In August 2015, the agreement with St. Louis County was amended by the Company to extend through December 21, 2029 (originally December 21, 2021), which is consistent with the maturity date of the Chapter 100 Bonds. The Company has determined that it has a legal right of offset for the obligations under the lease agreement with the proceeds receivable from the Chapter 100 Bonds and intends to offset the balance. As a result, the offsetting amounts have not been recorded in the financial statements. The bonds require the Company to maintain a minimum level of employment throughout the term of the loan and an additional investment in the St. Louis facility of at least $47.0 million by December 31, 2019.
In addition to the terms of the bonds indicated above, the Company also entered into an agreement under which it makes "Payments In Lieu Of Taxes" (PILOT) fee payments in lieu of property taxes, which is equal to 50% of the property taxes that would have otherwise been payable on the property. The PILOT fees will increase in years which the Company has not maintained the minimum number of employees as required by the agreement on a prospective basis.
The Company has possessory and equitable title to the property, and at any time can purchase legal title for a nominal fee. In addition, as the holder of the bonds, the Company can waive any default on the lease payments. As the Company retains all benefits of ownership and can take title at any time, at which point the bonds it holds would be redeemed to settle its obligations under the lease agreement, the Company has concluded the land and personal property continue to be assets and are recorded on the consolidated balance sheets.
7.    PENSION AND POST-RETIREMENT BENEFITS
Employee future benefits
The components of net periodic benefit cost from continuing operations for the defined benefit plans and other benefit plans for the three and six months ended April 30, 2017 and 2016 were as follows:
 
Three months ended April 30,
 
2017
 
2016
 
Defined benefit
pension plans
 
Other benefit
plans
 
Defined benefit
pension plans
 
Other benefit
plans
 
$
 
$
 
$
 
$
Service cost
0.6

 
—

 
0.4

 
—

Interest cost
1.0

 
—

 
1.3

 
—

Expected return on plan assets
(1.0
)
 
—

 
(1.2
)
 
—

Amortization of actuarial loss
0.7

 
—

 
0.4

 
—

Net periodic benefit costs
1.3

 
—

 
0.9

 
—

 
Six months ended April 30,
 
2017
 
2016
 
Defined benefit
pension plans
 
Other benefit
plans
 
Defined benefit
pension plans
 
Other benefit
plans
 
$
 
$
 
$
 
$
Service cost
1.2

 
—

 
0.9

 
—

Interest cost
2.0

 
0.1

 
2.6

 
0.1

Expected return on plan assets
(2.0
)
 
—

 
(2.5
)
 
—

Amortization of actuarial loss
1.4

 
—

 
0.8

 
—

Net periodic benefit costs
2.6

 
0.1

 
1.8

 
0.1


18

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

Based on current information available from actuarial estimates, the Company anticipates that contributions required under its defined benefit pension plans and other benefit plans for fiscal 2017 will be approximately $3.9 million compared to contributions of $5.2 million that were made in fiscal 2016. The decrease in the expected fiscal 2017 contributions compared to fiscal 2016 are primarily the result of decreased obligations on a pension plan for the Bourgoin, France facility due to a workforce reduction in fiscal 2016. Required contributions to defined benefit pension plans in future years may vary and will be dependent upon a number of variables, including the long-term rate of return on plan assets.
The Company recognizes a termination liability for the Company's Italy operations. In accordance with Italian severance pay statutes, an employee benefit is accrued for service to date and is payable when the employee's employment with the Company ceases. The termination indemnity liability is calculated in accordance with local civil and labor laws based on each employee's length of service, employment category and remuneration. The Italian termination liability is adjusted annually by a cost-of-living index provided by the Italian government. Although there is no vesting period, the Italian government has established private accounts for these benefits and has required the Company to contribute $3.9 million and $3.4 million in fiscal 2017 and 2016, respectively, to these accounts, with additional contributions in the future. The liability recorded in the consolidated balance sheets is the amount to which the employees would be entitled if their employment with the Company ceased. The related expenses for the three months ended April 30, 2017 and 2016 was $0.9 million and $0.7 million, respectively, and the related expenses for the six months ended April 30, 2017 and 2016 was $1.8 million and $1.4 million, respectively.
The employee future benefit expense recorded in continuing operations in connection with defined benefit pension plans, other post-retirement benefit plans and the unfunded termination indemnities for the three months ended April 30, 2017 and 2016 was $2.2 million and $1.6 million, respectively. For the six months ended April 30, 2017 and 2016, the employee future benefit expense was $4.5 million and $3.3 million, respectively.
8.    EARNINGS (LOSS) PER SHARE
Basic earnings (loss) per ordinary share is computed by dividing net income (loss) available to the Company by the weighted-average number of ordinary shares outstanding during the period. Diluted earnings (loss) per ordinary share is computed by dividing net income (loss) available to the Company by the weighted-average number of ordinary shares outstanding adjusted to give effect to potentially dilutive securities.
The details of the computation of basic and diluted earnings (loss) per ordinary share are as follows:
 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
Numerator (in millions):
 
 
 
 
 
 
 
Income (loss) from continuing operations
$
27.6

 
$
1.9

 
$
55.9

 
$
(18.1
)
Loss from discontinued operations
$
—

 
$
(1.0
)
 
$
—

 
$
(3.1
)
 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted-average number of shares of ordinary shares - basic
145,136,214

 
115,609,756

 
145,132,349

 
115,609,756

Effect of dilutive securities:
 
 
 
 
 
 
 
Restricted stock units
1,092,951

 
—

 
1,116,435

 
—

Stock options
37,963

 
—

 
27,567

 
—

Weighted-average number of shares of ordinary shares - diluted
146,267,128

 
115,609,756

 
146,276,351

 
115,609,756

 
 
 
 
 
 
 
 
Earnings (loss) per ordinary share - basic:
 
 
 
 
 
 
 
From continuing operations
$
0.19

 
$
0.02

 
$
0.39

 
$
(0.16
)
From discontinued operations
$
—

 
$
(0.01
)
 
$
—

 
$
(0.03
)
 
 
 
 
 
 
 
 
Earnings (loss) per ordinary share - diluted:
 
 
 
 
 
 
 
From continuing operations
$
0.19

 
$
0.02

 
$
0.38

 
$
(0.16
)
From discontinued operations
$
—

 
$
(0.01
)
 
$
—

 
$
(0.03
)

19

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)


9.    STOCK BASED COMPENSATION
A summary of equity based compensation expense recognized during the three and six months ended April 30, 2017 and 2016 is as follows:
 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Management Equity Incentive Plan (MEIP)
1.9

 
2.0

 
4.2

 
3.0

Restricted Stock Units
4.0

 
—

 
5.3

 
—

Stock Options
1.1

 
—

 
1.5

 
—

Stock Based Compensation Expense
7.0

 
2.0

 
11.0

 
3.0

Management Equity Incentive Plan (MEIP)
Prior to the IPO, the Company was a wholly-owned indirect subsidiary of the Partnership. The Partnership adopted the Management Equity Incentive Plan, or the MEIP, with an effective date of March 11, 2014. The purpose of the MEIP is to provide eligible participants with an opportunity to receive grants of profit interests in the Partnership designated as management units. The award of management units pursuant to this MEIP is intended to compensate employees of the Partnership and its subsidiaries, including the Company. The participants in the MEIP, as a group, are eligible to participate in the gain on the investment earned by JLL and DSM with respect to Patheon once certain specified distribution or return thresholds have been achieved. Upon issuance, MEIP units were subject to certain forfeiture (vesting) provisions which meant that if a holder's employment with Patheon terminated prior to the satisfaction of the applicable provision, the unvested MEIP units would be forfeited and the vested MEIP units could be converted into Class A Units in the Partnership on a cashless basis or by making an additional cash contribution in order to receive additional Class A Units ("Partnership Shares").
The aggregate number, class and tranche of management units that were issued under the MEIP was determined by the JLL/Delta Patheon GP Ltd., the general partner of the Partnership. The Partnership last issued MEIP units on December 9, 2015. As a result of the IPO and the adoption of the Patheon N.V. 2016 Omnibus Incentive Plan (the “Omnibus Plan”) described below, the Partnership will no longer grant awards under the MEIP to our employees.
The granted MEIP units consist of Class B, Class C, Class D, and Class E units. From June 24, 2014 to December 9, 2015, the Partnership granted units under five different valuation tranches, with each tranche issued at the most recent quarterly valuation of the Company at the time of the grant.
71.4% of the Class B units have a four year service-based component for vesting ("Service-based Class B units") and the remaining Class B units ("Exit Event Class B units") vest if the holder is employed upon the occurrence of an Exit Event. An Exit Event is defined as the earliest to occur of (i) a change of control and (ii) in connection with or following an initial public offering, the sale or disposition by JLL of equity securities such that, immediately following such sale or disposition, JLL and its affiliates either (A) own less than 20% of the equity securities then issued and outstanding, calculated on a fully diluted basis, or (B) have received, in the aggregate, distributions in respect of such sale or distribution (together with any sale or distribution occurring prior thereto) equal to or in excess of 250% of its aggregate capital contributions made in respect of such equity securities prior to such sale or distribution.
Each of the Class C, D, and E units have a performance and service condition related to vesting. These units vest upon the earlier to occur of (i) JLL receiving distributions in the aggregate equal to return on capital thresholds of 2.0x, 2.5x and 3.0x, respectively, or (ii) an Exit Event, as defined above, does not occur prior to the fifth anniversary of an IPO and the return thresholds in (i) are met based on the average price of the Company's publicly traded shares for any twenty day period following the fifth anniversary of an IPO.
If any employee is terminated for any reason prior the achievement of the above vesting conditions, all unvested units in any class are forfeited.
A summary of the MEIP activity for the six months ended April 30, 2017 is as follows:

20

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

 
Class B
Class C
Class D
Class E
Total
 
Weighted Average Fair Value
Outstanding as of October 31, 2016
59,290

8,470

8,470

8,470

84,700

 
$
687.27

Forfeited
(288
)
(50
)
(50
)
(50
)
(438
)
 
$
870.09

Outstanding as of April 30, 2017
59,002

8,420

8,420

8,420

84,262

 
$
686.32

Through the IPO, JLL and DSM received an aggregate return on capital of approximately 2.9x their invested capital, based on the value of ordinary shares of Patheon distributed by the Partnership to JLL and DSM at the IPO price and the value of cash and in-kind distributions made by the Partnership prior to the IPO.
In connection with the IPO, a total of 6,106,540 ordinary shares ("MEIP shares") were distributed to the Partnership to be held for the benefit of the MEIP participants until an Exit Event occurs or until MEIP participants are otherwise permitted to transfer such interests in accordance with the terms of the partnership agreement of the Partnership and respective MEIP unit award agreements, at which time MEIP participants will receive their allocable distribution of MEIP shares. These shares represent the value of the MEIP units, in the aggregate, as determined under the MEIP, as a result of the distribution of ordinary shares to the limited partners of the Partnership in connection with the IPO. MEIP shares were issued to the Partnership with respect to Class B, C and D units for the first three valuation tranches as the applicable distribution threshold was achieved. No MEIP shares were allocated to the Partnership with respect to the final two valuation tranches or the Class E units, as the distribution thresholds and the 3.0x capital return threshold, respectively, were not achieved as of the IPO.
Because no additional MEIP awards will be granted and because the ordinary shares were distributed to JLL and DSM prior to an Exit Event, the MEIP awards will not benefit from further appreciation of those shares. As such, the Company issued a total of 3,388,481 Restricted Share Units ("MEIP RSUs") under the Omnibus Plan in order to provide the MEIP participants with the opportunity to participate in the additional appreciation the MEIP awards could have generated if the Partnership had not distributed ordinary shares of the Company to JLL and DSM. MEIP RSUs were issued in relation to all unit classes and valuation tranches.
The MEIP shares issued with respect to the Class B Units remain subject to the same vesting conditions as the Class B Units. As a result, MEIP shares issued in relation to Service-based Class B units are vested to the extent of each original MEIP grant's four year vesting schedule. The MEIP shares issued in relation to Exit Event Class B units are still subject to the defined Exit Event and are not vested. Lastly, the MEIP shares issued in relation to Class C and D units are fully vested due to their respective return thresholds being achieved through the IPO. The fair value of the MEIP shares are $21.00, the price of the shares at the IPO.
The MEIP RSUs are subject to the same time-based vesting criteria as the original MEIP awards as well as the achievement of performance criteria, which is measured by the Company’s stock price at the earlier to occur of (i) an Exit Event, as defined above, or (ii) the 5-year anniversary of the IPO, at which time all or a percentage of RSUs would settle based upon the attainment of an share price target, with the remaining percentage of RSUs (if any) forfeited. The share price target is $48.47 per share, at which 100% of the RSUs would settle on the applicable vesting date with the share price at or above the target. No RSUs would settle on the vesting date with the share price at or below the IPO price of $21.00, with the settlement amount for a share price between $21.00 and $48.47 calculated on a pro rata basis. The estimated fair value of the MEIP RSUs are $8.41 per unit and was estimated using a Monte Carlo simulation model.
On December 8, 2016, the Company entered into a separation agreement with a senior officer ("Separation Agreement"). The agreement, in part, replaced the senior officer's 196,485 MEIP RSUs with an equal amount of MEIP RSUs with similar terms but with a provision that the MEIP RSUs will vest, and the performance criteria be measured, on December 31, 2017 (the "Separation Date"). The estimated fair value of these replacement MEIP RSUs was $13.87 per unit and was estimated using a Monte Carlo simulation model.
The Monte Carlo simulation model incorporated the following weighted average assumptions:
Risk free interest rate
0.9
%
Expected volatility
41.6
%
Estimated years to exit event
2.98

The Company previously expensed the service-based Class B units using the graded vesting attribution method and is continuing to do so after the allocation of MEIP shares. In addition, the allocation of MEIP shares and MEIP RSUs in respect to

21

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

the MEIP units resulted in an increase in fair value from the value attributed to the service-based Class B units at the time of the IPO, which the Company will expense on a straight line basis over the five year period following the IPO date, which represents the requisite service period of the MEIP RSUs. In total, the Company recorded $1.4 million and $2.9 million of compensation expense for the three and six months ended April 30, 2017, respectively, relating to these units. The Company recorded $2.0 million and 3.0 million of compensation expense for the three and six months ended April 30, 2016, respectively, relating to these units. The total unrecognized compensation expense for the Service-based Class B units is $8.5 million, which is expected to be recognized through fiscal 2021.
For the Exit Event Class B units, the allocation of MEIP shares and MEIP RSUs resulted in an increased fair value which will serve as the basis for recognizing compensation expense for these units. The fair value of the MEIP RSUs will be expensed on a straight line basis over five years, starting with the IPO date. The Company recognized $0.2 million and $0.4 million of compensation expense for the three and six months ended April 30, 2017, respectively. The fair value of the MEIP shares issued in respect of the Exit Event Class B units will remain unrecognized until an Exit Event occurs. The total unrecognized compensation expense for the MEIP shares and MEIP RSUs issued in respect of the Exit Event Class B units is $31.9 million, of which $3.4 million is expected to be recognized through fiscal 2021 and the remaining amount expensed on the occurrence of an Exit Event.
In the third quarter of fiscal 2016, the Company recorded two one time compensation expenses in relation to the allocation of MEIP shares and MEIP RSUs in respect of the C, D and E units. A $9.0 million expense was recorded to account for the fair value of MEIP units that fully vested as a result of their respective return thresholds being met through the IPO. Additionally, a $1.5 million expense was recorded to account for the unvested MEIP units that were allocated MEIP RSUs, in which requisite service requirements had already been partially met at the time of the IPO. The Company reversed $0.1 million of these expenses in the second quarter of fiscal 2017 due to the Separation Agreement.
In addition, the Company recognized $0.4 million and $1.0 million of compensation expense for the three and six months ended April 30, 2017, respectively, to account for the remaining fair value of the C, D and E MEIP units and the incremental fair value that resulted from the conversion to MEIP shares and MEIP RSUs. These amounts are inclusive of $0.2 million reversed relating to the senior officer's awards that were replaced in the Separation Agreement. The compensation expense will be recorded on a straight line basis over five years. The total unrecognized compensation expense for the C, D, and E units is $8.9 million, which will be recognized through fiscal 2021.
As a result of the Separation Agreement, the Company recorded $1.0 million of additional expense in the second quarter of fiscal 2017, not including a total of $0.3 million in expense reversals, as outlined above. The total unrecognized compensation expense for the replacement awards is $1.7 million, which will be recognized through the Separation Date.
Patheon N.V. 2016 Omnibus Incentive Plan
In July 2016, the Company adopted the Omnibus Plan in order to align the long-term financial interests of selected participants with those of our shareholders, strengthen the commitment of such persons to the Company and our affiliates, and attract and retain competent and dedicated persons whose efforts will result in our long-term growth and profitability. The Omnibus Plan provides for the issuance of options, share appreciation rights, restricted shares, restricted shares units, share bonuses, other share-based awards and cash awards to selected officers, employers, non-employee directors and consultants.
Restricted Stock Units
As of April 30, 2017, the Company has a total of (i) 1,366,383 restricted stock units outstanding to certain members of management and (ii) 41,635 restricted stock units to non-employee directors (collectively, the "Standard RSUs"), excluding the MEIP RSUs outlined above. The Standard RSUs granted to management vest in equal installments over three years and Standard RSUs granted to non-employee directors vest over one year or at the conclusion of the director's service to the Company. The Standard RSUs are not subject to performance based criteria and have a weighted average fair value of $24.79.
In the six months ended April 30, 2017, the Company issued 70,700 ordinary shares for vested restricted stock units. To satisfy certain tax withholding requirements, the Company purchased 8,528 of these shares at a weighted average vesting date fair value of $27.15. These shares are currently being held at cost as treasury shares on the balance sheet.
During the three and six months ended April 30, 2017, $3.0 million and $4.3 million of stock compensation expense was recognized in relation to the Standard RSUs. As of April 30, 2017, unrecognized stock compensation expense related to Standard RSUs was $29.5 million, which will be recognized through fiscal 2020.
A summary of Standard RSUs activity for the six months ended April 30, 2017 is as follows:

22

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

 
Restricted Share Units
Weighted Average Grant Date Fair Value
 
 
$
Outstanding as of October 31, 2016
450,184

21.00

Granted
1,028,534

26.46

Vested
(70,700
)
21.00

Outstanding as of April 30, 2017
1,408,018

24.79

As of April 30, 2017, no Standard RSUs have been forfeited.
Stock Options
As of April 30, 2017, the Company has granted 1,747,750 stock options to certain members of management. The stock options were granted with a weighted average exercise price of $23.28 per share, with 1,033,465 of the granted stock options ("Regular Options") vesting equally over three years. The remaining stock options ("EBITDA Options") were granted to a senior officer and vest based on performance based criteria, using Credit Agreement Adjusted EBITDA as the performance metric. Credit Agreement Adjusted EBITDA is defined as the Company's Adjusted EBITDA, as defined in Note 11, plus pro forma cost savings, synergies and pre-acquisition results.
The estimated weighted average fair value of stock options is $9.08 per option and was estimated using a Black-Scholes valuation model, using the following weighted average assumptions:
Risk free interest rate
1.6
%
Expected volatility
38.1
%
Expected life of options (in years)
6.0

Dividend yield
—
%
During the three and six months ended April 30, 2017, $0.8 million and $1.2 million of stock compensation expense was recognized in relation to stock options. In the second quarter of fiscal 2017, $0.3 million of stock compensation expense was recognized for the EBITDA Options, due to a portion of the performance based criteria deemed probable as of April 30, 2017. As of April 30, 2017, total unrecognized compensation expense related to unvested Regular Options was $8.1 million, which is expected to be recognized through fiscal 2020, and total unrecognized compensation expense for the unvested EBITDA Options was $5.6 million, which will be recognized over the requisite service period when the performance based criteria is deemed probable to occur.
A summary of stock option activity for the six months ended April 30, 2017 is as follows:
 
Stock Options
Weighted Average Fair Value
 
 
$
Outstanding as of October 31, 2016
1,021,584

8.29

Granted
726,166

10.18

Outstanding as of April 30, 2017
1,747,750

9.08

As of April 30, 2017, no stock options have been forfeited or exercised.
10.    FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT
The Company has determined the estimated fair values of its financial instruments based on appropriate valuation methodologies; however, considerable judgment is required to develop these estimates. The fair values of the Company's financial instruments are not materially different from their carrying values.
Fair value measurements

23

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

The Company classifies and discloses its fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy has the following levels: (a) quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1); (b) inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices) (Level 2); and (c) inputs for the asset or liability that are not based on observable market data (unobservable inputs) (Level 3).
The fair value is principally applied to financial assets and liabilities such as derivative instruments consisting of foreign exchange forward contracts, available-for-sale securities relating to Republic of Austria bonds, held-for-trading securities relating to the Company's U.S. deferred compensation plan, and a liability relating to an earnout payment on future Biologics operating results. The following table provides a summary of the financial assets and liabilities that are measured at fair value as of April 30, 2017 and October 31, 2016:
 
Fair value measurement at April 30, 2017
 
Fair value measurement at October 31, 2016
Assets measured at fair value
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
 
$
 
$
Available-for-sale securities
1.4

 
—

 
—

 
1.4

 
1.4

 
—

 
—

 
1.4

Held-for-trading securities
—

 
1.5

 
—

 
1.5

 
—

 
1.4

 
—

 
1.4

Total assets
1.4

 
1.5

 
—

 
2.9

 
1.4

 
1.4

 
—

 
2.8

 
Fair value measurement at April 30, 2017
 
Fair value measurement at October 31, 2016
Liabilities measured at fair value
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
 
$
 
$
Foreign exchange forward contracts
—

 
1.8

 
—

 
1.8

 
—

 
2.7

 
—

 
2.7

Earnout liability
—

 
—

 
37.9

 
37.9

 
—

 
—

 
33.8

 
33.8

Total liabilities
—

 
1.8

 
37.9

 
39.7

 
—

 
2.7

 
33.8

 
36.5

Level 1 - Based on quoted market prices in active markets.
Level 2 - Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.
Level 3 - Unobservable inputs that are not corroborated by market data.
The following table presents the fair value of the Company's financial instruments and their classifications on the consolidated balance sheets as of April 30, 2017 and October 31, 2016:
 
Assets as of April 30, 2017
 
Assets as of October 31, 2016
 
Balance sheet location
Fair value
 
Balance sheet location
Fair value
 
 
$
 
 
$
Available-for-sale securities
Investments
1.4

 
Investments
1.4

Held-for-trade securities
Investments
1.5

 
Investments
1.4

Total
 
2.9

 
 
2.8

 
Liabilities as of April 30, 2017
 
Liabilities as of October 31, 2016
 
Balance sheet location
Fair value
 
Balance sheet location
Fair value
 
 
$
 
 
$
Foreign exchange forward contracts
Accounts payable and accrued liabilities
1.8

 
Accounts payable and accrued liabilities
2.7

Earnout liability
Other long-term liabilities
37.9

 
Other long-term liabilities
33.8

Total
 
39.7

 
 
36.5

The Company has the option to net settle its derivatives with the counter party under the terms of its contracts and as such any unrealized positions are recorded net. As of April 30, 2017, the Company had gross unrealized losses of $2.0 million and gross unrealized gains of $0.2 million under its derivative contracts. As of October 31, 2016, the Company had gross unrealized losses of $2.7 million and gross unrealized gains of less than $0.1 million under its derivative contracts.

24

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

Long-term obligations
As of April 30, 2017, the fair values and carrying values of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:
 
Fair Value
 
 
 
Level 1
Level 2
Level 3
Total
 
Carrying Value
 
$
$
$
$
 
$
Long-term debt, including current portion
—

2,179.3

—

2,179.3

 
2,134.0

As of October 31, 2016, the fair values and carrying values of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:
 
Fair Value
 
 
 
Level 1
Level 2
Level 3
Total
 
Carrying Value
 
$
$
$
$
 
$
Long-term debt, including current portion
—

2,156.8

—

2,156.8

 
2,119.0

The fair value of the Company's long-term debt, including the current portion of long-term debt, is based on the quoted market prices for the same issues or on the current rates offered for debt of similar remaining maturities.
Foreign exchange forward contracts and other arrangements
The Company utilizes financial instruments to manage the risk associated with fluctuations in foreign exchange and interest rates. The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk management objective and strategy for undertaking various hedge transactions.
As of April 30, 2017, the Company's Canadian operations had entered into foreign exchange forward contracts to sell a net aggregate amount of $64.0 million U.S. dollars. These contracts hedge the Canadian operations expected exposure to U.S. dollar denominated receivables and mature at the latest on March 15, 2018, at an average exchange rate of $1.3254 Canadian dollars per U.S. dollar. The mark-to-market value of these financial instruments as of April 30, 2017 was a net unrealized loss of $1.8 million, which has been recorded in accumulated other comprehensive income in shareholders' deficit, net of associated income tax.
The Company acquired a portion of its Biologics business from DSM ("the DPP acquisition") in March 2014. In connection with the DPP acquisition, DSM was entitled to receive certain additional future contingent payments based on the performance of the acquired biologics business (the "earnout"). Under the terms of the original contribution agreement, the earnout only related to the DSM biologics business acquired in March 2014 and the earnout liability was payable by the Partnership, the parent of the Company before the Company's IPO on July 21, 2016. The value of the earnout liability as of January 29, 2016 was $36.0 million.
On January 29, 2016, the Company, the Partnership, JLL, and DSM entered into an agreement (the "Earnout Agreement") whereby the Partnership’s earnout liability was legally assigned to the Company. The assignment of the liability from the Partnership to the Company was deemed a capital transaction with the Partnership of $36.0 million.
Concurrently, the calculation of the earnout consideration was revised to include the future earnings of the Company’s entire biologics business ("Biologics Adjusted EBITDA"), which includes biologics business acquired in connection with a September 2014 acquisition of Gallus Pharmaceuticals. As a result of executing this Earnout Agreement, the Company will pay additional consideration to DSM based on the achievement of certain Biologics Adjusted EBITDA targets, as defined in the Earnout Agreement, of the Company’s biologics business at the conclusion of the 2020 fiscal year. If the Company sells or disposes of the biologics business prior to the end of the 2020 fiscal year, Biologics Adjusted EBITDA will be calculated by applying a 10% compounded annual growth rate through the remaining period ending October 31, 2020 to the Biologics Adjusted EBITDA for the twelve-month period ended on the last day of the month immediately preceding the date of such sale or disposition. The Company's maximum and minimum payments to DSM under the terms of the Earnout Agreement is $60.0 million and $25.0 million, respectively. Using the revised earnout definition, the value of the earnout liability as of January 31, 2016 was $31.1 million and resulted in the Company recognizing income of $4.9 million in the first quarter of fiscal 2016.
The Company estimated the value of the earnout by valuing the three payout tranches. The first tranche of the $25.0 million minimum earnout payment, which is not contingent to Biologics Adjusted EBITDA performance, was estimated by discounting

25

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

the $25.0 million using cost of debt of the Company. The values of the remaining two tranches, (i) an additional $25.0 million earnout payment which will be realized gradually as Biologics Adjusted EBITDA reaches $98.0 million, and (ii) an additional $10.0 million earnout payment which will be achieved gradually as Biologics Adjusted EBITDA approaches $110.0 million, were estimated using an option pricing framework, where the Company used a modified Black-Scholes model.
The Company adjusted the earnout value to its estimated fair value as of April 30, 2017 to $37.9 million. The Company recorded $0.5 million and $4.1 million of expense in the three and six months ended April 30, 2017, respectively, relating to marking the liability to its estimated fair value. The Company recorded $1.2 million of expense and $3.7 million of income in the three and six months ended April 30, 2016, respectively, relating to marking the liability to its estimated fair value. The April 30, 2017 earnout valuation applies an asset volatility of 30% and an asset beta of 0.9. A 1% change in asset volatility would have an impact on the value of +/- $0.3 million while a 0.1 change in beta would have an impact on the value of +/- $0.3 million. Assumptions are Level 3 in nature.
The earnout liability activity is summarized as follows for the six months ended April 30, 2017:
 
Total
 
$
Balance at October 31, 2016
33.8

Change in fair value
4.1

Balance at April 30, 2017
37.9

The change in fair value relating to the earnout is recorded in other operating income on the consolidated statements of operations.
Risks arising from financial instruments and risk management
The Company's activities expose it to a variety of financial risks: market risk (including foreign exchange and interest rate), credit risk and liquidity risk. The Company's overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the Company's financial performance. The Company uses derivative financial instruments to hedge certain risk exposures. The Company does not purchase any derivative financial instruments for speculative purposes.
Financial risk management is the responsibility of the Company's corporate treasury. The corporate treasury works with the Company's operational personnel to identify, evaluate and, where appropriate, hedge financial risks. The Company's corporate treasury also monitors material risks and discusses them with the Audit Committee of the Board of Directors.
Foreign exchange risk
As of April 30, 2017, the Company operated in Canada, the United States, Italy, France, the United Kingdom, The Netherlands, Australia, Germany, Austria, and Japan. Foreign exchange risk arises because the value of the local currency receivable or payable for transactions denominated in foreign currencies may vary due to changes in exchange rates ("transaction exposures") and because the non-U.S. dollar denominated financial statements of the Company may vary on consolidation into the reporting currency of U.S. dollars ("translation exposures").
The Company's most significant transaction exposure is from its Canadian operations. Approximately 90% of the cash receipts and 15% of the cash outflows relating to Canadian operations are transacted in U.S. dollars. As a result, the Company may experience transaction exposures because of volatility in the exchange rate between the Canadian and U.S. dollar. Based on the Company's current U.S. denominated net inflows, as of April 30, 2017, fluctuations of +/- 10% would, everything else being equal, have an effect on year to date income before income taxes of approximately +/- $5.8 million, prior to hedging activities.
The objective of the Company's foreign exchange risk management activities is to minimize transaction exposures and the resulting volatility of the Company's earnings. The Company manages this risk by entering into foreign exchange contracts. As of April 30, 2017, the Company has entered into foreign exchange contracts to cover approximately 68% of its Canadian-U.S. dollar cash flow exposures for the next twelve months.
The amount of the Company's Euro denominated debt designated as a hedge against its net investment in its subsidiaries in Austria, The Netherlands, Germany, France and Italy, is €463.1 million as of April 30, 2017. This hedge was originally designated in March 2014 as a part of the Company's acquisition of manufacturing sites from DSM and is re-designated on a quarterly basis. As of April 30, 2017, the balance of the net investment hedge was $74.7 million and is included in accumulated

26

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

other comprehensive income in shareholders' deficit. Any unrealized exchange losses are included in the consolidated statement of operations due to ineffectiveness.
The following table summarizes the net investment hedge foreign exchange activity for the three and six months ended April 30, 2017 and 2016 since net investment hedge inception:
 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Foreign exchange (loss) gain for the period from net investment hedge
(4.6
)
 
(29.0
)
 
4.0

 
(21.0
)
Release of ineffective portion of net investment hedge to consolidated statement of operations
—

 
3.3

 
—

 
2.2

Net (loss) gain to other comprehensive income for the period related to net investment hedge
(4.6
)
 
(25.7
)
 
4.0

 
(18.8
)
Translation gains and losses related to certain foreign currency denominated intercompany loans are included as part of the net investment in certain foreign subsidiaries, and are included in accumulated other comprehensive income in shareholders' deficit.
The following table summarizes the foreign currency activity on the intercompany loans that are included as part of the net investment in certain foreign subsidiaries for the three and six months ended April 30, 2017 and 2016 since net investment hedge inception:
 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Foreign exchange gain for the period from long-term intercompany loan revaluation
—

 
3.8

 
—

 
3.0

Credit risk
Credit risk arises from cash and cash equivalents held with banks and financial institutions, derivative financial instruments (foreign exchange contracts with positive fair values), and credit exposure to customers, including outstanding accounts receivable. The maximum exposure to credit risk is equal to the carrying value of the financial assets.
The objective of managing counterparty credit risk is to prevent losses in financial assets. The Company regularly assesses the credit quality of the counterparties, taking into account their financial position, past experience and other factors. Management also regularly monitors the utilization of credit limits. In cases where the credit quality of a customer does not meet the Company's requirements, a cash deposit is received before any services are provided. As of April 30, 2017 and October 31, 2016, the Company held deposits of $4.1 million and $4.3 million, respectively.
Liquidity risk
Liquidity risk arises when financial obligations exceed financial assets available at a particular point in time. The Company's objective in managing liquidity risk is to maintain sufficient readily available reserves in order to meet its liquidity requirements at all times. The Company mitigates liquidity risk by maintaining cash and cash equivalents on-hand and through the availability of funding from credit facilities. As of April 30, 2017, the Company was holding cash and cash equivalents of $92.7 million and had undrawn lines of credit available to it of $209.3 million.
11.    SEGMENT INFORMATION
The Company’s four operating segments are: North America DPS, Europe DPS, PDS and DSS. The North America DPS and Europe DPS operating segments meet the aggregation criteria to be presented as one DPS reportable segment. As a result, the Company has three reportable segments: DPS, PDS and DSS. Costs relating to Corporate operations are classified as Other.
The DPS segment includes commercial manufacturing outsourcing services, the PDS segment includes pharmaceutical development services, and the DSS segment includes active pharmaceutical ingredients and pharmaceutical intermediates. Corporate expenses primarily relate to general, administrative and sales and marketing expenses related to the corporate

27

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

organization. These expenses are centrally directed and controlled and are not included in internal measures of segment operating performance. The CODM does not evaluate its operating segments using discrete asset information.
 
Three months ended April 30, 2017
 
DPS
 
PDS
 
DSS
 
Other
 
Intersegment Eliminations
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
Revenues
297.2

 
57.8

 
129.2

 
—

 
(0.8
)
 
483.4

Adjusted EBITDA
77.4

 
18.4

 
26.1

 
(27.5
)
 
(0.2
)
 
94.2

Depreciation and amortization
15.4

 
1.9

 
16.1

 
0.9

 
 
 
34.3

Capital expenditures
19.5

 
1.7

 
11.6

 
7.4

 
 
 
40.2


 
Three months ended April 30, 2016
 
DPS
 
PDS
 
DSS
 
Other
 
Intersegment Eliminations
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
Revenues
287.4

 
53.4

 
127.9

 
—

 
(0.1
)
 
468.6

Adjusted EBITDA
72.7

 
16.7

 
30.8

 
(22.2
)
 
 
 
98.0

Depreciation and amortization
14.9

 
1.3

 
10.2

 
0.6

 
 
 
27.0

Capital expenditures
11.7

 
5.9

 
9.0

 
4.3

 
 
 
30.9


 
Six months ended April 30, 2017
 
DPS
 
PDS
 
DSS
 
Other
 
Intersegment Eliminations
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
Revenues
572.4

 
110.1

 
259.1

 
—

 
(0.8
)
 
940.8

Adjusted EBITDA
138.8

 
34.7

 
58.1

 
(54.7
)
 
(0.2
)
 
176.7

Depreciation and amortization
30.7

 
3.7

 
25.8

 
1.7

 
 
 
61.9

Capital expenditures
56.4

 
3.1

 
29.5

 
10.2

 
 
 
99.2


 
Six months ended April 30, 2016
 
DPS
 
PDS
 
DSS
 
Other
 
Intersegment Eliminations
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
Revenues
545.9

 
101.9

 
226.8

 
—

 
(0.1
)
 
874.5

Adjusted EBITDA
127.8

 
30.5

 
45.6

 
(46.9
)
 
 
 
157.0

Depreciation and amortization
29.7

 
2.5

 
20.1

 
1.2

 
 
 
53.5

Capital expenditures
56.7

 
15.6

 
16.3

 
6.5

 
 
 
95.1

The Company evaluates the performance of its segments based on segment Adjusted EBITDA. The Company's Adjusted EBITDA is income (loss) from continuing operations before repositioning expenses (including certain product returns and
inventory write-offs recorded in gross profit), interest expense, foreign exchange losses reclassified from other comprehensive income (loss), refinancing expenses, acquisition and integration costs (including certain product returns and inventory write-offs recorded in gross profit), gains and losses on sale of capital assets, Biologics earnout income and expense, income taxes, impairment charges, remediation costs, depreciation and amortization, stock-based compensation expense, consulting costs related to our operational initiatives, purchase accounting adjustments, acquisition-related litigation expenses and other income and expenses. Adjusted EBITDA is one of several metrics used to measure segment operating performance and is also used to determine executive compensation. "Adjusted EBITDA margin" is Adjusted EBITDA as a percentage of revenues. The Company's presentation of Adjusted EBITDA may not be comparable to similarly-titled measures used by other companies and is not equivalent to "Consolidated EBITDA" as defined in the Credit Agreement (as discussed in Note 5).
Below is a reconciliation of Adjusted EBITDA to its most comparable U.S. GAAP measure.

28

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Total Adjusted EBITDA
94.2

 
98.0

 
176.7

 
157.0

Depreciation and amortization
(34.3
)
 
(27.0
)
 
(61.9
)
 
(53.5
)
Repositioning expenses (1)
(2.2
)
 
(1.3
)
 
(3.5
)
 
(2.5
)
Acquisition and integration costs
(8.1
)
 
(7.6
)
 
(11.6
)
 
(10.2
)
Interest expense, net
(30.8
)
 
(42.6
)
 
(59.0
)
 
(86.4
)
Benefit from (provision for) income taxes
1.5

 
(0.7
)
 
22.8

 
—

Refinancing expenses
(6.3
)
 
—

 
(6.3
)
 
—

Operational initiatives related consulting costs
(1.4
)
 
(1.9
)
 
(2.5
)
 
(3.3
)
IPO costs
—

 
(0.4
)
 
—

 
(0.8
)
Acquisition related litigation expenses
(3.7
)
 
(0.9
)
 
(6.0
)
 
(1.9
)
Stock based compensation expense
(7.0
)
 
(2.0
)
 
(11.0
)
 
(3.0
)
FDA remediation costs
—

 
(10.1
)
 
—

 
(18.5
)
Environmental remediation costs
—

 
—

 
(3.7
)
 
—

Bargain purchase gain
26.4

 
—

 
26.4

 
—

Other
(0.7
)
 
(1.6
)
 
(4.5
)
 
5.0

Net income (loss) from continuing operations
27.6

 
1.9

 
55.9

 
(18.1
)
(1) Repositioning expenses for the three and six months ended April 30, 2017 includes $0.4 million and $1.1 million of inventory reserves related to the Swindon wind down recorded in cost of goods sold.
As illustrated in the table below, revenues are attributed to countries based on the location of the customer's billing address, capital assets are attributed to the country in which they are located and goodwill is attributed to the country in which the entity to which the goodwill pertains is located:
 
Three months ended April 30, 2017
 
Canada
 
US*
 
Europe
 
Other**
 
Total
 
$
 
$
 
$
 
$
 
$
Revenues
4.2

 
282.8

 
167.9

 
28.5

 
483.4

* Includes Puerto Rico
** Primarily includes Japan
 
Three months ended April 30, 2016
 
Canada
 
US*
 
Europe
 
Other**
 
Total
 
$
 
$
 
$
 
$
 
$
Revenues
5.1

 
317.6

 
124.8

 
21.1

 
468.6

* Includes Puerto Rico
** Primarily includes Japan
 
As of and for the six months ended April 30, 2017
 
Canada
 
US*
 
Europe
 
Other**
 
Total
 
$
 
$
 
$
 
$
 
$
Revenues
11.2

 
564.7

 
320.7

 
44.2

 
940.8

Capital Assets
100.1

 
687.6

 
367.5

 
14.1

 
1,169.3

Goodwill
2.5

 
269.4

 
7.4

 
2.1

 
281.4

* Includes Puerto Rico
** Other revenues primarily include Japan

29

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

 
As of and for the six months ended April 30, 2016
 
Canada
 
US*
 
Europe
 
Other**
 
Total
 
$
 
$
 
$
 
$
 
$
Revenues
12.4

 
589.4

 
236.7

 
36.0

 
874.5

Capital Assets
100.8

 
487.3

 
341.6

 
16.1

 
945.8

Goodwill
2.8

 
269.4

 
7.7

 
2.2

 
282.1

* Includes Puerto Rico
** Other revenues primarily include Japan
12.    REPOSITIONING EXPENSES
During the three and six months ended April 30, 2017, the Company incurred $1.8 million and $2.4 million in repositioning expenses, respectively, primarily from severance payments resulting from operational initiatives. In addition, the Company recorded inventory reserves of $0.4 million and $1.1 million for the three and six months ended April 30, 2017 relating to raw material and work in process inventory associated with the final phase of the winding down of the older section of the Swindon facility ("Swindon wind down") to allow us to re-purpose that area, which was expensed through cost of goods sold.
During the three and six months ended April 30, 2016, the Company incurred $1.3 million and $2.5 million in repositioning expenses, primarily from severance payments resulting from a realignment of DPS operations.
The following is a summary of these expenses and other charges associated with operational improvements as of and for the three and six months ended April 30, 2017 and 2016:
 
As of and for the three months ended April 30, 2017
 
DPS
 
PDS
 
DSS
 
Other
 
Total
 
$
 
$
 
$
 
$
 
$
Total repositioning liability at January 31, 2017
 
 
 
 
 
 
 
 
4.6

Employee-related expenses
1.7

 
—

 
—

 
0.1

 
1.8

Repositioning expenses paid
 
 
 
 
 
 
 
 
(1.6
)
Foreign exchange
 
 
 
 
 
 
 
 
0.1

Total repositioning liability at April 30, 2017
 
 
 
 
 
 
 
 
4.9

 
As of and for the three months ended April 30, 2016
 
DPS
 
PDS
 
DSS
 
Other
 
Total
 
$
 
$
 
$
 
$
 
$
Total repositioning liability at January 31, 2016
 
 
 
 
 
 
 
 
4.9

Employee-related expenses
1.6

 
—

 
—

 
—

 
1.6

Consulting, professional and project management costs
(0.3
)
 
—

 
—

 
—

 
(0.3
)
Total expenses
1.3

 
—

 
—

 
—

 
1.3

Repositioning expenses paid
 
 
 
 
 
 
 
 
(3.1
)
Foreign exchange
 
 
 
 
 
 
 
 
0.3

Total repositioning liability at April 30, 2016
 
 
 
 
 
 
 
 
3.4

 
As of and for the six months ended April 30, 2017
 
DPS
 
PDS
 
DSS
 
Other
 
Total
 
$
 
$
 
$
 
$
 
$
Total repositioning liability at October 31, 2016
 
 
 
 
 
 
 
 
5.4

Employee-related expenses
1.9

 
—

 
—

 
0.5

 
2.4

Repositioning expenses paid
 
 
 
 
 
 
 
 
(3.1
)
Foreign exchange
 
 
 
 
 
 
 
 
0.2

Total repositioning liability at April 30, 2017
 
 
 
 
 
 
 
 
4.9


30

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

The balance of repositioning liabilities as of April 30, 2017 was recorded in accounts payable and accrued liabilities on the consolidated balance sheet. The Company does not have any long-term repositioning liabilities as of April 30, 2017.
 
As of and for the six months ended April 30, 2016
 
DPS
 
PDS
 
DSS
 
Other
 
Total
 
$
 
$
 
$
 
$
 
$
Total repositioning liability at October 31, 2015
 
 
 
 
 
 
 
 
22.9

Employee-related expenses
2.8

 
—

 
—

 
—

 
2.8

Consulting, professional and project management costs
(0.3
)
 
—

 
—

 
—

 
(0.3
)
Total expenses
2.5

 
—

 
—

 
—

 
2.5

Repositioning expenses paid
 
 
 
 
 
 
 
 
(21.8
)
Foreign exchange
 
 
 
 
 
 
 
 
(0.2
)
Total repositioning liability at April 30, 2016
 
 
 
 
 
 
 
 
3.4

The balance of repositioning liabilities as of April 30, 2016 was recorded in accounts payable and accrued liabilities on the consolidated balance sheet. The Company does not have any long-term repositioning liabilities as of April 30, 2016.
13.    RELATED PARTIES
Related Party Transactions
JLL Partners
The Company has a service agreement with JLL Partners Inc. and some JLL Partners affiliates whereby the Company will reimburse the parties for management, consulting, financial, and other business services provided under the agreement. The amounts spent on these services, as well as the amounts payable outstanding in relation to these services, are shown in the tables below.
DSM
The Company has transition service agreements ("TSAs") with DSM resulting from the DPP Acquisition whereby DSM performs certain shared service functions on behalf of the Company. Additionally, the Company performs certain services on behalf of DSM. The revenue and expenses relating to these services, as well as the accounts receivable and payable outstanding in relation to these services, are shown in the tables below.
BLS
The Company has a management service agreement with BLS whereby the Company will provide various management, financial, legal and other business services to BLS. The expenses relating to these services are charged to BLS and the related accounts receivable outstanding in relation to these services are shown in the tables below. We performed production services for BLS in the first quarter of fiscal 2016 before BLS sold their commercial business to a third party.

 
Three months ended April 30,
 
Six months ended April 30,
Revenues/Expenses
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
JLL Partners Expenses
0.1

 
0.1

 
0.1

 
0.2

 
 
 
 
 
 
 
 
DSM Revenues
0.1

 
0.8

 
0.3

 
0.9

DSM Expenses
1.9

 
2.5

 
5.1

 
5.2

 
 
 
 
 
 
 
 
Banner Life Sciences Revenues
0.7

 
1.4

 
0.7

 
7.9


31

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

 
Balances as of
Accounts Receivable/Payable Balances
April 30, 2017
 
October 31, 2016
 
$
 
$
JLL Partners Accounts Payable
0.1

 
—

 
 
 
 
DSM Accounts Receivable
0.1

 
0.4

DSM Accounts Payable
1.7

 
0.2

 
 
 
 
Banner Life Sciences Accounts Receivable
1.2

 
1.1

Equity Method Investments
Banner Life Sciences
In October 2015, the Company invested $5.0 million in Banner Life Sciences. The investment resulted in Banner Life Sciences becoming a variable interest entity, but the entity is not consolidated as the Company does not have the ability to control the entity and therefore does not have the power to direct Banner Life Sciences' activities. The Company's maximum exposure to loss relating to this variable interest entity is limited to the carrying value of the investment. The investment is presented within investments in the consolidated balance sheets. In March 2016, the Company received a $2.4 million cash distribution from Banner Life Sciences.
Percivia
The Company holds a 50.0% interest in Percivia, a limited liability company for the purpose of performing research and development activities and licensing certain technology. In February 2016, the Company received a $1.2 million return of capital from Percivia in the form of a cash distribution.
Chemiepark
The Company holds a 47.5% interest in Chemiepark, a company tasked with providing fire protection for the chemicals site in Linz, Austria.
 
Values as of
Equity Method Investment Values
April 30, 2017
 
October 31, 2016
 
$
 
$
Banner Life Sciences
2.5

 
2.9

Percivia
5.7

 
5.7

Chemiepark
0.1

 
0.1

Total
8.3

 
8.7

Investment carrying values are presented within investments in the consolidated balance sheets.
 
Three months ended April 30,
 
Six months ended April 30,
Equity Method (Loss)/Gain
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Banner Life Sciences
(0.2
)
 
(0.5
)
 
(0.3
)
 
1.3

Percivia
—

 
0.1

 
—

 
0.2

Total
(0.2
)
 
(0.4
)
 
(0.3
)
 
1.5

Equity method earnings are presented within other income in the consolidated statement of operations.
14.    INCOME TAXES
The Company accounts for income taxes under FASB ASC 740, Income Taxes ("ASC 740"). The Company calculates its quarterly tax provision consistent with the guidance provided by ASC 740-270, whereby the Company forecasts its estimated

32

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

annual effective tax rate then applies that rate to its year-to-date pre-tax book (loss) income. The effective tax rate may be subject to fluctuations during the year as new information is obtained, which may affect the assumptions used to estimate the annual effective rate, including factors such as the valuation allowances against deferred tax assets, the recognition or de-recognition of tax benefits related to uncertain tax positions, or changes in or the interpretation of tax laws in jurisdictions where the Company conducts business. The Company has recorded valuation allowances against certain Netherlands and other foreign jurisdictions due to insufficient evidence supporting the Company's ability to use these assets in the future.
For the six months ended April 30, 2017 and 2016, the Company recorded a benefit from income taxes in continuing operations of $22.8 million and $0.0 million, respectively. The increase in tax benefit for the six months ended April 30, 2017 was primarily attributable to changes in the Company’s jurisdictional combination of pre-tax income, the Company’s change in tax classification of a United States subsidiary ("US subsidiary") and changes to other discrete tax items, which may have unique tax implications, depending on the nature of the item.
In the first quarter of fiscal 2017, the Company filed an election to change the tax classification of a US subsidiary from a partnership to an association taxable as a corporation. As a result of the change in tax classification, the Company recognized a $28.3 million deferred tax benefit related to the change in its deferred tax assets and liabilities. The Company previously accounted for the deferred tax basis difference using outside basis of the partnership's investments. The Company derecognized the deferred tax liability for the outside basis difference and recognized deferred tax assets and liabilities for existing temporary differences between the tax basis and financial reporting basis of the assets and liabilities of the subsidiary.
In the second quarter of fiscal 2017, the Company amended prior year federal and state returns, originally filed by a predecessor owner, for a U.S. subsidiary. As a result of the amended returns, the Company recognized a $3.5 million deferred tax benefit for an increase in net operating losses.
Valuation allowances are provided to reduce the related deferred income tax assets to an amount which will, more likely than not, be realized. As of April 30, 2017, the Company has multiple subsidiaries that continue to maintain either full or a partial valuation allowances on their deferred tax assets as there is not sufficient evidence to support the reversal of all or some portion of these allowances. However, given current and anticipated future earnings in the Company's Austrian subsidiaries, the Company believes that within the next twelve months there is a reasonable possibility positive evidence will become available that would require the release of all or a portion of the valuation allowance recorded at the Company’s Austrian subsidiaries.
The Company evaluates uncertain tax positions on a quarterly basis and considers various factors, including, but not limited to, changes in tax law, the measurement of tax positions taken or expected to be taken in tax returns, the effective settlement of matters subject to audit, information obtained during in process audit activities and changes in facts or circumstances related to a tax position. The Company also accrues for potential interest and penalties related to unrecognized tax benefits within the provision for income taxes on the consolidated statement operations. As of April 30, 2017, the Company did not have a material change in the total amount of unrecognized tax positions and does not expect a material change over the next twelve months.
The Company early adopted ASU No. 2016-09 "Improvements to Employee Share-Based Payment Accounting" during the second quarter of fiscal 2017. ASU 2016-09 eliminates the requirement for additional paid in capital ("APIC") pools and requires excess tax benefits and tax deficiencies to be recorded in the income statement when the awards vest or are settled.  The adoption of ASU 2016-09 had no financial statement impact on the Company.
15.    OTHER INFORMATION
Foreign exchange
During the three and six months ended April 30, 2017, the Company recorded a foreign exchange loss of $0.7 million and $5.5 million, respectively. These amounts resulted from hedge and operating exposures. During the three and six months ended April 30, 2016, the Company recorded foreign exchange losses of $7.1 million and $11.4 million, respectively
Management Incentive Plan
On March 11, 2014, the Company adopted the Management Long-Term Incentive Plan (the "LTIP") to provide long-term incentives to select key management employees of Patheon and its subsidiaries who have contributed and are expected to contribute materially to the success of the Company, and to reward outstanding performance by such employees. Leadership, key positions or identified key talent may be invited to participate in the LTIP during an identified plan year. Compensation is payable under this plan upon an Exit Event by the controlling investors of the Company (JLL and DSM), if the participant is still employed by the Company, or a qualifying termination, as defined.

33

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

An Exit Event is defined as the earlier of: (a) a change of control, and (b) in connection with or following an Initial Public Offering ("IPO"), the sale or disposition by JLL or any of its affiliates of equity securities such that, immediately following such sale or disposition, either (i) JLL and its affiliates own less than 20% of the outstanding equity securities of the Partnership or the Partnership offeror, calculated on a fully-diluted basis, or (ii) JLL and its affiliates have received, in the aggregate, distributions in respect of such sale or disposition (together with any sale or disposition occurring prior thereto) equal to or in excess of 250% of the initial capital contributions and any additional capital contributions made by JLL and its affiliates for all equity securities of the Partnership or the Partnership offeror held by JLL and its affiliates prior to such sale or disposition.
Not later than 90 days following commencement of each applicable Company fiscal year that would end during the term of the LTIP, the compensation committee of the board of directors of the Company (the "Compensation Committee") will determine, in its sole and absolute discretion, with respect to such fiscal year, (i) the Participants (as defined in the LTIP) with respect to that fiscal year, (ii) the EBITDA Target (as defined in the LTIP), and (iii) the targeted amount of each Award. Each award shall be evidenced by a written notice and shall be deemed granted on the first day of the fiscal year with respect to which the Compensation Committee resolves to grant such award (the "Grant Date"). Awards are denominated as a percentage of the Participant’s base salary, with the target percentage based on the Participant’s level within the organization, as determined by the Compensation Committee in its sole and absolute discretion. All awards will be paid in the form of cash, or other property having a value equal to such cash payment, as determined by the Compensation Committee in its sole and absolute discretion.
Under the LTIP, the Company has granted $9.6 million in outstanding awards from March 11, 2014 through April 30, 2017, all of which vest over a five-year period. Through April 30, 2017, the Company has paid out $0.2 million in payments due to qualified terminations. The Company does not accrue for the overall payout as the Exit Event is deemed to not be probable until the actual occurrence of the event.
Contingencies
Procaps Antitrust Matter
On December 10, 2012, Procaps S.A. (‘‘Procaps’’) filed a complaint against the Company in the United States District Court for the Southern District of Florida (the ‘‘District Court’’) (Case No. 12-cv-24356-DLG). The complaint involves the Company’s collaboration agreement with Procaps, pursuant to which both companies agreed to work together with respect to the marketing of a line of certain prescription pharmaceutical soft-gel development and manufacturing services. Procaps alleges that the Company’s acquisition of Banner, a business that historically has generated less than 10% of its revenues from softgel services for prescription pharmaceuticals, transformed the collaboration agreement into an anticompetitive restraint of trade and an agreement between direct competitors to set prices, divide markets and/or allocate geographic territories. Procaps seeks (i) a declaratory judgment that the collaboration agreement must cease and/or terminate; (ii) an injunction requiring that Patheon divest all of Banner’s soft-gel manufacturing capabilities; and (iii) monetary damages under federal and state antitrust and unfair competition laws, including treble damages for violations of the Sherman Act. Patheon subsequently answered Procaps’ complaint and filed its affirmative defenses to the complaint. In July 2014, upon Motion for Summary Judgment by Patheon, the court dismissed Procaps’ unfair competition claims, leaving only the antitrust claims in dispute. In March 2015, the court ordered trial to commence on November 16, 2015.
In October 2015, the court granted Patheon’s motion for summary judgment with respect to all of Procaps’ remaining claims in this matter. In November 2015, Procaps filed a notice of appeal with the United States Court of Appeals for the Eleventh Circuit (the ‘‘11th Circuit Court’’). Procaps filed its initial brief with the 11th Circuit Court in February 2016 and we filed our reply brief in May 2016. Procaps filed its reply to our reply brief in June 2016. The 11th Circuit Court heard oral argument in this matter in November 2016 and in December 2016 affirmed the District Court's decision in favor of Patheon.
In May 2016, Procaps filed a request for arbitration with the International Court of Arbitration of the International Chamber of Commerce. The request for arbitration involves the above-mentioned collaboration agreement. Procaps alleges that (i) Patheon’s acquisition of Banner violated the exclusivity provision of the collaboration agreement, (ii) Patheon failed to return or destroy confidential information of Procaps, (iii) Patheon was unjustly enriched by obtaining the benefit of such confidential information to which it was not entitled, and (iv) Patheon breached implied duties of good faith and fair dealing in carrying out the collaboration agreement. Procaps seeks (i) with respect to the alleged breaches, compensatory damages and (ii) with respect to the claim for unjust enrichment, (a) disgorgement of profits received by Patheon by using any confidential information of Procaps, (b) repayment for all payments made to Patheon pursuant to the collaboration agreement, and (c) payment for the value of any intellectual property associated with the collaboration agreement. The Company filed its answer to the request for arbitration with the International Court of Arbitration of the International Chamber of Commerce in June 2016. The arbitration hearing on the merits in this matter was held in March 2017 and final arguments were heard in May 2017.

34

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

The Company has not included any accrual in the consolidated financial statements as of April 30, 2017 related to these matters as a result of its assessment that the likelihood of a material loss in connection with these matters is not probable. However, an adverse outcome in this matter could have a material adverse effect on the Company’s business, results of operations and financial condition.
Oral Contraceptive Litigation
A civil action is pending in the Commonwealth of Pennsylvania against the Company and one of its customers in connection with the recall of certain lots of allegedly defective products manufactured by the Company for the customer. The customer has given the Company notice of its intent to seek indemnification from the Company for all damages, costs and expenses, pursuant to the manufacturing services agreement between the customer and the Company.
The action was filed in Court of Common Pleas of Philadelphia Country, in Philadelphia, Pennsylvania in November 2015 on behalf of 113 plaintiffs who were originally part of a putative class action commenced in state court in Georgia in October 2011 on behalf of 115 plaintiffs and removed by defendants to the United States District Court for the Northern District of Georgia ("Georgia District Court") under the Class Action Fairness Act ("CAFA"). Defendants opposed class certification and class certification was denied. The Georgia action was ordered to proceed as a two-plaintiff action in the Georgia District Court on behalf of the two named plaintiffs, whereupon plaintiffs' lawyers commenced a new action in the Court of Common Pleas in Philadelphia on behalf of the remaining 113 plaintiffs. The two-plaintiff action was dismissed by the Georgia District Court on October 28, 2016 on a motion for summary judgment brought by defendants.
Defendants removed the action to the United States District Court for the Eastern District of Pennsylvania ("Pennsylvania District Court"). In September 2016, the Pennsylvania District Court remanded the action back to the Court of Common Pleas in Philadelphia. Defendants appealed the order of remand and, in February 2017, the United States Court of Appeals for the Third Circuit reversed and vacated the Pennsylvania District Court's remand order and remanded the matter to the Pennsylvania District Court for further proceedings. As the litigation is at an early stage, the Company is unable to estimate the potential damages for which the Company may be directly or indirectly liable.
Italian Client Dispute
In November 2015, the largest client of Patheon Italia S.p.A.’s (‘‘Patheon Italia’’), Ferentino, Italy facility filed a motion for injunctive relief in a Milan court under Article 700 of the Italian Civil Code. The client claims that remediation actions implemented by the Ferentino facility in response to an FDA inspection in May 2015, including, among other things, the use of a third party to certify all production batches for release, caused a significant slowdown in the quality control testing and batch release processes for the client’s product, thereby impairing the client’s ability to supply product in the amounts needed to fulfill the client's needs. The client sought an injunction ordering the Ferentino facility to (i) deliver products set forth in an October 6-7, 2015 release plan discussed by the parties; (ii) transfer products and documentation to the client to enable the client to perform the necessary quality control testing and release the products; and (iii) continue manufacture of the products at the capacity levels set forth in the supply agreement between the parties. The client further asked the court to impose a penalty of €0.2 million per day for every day that the Ferentino facility failed to comply with the order.
On December 7, 2015, Patheon Italia filed a response to the motion, denying all the claims set forth in the client’s motion and asserting several defenses. In particular, Patheon Italia informed the court that the parties had in fact executed an amendment to the existing quality agreement agreeing to transfer the testing and release responsibilities to the client, such amendment was executed prior to the filing of the motion by the client and should have been disclosed to the court in the client’s motion.
On December 10, 2015, the court held a hearing in this matter and on December 18, 2015, denied the client’s motion. The client has filed an appeal to the court's decision, which was heard on February 11, 2016. On February 29, 2016, the appeals court denied the client's appeal. The supply agreement with the client includes an arbitration provision and in its initial motion, the client indicated its intention to file an arbitration claim seeking money damages in this matter. This matter is in the early stages and the Company is unable to estimate the potential damages for which Patheon Italia may be liable if the client files an arbitration claim and prevails in such proceeding.
Statements of cash flows non-cash investing and financing activities

35

Notes to Unaudited Consolidated Financial Statements for the Three and Six Months Ended April 30, 2017
(Dollar information in tabular form is expressed in millions of U.S. dollars, except share data)

 
Six months ended April 30,
 
2017
 
2016
Non-cash financing activities:
$
 
$
Assumption of earnout liability from the Partnership (1)
—

 
36.0

Treasury stock purchases to satisfy certain tax withholdings (2)
0.1

 
—

Increase in capital lease obligations
1.0

 
—

(1) Refer to Note 9 for further information
(2) Represents the tax payable held as of April 30, 2017 relating to a second quarter treasury stock purchase.

16.    SUBSEQUENT EVENTS
On May 15, 2017, the Company and Thermo Fisher Scientific Inc. ("Thermo Fisher") and Thermo Fisher (CN) Luxembourg Sarl (the “Buyer”) entered into a Purchase Agreement pursuant to which the Buyer will commence a tender offer to all outstanding shares of the Company for $35.00 per share (the "Offer Consideration"). The transaction represents a purchase price of approximately $7.2 billion, which includes the assumption of approximately $2.0 billion of net debt. The closing of the tender offer (the “Closing”) will constitute an Exit Event under the MEIP and the LTIP and, accordingly, (i) all management units under the MEIP that are unvested as of the Closing will vest in full, (ii) the MEIP RSUs will settle in accordance with their terms based on the Offer Consideration; and (iii) all outstanding awards under the LTIP will become payable. All remaining unvested equity awards under the Company's Omnibus Incentive Plan will convert into an equity award of Thermo Fisher with the same value and substantially similar other terms as the existing Company equity award.

36

Item 2.    Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion is designed to provide a better understanding of our consolidated financial statements, including a brief discussion of our business, key factors that impact our performance and a summary of our operating results. The following discussion should be read in conjunction with our unaudited consolidated financial statements and the notes thereto included in this Form 10-Q and with our audited consolidated financial statements and notes included in our 2016 Form 10-K.
Cautionary Statement Regarding Forward-Looking Statements
This Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks, uncertainties and assumptions that are difficult to predict. Forward-looking statements are predictions based on our current expectations and our projections about future events, and are not statements of historical fact. Forward-looking statements include statements concerning our business strategy, among other things, including anticipated trends and developments in, and management plans for, our business and the markets in which we operate. In some cases, you can identify these statements by forward-looking words, such as “estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,” “believe,” “forecast,” “foresee,” “likely,” “may,” “should,” “might,” “will,” and “could,” the negative or plural of these words and other comparable terminology. All forward-looking statements included in this Form 10-Q are based upon information available to us as of the filing date of this Form 10-Q, and we undertake no obligation to update any of these forward-looking statements for any reason. You should not place undue reliance on these forward-looking statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these statements. These factors include the matters discussed in the section entitled “Part II - Other Information - Item 1A - Risk Factors” in this Form 10-Q, and elsewhere in this Form 10-Q. You should carefully consider the risks and uncertainties described under these sections.
Overview
Our Company
Patheon N.V. is a leading global provider of outsourced pharmaceutical development and manufacturing, or CDMO, services. We provide a comprehensive, integrated and highly customizable range of active pharmaceutical ingredient, or API, and finished drug product services to our customers, from formulation development to clinical and commercial-scale manufacturing, packaging, and life cycle management. Our services address both small molecule and large molecule biological drugs. We believe we are the only end-to-end integrated provider of such services, which, combined with our scientific and regulatory expertise and specialized capabilities, allows our customers to partner with a single outsourced provider to address their most complex development and manufacturing needs for a given product or service, or across the spectrum. We believe we have the broadest technological capabilities in our industry, across the full spectrum of development and manufacturing, to support our end-to-end integrated platform.
We believe we are a critical partner for our customers who increasingly rely on our customized formulation, development and manufacturing expertise to address growing drug complexity, cost pressures and regulatory scrutiny. We partner with many of our customers early in the drug development process, providing us the opportunity to continue to expand our relationship with our customers as molecules progress through the clinical phase and into commercial manufacturing. This results in long-term relationships with our customers and a recurring revenue stream. We believe our breadth of services, reliability and scale address our customers’ increasing need to outsource and desire to reduce the number of supply chain partners while maintaining a high quality of service.
We currently operate in the following three reportable business segments:
•
Drug Product Services, or DPS, which provides manufacturing and packaging for approved prescription, OTC, and nutritional products.
•
Pharmaceutical Development Services, or PDS, which provides a wide spectrum of advanced formulation, production and technical services from the early stages of a product’s development to regulatory approval and beyond, as well as for new formulations of approved products for lifecycle extension.
•
Drug Substance Services, or DSS, which provides development and manufacturing for the biologically active component of a pharmaceutical product from early development through commercial production.
Patheon N.V. (“Patheon” or "the Company") was formed on December 24, 2013, as Patheon Coöperatief U.A., a Dutch cooperative with excluded liability for its members (coöperative met uitgesloten aansparkelijkheid) and a wholly owned indirect subsidiary of JLL/Delta Patheon Holdings, L.P. (the “Partnership”), which in turn is owned 51% by JLL Patheon Co-

37

Investment Fund L.P. ("JLL") and 49% by Koninklijke DSM N.V. ("DSM"). On June 3, 2016, the Company was converted into a Dutch limited liability company (naamloze vennootschap) and changed its name to Patheon N.V.
On July 21, 2016, the Company amended its articles of association, resulting in a split of the Company's ordinary shares and a $1.2 million contribution by the Partnership to the Company's equity capital in connection with the share split. This share split and capital contribution resulted in a total of 115,609,756 ordinary shares outstanding at a par value of €0.01 per share.
On July 21, 2016, the Company consummated an initial public offering ("IPO") of an additional 29,464,286 ordinary shares at a public offering price of $21.00 per share, which included 4,464,286 ordinary shares sold pursuant to the option granted to the underwriters to purchase additional ordinary shares from the Company. As part of the IPO, DSM sold 4,761,905 ordinary shares distributed to them in connection to their Partnership ownership to the public. A total of 34,226,191 ordinary shares were sold in connection to the IPO. The Company did not receive any proceeds from the ordinary shares sold by DSM. The IPO was completed on July 26, 2016.
Ordinary shares owned by the public constitute approximately 24% of the Company. Through their respective ordinary shares, JLL, DSM and the Partnership own approximately 38%, 34% and 4% of the Company. The Partnership's ownership comprises of shares held for the benefit of certain employees.
As the Company has done historically, we will continue to evaluate and pursue strategic investments and acquisitions to support expanding customer needs, complement our existing platform and broaden our capabilities in high value-added product and services offerings in response to market demand. Targets of these strategic investments and acquisitions may include existing CDMO businesses, business operating in logical adjacencies and facilities currently operated by our clients or other pharmaceutical or biotechnology companies for their internal production purposes.
On May 15, 2017, the Company and Thermo Fisher Scientific Inc. ("Thermo Fisher") and Thermo Fisher (CN) Luxembourg Sarl (“Buyer”) entered into a Purchase Agreement pursuant to which the Buyer will commence a tender offer to all outstanding shares of the Company for $35.00 per share. The transaction represents a purchase price of approximately $7.2 billion, which includes the assumption of approximately $2.0 billion of net debt.
In addition, we have streamlined and rationalized our business:
•
We launched our OneSource initiative in 2015 which combines drug substance and drug product development and manufacturing into a single customized solution.
•
Over the prior two years, we sold our DPx Fine Chemicals business, our Biosolutions business and our Banner Pharmacaps entity in Mexico. Additionally, we spun off Banner Life Sciences, our proprietary products business, into a separate legal entity.
•
On February 1, 2017, we completed an acquisition of an API facility in Florence, SC. With this acquisition, the Company expanded its capacity for manufacturing highly potent compounds and added capabilities to support solid state chemistry, micronization and future commercial spray drying.
•
We outsourced certain IT, finance and procurement back-office support functions.
Selected Financial Results
The following is a summary of certain key financial results for the three months ended April 30, 2017 (a more detailed discussion is contained in "Results of Operations" below):
•
Revenues for the three months ended April 30, 2017 increased $14.8 million, or 3.2%, to $483.4 million from $468.6 million for the three months ended April 30, 2016. On a constant currency basis, revenue would have increased $23.3 million, or 5.0%.
•
Gross profit for the three months ended April 30, 2017 increased $2.4 million, or 1.7%, to $140.7 million from $138.3 million for the three months ended April 30, 2016.
•
Net income from continuing operations for the three months ended April 30, 2017 was $27.6 million, compared to net income of $1.9 million for the three months ended April 30, 2016.
•
Adjusted EBITDA for the three months ended April 30, 2017 decreased $3.8 million to $94.2 million, from $98.0 million for the three months ended April 30, 2016.
Opportunities and Trends
Our target markets include the highly fragmented global markets for the manufacture of finished pharmaceutical dosage forms, pharmaceutical development services, chemical API manufacturing, and biologic pharmaceutical contract manufacturing. The

38

outsourcing of product development by the pharmaceutical industry is an important driver of growth in our business. In 2016, the pharmaceutical industry spent approximately $157.0 billion on formulation, development and manufacturing, according to Evaluate Pharma, and approximately $40.0 billion was outsourced to CDMOs such as Patheon, according to Root Analysis. Currently, only 25% to 30% of pharmaceutical industry spending on formulation, development and manufacturing is outsourced, and in the future it is expected that our customer base will expand the use of outsourcing to CDMOs because of changing industry dynamics, driving growth of our market. Industry resources indicate that the outsourced pharmaceutical manufacturing market is expected to grow at approximately 7 to 8% annually in the foreseeable future. We believe the market for products requiring specialized capabilities (e.g., sterile production, solubility solutions) is growing at a higher rate than the overall market. Furthermore, more than 60% to 90% of all new compounds entering development will require specialized manufacturing and/or molecular profile modification, according to industry research. According to Frost & Sullivan, a global market research firm, the CDMO API small molecule market for innovative chemical API manufacturing totaled approximately $19.5B in 2016 and may experience growth of approximately 7-9% annually through 2020. According to High Tech Business Decisions, a business intelligence information provider, the API large molecule market for mammalian biologics pharmaceutical contract manufacturing totaled approximately $2.4 billion in 2016 and may experience growth of approximately 7-9% annually through 2022.
Results of Operations
Three months ended April 30, 2017 compared to three months ended April 30, 2016  
 
Three months ended April 30,
 
 
 
 
 
2017
 
2016
 
$
 
%
(in millions of U.S. dollars)
$
 
$
 
Change
 
Change
Revenues
483.4

 
468.6

 
14.8

 
3.2

Cost of goods sold
342.7

 
330.3

 
12.4

 
3.8

Gross profit
140.7

 
138.3

 
2.4

 
1.7

Selling, general and administrative expenses
92.1

 
74.8

 
17.3

 
23.1

Research and development
0.4

 
0.6

 
(0.2
)
 
(33.3
)
Repositioning expenses
1.8

 
1.3

 
0.5

 
38.5

Acquisition and integration costs
8.1

 
7.6

 
0.5

 
6.6

Other operating expense
0.5

 
1.2

 
(0.7
)
 
*

Operating income
37.8

 
52.8

 
(15.0
)
 
(28.4
)
Interest expense, net
30.8

 
42.6

 
(11.8
)
 
(27.7
)
Foreign exchange loss, net
0.7

 
7.1

 
(6.4
)
 
*

Refinancing expenses
6.3

 
—

 
6.3

 
—

Bargain purchase gain
(26.4
)
 
—

 
(26.4
)
 
—

Other loss, net
0.3

 
0.5

 
(0.2
)
 
*

Income before income taxes
26.1

 
2.6

 
23.5

 
903.8

(Benefit from) provision for income taxes
(1.5
)
 
0.7

 
(2.2
)
 
*

Net income from continuing operations
27.6

 
1.9

 
25.7

 
1,352.6

Net loss from discontinued operations
—

 
(1.0
)
 
1.0

 
*

Net income
27.6

 
0.9

 
26.7

 
2,966.7

* Not meaningful

Operating Income Summary
Revenues for the three months ended April 30, 2017 increased $14.8 million, or 3.2%, to $483.4 million, from $468.6 million for the three months ended April 30, 2016. On a constant currency basis, revenues would have increased $23.3 million, or 5.0%.
•
DPS revenues for the three months ended April 30, 2017 increased $9.8 million, or 3.4%, to $297.2 million, from $287.4 million for the three months ended April 30, 2016 primarily due to new product launches at our Greenville, NC site and increased sterile business at our Italian sites.

39

•
PDS revenues for the three months ended April 30, 2017 increased $4.4 million, or 8.2%, to $57.8 million, from $53.4 million for the three months ended April 30, 2016 primarily due to recoveries at our Ferentino site as well as continued growth in our Canadian sites.
•
DSS revenues for the three months ended April 30, 2017 increased $1.3 million, or 1.0%, to $129.2 million from $127.9 million for the three months ended April 30, 2016 primarily from increased revenues from the RCI Acquisition, higher shipments in our European API business and increased activity in our Biologics business, partially offset by declining sales in our legacy US API sites.
Gross profit for the three months ended April 30, 2017 increased $2.4 million, or 1.7%, to $140.7 million, from $138.3 million for the three months ended April 30, 2016. The decrease in gross profit margin from 29.5% for the three months ended April 30, 2016 to 29.1% for the three months ended April 30, 2017 was primarily due to increased investment in quality and other manufacturing support ahead of increased commercialization of our Biologics business, as well as unfavorable mix, partially offset by flow through from increased revenues and the elimination of FDA remediation costs at our Ferentino facility present in prior year gross profit.
Selling, general and administrative expenses for the three months ended April 30, 2017 increased $17.3 million, or 23.1%, to $92.1 million, from $74.8 million for the three months ended April 30, 2016, primarily due to increased incentive and stock based compensation, higher salary costs associated with the Company's growth strategy and increased public company compliance costs.
Acquisition and integration costs for the three months ended April 30, 2017 increased $0.5 million to $8.1 million from $7.6 million for the three months ended April 30, 2016. Acquisition and integration costs during the three months ended April 30, 2017 primarily related to the Roche Acquisition and other corporate development activities while acquisition and integration costs for the three months ended April 30, 2016 primarily related to due diligence on potential corporate development transactions. The nature of these costs includes due diligence costs, consultants, system and customer conversions, and other integration-related costs. These costs are recognized as operating expenses as incurred.
Other operating loss for the three months ended April 30, 2017 was $0.5 million, compared to $1.2 million for the three months ended April 30, 2016. These amounts relate to the Company's mark to market adjustments on the earnout liability.
Interest expense for the three months ended April 30, 2017 was $30.8 million compared to $42.6 million for the three months ended April 30, 2016. The decrease in interest expense is primarily due to the redemption of the Senior PIK Toggle Notes in the fourth quarter of 2016.
Refinancing expense for the three months ended April 30, 2017 was $6.3 million, which related to the refinancing of the Company's Credit Facility Agreement. The Company did not incur refinancing expenses for the three months ended April 30, 2016.
Benefit from income taxes for the three months ended April 30, 2017 was $1.5 million and provision for income taxes for the three months ended April 30, 2016 was $0.7 million. The increase in tax benefit for the three months ended April 30, 2017 was primarily attributable to changes in the Company’s jurisdictional combination of pre-tax income and changes to other discrete tax items, which may have unique tax implications, depending on the nature of the item.
We recorded a net loss from discontinued operations of $1.0 million for the three months ended April 30, 2016 as a result of miscellaneous transaction activity with our discontinued operations. No discontinued operations activity was recorded for the three months ended April 30, 2017.
Adjusted EBITDA Reconciliation
A reconciliation of Adjusted EBITDA to net income from continuing operations is set forth below:

40

 
 
Three months ended April 30,
 
2017
 
2016
(in millions of U.S. dollars)
$
 
$
Total Adjusted EBITDA
94.2

 
98.0

Depreciation and amortization
(34.3
)
 
(27.0
)
Repositioning expenses (1)
(2.2
)
 
(1.3
)
Acquisition and integration costs
(8.1
)
 
(7.6
)
Interest expense, net
(30.8
)
 
(42.6
)
Benefit from (provision for) income taxes
1.5

 
(0.7
)
Refinancing expenses
(6.3
)
 
—

Operational initiatives related consulting costs
(1.4
)
 
(1.9
)
IPO costs
—

 
(0.4
)
Acquisition related litigation expenses
(3.7
)
 
(0.9
)
Stock based compensation expense
(7.0
)
 
(2.0
)
FDA remediation costs
—

 
(10.1
)
Bargain purchase gain
26.4

 
—

Other
(0.7
)
 
(1.6
)
Net income from continuing operations
27.6

 
1.9

(1) Repositioning expenses for the three months ended April 30, 2017 includes $0.4 million of inventory reserves related to the Swindon wind down recorded in cost of goods sold.
The following provides certain information regarding our business segments for the three months ended April 30, 2017 and 2016:  
 
Three months ended April 30,
 
 
 
 
 
2017
 
2016
 
$
 
%
(in millions of U.S. dollars)
$
 
$
 
Change
 
Change
Revenues
 
 
 
 
 
 
 
Drug Product Services
297.2

 
287.4

 
9.8

 
3.4

Pharmaceutical Development Services
57.8

 
53.4

 
4.4

 
8.2

Drug Substance Services
129.2

 
127.9

 
1.3

 
1.0

Inter-segment Eliminations
(0.8
)
 
(0.1
)
 
(0.7
)
 
*

Total Revenues
483.4

 
468.6

 
14.8

 
3.2

Adjusted EBITDA
 
 
 
 
 
 
 
Drug Product Services
77.4

 
72.7

 
4.7

 
6.5

Pharmaceutical Development Services
18.4

 
16.7

 
1.7

 
10.2

Drug Substance Services
26.1

 
30.8

 
(4.7
)
 
(15.3
)
Other
(27.5
)
 
(22.2
)
 
(5.3
)
 
(23.9
)
Inter-segment Eliminations
(0.2
)
 
—

 
(0.2
)
 
*

Total Adjusted EBITDA
94.2

 
98.0

 
(3.8
)
 
(3.9
)
* Not meaningful
Drug Product Services
Total DPS revenues for the three months ended April 30, 2017 increased $9.8 million, or 3.4%, to $297.2 million, from $287.4 million for the three months ended April 30, 2016. On a constant currency basis, DPS revenues would have increased by $14.3 million, or 5.0%. The increase was primarily due to new product launches at our Greenville, NC site and increased sterile business at our Italian sites.

41

Total DPS Adjusted EBITDA for the three months ended April 30, 2017 increased $4.7 million, or 6.5%, to $77.4 million, from $72.7 million for the three months ended April 30, 2016. This represents an Adjusted EBITDA margin of 26.0% for the three months ended April 30, 2017 compared to 25.3% for the three months ended April 30, 2016. The increase in Adjusted EBITDA and margin was primarily due to the flow through from the higher revenue as well as favorable foreign exchange impacts, partially offset by higher inventory write-offs. Consistent with management's definition of Adjusted EBITDA, total DPS Adjusted EBITDA for the three months ended April 30, 2017 did not include repositioning expenses of $2.1 million and stock based compensation of $1.4 million.
Pharmaceutical Development Services
Total PDS revenues for the three months ended April 30, 2017 increased by $4.4 million, or 8.2%, to $57.8 million from $53.4 million for the three months ended April 30, 2016. Higher revenue was primarily due to recoveries at our Ferentino site as well as continued growth in our Canadian sites.
Total PDS Adjusted EBITDA for the three months ended April 30, 2017 increased $1.7 million, or 10.2%, to $18.4 million, from $16.7 million for the three months ended April 30, 2016. This represents an Adjusted EBITDA margin of 31.8% for the three months ended April 30, 2017 compared to 31.3% for the three months ended April 30, 2016. The increase in Adjusted EBITDA and margin was primarily due to the flow through from the higher revenue, partially offset by investment in headcount ahead of expected continued growth.
Drug Substance Services
Total DSS revenues for the three months ended April 30, 2017 increased by $1.3 million, or 1.0%, to $129.2 million from $127.9 million for the three months ended April 30, 2016. On a constant currency basis, DSS revenues would have increased by $4.6 million, or 3.6%. Increased revenue was primarily from increased revenues from the RCI Acquisition, higher shipments in our European API business and increased activity in our Biologics business, partially offset by declining sales in our legacy US API sites.
Total DSS Adjusted EBITDA for the three months ended April 30, 2017 decreased by $4.7 million, or 15.3%, to $26.1 million from $30.8 million for the three months ended April 30, 2016. This represents an Adjusted EBITDA margin of 20.2% for the three months ended April 30, 2017 compared to 24.1% for the three months ended April 30, 2016. The decrease in Adjusted EBITDA and margin is primarily due to increased investment in quality and other manufacturing support ahead of increased commercialization of our Biologics business, partially offset by flow through from the RCI Acquisition. Consistent with management's definition of Adjusted EBITDA, total DSS Adjusted EBITDA for the three months ended April 30, 2017 did not include acquisition and integration expenses of $2.5 million and stock based compensation of $0.6 million.
Other
Total Other Adjusted EBITDA loss for the three months ended April 30, 2017 decreased by $5.3 million, or 23.9%, to a loss of $27.5 million from a loss of $22.2 million for the three months ended April 30, 2016 due to increased compensation costs associated with the Company's growth strategy. Consistent with management's definition of Adjusted EBITDA, total Other Adjusted EBITDA loss for the three months ended April 30, 2017 did not include acquisition and integration costs of $5.5 million, refinancing expenses of $6.3 million, stock-based compensation of $4.8 million, Procaps litigation expenses of $3.7 million and consulting costs relating to operational excellence initiatives of $1.3 million.

42

Six months ended April 30, 2017 compared to six months ended April 30, 2016  
 
Six months ended April 30,
 
 
 
 
 
2017
 
2016
 
$
 
%
(in millions of U.S. dollars)
$
 
$
 
Change
 
Change
Revenues
940.8

 
874.5

 
66.3

 
7.6

Cost of goods sold
670.4

 
637.3

 
33.1

 
5.2

Gross profit
270.4

 
237.2

 
33.2

 
14.0

Selling, general and administrative expenses
173.2

 
148.5

 
24.7

 
16.6

Research and development
1.1

 
1.3

 
(0.2
)
 
(15.4
)
Repositioning expenses
2.4

 
2.5

 
(0.1
)
 
(4.0
)
Acquisition and integration costs
11.6

 
10.2

 
1.4

 
13.7

Other operating expense (income)
4.1

 
(3.7
)
 
7.8

 
*

Operating income
78.0

 
78.4

 
(0.4
)
 
(0.5
)
Interest expense, net
59.0

 
86.4

 
(27.4
)
 
(31.7
)
Foreign exchange loss, net
5.5

 
11.4

 
(5.9
)
 
*

Refinancing expenses
6.3

 
—

 
6.3

 
—

Bargain purchase gain
(26.4
)
 
—

 
(26.4
)
 
—

Other loss (income), net
0.5

 
(1.3
)
 
1.8

 
*

Income (loss) before income taxes
33.1

 
(18.1
)
 
51.2

 
282.9

Benefit from income taxes
(22.8
)
 
—

 
(22.8
)
 
*

Net income (loss) from continuing operations
55.9

 
(18.1
)
 
74.0

 
408.8

Net loss from discontinued operations
—

 
(3.1
)
 
3.1

 
*

Net income (loss)
55.9

 
(21.2
)
 
77.1

 
(363.7
)
* Not meaningful

Operating Income Summary
Revenues for the six months ended April 30, 2017 increased $66.3 million, or 7.6%, to $940.8 million, from $874.5 million for the six months ended April 30, 2016. On a constant currency basis, revenue would have increased $78.6 million, or 9.0%.
•
DPS revenues for the six months ended April 30, 2017 increased $26.5 million, or 4.9%, to $572.4 million, from $545.9 million for the six months ended April 30, 2016 primarily due to the recovery of volumes lost in the first half of fiscal 2016 due to FDA remediation activities at our Ferentino site and new product launches at our Greenville, North Carolina site, partially offset by lower revenues due to the Swindon wind down.
•
PDS revenues for the six months ended April 30, 2017 increased $8.2 million, or 8.0%, to $110.1 million, from $101.9 million for the six months ended April 30, 2016 primarily due to recoveries at our Ferentino site as well as continued growth in most North America sites.
•
DSS revenues for the six months ended April 30, 2017 increased $32.3 million, or 14.2%, to $259.1 million, from $226.8 million for the six months ended April 30, 2016 primarily from increased revenues from the RCI Acquisition, higher shipments in our European API business and increased activity in our Biologics business, partially offset by lower growth in our legacy US API sites.
Gross profit for the six months ended April 30, 2017 increased $33.2 million, or 14.0%, to $270.4 million, from $237.2 million for the six months ended April 30, 2016. The increase in gross profit margin from 27.1% for the six months ended April 30, 2016 to 28.7% for the six months ended April 30, 2017 was primarily due to flow through from increased revenues and the elimination of FDA remediation costs at our Ferentino facility present in prior year gross profit, partially offset by increased investment in quality and other manufacturing support ahead of increased commercialization of our Biologics business and environmental remediation costs recorded in the first quarter of fiscal 2017.
Selling, general and administrative expenses for the six months ended April 30, 2017 increased $24.7 million, or 16.6%, to $173.2 million, from $148.5 million for the six months ended April 30, 2016 primarily due to increased incentive and stock

43

based compensation, higher salary costs associated with the Company's growth strategy and increased public company compliance costs.
Acquisition and integration costs for the six months ended April 30, 2017 increased $1.4 million, to $11.6 million, from $10.2 million for the six months ended April 30, 2016. Acquisition and integration costs during the six months ended April 30, 2017 primarily related to the RCI Acquisition and other corporate development activities while acquisition and integration costs for the six months ended April 30, 2016 primarily related to due diligence on potential corporate development transactions. The nature of these costs includes due diligence costs, consultants, system and customer conversions, and other integration-related costs. These costs are recognized as operating expenses as incurred.
Other operating loss for the six months ended April 30, 2017 was $4.1 million, which primarily relates to the mark to market activity on the Biologics earnout. For the six months ended April 30, 2016, the other operating gain of $3.7 million related to the Company revising the earnout calculation upon assuming the earnout liability as well as marking the liability to market on an ongoing basis.
Interest expense for the six months ended April 30, 2017 was $59.0 million compared to $86.4 million for the six months ended April 30, 2016. The decrease in interest expense is primarily due to the redemption of the Senior PIK Toggle Notes in the fourth quarter of 2016.
Refinancing expense for the six months ended April 30, 2017 was $6.3 million, which related to the refinancing of the Company's Credit Facility Agreement. The Company did not incur refinancing expenses for the six months ended April 30, 2016.
Income tax benefit for the six months ended April 30, 2017 was $22.8 million and income tax expense for the six months ended April 30, 2016 was $0.0 million. The increase in tax benefit for the six months ended April 30, 2017 was primarily attributable to changes in the Company’s jurisdictional combination of pre-tax income, the Company’s change in tax classification of a United States subsidiary ("US subsidiary") and changes to other discrete tax items, which may have unique tax implications, depending on the nature of the item. The current year benefit was largely affected by the Company filing an election to change the tax classification of a US subsidiary from a partnership to an association taxable as a corporation. As a result of the change in tax classification, the Company recognized a $28.3 million deferred tax benefit related to the change in its deferred tax assets and liabilities. The Company previously accounted for the deferred tax basis difference using outside basis of the partnership's investments. The Company derecognized the deferred tax liability for the outside basis difference and recognized deferred tax assets and liabilities for existing temporary differences between the tax basis and financial reporting basis of the assets and liabilities of the subsidiary.
We recorded a net loss from discontinued operations of $3.1 million for the six months ended April 30, 2016 which related to minor adjustments as a result of miscellaneous transaction activity with our discontinued operations. No discontinued operations activity was recorded for the six months ended April 30, 2017.
Revenues and Adjusted EBITDA by Business Segment

A reconciliation of Adjusted EBITDA to net loss from continuing operations is set forth below:

44

 
 
Six months ended April 30,
 
2017
 
2016
(in millions of U.S. dollars)
$
 
$
Total Adjusted EBITDA
176.7

 
157.0

Depreciation and amortization
(61.9
)
 
(53.5
)
Repositioning expenses (1)
(3.5
)
 
(2.5
)
Acquisition and integration costs
(11.6
)
 
(10.2
)
Interest expense, net
(59.0
)
 
(86.4
)
Benefit from income taxes
22.8

 
—

Refinancing expenses
(6.3
)
 
—

Operational initiatives related consulting costs
(2.5
)
 
(3.3
)
IPO costs
—

 
(0.8
)
Acquisition related litigation expenses
(6.0
)
 
(1.9
)
Stock based compensation expense
(11.0
)
 
(3.0
)
FDA remediation costs
—

 
(18.5
)
Environmental remediation costs
(3.7
)
 
—

Bargain purchase gain
26.4

 
—

Other
(4.5
)
 
5.0

Net income (loss) from continuing operations
55.9

 
(18.1
)
(1) Repositioning expenses for the three months ended April 30, 2017 includes $1.1 million of inventory reserves related to the Swindon wind down recorded in cost of goods sold.

The following provides certain information regarding our business segments for the six months ended April 30, 2017 and 2016: 
 
Six months ended April 30,
 
 
 
 
 
2017
 
2016
 
$
 
%
(in millions of U.S. dollars)
$
 
$
 
Change
 
Change
Revenues
 
 
 
 
 
 
 
Drug Product Services
572.4

 
545.9

 
26.5

 
4.9

Pharmaceutical Development Services
110.1

 
101.9

 
8.2

 
8.0

Drug Substance Services
259.1

 
226.8

 
32.3

 
14.2

Other
—

 
—

 
—

 
—

Inter-segment Eliminations
(0.8
)
 
(0.1
)
 
(0.7
)
 
*

Total Revenues
940.8

 
874.5

 
67.0

 
7.7

Adjusted EBITDA
 
 
 
 
 
 
 
Drug Product Services
138.8

 
127.8

 
11.0

 
8.6

Pharmaceutical Development Services
34.7

 
30.5

 
4.2

 
13.8

Drug Substance Services
58.1

 
45.6

 
12.5

 
27.4

Other
(54.7
)
 
(46.9
)
 
(7.8
)
 
(16.6
)
Inter-segment Eliminations
(0.2
)
 
—

 
(0.2
)
 
*

Total Adjusted EBITDA
176.7

 
157.0

 
19.9

 
12.7

Drug Product Services
Total DPS revenues for the six months ended April 30, 2017 increased $26.5 million, or 4.9%, to $572.4 million, from $545.9 million for the six months ended April 30, 2016. On a constant currency basis, DPS revenues would have increased $33.3 million, or 6.1%. The increase was primarily due to the recovery of volumes lost in the first half of fiscal 2016 due to FDA

45

remediation activities at our Ferentino site and new product launches at our Greenville, North Carolina site, partially offset by lower revenues due to the Swindon wind down.
Total DPS Adjusted EBITDA for the six months ended April 30, 2017 increased $11.0 million, or 8.6%, to $138.8 million, from $127.8 million for the six months ended April 30, 2016. This represents an Adjusted EBITDA margin of 24.2% for the six months ended April 30, 2017 compared to 23.4% for the six months ended April 30, 2016. The increase in Adjusted EBITDA and margin was primarily due to the flow through from the higher revenue partially offset by increased investment in
our quality function. Consistent with management's definition of Adjusted EBITDA, total DPS Adjusted EBITDA for the six months ended April 30, 2017 did not include environmental remediation expenses of $3.7 million, repositioning expenses
of $3.0 million and stock-based compensation of $1.6 million.
Pharmaceutical Development Services
Total PDS revenues for the six months ended April 30, 2017 increased by $8.2 million, or 8.0%, to $110.1 million from $101.9 million for the six months ended April 30, 2016. On a constant currency basis, PDS revenues increased by $9.3 million, or 9.1%. Higher revenue was primarily due to recoveries at our Ferentino site as well as continued growth in most North America sites.
Total PDS Adjusted EBITDA for the six months ended April 30, 2017 increased $4.2 million, or 13.8%, to $34.7 million from $30.5 million for the six months ended April 30, 2016. This represents an Adjusted EBITDA margin of 31.5% for the six months ended April 30, 2017 compared to 29.9% for the six months ended April 30, 2016. The increase in adjusted
EBITDA and margin was primarily due to the flow through from the higher revenue.
Drug Substance Services
Total DSS revenues for the six months ended April 30, 2017 increased by $32.3 million, or 14.2%, to $259.1 million from $226.8 million for the six months ended April 30, 2016. On a constant currency basis, DSS revenues increased by $36.7 million, or 16.2%. Increased revenue was primarily from increased revenues from the RCI Acquisition, higher shipments in our European API business and increased activity in our Biologics business, partially offset by lower growth in our legacy US API sites.
Total DSS Adjusted EBITDA for the six months ended April 30, 2017 increased $12.5 million, or 27.4%, to $58.1 million from $45.6 million for the six months ended April 30, 2016. This represents an Adjusted EBITDA margin of 22.4% for the six months ended April 30, 2017 compared to 20.1% for the six months ended April 30, 2016. The increase is primarily due to flow through from higher volumes, including increased revenues from the RCI Acquisition, partially offset by increased investment in quality and other manufacturing support ahead of increased commercialization of our Biologics business. Consistent with management's definition of Adjusted EBITDA, total DSS Adjusted EBITDA for the six months ended April 30, 2017 did not include acquisition and integration expenses of $2.6 million and stock based compensation of $0.7 million.
Other
Total Other Adjusted EBITDA loss for the six months ended April 30, 2017 increased by $7.8 million, or 16.6%, to a loss of $54.7 million from a loss of $46.9 million for the six months ended April 30, 2016. The increase was primarily due to increased compensation costs associated with the Company's growth strategy. Consistent with management's definition of Adjusted EBITDA, total Other Adjusted EBITDA for the six months ended April 30, 2017 did not include acquisition and integration expenses of $8.8 million, stock-based compensation expense of $8.6 million, Procaps litigation expenses of $6.0 million, refinancing expenses of $6.3 million and consulting costs relating to operational excellence initiatives of $2.3 million.
Liquidity and Capital Resources
Overview
Cash and cash equivalents totaled $92.7 million at April 30, 2017 and $165.0 million at October 31, 2016. Our total debt was $2,088.8 million at April 30, 2017 and $2,068.7 million at October 31, 2016.
Our primary source of liquidity is cash flow from operations and available borrowings under our credit arrangements. Our principal uses of cash have been for operating expenditures, capital expenditures, repositioning expenditures, debt servicing requirements, integration costs associated with our acquisitions and employee benefit obligations. We expect cash flow from operations, cash on hand and available borrowing under our current revolver to be sufficient to fund our existing level of operating expenses, capital expenditures, interest expense and debt payments for at least the next 12 months.

46



From time to time, we evaluate strategic opportunities, including potential acquisitions, divestitures or investments in complementary businesses, and we anticipate continuing to make such evaluations. We may also access capital markets through the issuance of debt or equity securities in connection with the acquisition of complementary businesses or other significant assets or for other strategic opportunities. Our ability to make acquisitions, divestitures and investments, to issue debt and to declare and pay dividends is limited to varying degrees by the terms and restrictions contained in our debt instruments described below.
Our principal ongoing investment activities are project-related and sustaining capital programs at our network of sites. The majority of our capital allocation is normally invested in project-related programs, which are defined as outlays that will generate growth in capacity and revenues, while sustaining expenditures related to the preservation of existing assets and capacity.
If our cash flow is not sufficient to service our debt and adequately fund our business, we may be required to seek further additional financing or refinancing or dispose of assets. We may not be able to affect any of these alternatives on satisfactory terms or at all. In addition, our financial leverage could adversely affect our ability to raise additional capital to fund our operations, could impair our ability to respond to operational challenges, changing business and economic conditions and new business opportunities and may make us vulnerable in the event of a downturn in our business.
Summary of Cash Flows
Cash Used In Operating Activities
The following table summarizes the cash used in operating activities for the periods indicated:
 
Six months ended April 30,
 
2017
 
2016
(in millions of U.S. dollars)
$
 
$
Cash provided by (used in) operating activities of continuing operations
20.9

 
(43.0
)
Cash used in operating activities of discontinued operations
—

 
(2.9
)
Cash provided by (used in) operating activities
20.9

 
(45.9
)
Cash provided by operating activities of continuing operations for the six months ended April 30, 2017 increased $63.9 million, to a source of $20.9 million, from a use of $43.0 million for the six months ended April 30, 2016. The increase was primarily due to improved operating results and working capital performance, partially offset by a reduced benefit from deferred revenues compared to the prior period.
Cash Used in Investing Activities
The following table summarizes the cash used in investing activities for the periods indicated:

 
Six months ended April 30,
 
2017
 
2016
(in millions of U.S. dollars)
$
 
$
Cash used in investing activities of continuing operations
(109.5
)
 
(92.7
)
Cash used in investing activities of discontinued operations
—

 
(3.3
)
Cash used in investing activities
(109.5
)
 
(96.0
)
Cash used for investing activities of continuing operations for the six months ended April 30, 2017 increased $16.8 million, to $109.5 million from $92.7 million for the six months ended April 30, 2016. Cash used for investing activities in both periods primarily relate to project related capital expenditures.
Cash Used in Financing Activities
The following table summarizes the cash used in financing activities for the periods indicated:

47



 
Six months ended April 30,
 
2017
 
2016
(in millions of U.S. dollars)
$
 
$
Cash provided by (used in) financing activities of continuing operations
17.6

 
(9.2
)
Cash provided by (used in) financing activities of discontinued operations
—

 
—

Cash provided by (used in) financing activities
17.6

 
(9.2
)
Cash provided by financing activities for the six months ended April 30, 2017 was $17.6 million compared to cash used in financing activities of $9.2 million for the six months ended April 30, 2016. Cash provided by financing activities for the six months ended April 30, 2017 primarily related to long term debt proceeds and repayments as a result of the Refinancing and cash provided by financing activities for the six months ended April 30, 2016 primarily related to various repayments required by our debt agreements.
Financing Arrangements
2017 Term Loans and Revolving Line
On April 20, 2017, the Company completed the refinancing of its term loans and revolving credit facility (the "Refinancing'") existing credit facility (the "Refinancing") by entering into Amendment No. 4 of the original credit facility agreement dated as of March 11, 2014 (the "Credit Facility"). Under Amendment No. 4, the existing term loans were refinanced with new term loans ("Tranche B Term Loans"). The Tranche B Term Loans consisted of (i) Tranche B US Dollar Term Loans in the amount of $1.133 billion and (ii) Tranche B Euro Term Loans in the amount of €463.1 million, or $496.3 million. The Tranche B Term Loans will mature on April 20, 2024.
Under Amendment No. 4, the Company increased the size of the revolver facility (the "Revolving Facility") to $250.0 million, of which up to $75.0 million is available for letters of credit. Of the total revolving commitments, $87.1 million will terminate on March 11, 2019 (the "Tranche A Commitments") and the remaining commitments (the "Tranche B Commitments") will terminate on April 20, 2022.
The US Dollar denominated Tranche B Term Loans bear interest at a rate per annum equal to, at the option of the Company, a base rate plus 2.25% or LIBOR with a floor of 1% plus 3.25%. The margin applied to the base rate will be reduced to 2.0% and the margin applied to LIBOR will be reduced to 3.0% if the Company achieves, and as long as the Company maintains, a B2/Stable credit rating or better from Moody's Inventors Service, Inc.
The Euro denominated Tranche B Term Loans bear interest at a rate per annum equal to LIBOR with a floor of 1% plus 3.00%.
Borrowings under the Revolving Facility bear interest at a rate per annum equal to, at the option of the Company, a base rate plus 2.25% or LIBOR plus an applicable margin of 3.25%. The Company will also pay a commitment fee of 0.50% per annum on the unused portion of the Revolving Facility with a step down to 0.375% when the First Lien Leverage Ratio (as defined below) is less than or equal to 3.00 to 1.00.
As of April 30, 2017, the Company borrowed $50.0 million against the Revolving Facility, which will renew until paid.
Under the Revolving Facility, we are required to maintain a First Lien Leverage Ratio below a certain amount for each of the Testing Periods as set forth in the Credit Agreement after such time as we have borrowed 25% of the available credit under the Secured Revolving Facility, or $62.5 million. For purposes of the Credit Agreement, a Testing Period means a single period consisting of the most recent four consecutive fiscal quarters ending on the covenant determination date. As of April 30, 2017, we were not required to calculate the First Lien Leverage Ratio as we have not borrowed 25% or $62.5 million under the Secured Revolving Facility. The following table discloses the maximum First Lien Leverage Ratios permitted under the Credit Agreement:
Testing Period Ending
Maximum Ratio
April 30, 2014 through October 31, 2014
6.75 to 1.00
November 1, 2014 through October 31, 2015
6.50 to 1.00
November 1, 2015 through October 31, 2016
6.25 to 1.00
November 1, 2016 through October 31, 2017
6.00 to 1.00
November 1, 2017 and thereafter
5.75 to 1.00

48



"First Lien Leverage Ratio" is generally defined in the Credit Agreement as the ratio of (i) the sum of the aggregate principal amount of our and our restricted subsidiaries' indebtedness for borrowed money, principal amount of capital lease obligations and debt obligations evidenced by bonds, promissory notes, debentures or debt securities that is secured by a first priority lien on the collateral minus unrestricted cash and cash equivalents held by us and our restricted subsidiaries in each case set forth in the Credit Agreement to (ii) Consolidated EBITDA. Consolidated EBITDA is generally defined in the Credit Agreement as income (loss) from continuing operations before repositioning expenses, interest expense, foreign exchange losses reclassified from other comprehensive income (loss), refinancing expenses, acquisition-related costs, gains and losses on sale of capital assets, income taxes, asset impairment charges, depreciation and amortization, stock-based compensation expense, consulting costs related to our operational initiatives, purchase accounting adjustments, other income and expenses, non-cash charges, expenses related to the DPP Acquisition, pro forma cost savings from operational excellence initiatives and plant consolidations, pro forma synergies from the DPP Acquisition, and proceeds from business interruption insurance, among other adjustments. Consolidated EBITDA is not equivalent to Adjusted EBITDA, which is our measure of segment performance.
We are required to make the following mandatory prepayments in respect of the Secured Term Loans: (i) 50% of Excess Cash Flow (as defined in the Credit Agreement) when we maintain a First Lien Leverage Ratio of greater than 4.00 to 1.00, with step downs to (a) 25% when we maintain a First Lien Leverage Ratio of less than or equal to 4.00 to 1.00 but greater than 3.50 to 1.00 and (b) 0% when we maintain a First Lien Leverage Ratio of less than or equal to 3.50 to 1.00; (ii) 100% of the net cash proceeds of certain asset sales (including insurance and condemnation proceeds), subject to thresholds, reinvestment rights and certain other exceptions; and (iii) 100% of the net cash proceeds of issuances of debt obligations, subject to certain exceptions and thresholds. "Excess Cash Flow" is generally defined as Consolidated EBITDA (as defined in the Credit Agreement) plus, (i) decreases in working capital, (ii) extraordinary or nonrecurring income or gains and (iii) certain other adjustments, minus, (a) increases in working capital, (b) cash interest, (c) cash taxes, (d) cash capital expenditures (e) scheduled debt amortization and (f) certain other adjustments. No Excess Cash Flow payment was required for fiscal 2015. As the Excess Cash Flow calculation is performed annually, no payment is due for the six months ended April 30, 2017. We may voluntarily repay borrowings under the Credit Facility at any time.
If we fail to maintain the applicable First Lien Leverage Ratio, we may nevertheless avoid a default by (i) repaying outstanding borrowings under the Revolving Line in an amount sufficient to avoid triggering the First Lien Leverage Ratio for that fiscal quarter or (ii) accepting a cash contribution of qualified equity in an amount which, if treated as Consolidated EBITDA, would bring us into compliance with the applicable First Lien Leverage Ratio for that fiscal quarter, in each case during the 11 business days following the deadline for delivery of our compliance certificate for that fiscal quarter. In addition, maintenance of the First Lien Leverage Ratio is required only with respect to the Revolving Line; the Term Loans do not directly benefit from the financial covenant and, until the Revolving Line is terminated and all outstanding borrowings thereunder are accelerated, will remain unaffected by a default under the Revolving Line that arises from our failure to maintain the applicable First Lien Coverage Ratio.
The Credit Agreement contains other customary terms, including (i)  representations, warranties and affirmative covenants, (ii)  negative covenants (in addition to the limitation on distributions and the requirement to maintain the First Lien Leverage Ratio levels as described above), such as limitations on indebtedness, liens, mergers, acquisitions, asset sales, investments, prepayments of subordinated debt, and transactions with affiliates, in each case subject to baskets, thresholds and other exceptions, and (iii)  events of default, such as for non-payment, breach of other covenants, misrepresentations, cross default to other debt, change in control, bankruptcy events, ERISA events, unsatisfied judgments and actual or asserted invalidity of guarantees or security documents.
As of April 30, 2017, we were in compliance with the covenants in the Credit Facility.
Provided that we are in compliance with the First Lien Leverage Ratio test and no default under the Credit Agreement is continuing or would result therefrom, the covenant in the Credit Agreement that limits our ability to pay dividends or make other distributions to its shareholders generally permits (with certain exceptions and qualifications) us to pay dividends or make such distributions in an aggregate amount, when taken together with the aggregate amount of any prepayment, repurchase, redemption or defeasance of subordinated indebtedness, not to exceed the greater of (x) 3.00% of Consolidated Total Assets and (y) $65.0 million and (ii) in aggregate amount not to exceed the available amount (as defined in the Credit Agreement) at such time.
The Credit Facility is guaranteed by the Company and certain subsidiaries, and is secured by a first priority pledge on substantially all of the assets of the Company and the subsidiary guarantors, in each case subject to certain exceptions.
Consolidated EBITDA is based on the definition in the Credit Agreement, is not defined under U.S. GAAP and is subject to important limitations. We have included the calculation of Consolidated EBITDA, and associated reconciliations, for the period

49



presented below as Consolidated EBITDA is a component of certain covenants under the Credit Agreement. Because not all companies use identical calculations, our presentation of Consolidated EBITDA may not be comparable to other similarly titled measures of other companies.
Our Consolidated EBITDA for the last four fiscal quarters ended April 30, 2017 based on the definition in our Credit Agreement is calculated as follows:
 
Twelve months ended
 
April 30, 2017
(in millions of U.S. dollars)
$
Consolidated EBITDA per Credit Agreement
458.3

Less:
 
Pro forma cost savings
(37.3
)
Other
(6.7
)
Adjusted EBITDA
414.3

(Deduct) add:
 
Depreciation and amortization
(121.4
)
Repositioning expenses
(10.2
)
Acquisition and integration costs
(18.0
)
Interest expense, net
(133.0
)
Benefit from income taxes
46.8

Refinancing expenses
(27.9
)
Operational initiatives related consulting costs
(3.4
)
IPO costs
(1.2
)
Acquisition related litigation expenses
(8.1
)
Stock based compensation expense
(29.6
)
FDA remediation costs
(14.3
)
Environmental remediation costs
(3.7
)
Other
(7.9
)
Income from continuing operations
108.8

Add (deduct):
 
Depreciation and amortization
121.4

Stock-based compensation
29.6

Net change in non-cash working capital
(84.4
)
Net change in deferred revenues
25.0

Non-cash interest
27.2

Bargain purchase gain
(26.4
)
Other, primarily changes in long-term assets and liabilities and deferred taxes
(76.5
)
Cash flows from operating activities of continuing operations
124.7

Cash flows from operating activities of discontinued operations
—

Cash flows from operating activities
124.7

 
 
Cash flows from investing activities
(220.2
)
Cash flows from financing activities
10.8

Pro forma cost savings represents the estimated annual financial impact of the actions related to our OE Program initiatives, headcount reductions and plant consolidation savings as if such activities were completed as of May 1, 2016.

50



The calculation of the first lien leverage ratio, if required, would include total debt secured by a first priority lien as of April 30, 2017 of $1,637.6 million. Net debt is then calculated to be $1,544.9 million (total debt secured by a first priority lien less total cash as of April 30, 2017 of $92.7 million). As a result our first lien leverage ratio as of April 30, 2017 would be 3.37.
2014 Senior Unsecured Notes
In February 2014, we issued $450.0 million in aggregate principal amount of 7.50% senior unsecured notes due February 1, 2022 (the ‘‘Notes’’) in a private placement, pursuant to which it entered into an indenture (the ‘‘Indenture’’) with a commercial bank acting as trustee (the ‘‘Trustee’’).
Interest on the Notes accrues at a rate of 7.50% per annum and is payable semiannually in arrears on each February 1 and August 1, commencing on August 1, 2014. Interest is computed on the basis of a 360-day year comprised of twelve 30-day months. The Notes are generally required to be guaranteed by each of our restricted subsidiaries that guarantees the Credit Facility or that guarantees other material indebtedness of ours or other Note guarantors.
Except for offers to purchase Notes upon certain asset sales or a change in control, no mandatory redemption or sinking fund payment is required with respect to the Notes.
On and after February 1, 2017, we may redeem all or a portion of the Notes at the applicable redemption prices set forth below, plus unpaid interest accruing on the principal amount redeemed to the Redemption Date:
Year
%
2017
105.625
2018
103.750
2019
101.875
2020 and thereafter
100.000
In addition, we may redeem all of the Notes at a redemption price equal to the principal amount redeemed, plus unpaid interest accruing to the Redemption Date, upon certain adverse changes in applicable tax laws.
The Notes are guaranteed by the Company and the Indenture does not require us to maintain compliance with any financial covenants. The Indenture does contain customary affirmative and negative covenants, including with respect to mergers, asset sales, restricted payments, restricted investments, issuance of debt and equity, liens, and affiliate transactions, subject to baskets and other exceptions. However, we will be exempt from many of the negative covenants if the Notes receive investment grade ratings from both Moody’s and S&P. The Indenture also contains customary events of default, such as for non-payment, breach of other covenants, misrepresentation, cross default to other material debt, bankruptcy events, unsatisfied judgments, and actual or asserted invalidity of guarantees.
As of April 30, 2017, we were in compliance with the covenants in the Indenture.
Financing Ratios
Total interest-bearing debt at April 30, 2017 was $2,088.8 million, $20.1 million higher than at October 31, 2016, primarily due to foreign exchange impacts on our Euro denominated debt. At April 30, 2017, our consolidated ratio of interest-bearing debt to shareholders' deficit was 739.4%, compared to 593.8% at October 31, 2016.
Off-Balance Sheet Arrangements
We do not have any relationships with entities often referred to as structured finance or special purpose entities that were established for the purpose of facilitating off-balance sheet arrangements. As such, we are not exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.
Recent Accounting Pronouncements
See Note 2 to our unaudited consolidated financial statements contained in this quarterly report for a description of recent accounting pronouncements, including the expected dates of adoption and estimated effects, if any, on our consolidated financial statements.
Critical Accounting Estimates

51



For information regarding our critical accounting policies and estimates, please refer to "Management's Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Estimates" contained in our Form 10-K for the fiscal year ended October 31, 2016. There have been no material changes to the critical accounting policies previously disclosed in that report.

52



Item 3.    Quantitative and Qualitative Disclosures about Market Risk
There have been no material changes to our exposure to market risks as described in Part II, Item 7A of our Annual Report on Form 10-K for the fiscal year ended October 31, 2016.

53



Item 4.    Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of such date. Our disclosure controls and procedures are designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There have been no changes in the Company's internal controls over financial reporting during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.


54




Part II.    Other Information
Item 1.    Legal Proceedings
The information required by this item is incorporated by reference to Part I, Item 1, Note 15: Other Information.
Item 1A. Risk Factors
There have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the fiscal year ended October 31, 2016.
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds
None.
Item 3.    Defaults upon Senior Securities
None.
Item 4.    Mine Safety Disclosures
Not applicable.
Item 5.    Other Information
None.

55



Item 6.    Exhibits
Exhibit
 
 
Incorporated by Reference
Filed
Number
 
Exhibit Description
Form
Exhibit
Filing Date
Herewith
2.1

 
Stock Purchase Agreement, dated November 25, 2016, by and among DPI Newco LLC, Roche Carolina Inc., Roche Holdings, Inc., and Patheon Holdings I B.V., solely for the purposes of Article XII thereof
8-K
2.1
2/1/2017
 
2.2

 
Purchase Agreement, dated as of May 15, 2017, by and between Thermo Fisher Scientific Inc., Thermo Fisher (CN) Luxembourg S.à r.l. and Patheon N.V.

8-K
2.2
5/15/2017
 
10.1

 
Amendment No. 4 and Refinancing Amendment No. 1 to Credit Agreement and Incremental Revolving Credit Assumption Agreement dated as of April 20, 2017, by and among Patheon Holdings I B.V., the other credit parties party thereto, the lending institutions party thereto and Credit Suisse AG, as successor administrative agent to UBS AG, Stamford Branch
8-K
10.1
4/26/2017
 
31.1

 
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
 
 
*
31.2

 
Certification of Periodic Report by Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
 
 
*
32.1

 
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
 
 
*
101.INS

 
XBRL Instance Document
 
 
 
*
101.SCH

 
XBRL Taxonomy Extension Schema Document
 
 
 
*
101.CAL

 
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
 
*
101.DEF

 
XBRL Taxonomy Extension Definition Linkbase Document
 
 
 
*
101.LAB

 
XBRL Taxonomy Extension Label Linkbase Document
 
 
 
*
101.PRE

 
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
 
*

† Indicates a management contract or compensatory plan or arrangement

56



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Patheon N.V.
(Registrant)
 

By:    /s/ James Mullen
James Mullen
Chief Executive Officer
(Principal Executive Officer and Duly Authorized Officer)

June 9, 2017



By:    /s/ Stuart Grant
Stuart Grant
Chief Financial Officer
(Principal Financial Officer and Duly Authorized Officer)

June 9, 2017


57
 EX-31.1 2 q22017-exhibit311.htm EXHIBIT 31.1 Exhibit


Exhibit 31.1
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, James Mullen, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended April 30, 2017 of Patheon N.V.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



/s/ James Mullen
James Mullen
Chief Executive Officer

June 9, 2017



 EX-32.1 3 q22017-exhibit321.htm EXHIBIT 32.1 Exhibit


Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report on Form 10-Q of Patheon N.V. (the “Company”), for the quarterly period ended April 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ James Mullen
James Mullen
Chief Executive Officer

June 9, 2017



/s/ Stuart Grant
Stuart Grant
Chief Financial Officer

June 9, 2017


 EX-32.2 4 q22017-exhibit312.htm EXHIBIT 32.2 Exhibit


Exhibit 31.2
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Stuart Grant, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended April 30, 2017 of Patheon N.V.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



/s/ Stuart Grant
Stuart Grant
Chief Financial Officer

June 9, 2017



 EX-101.INS 5 pti-20170430.xml XBRL INSTANCE DOCUMENT 0001643848 2016-11-01 2017-04-30 0001643848 2017-05-31 0001643848 2016-10-31 0001643848 2017-04-30 0001643848 2015-11-01 2016-04-30 0001643848 2016-02-01 2016-04-30 0001643848 2017-02-01 2017-04-30 0001643848 us-gaap:RetainedEarningsMember 2016-10-31 0001643848 us-gaap:TreasuryStockMember 2017-04-30 0001643848 us-gaap:CommonStockMember 2016-10-31 0001643848 us-gaap:TreasuryStockMember 2016-11-01 2017-04-30 0001643848 us-gaap:RetainedEarningsMember 2016-11-01 2017-04-30 0001643848 us-gaap:TreasuryStockMember 2016-10-31 0001643848 us-gaap:RetainedEarningsMember 2017-04-30 0001643848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-11-01 2017-04-30 0001643848 us-gaap:AdditionalPaidInCapitalMember 2016-11-01 2017-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2016-11-01 2017-04-30 0001643848 us-gaap:CommonStockMember 2017-04-30 0001643848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-10-31 0001643848 us-gaap:AdditionalPaidInCapitalMember 2016-10-31 0001643848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-04-30 0001643848 us-gaap:AdditionalPaidInCapitalMember 2017-04-30 0001643848 2015-10-31 0001643848 2016-04-30 0001643848 2016-07-21 0001643848 pti:JLLPatheonCoInvestmentFundL.P.Member 2013-12-24 0001643848 2016-07-26 2016-07-26 0001643848 us-gaap:IPOMember 2016-07-21 2016-07-21 0001643848 pti:JLLDeltaPatheonHoldingsMember 2016-07-26 0001643848 pti:JLLPatheonCoInvestmentFundL.P.Member 2016-07-26 0001643848 us-gaap:IPOMember 2016-07-21 0001643848 pti:KoninklijkeDSMMember 2016-07-26 0001643848 2016-07-21 2016-07-21 0001643848 us-gaap:IPOMember 2016-07-26 2016-07-26 0001643848 pti:KoninklijkeDSMMember 2013-12-24 0001643848 pti:KoninklijkeDSMMember us-gaap:IPOMember 2016-07-21 2016-07-21 0001643848 us-gaap:AccountingStandardsUpdate201503Member us-gaap:LongTermDebtMember 2017-04-30 0001643848 pti:RocheCarolinaInc.Member 2017-02-01 2017-02-01 0001643848 pti:RocheCarolinaInc.Member 2015-11-01 2016-04-30 0001643848 pti:RocheCarolinaInc.Member 2017-02-01 0001643848 pti:RocheCarolinaInc.Member 2015-03-31 0001643848 pti:RocheCarolinaInc.Member 2017-02-01 2017-04-30 0001643848 pti:DPPAcquisitionMember 2016-02-01 2016-04-30 0001643848 pti:DPPAcquisitionMember 2015-11-01 2016-04-30 0001643848 pti:DPPAcquisitionMember 2016-11-01 2017-04-30 0001643848 pti:DPPAcquisitionMember 2017-02-01 2017-04-30 0001643848 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember pti:DPxFineChemicalsMember 2016-02-01 2016-04-30 0001643848 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember pti:DPxFineChemicalsMember 2015-11-01 2016-04-30 0001643848 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember pti:BiosolutionsMember 2015-07-31 2015-07-31 0001643848 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember pti:DPxFineChemicalsMember 2015-08-31 0001643848 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember pti:BannerPharmacapsMember 2015-05-12 2015-05-12 0001643848 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember pti:BannerPharmacapsMember 2015-05-12 0001643848 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember pti:BiosolutionsMember 2015-07-31 0001643848 us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember pti:BannerLifeSciencesMember us-gaap:InProcessResearchAndDevelopmentMember 2015-11-01 2016-04-30 0001643848 us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember pti:BannerLifeSciencesMember us-gaap:InProcessResearchAndDevelopmentMember 2016-01-31 0001643848 pti:RegulatoryPermitsMember 2017-04-30 0001643848 us-gaap:InProcessResearchAndDevelopmentMember 2017-04-30 0001643848 us-gaap:DevelopedTechnologyRightsMember 2017-04-30 0001643848 pti:TradeSecretsandPatentsMember 2017-04-30 0001643848 us-gaap:NoncompeteAgreementsMember 2016-11-01 2017-04-30 0001643848 us-gaap:NoncompeteAgreementsMember 2017-04-30 0001643848 pti:FavorableAgreementsMember 2017-04-30 0001643848 us-gaap:TradeNamesMember 2017-04-30 0001643848 pti:TradeSecretsandPatentsMember 2016-11-01 2017-04-30 0001643848 us-gaap:CustomerRelationshipsMember 2017-04-30 0001643848 us-gaap:TradeNamesMember 2016-11-01 2017-04-30 0001643848 us-gaap:DevelopedTechnologyRightsMember 2016-11-01 2017-04-30 0001643848 us-gaap:CustomerRelationshipsMember 2016-11-01 2017-04-30 0001643848 pti:FavorableAgreementsMember 2016-11-01 2017-04-30 0001643848 pti:SeniorNotesDueFebruary20227.50Member us-gaap:DebtInstrumentRedemptionPeriodFourMember us-gaap:SeniorNotesMember 2014-02-01 2014-02-28 0001643848 pti:SeniorNotesDueFebruary20227.50Member us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:SeniorNotesMember 2014-02-01 2014-02-28 0001643848 pti:SeniorNotesDueFebruary20227.50Member us-gaap:DebtInstrumentRedemptionPeriodThreeMember us-gaap:SeniorNotesMember 2014-02-01 2014-02-28 0001643848 pti:SeniorNotesDueFebruary20227.50Member us-gaap:DebtInstrumentRedemptionPeriodFiveMember us-gaap:SeniorNotesMember 2014-02-01 2014-02-28 0001643848 pti:EuroTermLoanDueMarch2021Member us-gaap:ForeignLineOfCreditMember 2016-10-31 0001643848 pti:USDTermLoanDueMarch2021Member us-gaap:DomesticLineOfCreditMember 2016-10-31 0001643848 pti:SeniorNotesDueFebruary20227.50Member us-gaap:SeniorNotesMember 2017-04-30 0001643848 pti:EuroTermLoanDueApril202024Member us-gaap:ForeignLineOfCreditMember 2017-04-30 0001643848 pti:USDTermLoanDueApril202024Member us-gaap:DomesticLineOfCreditMember 2016-10-31 0001643848 pti:GovernmentofAustriaResearchandDevelopmentLoansDueMarch2019Member us-gaap:LoansPayableMember 2016-10-31 0001643848 us-gaap:RevolvingCreditFacilityMember pti:NonInterestBearingLoanDueMay2016Member 2016-10-31 0001643848 pti:GovernmentofAustriaResearchandDevelopmentLoansDueMarch2019Member us-gaap:LoansPayableMember 2017-04-30 0001643848 us-gaap:RevolvingCreditFacilityMember pti:NonInterestBearingLoanDueMay2016Member 2017-04-30 0001643848 pti:EuroTermLoanDueMarch2021Member us-gaap:ForeignLineOfCreditMember 2017-04-30 0001643848 pti:ItalianBankLoanDueJune2020Member us-gaap:LoansPayableMember 2017-04-30 0001643848 pti:ItalianSubsidizedLoanDueJune2020Member us-gaap:LoansPayableMember 2017-04-30 0001643848 pti:SeniorNotesDueFebruary20227.50Member us-gaap:SeniorNotesMember 2016-10-31 0001643848 pti:ItalianSubsidizedLoanDueJune2020Member us-gaap:LoansPayableMember 2016-10-31 0001643848 pti:EuroTermLoanDueApril202024Member us-gaap:ForeignLineOfCreditMember 2016-10-31 0001643848 pti:ItalianBankLoanDueJune2020Member us-gaap:LoansPayableMember 2016-10-31 0001643848 us-gaap:CapitalLeaseObligationsMember 2017-04-30 0001643848 pti:USDTermLoanDueMarch2021Member us-gaap:DomesticLineOfCreditMember 2017-04-30 0001643848 pti:USDTermLoanDueApril202024Member us-gaap:DomesticLineOfCreditMember 2017-04-30 0001643848 us-gaap:CapitalLeaseObligationsMember 2016-10-31 0001643848 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2017-04-20 2017-04-20 0001643848 us-gaap:LineOfCreditMember 2017-04-20 2017-04-20 0001643848 pti:ItalianBankLoanDueJune2020Member us-gaap:LoansPayableMember 2016-02-01 2016-04-30 0001643848 us-gaap:LoansPayableMember 2013-05-01 2013-07-31 0001643848 pti:FirstLienLeverageRatioGreaterthan4.00to1.00Member us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2017-04-20 2017-04-20 0001643848 pti:FIrstLienLeverageRatioislessthanorequalto3.00to1.00Member us-gaap:RevolvingCreditFacilityMember pti:SecuredRevolvingFacilityDueApril202024Member us-gaap:LineOfCreditMember 2017-04-20 0001643848 pti:FirstLienLeverageRatioGreaterthan4.00to1.00Member us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2017-04-20 0001643848 us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2017-02-01 2017-04-30 0001643848 us-gaap:RevolvingCreditFacilityMember pti:USDTermLoanDueApril202024Member us-gaap:DomesticLineOfCreditMember 2017-04-20 0001643848 pti:ItalianSubsidizedLoanDueJune2020Member us-gaap:LoansPayableMember 2016-02-01 2016-04-30 0001643848 pti:ItalianBankLoanDueJune2020Member us-gaap:LoansPayableMember 2013-05-01 2013-07-31 0001643848 pti:FirstLienLeverageRatioofLessThanorEqualto3.50to1.00Member us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2017-04-20 0001643848 us-gaap:LetterOfCreditMember pti:USDTermLoanDueApril202024Member us-gaap:DomesticLineOfCreditMember 2017-04-20 0001643848 us-gaap:SecuredDebtMember pti:EuroTermLoanDueApril202024Member us-gaap:ForeignLineOfCreditMember 2017-04-20 0001643848 pti:FirstLienLeverageRatioLessThanorEqualto4.00to1.00ButGreaterThan3.50to1.00Member us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember us-gaap:MaximumMember 2017-04-20 0001643848 us-gaap:SecuredDebtMember pti:EuroTermLoanDueApril202024Member us-gaap:ForeignLineOfCreditMember us-gaap:MinimumMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-04-20 2017-04-20 0001643848 pti:SeniorNotesDueFebruary20227.50Member us-gaap:SeniorNotesMember 2014-02-28 0001643848 us-gaap:RevolvingCreditFacilityMember pti:SecuredRevolvingFacilityDueApril202024Member us-gaap:LineOfCreditMember 2017-04-20 0001643848 pti:FIrstLienLeverageRatioislessthanorequalto3.00to1.00Member us-gaap:RevolvingCreditFacilityMember pti:SecuredRevolvingFacilityDueApril202024Member us-gaap:LineOfCreditMember 2017-04-20 2017-04-20 0001643848 pti:FirstLienLeverageRatioofLessThanorEqualto3.50to1.00Member us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2017-04-20 2017-04-20 0001643848 us-gaap:RevolvingCreditFacilityMember pti:USDTermLoanDueToTerminateonMarch112019Member us-gaap:DomesticLineOfCreditMember 2017-04-20 0001643848 pti:FirstLienLeverageRatioLessThanorEqualto4.00to1.00ButGreaterThan3.50to1.00Member us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember us-gaap:MinimumMember 2017-04-20 0001643848 us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2017-04-20 2017-04-20 0001643848 us-gaap:RevolvingCreditFacilityMember pti:SecuredRevolvingFacilityDueApril202024Member us-gaap:LineOfCreditMember 2017-04-20 2017-04-20 0001643848 us-gaap:SecuredDebtMember pti:USDTermLoanDueApril202024Member us-gaap:DomesticLineOfCreditMember us-gaap:BaseRateMember 2017-04-20 2017-04-20 0001643848 us-gaap:SecuredDebtMember pti:USDTermLoanDueApril202024Member us-gaap:DomesticLineOfCreditMember us-gaap:MinimumMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-04-20 2017-04-20 0001643848 pti:ItalianSubsidizedLoanDueJune2020Member us-gaap:LoansPayableMember 2013-07-31 0001643848 us-gaap:NotesPayableOtherPayablesMember 2015-08-31 0001643848 us-gaap:RevolvingCreditFacilityMember pti:USDTermLoanDueApril202024Member us-gaap:DomesticLineOfCreditMember us-gaap:BaseRateMember 2017-04-20 2017-04-20 0001643848 us-gaap:SecuredDebtMember pti:USDTermLoanDueApril202024Member us-gaap:DomesticLineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-04-20 2017-04-20 0001643848 pti:ItalianBankLoanDueJune2020Member us-gaap:LoansPayableMember 2013-07-31 0001643848 us-gaap:RevolvingCreditFacilityMember pti:USDTermLoanDueApril202024Member us-gaap:DomesticLineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-04-20 2017-04-20 0001643848 us-gaap:SecuredDebtMember pti:USDTermLoanDueApril202024Member us-gaap:DomesticLineOfCreditMember us-gaap:MinimumMember us-gaap:BaseRateMember 2017-04-20 2017-04-20 0001643848 us-gaap:SecuredDebtMember us-gaap:DomesticLineOfCreditMember 2017-04-30 0001643848 us-gaap:SecuredDebtMember pti:USDTermLoanDueApril202024Member us-gaap:DomesticLineOfCreditMember 2017-04-20 0001643848 pti:ItalianBankLoanDueJune2020Member us-gaap:LoansPayableMember pti:Euribor6monthMember 2013-05-01 2013-07-31 0001643848 us-gaap:RevolvingCreditFacilityMember pti:SecuredRevolvingFacilityDueApril202024Member us-gaap:LineOfCreditMember 2017-04-30 0001643848 pti:InvestmentinFacilityMember 2015-08-31 0001643848 pti:FirstLienLeverageRatioLessThanorEqualto4.00to1.00ButGreaterThan3.50to1.00Member us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2017-04-20 2017-04-20 0001643848 pti:ItalianSubsidizedLoanDueJune2020Member us-gaap:LoansPayableMember 2013-05-01 2013-07-31 0001643848 us-gaap:SecuredDebtMember pti:EuroTermLoanDueApril202024Member us-gaap:ForeignLineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-04-20 2017-04-20 0001643848 pti:LeverageRatioTestingPeriodRangeTwoMember us-gaap:RevolvingCreditFacilityMember pti:SecuredRevolvingFacilityDueMarch2019Member us-gaap:LineOfCreditMember 2014-03-11 0001643848 pti:LeverageRatioTestingPeriodRangeFourMember us-gaap:RevolvingCreditFacilityMember pti:SecuredRevolvingFacilityDueMarch2019Member us-gaap:LineOfCreditMember 2014-03-11 0001643848 pti:LeverageRatioTestingPeriodRangeThreeMember us-gaap:RevolvingCreditFacilityMember pti:SecuredRevolvingFacilityDueMarch2019Member us-gaap:LineOfCreditMember 2014-03-11 0001643848 pti:LeverageRatioTestingPeriodRangeFiveMember us-gaap:RevolvingCreditFacilityMember pti:SecuredRevolvingFacilityDueMarch2019Member us-gaap:LineOfCreditMember 2014-03-11 0001643848 pti:LeverageRatioTestingPeriodRangeOneMember us-gaap:RevolvingCreditFacilityMember pti:SecuredRevolvingFacilityDueMarch2019Member us-gaap:LineOfCreditMember 2014-03-11 0001643848 pti:EuroTermLoanDueApril202024Member us-gaap:ForeignLineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-02-01 2017-04-30 0001643848 pti:EuroTermLoanDueMarch2021Member us-gaap:ForeignLineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-02-01 2017-04-30 0001643848 pti:USDTermLoanDueApril202024Member us-gaap:DomesticLineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-02-01 2017-04-30 0001643848 pti:EuroTermLoanDueMarch2021Member us-gaap:ForeignLineOfCreditMember us-gaap:BaseRateMember 2017-02-01 2017-04-30 0001643848 us-gaap:RevolvingCreditFacilityMember pti:NonInterestBearingLoanDueMay2016Member 2017-02-01 2017-04-30 0001643848 pti:USDTermLoanDueMarch2021Member us-gaap:DomesticLineOfCreditMember us-gaap:BaseRateMember 2017-02-01 2017-04-30 0001643848 pti:GovernmentofAustriaResearchandDevelopmentLoansDueMarch2019Member us-gaap:MinimumMember 2017-04-30 0001643848 pti:USDTermLoanDueMarch2021Member us-gaap:DomesticLineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-02-01 2017-04-30 0001643848 pti:ItalianBankLoanDueJune2020Member us-gaap:LoansPayableMember pti:Euribor6monthMember 2017-02-01 2017-04-30 0001643848 pti:GovernmentofAustriaResearchandDevelopmentLoansDueMarch2019Member us-gaap:MaximumMember 2017-04-30 0001643848 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2016-11-01 2017-04-30 0001643848 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2015-11-01 2016-04-30 0001643848 us-gaap:PensionPlansDefinedBenefitMember 2016-11-01 2017-04-30 0001643848 us-gaap:PensionPlansDefinedBenefitMember 2015-11-01 2016-04-30 0001643848 us-gaap:PensionPlansDefinedBenefitMember 2017-02-01 2017-04-30 0001643848 us-gaap:PensionPlansDefinedBenefitMember 2016-02-01 2016-04-30 0001643848 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2016-02-01 2016-04-30 0001643848 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-02-01 2017-04-30 0001643848 country:IT 2015-11-01 2016-10-31 0001643848 country:IT 2015-11-01 2016-04-30 0001643848 country:IT 2016-11-01 2017-04-30 0001643848 country:IT 2016-02-01 2016-04-30 0001643848 2015-11-01 2016-10-31 0001643848 country:IT 2017-02-01 2017-04-30 0001643848 us-gaap:EmployeeStockOptionMember 2016-11-01 2017-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember 2015-11-01 2016-04-30 0001643848 us-gaap:EmployeeStockOptionMember 2016-02-01 2016-04-30 0001643848 us-gaap:EmployeeStockOptionMember 2017-02-01 2017-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember 2016-02-01 2016-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember 2016-11-01 2017-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember 2017-02-01 2017-04-30 0001643848 us-gaap:EmployeeStockOptionMember 2015-11-01 2016-04-30 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember us-gaap:CommonClassBMember 2016-11-01 2017-04-30 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember pti:CommonClassDMember 2017-04-30 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember pti:CommonClassDMember 2016-10-31 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember us-gaap:CommonClassCMember 2017-04-30 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember 2017-04-30 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember 2016-10-31 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember us-gaap:CommonClassBMember 2016-10-31 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember 2016-11-01 2017-04-30 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember us-gaap:CommonClassBMember 2017-04-30 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember pti:CommonClassEMember 2017-04-30 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember us-gaap:CommonClassCMember 2016-10-31 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember pti:CommonClassEMember 2016-10-31 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember pti:CommonClassEMember 2016-11-01 2017-04-30 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember us-gaap:CommonClassCMember 2016-11-01 2017-04-30 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember pti:CommonClassDMember 2016-11-01 2017-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember 2016-11-01 2017-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember 2016-10-31 0001643848 us-gaap:RestrictedStockUnitsRSUMember 2017-04-30 0001643848 us-gaap:EmployeeStockOptionMember 2017-04-30 0001643848 us-gaap:EmployeeStockOptionMember 2016-10-31 0001643848 us-gaap:EmployeeStockOptionMember 2016-11-01 2017-04-30 0001643848 pti:DPxManagementEquityIncentivePlanMember pti:CommonClassCClassDClassEStockMember 2017-04-30 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember us-gaap:IPOMember 2016-07-26 0001643848 pti:DPxManagementEquityIncentivePlanMember 2016-11-01 2017-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2017-02-01 2017-04-30 0001643848 us-gaap:EmployeeStockOptionMember us-gaap:IPOMember 2016-07-26 0001643848 pti:DPxManagementEquityIncentivePlanMember pti:CommonClassCClassDClassEStockMember 2017-02-01 2017-04-30 0001643848 pti:DPxManagementEquityIncentivePlanMember pti:CommonClassDMember 2016-11-01 2017-04-30 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember us-gaap:CommonClassBMember 2017-02-01 2017-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2017-04-30 0001643848 us-gaap:EmployeeStockOptionMember us-gaap:IPOMember 2017-02-01 2017-04-30 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember 2016-02-01 2016-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember us-gaap:IPOMember us-gaap:DirectorMember 2016-11-01 2017-04-30 0001643848 pti:DPxManagementEquityIncentivePlanMember us-gaap:CommonClassBMember 2017-04-30 0001643848 pti:DPxManagementEquityIncentivePlanMember us-gaap:CommonClassCMember 2016-11-01 2017-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember pti:DPxManagementEquityIncentivePlanMember 2016-12-08 2016-12-08 0001643848 us-gaap:EmployeeStockOptionMember us-gaap:IPOMember 2016-07-26 2016-07-26 0001643848 us-gaap:RestrictedStockUnitsRSUMember pti:DPxManagementEquityIncentivePlanMember 2017-02-01 2017-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember us-gaap:IPOMember us-gaap:ManagementMember 2016-11-01 2017-04-30 0001643848 pti:DPxManagementEquityIncentivePlanMember us-gaap:CommonClassBMember 2016-11-01 2017-04-30 0001643848 pti:DPxManagementEquityIncentivePlanMember pti:CommonClassCClassDClassEStockMember 2016-11-01 2017-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember pti:DPxManagementEquityIncentivePlanMember 2016-11-01 2017-04-30 0001643848 us-gaap:EmployeeStockOptionMember pti:EBITDAOptionsMember 2017-02-01 2017-04-30 0001643848 us-gaap:EmployeeStockOptionMember us-gaap:IPOMember 2016-11-01 2017-04-30 0001643848 us-gaap:EmployeeStockOptionMember us-gaap:IPOMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2016-07-26 2016-07-26 0001643848 us-gaap:RestrictedStockUnitsRSUMember us-gaap:IPOMember 2016-07-26 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember pti:CommonClassCClassDClassEStockMember 2017-02-01 2017-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember pti:DPxManagementEquityIncentivePlanMember us-gaap:CommonClassBMember 2017-02-01 2017-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember pti:DPxManagementEquityIncentivePlanMember 2016-07-26 0001643848 us-gaap:RestrictedStockUnitsRSUMember pti:DPxManagementEquityIncentivePlanMember 2016-12-08 0001643848 us-gaap:RestrictedStockUnitsRSUMember pti:DPxManagementEquityIncentivePlanMember 2017-04-30 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember 2015-11-01 2016-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember pti:DPxManagementEquityIncentivePlanMember us-gaap:CommonClassBMember 2016-11-01 2017-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember pti:DPxManagementEquityIncentivePlanMember pti:CommonClassCClassDClassEStockMember 2017-02-01 2017-04-30 0001643848 pti:DPxManagementEquityIncentivePlanMember pti:CommonClassEMember 2016-11-01 2017-04-30 0001643848 us-gaap:StockCompensationPlanMember pti:DPxManagementEquityIncentivePlanMember 2016-07-26 0001643848 us-gaap:EmployeeStockOptionMember pti:EBITDAOptionsMember 2017-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember 2016-02-01 2016-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember 2017-02-01 2017-04-30 0001643848 pti:DPxManagementEquityIncentivePlanMember 2017-02-01 2017-04-30 0001643848 us-gaap:EmployeeStockOptionMember 2015-11-01 2016-04-30 0001643848 us-gaap:EmployeeStockOptionMember 2017-02-01 2017-04-30 0001643848 us-gaap:EmployeeStockOptionMember 2016-02-01 2016-04-30 0001643848 us-gaap:RestrictedStockUnitsRSUMember 2015-11-01 2016-04-30 0001643848 us-gaap:EmployeeStockOptionMember pti:DPxManagementEquityIncentivePlanMember 2016-11-01 2017-04-30 0001643848 us-gaap:InvestmentsMember 2017-04-30 0001643848 us-gaap:InvestmentsMember 2016-10-31 0001643848 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-10-31 0001643848 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-10-31 0001643848 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-10-31 0001643848 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-10-31 0001643848 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-10-31 0001643848 us-gaap:FairValueInputsLevel3Member 2016-10-31 0001643848 us-gaap:ForeignExchangeForwardMember 2016-10-31 0001643848 us-gaap:FairValueInputsLevel1Member 2017-04-30 0001643848 us-gaap:ForeignExchangeForwardMember 2017-04-30 0001643848 us-gaap:FairValueInputsLevel2Member 2017-04-30 0001643848 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel1Member 2017-04-30 0001643848 us-gaap:FairValueInputsLevel3Member 2017-04-30 0001643848 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member 2017-04-30 0001643848 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel1Member 2016-10-31 0001643848 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel3Member 2017-04-30 0001643848 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel3Member 2016-10-31 0001643848 us-gaap:FairValueInputsLevel1Member 2016-10-31 0001643848 us-gaap:FairValueInputsLevel2Member 2016-10-31 0001643848 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member 2016-10-31 0001643848 us-gaap:FairValueInputsLevel3Member pti:EarnoutMember 2016-11-01 2017-04-30 0001643848 us-gaap:FairValueInputsLevel3Member pti:EarnoutMember 2016-10-31 0001643848 us-gaap:FairValueInputsLevel3Member pti:EarnoutMember 2017-04-30 0001643848 pti:DebtTrancheTwoMember 2016-01-29 0001643848 country:CA 2016-11-01 2017-04-30 0001643848 pti:LiquidityRiskMember 2017-04-30 0001643848 pti:ForeignExchangeForwardIssuedJanuary2017Member us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember country:CA 2017-04-30 0001643848 2016-01-29 0001643848 pti:DebtTrancheOneMember 2016-01-29 2016-01-29 0001643848 2016-01-31 0001643848 pti:ForeignExchangeForwardIssuedJanuary2017Member us-gaap:DesignatedAsHedgingInstrumentMember country:CA 2017-04-30 0001643848 us-gaap:ForeignLineOfCreditMember 2016-11-01 2017-04-30 0001643848 pti:ForeignExchangeForwardIssuedJanuary2017Member us-gaap:DesignatedAsHedgingInstrumentMember country:CA 2017-02-01 2017-04-30 0001643848 us-gaap:FairValueInputsLevel3Member pti:EarnoutMember 2017-02-01 2017-04-30 0001643848 pti:DebtTrancheTwoMember 2016-01-29 2016-01-29 0001643848 us-gaap:FairValueInputsLevel3Member pti:EarnoutMember 2015-11-01 2016-04-30 0001643848 country:CA 2017-04-30 0001643848 pti:DebtTrancheThreeMember 2016-01-29 0001643848 pti:DebtTrancheThreeMember 2016-01-29 2016-01-29 0001643848 us-gaap:ForeignLineOfCreditMember 2017-04-30 0001643848 us-gaap:FairValueInputsLevel3Member pti:EarnoutMember 2016-02-01 2016-04-30 0001643848 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember country:CA 2016-11-01 2017-04-30 0001643848 2016-01-29 2016-01-29 0001643848 pti:CashOutflowsMember us-gaap:GeographicConcentrationRiskMember country:CA 2016-11-01 2017-04-30 0001643848 pti:LiquidityRiskMember us-gaap:LineOfCreditMember 2017-04-30 0001643848 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-04-30 0001643848 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-04-30 0001643848 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-04-30 0001643848 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2017-04-30 0001643848 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-04-30 0001643848 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2017-02-01 2017-04-30 0001643848 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2015-11-01 2016-04-30 0001643848 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2016-02-01 2016-04-30 0001643848 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2016-11-01 2017-04-30 0001643848 us-gaap:SubsidiariesMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2016-02-01 2016-04-30 0001643848 us-gaap:SubsidiariesMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2015-11-01 2016-04-30 0001643848 us-gaap:SubsidiariesMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2017-02-01 2017-04-30 0001643848 us-gaap:SubsidiariesMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2016-11-01 2017-04-30 0001643848 us-gaap:OtherNoncurrentLiabilitiesMember 2017-04-30 0001643848 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember 2016-10-31 0001643848 us-gaap:OtherNoncurrentLiabilitiesMember 2016-10-31 0001643848 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember 2017-04-30 0001643848 country:CA 2016-04-30 0001643848 country:US 2016-04-30 0001643848 country:CA 2015-11-01 2016-04-30 0001643848 us-gaap:EuropeMember 2016-04-30 0001643848 pti:OtherCountriesMember 2016-04-30 0001643848 us-gaap:EuropeMember 2015-11-01 2016-04-30 0001643848 country:US 2015-11-01 2016-04-30 0001643848 pti:OtherCountriesMember 2015-11-01 2016-04-30 0001643848 country:US 2017-04-30 0001643848 pti:OtherCountriesMember 2016-11-01 2017-04-30 0001643848 us-gaap:EuropeMember 2017-04-30 0001643848 pti:OtherCountriesMember 2017-04-30 0001643848 country:US 2016-11-01 2017-04-30 0001643848 us-gaap:EuropeMember 2016-11-01 2017-04-30 0001643848 us-gaap:EuropeMember 2016-02-01 2016-04-30 0001643848 country:US 2016-02-01 2016-04-30 0001643848 country:CA 2016-02-01 2016-04-30 0001643848 pti:OtherCountriesMember 2016-02-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:DPSMember 2017-02-01 2017-04-30 0001643848 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2017-02-01 2017-04-30 0001643848 us-gaap:IntersegmentEliminationMember 2017-02-01 2017-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:PDSMember 2017-02-01 2017-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:DSSMember 2017-02-01 2017-04-30 0001643848 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2016-11-01 2017-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:DSSMember 2016-11-01 2017-04-30 0001643848 us-gaap:IntersegmentEliminationMember 2016-11-01 2017-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:PDSMember 2016-11-01 2017-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:DPSMember 2016-11-01 2017-04-30 0001643848 country:CA 2017-02-01 2017-04-30 0001643848 country:US 2017-02-01 2017-04-30 0001643848 us-gaap:EuropeMember 2017-02-01 2017-04-30 0001643848 pti:OtherCountriesMember 2017-02-01 2017-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:PDSMember 2016-02-01 2016-04-30 0001643848 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2016-02-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:DSSMember 2016-02-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:DPSMember 2016-02-01 2016-04-30 0001643848 us-gaap:IntersegmentEliminationMember 2016-02-01 2016-04-30 0001643848 pti:SwindonWindDownMember 2016-11-01 2017-04-30 0001643848 pti:SwindonWindDownMember 2017-02-01 2017-04-30 0001643848 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2015-11-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:DPSMember 2015-11-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:PDSMember 2015-11-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:DSSMember 2015-11-01 2016-04-30 0001643848 us-gaap:IntersegmentEliminationMember 2015-11-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember us-gaap:EmployeeSeveranceMember pti:DPSMember 2016-11-01 2017-04-30 0001643848 us-gaap:CorporateNonSegmentMember us-gaap:EmployeeSeveranceMember us-gaap:CorporateAndOtherMember 2016-11-01 2017-04-30 0001643848 us-gaap:OperatingSegmentsMember us-gaap:EmployeeSeveranceMember pti:PDSMember 2016-11-01 2017-04-30 0001643848 us-gaap:OperatingSegmentsMember us-gaap:EmployeeSeveranceMember pti:DSSMember 2016-11-01 2017-04-30 0001643848 us-gaap:EmployeeSeveranceMember 2016-11-01 2017-04-30 0001643848 us-gaap:OperatingSegmentsMember us-gaap:EmployeeSeveranceMember pti:PDSMember 2015-11-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:ConsultingProfessionalandProjectManagementCostsMember pti:PDSMember 2015-11-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember us-gaap:EmployeeSeveranceMember pti:DPSMember 2015-11-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:ConsultingProfessionalandProjectManagementCostsMember pti:DSSMember 2015-11-01 2016-04-30 0001643848 us-gaap:CorporateNonSegmentMember us-gaap:EmployeeSeveranceMember us-gaap:CorporateAndOtherMember 2015-11-01 2016-04-30 0001643848 pti:ConsultingProfessionalandProjectManagementCostsMember 2015-11-01 2016-04-30 0001643848 us-gaap:CorporateNonSegmentMember pti:ConsultingProfessionalandProjectManagementCostsMember us-gaap:CorporateAndOtherMember 2015-11-01 2016-04-30 0001643848 us-gaap:EmployeeSeveranceMember 2015-11-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember us-gaap:EmployeeSeveranceMember pti:DSSMember 2015-11-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:ConsultingProfessionalandProjectManagementCostsMember pti:DPSMember 2015-11-01 2016-04-30 0001643848 us-gaap:CorporateNonSegmentMember us-gaap:EmployeeSeveranceMember us-gaap:CorporateAndOtherMember 2017-02-01 2017-04-30 0001643848 us-gaap:EmployeeSeveranceMember 2017-02-01 2017-04-30 0001643848 us-gaap:OperatingSegmentsMember us-gaap:EmployeeSeveranceMember pti:DPSMember 2017-02-01 2017-04-30 0001643848 2017-01-31 0001643848 us-gaap:OperatingSegmentsMember us-gaap:EmployeeSeveranceMember pti:PDSMember 2017-02-01 2017-04-30 0001643848 us-gaap:OperatingSegmentsMember us-gaap:EmployeeSeveranceMember pti:DSSMember 2017-02-01 2017-04-30 0001643848 us-gaap:OtherRestructuringMember 2017-02-01 2017-04-30 0001643848 pti:SwindonWindDownMember pti:InventoryReserveSecondPeriodMember 2017-04-30 0001643848 pti:SwindonWindDownMember pti:InventoryReserveFirstPeriodMember 2017-04-30 0001643848 us-gaap:CorporateNonSegmentMember us-gaap:EmployeeSeveranceMember us-gaap:CorporateAndOtherMember 2016-02-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember us-gaap:EmployeeSeveranceMember pti:DSSMember 2016-02-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:ConsultingProfessionalandProjectManagementCostsMember pti:DSSMember 2016-02-01 2016-04-30 0001643848 us-gaap:EmployeeSeveranceMember 2016-02-01 2016-04-30 0001643848 pti:ConsultingProfessionalandProjectManagementCostsMember 2016-02-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:ConsultingProfessionalandProjectManagementCostsMember pti:PDSMember 2016-02-01 2016-04-30 0001643848 us-gaap:CorporateNonSegmentMember pti:ConsultingProfessionalandProjectManagementCostsMember us-gaap:CorporateAndOtherMember 2016-02-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember us-gaap:EmployeeSeveranceMember pti:DPSMember 2016-02-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember pti:ConsultingProfessionalandProjectManagementCostsMember pti:DPSMember 2016-02-01 2016-04-30 0001643848 us-gaap:OperatingSegmentsMember us-gaap:EmployeeSeveranceMember pti:PDSMember 2016-02-01 2016-04-30 0001643848 pti:JLLPartnersInc.andDSMMember pti:BusinessServicesMember us-gaap:AffiliatedEntityMember 2017-04-30 0001643848 pti:BannerLifeSciencesMember pti:SharedServiceFunctionsMember us-gaap:AffiliatedEntityMember 2017-04-30 0001643848 pti:KoninklijkeDSMMember pti:SharedServiceFunctionsMember us-gaap:AffiliatedEntityMember 2017-04-30 0001643848 pti:BannerLifeSciencesMember pti:SharedServiceFunctionsMember us-gaap:AffiliatedEntityMember 2016-10-31 0001643848 pti:KoninklijkeDSMMember pti:SharedServiceFunctionsMember us-gaap:AffiliatedEntityMember 2016-10-31 0001643848 pti:JLLPartnersInc.andDSMMember pti:BusinessServicesMember us-gaap:AffiliatedEntityMember 2016-10-31 0001643848 us-gaap:EquityMethodInvesteeMember 2017-02-01 2017-04-30 0001643848 us-gaap:EquityMethodInvesteeMember pti:BannerLifeSciencesMember 2016-02-01 2016-04-30 0001643848 us-gaap:EquityMethodInvesteeMember pti:PerciviaMember 2017-02-01 2017-04-30 0001643848 us-gaap:EquityMethodInvesteeMember pti:PerciviaMember 2016-02-01 2016-04-30 0001643848 us-gaap:EquityMethodInvesteeMember pti:PerciviaMember 2016-11-01 2017-04-30 0001643848 us-gaap:EquityMethodInvesteeMember 2016-02-01 2016-04-30 0001643848 us-gaap:EquityMethodInvesteeMember 2015-11-01 2016-04-30 0001643848 us-gaap:EquityMethodInvesteeMember pti:BannerLifeSciencesMember 2015-11-01 2016-04-30 0001643848 us-gaap:EquityMethodInvesteeMember pti:PerciviaMember 2015-11-01 2016-04-30 0001643848 us-gaap:EquityMethodInvesteeMember 2016-11-01 2017-04-30 0001643848 us-gaap:EquityMethodInvesteeMember pti:BannerLifeSciencesMember 2017-02-01 2017-04-30 0001643848 us-gaap:EquityMethodInvesteeMember pti:BannerLifeSciencesMember 2016-11-01 2017-04-30 0001643848 us-gaap:EquityMethodInvesteeMember pti:ChemieParkMember 2017-04-30 0001643848 us-gaap:EquityMethodInvesteeMember pti:BannerLifeSciencesMember 2017-04-30 0001643848 us-gaap:EquityMethodInvesteeMember pti:BannerLifeSciencesMember 2016-10-31 0001643848 us-gaap:EquityMethodInvesteeMember pti:PerciviaMember 2017-04-30 0001643848 us-gaap:EquityMethodInvesteeMember pti:PerciviaMember 2016-10-31 0001643848 us-gaap:EquityMethodInvesteeMember 2017-04-30 0001643848 us-gaap:EquityMethodInvesteeMember 2016-10-31 0001643848 us-gaap:EquityMethodInvesteeMember pti:ChemieParkMember 2016-10-31 0001643848 us-gaap:EquityMethodInvesteeMember pti:PerciviaMember 2016-02-01 2016-02-29 0001643848 us-gaap:EquityMethodInvesteeMember pti:BannerLifeSciencesMember 2015-10-31 0001643848 us-gaap:EquityMethodInvesteeMember pti:BannerLifeSciencesMember 2016-03-01 2016-03-31 0001643848 pti:KoninklijkeDSMMember pti:SharedServiceFunctionsMember us-gaap:AffiliatedEntityMember 2016-11-01 2017-04-30 0001643848 pti:KoninklijkeDSMMember pti:SharedServiceFunctionsMember us-gaap:AffiliatedEntityMember 2015-11-01 2016-04-30 0001643848 pti:JLLPartnersInc.andDSMMember pti:BusinessServicesMember us-gaap:AffiliatedEntityMember 2017-02-01 2017-04-30 0001643848 pti:JLLPartnersInc.andDSMMember pti:BusinessServicesMember us-gaap:AffiliatedEntityMember 2015-11-01 2016-04-30 0001643848 pti:KoninklijkeDSMMember pti:SharedServiceFunctionsMember us-gaap:AffiliatedEntityMember 2016-02-01 2016-04-30 0001643848 pti:BannerLifeSciencesMember pti:SharedServiceFunctionsMember us-gaap:AffiliatedEntityMember 2015-11-01 2016-04-30 0001643848 pti:JLLPartnersInc.andDSMMember pti:BusinessServicesMember us-gaap:AffiliatedEntityMember 2016-02-01 2016-04-30 0001643848 pti:KoninklijkeDSMMember pti:SharedServiceFunctionsMember us-gaap:AffiliatedEntityMember 2017-02-01 2017-04-30 0001643848 pti:BannerLifeSciencesMember pti:SharedServiceFunctionsMember us-gaap:AffiliatedEntityMember 2016-11-01 2017-04-30 0001643848 pti:JLLPartnersInc.andDSMMember pti:BusinessServicesMember us-gaap:AffiliatedEntityMember 2016-11-01 2017-04-30 0001643848 pti:BannerLifeSciencesMember pti:SharedServiceFunctionsMember us-gaap:AffiliatedEntityMember 2017-02-01 2017-04-30 0001643848 pti:BannerLifeSciencesMember pti:SharedServiceFunctionsMember us-gaap:AffiliatedEntityMember 2016-02-01 2016-04-30 0001643848 pti:PatheonBiologicsLLCMember 2017-02-01 2017-04-30 0001643848 pti:PatheonBiologicsLLCMember 2016-11-01 2017-01-31 0001643848 pti:TreasuryStockPurchasestoSatisfyCertainTaxWithholdingsMember 2016-11-01 2017-04-30 0001643848 pti:AssumptionofEarnoutLiabilityMember 2016-11-01 2017-04-30 0001643848 pti:AssumptionofEarnoutLiabilityMember 2015-11-01 2016-04-30 0001643848 pti:TreasuryStockPurchasestoSatisfyCertainTaxWithholdingsMember 2015-11-01 2016-04-30 0001643848 pti:ManagementLongTermIncentivePlanMember 2014-03-11 2017-04-30 0001643848 pti:ManagementLongTermIncentivePlanMember 2014-03-11 2014-03-11 0001643848 2011-10-01 2011-10-31 0001643848 pti:ItalianClientDisputeMember country:IT 2015-11-01 2015-11-30 0001643848 pti:BannerAcquisitionMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pti:SoftgelServicesMember 2016-11-01 2017-04-30 0001643848 2015-11-01 2015-11-30 0001643848 pti:ManagementLongTermIncentivePlanMember 2014-03-11 0001643848 pti:ThermoFisherMember us-gaap:SubsequentEventMember 2017-05-15 2017-05-15 0001643848 pti:ThermoFisherMember us-gaap:SubsequentEventMember 2017-05-15 iso4217:EUR xbrli:shares iso4217:EUR pti:payment pti:vote pti:debt_instrument iso4217:USD pti:tranche pti:segment iso4217:USD xbrli:shares xbrli:pure xbrli:shares pti:plaintiff iso4217:CAD iso4217:USD false --10-31 Q2 2017 2017-04-30 10-Q 0001643848 145136214 Non-accelerated Filer Patheon N.V. 64000000 6200000 7100000 300000 100000 200000 7600000 10200000 8100000 11600000 7600000 10200000 8100000 11600000 257800000 0 0 0 3700000 10100000 18500000 0 0 300000 300000 5.75 6.00 6.75 6.25 6.50 3.00 4.00 4.00 3.50 3.50 65000000.0 0.03 6 P11D 3 0.5 0.25 0 0 1 1 0.01 0.01 0.01 0.01 0.01 0.01 2 0.5 2.50 2.5 0.2 0.2 0.68 3000000 -900000 -2800000 36000000 3400000 5800000 0.1 0.9 0.01 0.1 110000000 98000000 0.1 237200000 0 2100000 199300000 34700000 400000 700000 -2200000 0 98000000 -22200000 72700000 30800000 16700000 157000000 -46900000 127800000 45600000 30500000 94200000 -27500000 -200000 77400000 26100000 18400000 176700000 -54700000 -200000 138800000 58100000 34700000 161000000 69500000 900000 0 900000 7900000 2400000 200000 2200000 3600000 1500000 200000 1300000 400000 800000 0 0 62500000.0 62500000.0 0.25 0.25 200000 2 2 1 P90D 1 -1600000 5000000 -700000 -4500000 3300000 2200000 0 0 3800000 3000000 0 0 1300000 2500000 2200000 3500000 0.714 5 2.5 3.0 2.0 48.47 4464286 34226191 0.24 393600000 382200000 0 200000 100000 1700000 279300000 277100000 401000000 420900000 1100000 400000 1200000 100000 6600000 9300000 -99300000 -100100000 591400000 602400000 3800000 3000000 0 0 11000000 11000000 2000000 0 0 2000000 3000000 0 0 3000000 7000000 1100000 300000 800000 4000000 1000000 1500000 200000 3000000 9000000 1400000 1900000 400000 11000000 1500000 1200000 5300000 400000 4300000 2900000 4200000 1000000 0 -4100000 7600000 9500000 0 0 0 0 37963 1092951 27567 1116435 2589600000 2770100000 991400000 1003600000 2800000 1400000 1400000 0 2900000 1400000 1500000 0 1400000 1400000 1400000 0 0 1400000 1400000 1400000 0 0 26400000 0 0 26400000 26400000 25000000 7200000000 1000000 2000000000 9300000 -4900000 60000000 25000000 31100000 33800000 0 0 33800000 37900000 0 0 37900000 36000000 10000000 25000000 -6000000 -258800000 1200000 25900000 11400000 484000000 904900000 483400000 8100000 999100000 165100000 100000 2000000 67000000 59400000 9400000 128400000 36700000 155600000 10300000 0 1000000 328700000 184700000 165000000 92700000 92700000 -144000000 -72300000 -3300000 0 -2900000 0 0.01 0.01 0.01 0.01 500000000 500000000 145074042 145144742 145136214 115609756 1600000 1600000 4000000 -24200000 16300000 55100000 -800000 55900000 0.1 0.15 0.90 330300000 637300000 342700000 670400000 4300000 4100000 0.0225 0.0325 0.03 0.02 0.03 0.0225 0.0325 0.071 0.0325 0.0300 0.0250 0.0350 0.0710 0.0325 0.0225 0.0325 2128900000 20000000 0 511000000 3500000 700000 4100000 450000000 0 1138900000 700000 2146200000 50000000 504500000 0 2700000 700000 3600000 450000000 1133100000 0 1600000 700000 6000000 450000000.0 75000000.0 250000000.0 87100000.0 463100000.0 496300000.0 1133000000.000 0.005 0.0200 0.0156 0.005 0.0750 0.075 1.00000 1.01875 1.03750 1.05625 9900000 12200000 0 0 6300000 6300000 700000 1400000 900000 1800000 3400000 3900000 50300000 45200000 45200000 -50300000 -900000 -28300000 -3500000 -29700000 154200000 195500000 102300000 132400000 29800000 30200000 67100000 96700000 0 -400000 0 -800000 0 -700000 0 -1400000 5200000 0 1200000 0 2500000 0 1000000 0 2000000 0 1300000 100000 2600000 0 1000000 100000 2000000 0 900000 100000 1800000 0 1300000 100000 2600000 0 400000 0 900000 0 600000 0 1200000 3900000 27000000 600000 14900000 10200000 1300000 53500000 1200000 29700000 20100000 2500000 34300000 900000 15400000 16100000 1900000 61900000 1700000 30700000 25800000 3700000 1.3254 -1800000 2700000 2700000 0 2700000 0 1800000 1800000 0 1800000 0 -24000000 2600000 107000000 -800000 -2900000 200000 200000 300000 36400000 179000000 0 1900000 100000 100000 0 400000 0 200000 -900000 -3000000 0 2100000 7100000 -1300000 81800000 78800000 8100000 5600000 29500000 8500000 8900000 31900000 1700000 2400000 1300000 0 0.475 0.5 5000000 8700000 2900000 100000 5700000 8300000 2500000 100000 5700000 0.3 -1200000 3700000 -500000 -4100000 33800000 33800000 37900000 37900000 36500000 39700000 73400000 1000000 400000 49500000 19400000 2200000 900000 -3300000 310600000 1000000 2500000 248800000 54100000 2600000 1600000 233900000 P0Y P14Y6M P14Y2M12D P10Y9M18D P3Y P5Y7M6D -7100000 -11400000 -700000 -5500000 0 0 -6300000 -6300000 282100000 2800000 269400000 2200000 7700000 281600000 281400000 2500000 269400000 2100000 7400000 -200000 138300000 237200000 140700000 270400000 4300000 2600000 -18100000 26100000 33100000 1900000 -18100000 27600000 55900000 0.02 -0.16 0.19 0.39 0.02 -0.16 0.19 0.38 -1000000 -1000000 -3100000 -3100000 0 0 -0.01 -0.03 0.00 0.00 -0.01 -0.03 0.00 0.00 -400000 -500000 100000 1500000 1300000 200000 -200000 -200000 0 -300000 -300000 0 700000 0 -1500000 -22800000 8700000 14300000 172900000 141100000 -2900000 -4000000 1300000 -200000 247600000 235200000 -42600000 -86400000 -30800000 -59000000 14000000 9800000 122200000 130600000 395200000 451600000 192100000 228700000 80900000 92300000 400000 1100000 900000 1900000 3700000 6000000 2938000000 3052600000 2589600000 2770100000 573900000 606400000 36500000 0 2700000 33800000 39700000 0 1800000 37900000 50000000 209300000 0.00375 0.005 463100000 19500000 19400000 0 2156800000 0 2119000000 2156800000 0 2179300000 0 2134000000 2179300000 2049200000 2069400000 11500000 11200000 115 113 0 -200000 -348400000 -99300000 591400000 1600000 -842100000 0 -282500000 -100100000 602400000 1600000 -786200000 -200000 0.51 0.49 0.04 0.38 0.34 -9200000 17600000 -96000000 -109500000 -92700000 -109500000 -45900000 20900000 -43000000 20900000 900000 -21200000 27600000 55900000 55900000 4 3 52800000 78400000 37800000 78000000 8800000 7500000 44100000 39200000 47000000 14300000 5000000 -4700000 -7300000 -7300000 -29000000 -21000000 -4600000 4000000 -25700000 -18800000 -4600000 4000000 25800000 18900000 4600000 -4000000 -4000000 -400000 -800000 -700000 -1400000 -1400000 0 0 -3500000 -8100000 -700000 -2200000 -2200000 100000 100000 6900000 -1000000 -3400000 -1100000 -1100000 145500000 147700000 5100000 -4400000 -500000 1300000 -300000 -500000 -1200000 3700000 -500000 -4100000 36000000 0 0 100000 0 100000 3100000 21800000 1600000 3100000 9900000 9600000 0 10300000 30900000 4300000 11700000 9000000 5900000 95100000 6500000 56700000 16300000 15600000 40200000 7400000 19500000 11600000 1700000 99200000 10200000 56400000 29500000 3100000 1600000 3300000 2200000 4500000 21500000 24100000 1200000 2300000 0 584800000 600000 5400000 100000 600000 700000 30000000 1200000 100000 0 1900000 3300000 1400000 2500000 945800000 100800000 487300000 16100000 341600000 983600000 1169300000 100100000 687600000 14100000 367500000 101300000 137200000 100000 2500000 200000 5200000 100000 1900000 100000 5100000 0 2700000 600000 1300000 400000 1100000 1300000 0 0 0 -300000 0 0 1600000 0 0 1300000 0 0 -300000 1600000 2500000 0 0 0 -300000 0 0 2800000 0 0 2500000 0 0 -300000 2800000 1800000 100000 1700000 0 0 1800000 1800000 2400000 500000 1900000 0 0 2400000 22900000 4900000 3400000 5400000 4600000 4900000 400000 1100000 5400000 4900000 -300000 200000 -100000 -200000 -842100000 -786200000 1400000 800000 7900000 900000 700000 100000 700000 300000 468600000 0 -100000 287400000 127900000 53400000 5100000 317600000 21100000 124800000 874500000 0 -100000 545900000 226800000 101900000 12400000 589400000 36000000 236700000 483400000 0 -800000 297200000 129200000 57800000 4200000 282800000 28500000 167900000 940800000 0 -800000 572400000 259100000 110100000 11200000 564700000 44200000 320700000 74800000 148500000 92100000 173200000 3000000 11000000 P3Y P5Y P5Y P4Y 0 1028534 41635 1366383 13.87 8.41 26.46 450184 1408018 3388481 196485 21.00 24.79 70700 21.00 0 0.381 0.416 0.016 0.009 6106540 0 438 50 50 288 50 1747750 1033465 726166 9.08 1021584 84700 8470 8470 59290 8470 1747750 84262 8420 8420 59002 8420 8.29 687.27 9.08 686.32 870.09 10.18 27.15 23.28 24.79 21.00 35.00 200000 P6Y P2Y357D 21.00 145074042 145136214 9600000 4761905 29464286 70700 0 0 8528 200000 200000 1400000 1400000 0 1400000 0 1500000 1500000 0 1500000 0 100000 200000 74700000 2700000 2000000 115609756 115610000 115609756 115610000 146267000 146267128 146276351 146276000 115609756 115610000 115609756 115610000 145136214 145136000 145132349 145132000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">OTHER INFORMATION</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign exchange</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded a foreign exchange loss of </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;"> and $</font><font style="font-family:inherit;font-size:10pt;">5.5 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. These amounts resulted from hedge and operating exposures. During the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded foreign exchange losses of </font><font style="font-family:inherit;font-size:10pt;">$7.1 million</font><font style="font-family:inherit;font-size:10pt;"> and $</font><font style="font-family:inherit;font-size:10pt;">11.4 million</font><font style="font-family:inherit;font-size:10pt;">, respectively</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Management Incentive Plan</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 11, 2014, the Company adopted the Management Long-Term Incentive Plan (the "LTIP") to provide long-term incentives to select key management employees of Patheon and its subsidiaries who have contributed and are expected to contribute materially to the success of the Company, and to reward outstanding performance by such employees. Leadership, key positions or identified key talent may be invited to participate in the LTIP during an identified plan year. Compensation is payable under this plan upon an Exit Event by the controlling investors of the Company (JLL and DSM), if the participant is still employed by the Company, or a qualifying termination, as defined.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">An Exit Event is defined as the earlier of: (a) a change of control, and (b) in connection with or following an Initial Public Offering ("IPO"), the sale or disposition by JLL or any of its affiliates of equity securities such that, immediately following such sale or disposition, either (i) JLL and its affiliates own less than </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> of the outstanding equity securities of the Partnership or the Partnership offeror, calculated on a fully-diluted basis, or (ii) JLL and its affiliates have received, in the aggregate, distributions in respect of such sale or disposition (together with any sale or disposition occurring prior thereto) equal to or in excess of </font><font style="font-family:inherit;font-size:10pt;">250%</font><font style="font-family:inherit;font-size:10pt;"> of the initial capital contributions and any additional capital contributions made by JLL and its affiliates for all equity securities of the Partnership or the Partnership offeror held by JLL and its affiliates prior to such sale or disposition.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Not later than </font><font style="font-family:inherit;font-size:10pt;">90</font><font style="font-family:inherit;font-size:10pt;"> days following commencement of each applicable Company fiscal year that would end during the term of the LTIP, the compensation committee of the board of directors of the Company (the "Compensation Committee") will determine, in its sole and absolute discretion, with respect to such fiscal year, (i) the Participants (as defined in the LTIP) with respect to that fiscal year, (ii) the EBITDA Target (as defined in the LTIP), and (iii) the targeted amount of each Award. Each award shall be evidenced by a written notice and shall be deemed granted on the first day of the fiscal year with respect to which the Compensation Committee resolves to grant such award (the "Grant Date"). Awards are denominated as a percentage of the Participant&#8217;s base salary, with the target percentage based on the Participant&#8217;s level within the organization, as determined by the Compensation Committee in its sole and absolute discretion. All awards will be paid in the form of cash, or other property having a value equal to such cash payment, as determined by the Compensation Committee in its sole and absolute discretion.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the LTIP, the Company has granted </font><font style="font-family:inherit;font-size:10pt;">$9.6 million</font><font style="font-family:inherit;font-size:10pt;"> in outstanding awards from March 11, 2014 through </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, all of which vest over a </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-year period. Through </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company has paid out </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> in payments due to qualified terminations. The Company does not accrue for the overall payout as the Exit Event is deemed to not be probable until the actual occurrence of the event.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Procaps Antitrust Matter</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 10, 2012, Procaps S.A. (&#8216;&#8216;Procaps&#8217;&#8217;) filed a complaint against the Company in the United States District Court for the Southern District of Florida (the &#8216;&#8216;District Court&#8217;&#8217;) (Case No. 12-cv-24356-DLG). The complaint involves the Company&#8217;s collaboration agreement with Procaps, pursuant to which both companies agreed to work together with respect to the marketing of a line of certain prescription pharmaceutical soft-gel development and manufacturing services. Procaps alleges that the Company&#8217;s acquisition of Banner, a business that historically has generated less than </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> of its revenues from softgel services for prescription pharmaceuticals, transformed the collaboration agreement into an anticompetitive restraint of trade and an agreement between direct competitors to set prices, divide markets and/or allocate geographic territories. Procaps seeks (i) a declaratory judgment that the collaboration agreement must cease and/or terminate; (ii) an injunction requiring that Patheon divest all of Banner&#8217;s soft-gel manufacturing capabilities; and (iii) monetary damages under federal and state antitrust and unfair competition laws, including treble damages for violations of the Sherman Act. Patheon subsequently answered Procaps&#8217; complaint and filed its affirmative defenses to the complaint. In July 2014, upon Motion for Summary Judgment by Patheon, the court dismissed Procaps&#8217; unfair competition claims, leaving only the antitrust claims in dispute. In March 2015, the court ordered trial to commence on November 16, 2015.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2015, the court granted Patheon&#8217;s motion for summary judgment with respect to all of Procaps&#8217; remaining claims in this matter. In November 2015, Procaps filed a notice of appeal with the United States Court of Appeals for the Eleventh Circuit (the &#8216;&#8216;11th Circuit Court&#8217;&#8217;). Procaps filed its initial brief with the 11th Circuit Court in February 2016 and we filed our reply brief in May 2016. Procaps filed its reply to our reply brief in June 2016. The 11th Circuit Court heard oral argument in this matter in November 2016 and in December 2016 affirmed the District Court's decision in favor of Patheon. </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2016, Procaps filed a request for arbitration with the International Court of Arbitration of the International Chamber of Commerce. The request for arbitration involves the above-mentioned collaboration agreement. Procaps alleges that (i) Patheon&#8217;s acquisition of Banner violated the exclusivity provision of the collaboration agreement, (ii) Patheon failed to return or destroy confidential information of Procaps, (iii) Patheon was unjustly enriched by obtaining the benefit of such confidential information to which it was not entitled, and (iv) Patheon breached implied duties of good faith and fair dealing in carrying out the collaboration agreement. Procaps seeks (i) with respect to the alleged breaches, compensatory damages and (ii) with respect to the claim for unjust enrichment, (a) disgorgement of profits received by Patheon by using any confidential information of Procaps, (b) repayment for all payments made to Patheon pursuant to the collaboration agreement, and (c) payment for the value of any intellectual property associated with the collaboration agreement. The Company filed its answer to the request for arbitration with the International Court of Arbitration of the International Chamber of Commerce in June 2016. The arbitration hearing on the merits in this matter was held in March 2017 and final arguments were heard in May 2017.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has not included any accrual in the consolidated financial statements as of April 30, 2017 related to these matters as a result of its assessment that the likelihood of a material loss in connection with these matters is not probable. However, an adverse outcome in this matter could have a material adverse effect on the Company&#8217;s business, results of operations and financial condition.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Oral Contraceptive Litigation</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A civil action is pending in the Commonwealth of Pennsylvania against the Company and one of its customers in connection with the recall of certain lots of allegedly defective products manufactured by the Company for the customer.&#160;The customer has given the Company notice of its intent to seek indemnification from the Company for all damages, costs and expenses, pursuant to the manufacturing services agreement between the customer and the Company.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The action was filed in Court of Common Pleas of Philadelphia Country, in Philadelphia, Pennsylvania in November 2015 on behalf of </font><font style="font-family:inherit;font-size:10pt;">113</font><font style="font-family:inherit;font-size:10pt;"> plaintiffs who were originally part of a putative class action commenced in state court in Georgia in October 2011 on behalf of </font><font style="font-family:inherit;font-size:10pt;">115</font><font style="font-family:inherit;font-size:10pt;"> plaintiffs and removed by defendants to the United States District Court for the Northern District of Georgia ("Georgia District Court") under the Class Action Fairness Act ("CAFA"). Defendants opposed class certification and class certification was denied. The Georgia action was ordered to proceed as a </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">-plaintiff action in the Georgia District Court on behalf of the </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> named plaintiffs, whereupon plaintiffs' lawyers commenced a new action in the Court of Common Pleas in Philadelphia on behalf of the remaining </font><font style="font-family:inherit;font-size:10pt;">113</font><font style="font-family:inherit;font-size:10pt;"> plaintiffs. The </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">-plaintiff action was dismissed by the Georgia District Court on October 28, 2016 on a motion for summary judgment brought by defendants. </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Defendants removed the action to the United States District Court for the Eastern District of Pennsylvania ("Pennsylvania District Court"). In September 2016, the Pennsylvania District Court remanded the action back to the Court of Common Pleas in Philadelphia. Defendants appealed the order of remand and, in February 2017, the United States Court of Appeals for the Third Circuit reversed and vacated the Pennsylvania District Court's remand order and remanded the matter to the Pennsylvania District Court for further proceedings. As the litigation is at an early stage, the Company is unable to estimate the potential damages for which the Company may be directly or indirectly liable.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Italian Client Dispute</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2015, the largest client of Patheon Italia S.p.A.&#8217;s (&#8216;&#8216;Patheon Italia&#8217;&#8217;), Ferentino, Italy facility filed a motion for injunctive relief in a Milan court under Article 700 of the Italian Civil Code. The client claims that remediation actions implemented by the Ferentino facility in response to an FDA inspection in May 2015, including, among other things, the use of a third party to certify all production batches for release, caused a significant slowdown in the quality control testing and batch release processes for the client&#8217;s product, thereby impairing the client&#8217;s ability to supply product in the amounts needed to fulfill the client's needs. The client sought an injunction ordering the Ferentino facility to (i) deliver products set forth in an October 6-7, 2015 release plan discussed by the parties; (ii) transfer products and documentation to the client to enable the client to perform the necessary quality control testing and release the products; and (iii) continue manufacture of the products at the capacity levels set forth in the supply agreement between the parties. The client further asked the court to impose a penalty of </font><font style="font-family:inherit;font-size:10pt;">&#8364;0.2 million</font><font style="font-family:inherit;font-size:10pt;"> per day for every day that the Ferentino facility failed to comply with the order.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 7, 2015, Patheon Italia filed a response to the motion, denying all the claims set forth in the client&#8217;s motion and asserting several defenses. In particular, Patheon Italia informed the court that the parties had in fact executed an amendment to the existing quality agreement agreeing to transfer the testing and release responsibilities to the client, such amendment was executed prior to the filing of the motion by the client and should have been disclosed to the court in the client&#8217;s motion.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 10, 2015, the court held a hearing in this matter and on December 18, 2015, denied the client&#8217;s motion. The client has filed an appeal to the court's decision, which was heard on February 11, 2016. On February 29, 2016, the appeals court denied the client's appeal. The supply agreement with the client includes an arbitration provision and in its initial motion, the client indicated its intention to file an arbitration claim seeking money damages in this matter. This matter is in the early stages and the Company is unable to estimate the potential damages for which Patheon Italia may be liable if the client files an arbitration claim and prevails in such proceeding.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Statements of cash flows non-cash investing and financing activities</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Non-cash financing activities:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assumption of earnout liability from the Partnership </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Treasury stock purchases to satisfy certain tax withholdings </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase in capital lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) Refer to Note 9 for further information</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2) Represents the tax payable held as of April 30, 2017 relating to a second quarter treasury stock purchase.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table discloses the maximum First Lien Leverage Ratios permitted under the Credit Agreement:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Testing Period Ending</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Maximum&#160;Ratio</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2014 through October&#160;31, 2014</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.75&#160;to&#160;1.00</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2014 through October&#160;31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.50 to 1.00</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2015 through October 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.25 to 1.00</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2016 through October&#160;31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.00 to 1.00</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2017 and thereafter</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.75 to 1.00</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of presentation</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patheon consists of </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> reportable segments: Drug Product Services ("DPS"), Pharmaceutical Development Services ("PDS"), and Drug Substance Services ("DSS"). Drug Product Services provides manufacturing and packaging for approved prescription, over-the-counter, and nutritional products. Pharmaceutical Development Services provides a wide spectrum of advanced formulation, production, and technical services from the early stages of a product's development to regulatory approval and beyond, as well as for new formulations of approved products for life cycle extension. Drug Substance Services provides development and manufacturing for the biologically active component of a pharmaceutical product from early development through commercial production.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying unaudited consolidated financial statements have been prepared by the Company in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). Operating results for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results that may be expected for the fiscal year ending </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> ("fiscal </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">"). These consolidated financial statements do not include all the information and footnotes required by U.S. GAAP for annual financial statements and therefore should be read in conjunction with the audited consolidated financial statements and notes for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;"> ("fiscal </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">").</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions have been eliminated.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect: the reported amounts of assets and liabilities; the disclosure of contingent assets and liabilities at the date of the consolidated financial statements; and the reported amounts of revenue and expenses in the reporting period. Management believes that the estimates and assumptions used in preparing its consolidated financial statements are reasonable and prudent; however, actual results could differ from those estimates.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of presentation</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patheon consists of </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> reportable segments: Drug Product Services ("DPS"), Pharmaceutical Development Services ("PDS"), and Drug Substance Services ("DSS"). Drug Product Services provides manufacturing and packaging for approved prescription, over-the-counter, and nutritional products. Pharmaceutical Development Services provides a wide spectrum of advanced formulation, production, and technical services from the early stages of a product's development to regulatory approval and beyond, as well as for new formulations of approved products for life cycle extension. Drug Substance Services provides development and manufacturing for the biologically active component of a pharmaceutical product from early development through commercial production.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying unaudited consolidated financial statements have been prepared by the Company in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). Operating results for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results that may be expected for the fiscal year ending </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> ("fiscal </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">"). These consolidated financial statements do not include all the information and footnotes required by U.S. GAAP for annual financial statements and therefore should be read in conjunction with the audited consolidated financial statements and notes for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;"> ("fiscal </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">").</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions have been eliminated.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect: the reported amounts of assets and liabilities; the disclosure of contingent assets and liabilities at the date of the consolidated financial statements; and the reported amounts of revenue and expenses in the reporting period. Management believes that the estimates and assumptions used in preparing its consolidated financial statements are reasonable and prudent; however, actual results could differ from those estimates.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Changes in significant accounting policies</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of early adopting Accounting Standards Update 2016-09, 'Improvements to Employee Share-Based Payment Accounting', the Company is electing to account for forfeitures on stock based compensation awards as they occur. No adjustment is required to comply with the early adoption. The Company was previously not estimating forfeitures on stock based compensation awards since the impact of potential forfeiture was immaterial to the consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment information</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. GAAP requires segmentation based on an entity&#8217;s internal organization and reporting of revenue and operating income (loss) based upon internal accounting methods commonly referred to as the &#8220;management approach.&#8221; Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (&#8220;CODM&#8221;), or decision making group, in deciding how to allocate resources and in assessing performance. The Company&#8217;s CODM is its Chief Executive Officer.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> operating segments are: North America Drug Product Services, or North America DPS, Europe Drug Product Services, or Europe DPS, Pharmaceutical Development Services, or PDS and Drug Substance Services, or DSS. The North America DPS and Europe DPS operating segments meet the aggregation criteria to be presented as </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> reportable segment referred to as DPS. As a result, the Company has determined it has </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> reportable segments: DPS, PDS, and DSS. Corporate is not an individually reportable segment because the quantitative thresholds have not been met and as such has been reported in Other.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently adopted accounting pronouncements</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting Standards Update ("ASU")</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Date Adopted </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Improvements to Employee Share-Based Payment Accounting (ASU 2016-09)</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update simplifies several aspects of the accounting for</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities,</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and classification on the statement of cash flows.</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company early-adopted ASU 2016-09 during the second quarter of fiscal 2017, which had no effect on the Company's financial statements.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 1, 2017</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Simplifying the Accounting for Measurement-Period Adjustment (ASU 2015-16) </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update eliminated the requirement to an acquirer in a business combination to retrospectively adjust provisional amounts recognized at the acquisition date with a corresponding adjustment to goodwill. Instead, the update requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The impact will be dependent on future transactions.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Simplifying the Presentation of Debt Issuance Costs (ASU 2015-03)</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The pronouncement requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of the debt liability, consistent</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">with that of debt discounts. The pronouncement is being applied retrospectively and the Company's October 31, 2016 balance sheet has been adjusted. The April 30, 2017 and October 31, 2016 balance sheets were adjusted to decrease the deferred financing cost asset and decrease the long term debt liability by $45.2 million and $50.3 million, respectively.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2016</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently issued accounting pronouncements</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting Standards Update ("ASU")</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Expected Impact</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Effective Date</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (ASU 2017-07)</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update requires that an employer disaggregate the service cost component from the other components of net periodic benefit cost. In addition, only the service cost component will be eligible for capitalization. The amendment is applied retrospectively with earlier application permitted. </font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are assessing the impact to the individual line items to the Statements of Operations. The Company does not expect there to be a material impact to net income.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2018</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Simplifying the Test for Goodwill Impairment (ASU 2017-04) </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update simplified the subsequent measurement of goodwill by eliminating Step 2 of the goodwill impairment test. Instead, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The amendment also eliminated the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. The amendment is applied prospectively with earlier application permitted.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We do not expect to have a material impact on the Company&#8217;s financial statements.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2020</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Clarifying the Definition of a Business (ASU 2017-01)</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update narrows the definition of outputs and aligns it with how outputs are described in Topic 606. The amendment also provides a more robust framework to use in determining when a set of assets and activities is a business. The amendment is applied prospectively with earlier application permitted. </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The impact on the consolidated financial statements from the adoption of this guidance is dependent on future business combinations. </font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2018</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from Contracts with Customers and related standards (ASU's 2014-09, 2016-08, 2016-10, 2016-12, 2016-20)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update supersedes the existing revenue recognition guidance and provides a new framework for recognizing revenue. These updates identified practical expedients and clarified various aspects of the new revenue recognition standard outlined in Accounting Standards Update 2014-09. This standard may be adopted using either a retrospective or modified retrospective method. Early adoption is permitted.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are currently in the process of evaluating the impact of this standard. It is still too early in our process to determine the magnitude of the potential impact. However, based on our preliminary assessment, we believe the timing of revenue recognition for commercial and development contracts may differ from our current revenue recognition policies. The Company is determining the magnitude of this potential change. We plan to adopt the standard on November 1, 2018, and we have not yet selected a transition method.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2018</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date or, in some cases where early adoption is permitted, in advance of the specified effective date. The Company has assessed the recently issued standards that are not yet effective and, unless otherwise discussed above or in our audited consolidated financial statements and notes for fiscal </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, believes these standards will not have a material impact on the Company&#8217;s results of operations, cash flows, or financial position. A more detailed listing of recently issued accounting pronouncements are included in our audited consolidated financial statements and notes for fiscal </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following unaudited supplemental pro forma information presents the financial results as if the acquisition had occurred on November 1, 2015. The unaudited supplemental pro forma information does not purport to be indicative of what would have occurred had the acquisition been completed on November 1, 2015, nor is it indicative of any future results. </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:54%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">483.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">484.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">999.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">904.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(258.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) Net income from continuing operations for the six months ended April 30, 2016 includes </font><font style="font-family:inherit;font-size:8pt;">$257.8 million</font><font style="font-family:inherit;font-size:8pt;"> of impairment expense related to Roche's strategic realignment of the facility. This is not part of the acquisition transaction and as such is not removed from the pro forma financial information.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BUSINESS COMBINATIONS</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The acquisition activity referenced below has been accounted for using the acquisition method of accounting in accordance with ASC Subtopic 805-10, "Business Combinations," and the fair value concepts set forth in ASC Subtopic 820-10, "Fair Value Measurements and Disclosures". The total purchase price for each acquisition was allocated to the assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The allocation of the purchase price is based on estimates and assumptions that are subject to change within the measurement period. The excess of the fair values of the assets acquired and liabilities assumed over the consideration transferred was recorded as a bargain purchase gain.</font></div><div style="line-height:120%;padding-top:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">RCI Acquisition</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Background</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 1, 2017, the Company acquired the Roche Carolin, Inc. active pharmaceutical ingredients (API) facility located in Florence, South Carolina ("RCI Acquisition") from Roche Holdings, Inc. (Roche). Through the acquisition, the Company entered into a stock purchase agreement in which Roche provided amounts to satisfy certain capital expenditures and other liabilities of the facility and the Company provided an upfront payment of </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> to acquire the stock of Roche Carolina Inc. (RCI) and approximately </font><font style="font-family:inherit;font-size:10pt;">$9.3 million</font><font style="font-family:inherit;font-size:10pt;"> to acquire inventory, spare parts, prepaid expense and accounts payable and certain transaction expenses of Roche. The RCI Acquisition is included in the DSS segment.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the transaction, the parties entered into (i) a supply agreement for the production of certain pharmaceutical intermediates by the Company for Roche and (ii) a toll manufacturing agreement where the Company will assume the manufacturing of certain products produced by the facility.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The toll manufacturing agreement has a five-year initial term. During the first four years of the term, Roche is subject to a minimum annual purchasing commitment. The Company will manufacture certain existing Roche products and sell the products back to Roche at fiscal year 2016 standard costs. Annual volumes above the minimum annual commitment will be rolled into the subsequent year. If applicable, Roche will pay true-up payments for amounts below the minimum purchase requirement. A liability from this unfavorable product supply contract has been recognized as deferred revenue in order to reflect this liability at fair value as of the acquisition date.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Purchase Price Allocation</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preliminary purchase price allocation for the RCI Acquisition is as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:88%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">155.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total assets acquired </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">165.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total liabilities assumed </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total net assets </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Bargain purchase gain</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total purchase price</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The bargain purchase gain, net of taxes, is reflected in income before taxes in the statements of operations. In late 2015, Roche analyzed strategic alternatives for the facility, including potentially closing or divesting the facility.&#160;The cost to close the facility or continue operating an under utilized facility contributed to the bargain purchase gain noted above.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial results</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The revenues and net income from continuing operations from the RCI Acquisition for the period from February 1, 2017 to April 30, 2017 included in the consolidated statement of operations are as follows:</font></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">February 1, 2017 to April 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income from continuing operations </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) Net income from continuing operations includes the $</font><font style="font-family:inherit;font-size:8pt;">26.4 million</font><font style="font-family:inherit;font-size:8pt;"> of the bargain purchase gain.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pro forma financial information</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following unaudited supplemental pro forma information presents the financial results as if the acquisition had occurred on November 1, 2015. The unaudited supplemental pro forma information does not purport to be indicative of what would have occurred had the acquisition been completed on November 1, 2015, nor is it indicative of any future results. </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:54%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">483.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">484.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">999.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">904.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(258.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) Net income from continuing operations for the six months ended April 30, 2016 includes </font><font style="font-family:inherit;font-size:8pt;">$257.8 million</font><font style="font-family:inherit;font-size:8pt;"> of impairment expense related to Roche's strategic realignment of the facility. This is not part of the acquisition transaction and as such is not removed from the pro forma financial information.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited pro forma financial information was prepared using the acquisition method of accounting and is based on the historical financial information of the Company and RCI, reflecting the Company's and RCI's combined results of operations for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">. The historical financial information has been adjusted to give effect to the pro forma events that are (i)&#160;directly attributable to the RCI Acquisition, (ii)&#160;factually supportable and (iii)&#160;expected to have a continuing impact on the combined results of the Company and RCI. The unaudited pro forma consolidated results reflect primarily the following pro forma adjustments:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">additional revenue related to the amortization of deferred revenue on the unfavorable product supply contract;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">additional cost of goods sold resulting from increases in depreciation expense relating to the fair values of acquired property and equipment;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">removal of repositioning costs related to the acquisition; and </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the effect of the bargain purchase gain</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LONG-TERM DEBT</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt in the accompanying consolidated balance sheets at </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;"> consists of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:79%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of April 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of October 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">USD Term Loan at LIBOR with a floor of 1% plus 3.25% rate and maturity date of April 20, 2024 (the "Credit Agreement")</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,133.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Euro Term Loan at LIBOR with a floor of 1% plus 3.00% rate and maturity date of April 20, 2024 (the "Credit Agreement")</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">504.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">USD Term Loan with a base rate plus 2.25% or LIBOR with a floor of 1% plus 3.25% rate and maturity date of March 10, 2021 (the "Credit Agreement")</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,138.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Euro Term Loan with a base rate plus 2.50% or LIBOR with a floor of 1% plus 3.50% rate and maturity date of March 10, 2021 (the "Credit Agreement")</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.50% Senior Notes due February 1, 2022 (the "Notes")</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">450.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">450.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Secured Revolving Facility balance at LIBOR plus 3.25% rate and maturity terms on a rolling basis</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government of Austria research and development loans with annual interest rates ranging from 1.56% to 2.00% and maturities through March 2020</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Italian subsidized loan with annual interest rate of 0.5%, and maturity date of June 30, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Italian bank loan with Euribor 6-month + 7.1% rate, and maturity date of June 30, 2020</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital lease obligations </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term debt outstanding</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,146.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,128.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less original issue discount, net of accumulated amortization of $7.1 million and $6.2 million, respectively</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less deferred financing costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(45.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(50.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less current portion</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, end of the period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,069.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,049.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">2017 Term Loans and Revolving Line</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 20, 2017, the Company completed the refinancing of its term loans and amended the existing revolving credit facility (the "Refinancing'") by entering into Amendment No. 4 of the original credit facility agreement dated as of March 11, 2014 (the "Credit Facility"). Under Amendment No. 4, the existing term loans were refinanced with new term loans ("Tranche B Term Loans"). The Tranche B Term Loans consisted of (i) Tranche B US Dollar Term Loans in the amount of </font><font style="font-family:inherit;font-size:10pt;">$1.133 billion</font><font style="font-family:inherit;font-size:10pt;"> and (ii) Tranche B Euro Term Loans in the amount of </font><font style="font-family:inherit;font-size:10pt;">&#8364;463.1 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">$496.3 million</font><font style="font-family:inherit;font-size:10pt;">. The Tranche B Term Loans will mature on April 20, 2024. </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under Amendment No. 4, the Company increased the size of the revolver facility (the "Revolving Facility") to </font><font style="font-family:inherit;font-size:10pt;">$250.0 million</font><font style="font-family:inherit;font-size:10pt;">, of which up to </font><font style="font-family:inherit;font-size:10pt;">$75.0 million</font><font style="font-family:inherit;font-size:10pt;"> is available for letters of credit. Of the total revolving commitments, </font><font style="font-family:inherit;font-size:10pt;">$87.1 million</font><font style="font-family:inherit;font-size:10pt;"> will terminate on March 11, 2019 (the "Tranche A Commitments") and the remaining commitments (the "Tranche B Commitments") will terminate on April 20, 2022.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The US Dollar denominated Tranche B Term Loans bear interest at a rate per annum equal to, at the option of the Company, a base rate plus </font><font style="font-family:inherit;font-size:10pt;">2.25%</font><font style="font-family:inherit;font-size:10pt;"> or LIBOR with a floor of </font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;"> plus </font><font style="font-family:inherit;font-size:10pt;">3.25%</font><font style="font-family:inherit;font-size:10pt;">. The margin applied to the base rate will be reduced to </font><font style="font-family:inherit;font-size:10pt;">2.0%</font><font style="font-family:inherit;font-size:10pt;"> and the margin applied to LIBOR will be reduced to </font><font style="font-family:inherit;font-size:10pt;">3.0%</font><font style="font-family:inherit;font-size:10pt;"> if the Company achieves, and as long as the Company maintains, a B2/Stable credit rating or better from Moody's Inventors Service, Inc. </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Euro denominated Tranche B Term Loans bear interest at a rate per annum equal to LIBOR with a floor of </font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;"> plus </font><font style="font-family:inherit;font-size:10pt;">3.00%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Borrowings under the Revolving Facility bear interest at a rate per annum equal to, at the option of the Company, a base rate plus </font><font style="font-family:inherit;font-size:10pt;">2.25%</font><font style="font-family:inherit;font-size:10pt;"> or LIBOR plus an applicable margin of </font><font style="font-family:inherit;font-size:10pt;">3.25%</font><font style="font-family:inherit;font-size:10pt;">. The Company will also pay a commitment fee of </font><font style="font-family:inherit;font-size:10pt;">0.50%</font><font style="font-family:inherit;font-size:10pt;">&#160;per annum on the unused portion of the Revolving Facility with a step down to </font><font style="font-family:inherit;font-size:10pt;">0.375%</font><font style="font-family:inherit;font-size:10pt;"> when the First Lien Leverage Ratio (as defined below) is less than or equal to </font><font style="font-family:inherit;font-size:10pt;">3.00</font><font style="font-family:inherit;font-size:10pt;"> to 1.00.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company borrowed </font><font style="font-family:inherit;font-size:10pt;">$50.0 million</font><font style="font-family:inherit;font-size:10pt;"> against the Revolving Facility, which will renew until paid.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the Revolving Facility, the Company is required to maintain a First Lien Leverage Ratio below a certain amount for each of the Testing Periods as set forth in the Credit Agreement if the Company has borrowed </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;"> of the available credit on the Revolving Facility, or </font><font style="font-family:inherit;font-size:10pt;">$62.5 million</font><font style="font-family:inherit;font-size:10pt;">. For purposes of the Credit Agreement, a Testing Period means a single period consisting of the most recent four consecutive fiscal quarters ending on the covenant determination date. As of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company was not required to calculate the First Lien Leverage Ratio as the Company has not borrowed </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;"> or </font><font style="font-family:inherit;font-size:10pt;">$62.5 million</font><font style="font-family:inherit;font-size:10pt;"> under the Secured Revolving Facility. The following table discloses the maximum First Lien Leverage Ratios permitted under the Credit Agreement:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Testing Period Ending</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Maximum&#160;Ratio</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2014 through October&#160;31, 2014</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.75&#160;to&#160;1.00</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2014 through October&#160;31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.50 to 1.00</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2015 through October 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.25 to 1.00</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2016 through October&#160;31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.00 to 1.00</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2017 and thereafter</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.75 to 1.00</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">"First Lien Leverage Ratio" is generally defined in the Credit Agreement as the ratio of (i) the sum of the aggregate principal amount of the Company's and its restricted subsidiaries' indebtedness for borrowed money, principal amount of capital lease obligations and debt obligations evidenced by bonds, promissory notes, debentures or debt securities that is secured by a first priority lien on the collateral minus unrestricted cash and cash equivalents held by the Company and its restricted subsidiaries in each case set forth in the Credit Agreement to (ii) Consolidated EBITDA. Consolidated EBITDA is generally defined in the Credit Agreement as income (loss) from continuing operations before repositioning expenses, interest expense, foreign exchange losses reclassified from other comprehensive income (loss), refinancing expenses, acquisition-related costs, gains and losses on sale of capital assets, income taxes, asset impairment charges, depreciation and amortization, stock-based compensation expense, consulting costs related to the Company's operational initiatives, purchase accounting adjustments, other income and expenses, non-cash charges, expenses related to the DPP Acquisition, pro forma cost savings from operational excellence initiatives and plant consolidations, pro forma synergies from the DPP Acquisition, and proceeds from business interruption insurance, among other adjustments. Consolidated EBITDA is not equivalent to Adjusted EBITDA, which as discussed in Note 11, is the Company's measure of segment performance.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is required to make the following mandatory prepayments in respect of the Tranche B Term Loans: (i)&#160;</font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;"> of Excess Cash Flow (as defined in the Credit Agreement) when the Company maintains a First Lien Leverage Ratio of greater than </font><font style="font-family:inherit;font-size:10pt;">4.00</font><font style="font-family:inherit;font-size:10pt;"> to 1.00, with step downs to (a) </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;"> when the Company maintains a First Lien Leverage Ratio of less than or equal to </font><font style="font-family:inherit;font-size:10pt;">4.00</font><font style="font-family:inherit;font-size:10pt;"> to 1.00 but greater than </font><font style="font-family:inherit;font-size:10pt;">3.50</font><font style="font-family:inherit;font-size:10pt;"> to 1.00 and (b) </font><font style="font-family:inherit;font-size:10pt;">0%</font><font style="font-family:inherit;font-size:10pt;"> when the Company maintains a First Lien Leverage Ratio of less than or equal to </font><font style="font-family:inherit;font-size:10pt;">3.50</font><font style="font-family:inherit;font-size:10pt;"> to 1.00; (ii)&#160;</font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the net cash proceeds of certain asset sales (including insurance and condemnation proceeds), subject to thresholds, reinvestment rights and certain other exceptions; and (iii)&#160;</font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the net cash proceeds of issuances of debt obligations, subject to certain exceptions and thresholds. "Excess Cash Flow" is generally defined as Consolidated EBITDA (as defined in the Credit Agreement) plus, (i) decreases in working capital, (ii) extraordinary or nonrecurring income or gains and (iii) certain other adjustments, minus, (a) increases in working capital, (b) cash interest, (c) cash taxes, (d) cash capital expenditures (e) scheduled debt amortization and (f) certain other adjustments. As the Excess Cash Flow calculation is performed annually, </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> payment is due for the </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">. No Excess Cash Flow payment was required for fiscal 2016. The Company may voluntarily repay borrowings under the Credit Facility at any time.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If the Company has failed to maintain the applicable First Lien Leverage Ratio, it may nevertheless avoid a default by (i) repaying outstanding borrowings under the Revolving Facility in an amount sufficient to avoid triggering the First Lien Leverage Ratio for that fiscal quarter or (ii) accepting a cash contribution of qualified equity in an amount which, if treated as Consolidated EBITDA, would bring the Company into compliance with the applicable First Lien Leverage Ratio for that fiscal quarter, in each case during the </font><font style="font-family:inherit;font-size:10pt;">11</font><font style="font-family:inherit;font-size:10pt;"> business days following the deadline for delivery of the Company&#8217;s compliance certificate for that fiscal quarter. In addition, maintenance of the First Lien Leverage Ratio is required only with respect to the Revolving Line; the Term Loans do not directly benefit from the financial covenant and, until the Revolving Line is terminated and all outstanding borrowings thereunder are accelerated, will remain unaffected by a default under the Revolving Line that arises from the Company&#8217;s failure to maintain the applicable First Lien Coverage Ratio.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Agreement contains other customary terms, including (i)&#160;representations, warranties and affirmative covenants, (ii)&#160;negative covenants (in addition to the limitation on distributions and the requirement to maintain the First Lien Leverage Ratio levels as described above), such as limitations on indebtedness, liens, mergers, acquisitions, asset sales, investments, prepayments of subordinated debt, and transactions with affiliates, in each case subject to baskets, thresholds and other exceptions, and (iii)&#160;events of default, such as for non-payment, breach of other covenants, misrepresentations, cross default to other debt, change in control, bankruptcy events, ERISA events, unsatisfied judgments and actual or asserted invalidity of guarantees or security documents.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company was in compliance with the covenants in the Credit Facility.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provided that the Company is in compliance with the First Lien Leverage Ratio test and no default under the Credit Agreement is continuing or would result therefrom, the covenant in the Credit Agreement that limits the Company's ability to pay dividends or make other distributions to its shareholders generally permits (with certain exceptions and qualifications) the Company to pay dividends or make such distributions in an aggregate amount, when taken together with the aggregate amount of any prepayment, repurchase, redemption or defeasance of subordinated indebtedness, not to exceed the greater of (x) </font><font style="font-family:inherit;font-size:10pt;">3.00%</font><font style="font-family:inherit;font-size:10pt;"> of Consolidated Total Assets and (y) </font><font style="font-family:inherit;font-size:10pt;">$65.0 million</font><font style="font-family:inherit;font-size:10pt;"> and (ii) in aggregate amount not to exceed the available amount (as defined in the Credit Agreement) at such time.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Facility is guaranteed by the Company and certain subsidiaries, and is secured by a first priority pledge on substantially all of the assets of the Company and the subsidiary guarantors, in each case subject to certain exceptions.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">2014 Senior Unsecured Notes</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2014, the Company issued </font><font style="font-family:inherit;font-size:10pt;">$450.0 million</font><font style="font-family:inherit;font-size:10pt;"> in aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">7.50%</font><font style="font-family:inherit;font-size:10pt;"> senior unsecured notes due February 1, 2022 (the "Notes") in a private placement, pursuant to which it entered into an indenture (the &#8220;Indenture&#8221;) with a commercial bank acting as trustee.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest on the Notes accrues at a rate of </font><font style="font-family:inherit;font-size:10pt;">7.50%</font><font style="font-family:inherit;font-size:10pt;"> per annum and is payable semiannually in arrears on each February 1 and August 1, commencing on August 1, 2014. Interest is computed on the basis of a 360-day year comprised of twelve 30-day months. The Notes are generally required to be guaranteed by each of the Company&#8217;s restricted subsidiaries that guarantees the Credit Facility or that guarantees other material indebtedness of the Company or other Note guarantors.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Except for offers to purchase Notes upon certain asset sales or a change in control of the Company, no mandatory redemption or sinking fund payment is required with respect to the Notes.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On and after February 1, 2017, the Company may redeem all or a portion of the Notes at the applicable redemption prices set forth below (expressed as percentages of principal amount redeemed), plus unpaid interest accruing on the principal amount redeemed to the Redemption Date:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105.625</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103.750</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.875</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020 and thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.000</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, we may redeem all of the Notes at a redemption price equal to the principal amount redeemed, plus unpaid interest accruing to the Redemption Date, upon certain adverse changes in applicable tax laws.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Notes are guaranteed by the Company and the Indenture does not require the Company to maintain compliance with any financial covenants. The Indenture does contain customary affirmative and negative covenants, including with respect to mergers, asset sales, restricted payments, restricted investments, issuance of debt and equity, liens, and affiliate transactions, subject to baskets and other exceptions. However, the Company will be exempt from many of the negative covenants if the Notes receive investment grade ratings from both Moody&#8217;s and S&amp;P. The Indenture also contains customary events of default, such as for non-payment, breach of other covenants, misrepresentation, cross default to other material debt, bankruptcy events, unsatisfied judgments, and actual or asserted invalidity of guarantees.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company was in compliance with the covenants in the Indenture.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Other Financing Arrangements</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the third quarter of fiscal 2013, the Company received assistance from the Italian government in the form of </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> loans.&#160;One loan is a subsidized loan for approximately </font><font style="font-family:inherit;font-size:10pt;">&#8364;6.0 million</font><font style="font-family:inherit;font-size:10pt;">, of which the Company received </font><font style="font-family:inherit;font-size:10pt;">&#8364;5.4 million</font><font style="font-family:inherit;font-size:10pt;"> during the third quarter of 2013 and the remaining </font><font style="font-family:inherit;font-size:10pt;">&#8364;0.6 million</font><font style="font-family:inherit;font-size:10pt;"> in the second quarter of 2016. The subsidized loan has an annual interest rate of </font><font style="font-family:inherit;font-size:10pt;">0.5%</font><font style="font-family:inherit;font-size:10pt;">, a maturity date of June 30, 2020 and amortizes in fixed semi-annual installments. The second loan is a bank loan of approximately </font><font style="font-family:inherit;font-size:10pt;">&#8364;0.7 million</font><font style="font-family:inherit;font-size:10pt;">, of which the Company received </font><font style="font-family:inherit;font-size:10pt;">&#8364;0.6 million</font><font style="font-family:inherit;font-size:10pt;"> during the third quarter of 2013 and the remaining </font><font style="font-family:inherit;font-size:10pt;">&#8364;0.1 million</font><font style="font-family:inherit;font-size:10pt;"> in the second quarter of 2016. The bank loan bears interest at a 6-month Euribor rate plus </font><font style="font-family:inherit;font-size:10pt;">7.1%</font><font style="font-family:inherit;font-size:10pt;">, has a maturity date of June 30, 2020 and amortizes in </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> variable semi-annual installments beginning in December 2017. </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company receives research and development loans from the Austrian government. The loans hold various interest rates and have maturity dates through March 31, 2020. The aggregate current balance of these loans as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> is $</font><font style="font-family:inherit;font-size:10pt;">2.7 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2011, Gallus entered into an agreement with St. Louis County under the county's Chapter 100 program. Under the program, Gallus transferred title of the St. Louis location's buildings and property to St. Louis County in exchange for St. Louis County, Missouri Taxable Industrial Revenue Bonds (Chapter 100 Bonds) of equal value. Gallus then simultaneously leased back the land and facility from St. Louis County. The proceeds of principal and interest on the Chapter 100 Bonds are equal to the lease payment obligations on the Loan. This arrangement was acquired by the Company through the acquisition of Gallus Pharmaceuticals in September 2014.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2015, the agreement with St. Louis County was amended by the Company to extend through December 21, 2029 (originally December 21, 2021), which is consistent with the maturity date of the Chapter 100 Bonds. The Company has determined that it has a legal right of offset for the obligations under the lease agreement with the proceeds receivable from the Chapter 100 Bonds and intends to offset the balance. As a result, the offsetting amounts have not been recorded in the financial statements. The bonds require the Company to maintain a minimum level of employment throughout the term of the loan and an additional investment in the St. Louis facility of at least </font><font style="font-family:inherit;font-size:10pt;">$47.0 million</font><font style="font-family:inherit;font-size:10pt;"> by December 31, 2019.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the terms of the bonds indicated above, the Company also entered into an agreement under which it makes "Payments In Lieu Of Taxes" (PILOT) fee payments in lieu of property taxes, which is equal to </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;"> of the property taxes that would have otherwise been payable on the property. The PILOT fees will increase in years which the Company has not maintained the minimum number of employees as required by the agreement on a prospective basis.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has possessory and equitable title to the property, and at any time can purchase legal title for a nominal fee. In addition, as the holder of the bonds, the Company can waive any default on the lease payments. As the Company retains all benefits of ownership and can take title at any time, at which point the bonds it holds would be redeemed to settle its obligations under the lease agreement, the Company has concluded the land and personal property continue to be assets and are recorded on the consolidated balance sheets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On and after February 1, 2017, the Company may redeem all or a portion of the Notes at the applicable redemption prices set forth below (expressed as percentages of principal amount redeemed), plus unpaid interest accruing on the principal amount redeemed to the Redemption Date:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105.625</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103.750</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.875</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020 and thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.000</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has determined the estimated fair values of its financial instruments based on appropriate valuation methodologies; however, considerable judgment is required to develop these estimates. The fair values of the Company's financial instruments are not materially different from their carrying values.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair value measurements</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company classifies and discloses its fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy has the following levels: (a)&#160;quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1); (b)&#160;inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices) (Level 2); and (c)&#160;inputs for the asset or liability that are not based on observable market data (unobservable inputs) (Level 3).</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value is principally applied to financial assets and liabilities such as derivative instruments consisting of foreign exchange forward contracts, available-for-sale securities relating to Republic of Austria bonds, held-for-trading securities relating to the Company's U.S. deferred compensation plan, and a liability relating to an earnout payment on future Biologics operating results. The following table provides a summary of the financial assets and liabilities that are measured at fair value as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value measurement at April 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value measurement at October 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Assets measured at fair value</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sale securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Held-for-trading securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value measurement at April 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value measurement at October 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Liabilities measured at fair value</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnout liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 1 - Based on quoted market prices in active markets.</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 2 - Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 3 - Unobservable inputs that are not corroborated by market data.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the fair value of the Company's financial instruments and their classifications on the consolidated balance sheets as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Assets as of April 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Assets as of October 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance sheet location</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance sheet location</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sale securities</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Held-for-trade securities</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Liabilities as of April 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Liabilities as of October 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance sheet location</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance sheet location</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts&#160;payable and&#160;accrued&#160;liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts&#160;payable and&#160;accrued&#160;liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnout liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has the option to net settle its derivatives with the counter party under the terms of its contracts and as such any unrealized positions are recorded net. </font><font style="font-family:inherit;font-size:10pt;">As of April 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had gross unrealized losses of </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> and gross unrealized gains of </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> under its derivative contracts. As of </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company had gross unrealized losses of </font><font style="font-family:inherit;font-size:10pt;">$2.7 million</font><font style="font-family:inherit;font-size:10pt;"> and gross unrealized gains of less than </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> under its derivative contracts. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Long-term obligations</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">As of </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, the fair values and carrying values of the Company&#8217;s long-term debt, including the current portion of long-term debt, are categorized in the table below:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 1</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 2</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 3</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Carrying Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt, including current portion </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,179.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,179.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,134.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the fair values and carrying values of the Company&#8217;s long-term debt, including the current portion of long-term debt, are categorized in the table below:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 1</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 2</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 3</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Carrying Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt, including current portion </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,156.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,156.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,119.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the Company's long-term debt, including the current portion of long-term debt, is based on the quoted market prices for the same issues or on the current rates offered for debt of similar remaining maturities.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign exchange forward contracts and other arrangements</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company utilizes financial instruments to manage the risk associated with fluctuations in foreign exchange and interest rates. The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk management objective and strategy for undertaking various hedge transactions.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company's Canadian operations had entered into foreign exchange forward contracts to sell a net aggregate amount of $</font><font style="font-family:inherit;font-size:10pt;">64.0 million</font><font style="font-family:inherit;font-size:10pt;"> U.S. dollars. These contracts hedge the Canadian operations expected exposure to U.S. dollar denominated receivables and mature at the latest on </font><font style="font-family:inherit;font-size:10pt;">March&#160;15, 2018</font><font style="font-family:inherit;font-size:10pt;">, at an average exchange rate of $</font><font style="font-family:inherit;font-size:10pt;">1.3254</font><font style="font-family:inherit;font-size:10pt;"> Canadian dollars per U.S. dollar. The mark-to-market value of these financial instruments as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> was a net unrealized loss of $</font><font style="font-family:inherit;font-size:10pt;">1.8 million</font><font style="font-family:inherit;font-size:10pt;">, which has been recorded in accumulated other comprehensive income in shareholders' deficit, net of associated income tax.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company acquired a portion of its Biologics business from DSM ("the DPP acquisition") in March 2014. In connection with the DPP acquisition, DSM was entitled to receive certain additional future contingent payments based on the performance of the acquired biologics business (the "earnout"). Under the terms of the original contribution agreement, the earnout only related to the DSM biologics business acquired in March 2014 and the earnout liability was payable by the Partnership, the parent of the Company before the Company's IPO on July 21, 2016. The value of the earnout liability as of January 29, 2016 was </font><font style="font-family:inherit;font-size:10pt;">$36.0 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 29, 2016, the Company, the Partnership, JLL, and DSM entered into an agreement (the "Earnout Agreement") whereby the Partnership&#8217;s earnout liability was legally assigned to the Company. The assignment of the liability from the Partnership to the Company was deemed a capital transaction with the Partnership of </font><font style="font-family:inherit;font-size:10pt;">$36.0 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Concurrently, the calculation of the earnout consideration was revised to include the future earnings of the Company&#8217;s entire biologics business ("Biologics Adjusted EBITDA"), which includes biologics business acquired in connection with a September 2014 acquisition of Gallus Pharmaceuticals. As a result of executing this Earnout Agreement, the Company will pay additional consideration to DSM based on the achievement of certain Biologics Adjusted EBITDA targets, as defined in the Earnout Agreement, of the Company&#8217;s biologics business at the conclusion of the 2020 fiscal year. If the Company sells or disposes of the biologics business prior to the end of the 2020 fiscal year, Biologics Adjusted EBITDA will be calculated by applying a </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> compounded annual growth rate through the remaining period ending October 31, 2020 to the Biologics Adjusted EBITDA for the twelve-month period ended on the last day of the month immediately preceding the date of such sale or disposition. The Company's maximum and minimum payments to DSM under the terms of the Earnout Agreement is </font><font style="font-family:inherit;font-size:10pt;">$60.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. Using the revised earnout definition, the value of the earnout liability as of January 31, 2016 was </font><font style="font-family:inherit;font-size:10pt;">$31.1 million</font><font style="font-family:inherit;font-size:10pt;"> and resulted in the Company recognizing income of $</font><font style="font-family:inherit;font-size:10pt;">4.9 million</font><font style="font-family:inherit;font-size:10pt;"> in the first quarter of fiscal 2016. </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company estimated the value of the earnout by valuing the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> payout tranches. The first tranche of the </font><font style="font-family:inherit;font-size:10pt;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;"> minimum earnout payment, which is not contingent to Biologics Adjusted EBITDA performance, was estimated by discounting the </font><font style="font-family:inherit;font-size:10pt;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;"> using cost of debt of the Company. The values of the remaining two tranches, (i) an additional </font><font style="font-family:inherit;font-size:10pt;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;"> earnout payment which will be realized gradually as Biologics Adjusted EBITDA reaches </font><font style="font-family:inherit;font-size:10pt;">$98.0 million</font><font style="font-family:inherit;font-size:10pt;">, and (ii) an additional </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> earnout payment which will be achieved gradually as Biologics Adjusted EBITDA approaches </font><font style="font-family:inherit;font-size:10pt;">$110.0 million</font><font style="font-family:inherit;font-size:10pt;">, were estimated using an option pricing framework, where the Company used a modified Black-Scholes model.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adjusted the earnout value to its estimated fair value as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$37.9 million</font><font style="font-family:inherit;font-size:10pt;">. The Company recorded $</font><font style="font-family:inherit;font-size:10pt;">0.5 million</font><font style="font-family:inherit;font-size:10pt;"> and $</font><font style="font-family:inherit;font-size:10pt;">4.1 million</font><font style="font-family:inherit;font-size:10pt;"> of expense in the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, relating to marking the liability to its estimated fair value. The Company recorded $</font><font style="font-family:inherit;font-size:10pt;">1.2 million</font><font style="font-family:inherit;font-size:10pt;"> of expense and $</font><font style="font-family:inherit;font-size:10pt;">3.7 million</font><font style="font-family:inherit;font-size:10pt;"> of income in the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively, relating to marking the liability to its estimated fair value. The </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> earnout valuation applies an asset volatility of </font><font style="font-family:inherit;font-size:10pt;">30%</font><font style="font-family:inherit;font-size:10pt;"> and an asset beta of </font><font style="font-family:inherit;font-size:10pt;">0.9</font><font style="font-family:inherit;font-size:10pt;">. A </font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;"> change in asset volatility would have an impact on the value of +/- </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> while a </font><font style="font-family:inherit;font-size:10pt;">0.1</font><font style="font-family:inherit;font-size:10pt;"> change in beta would have an impact on the value of +/- </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">. Assumptions are Level 3 in nature.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The earnout liability activity is summarized as follows for the </font><font style="font-family:inherit;font-size:10pt;">six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:89%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at October 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at April 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The change in fair value relating to the earnout is recorded in other operating income on the consolidated statements of operations.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Risks arising from financial instruments and risk management</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's activities expose it to a variety of financial risks: market risk (including foreign exchange and interest rate), credit risk and liquidity risk. The Company's overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the Company's financial performance. The Company uses derivative financial instruments to hedge certain risk exposures. The Company does not purchase any derivative financial instruments for speculative purposes.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial risk management is the responsibility of the Company's corporate treasury. The corporate treasury works with the Company's operational personnel to identify, evaluate and, where appropriate, hedge financial risks. The Company's corporate treasury also monitors material risks and discusses them with the Audit Committee of the Board of Directors.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Foreign exchange risk</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company operated in Canada, the United States, Italy, France, the United Kingdom, The Netherlands, Australia, Germany, Austria, and Japan. Foreign exchange risk arises because the value of the local currency receivable or payable for transactions denominated in foreign currencies may vary due to changes in exchange rates ("transaction exposures") and because the non-U.S. dollar denominated financial statements of the Company may vary on consolidation into the reporting currency of U.S. dollars ("translation exposures").</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's most significant transaction exposure is from its Canadian operations. Approximately </font><font style="font-family:inherit;font-size:10pt;">90%</font><font style="font-family:inherit;font-size:10pt;"> of the cash receipts and </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;"> of the cash outflows relating to Canadian operations are transacted in U.S. dollars. As a result, the Company may experience transaction exposures because of volatility in the exchange rate between the Canadian and U.S. dollar. Based on the Company's current U.S. denominated net inflows, as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, fluctuations of +/- </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> would, everything else being equal, have an effect on year to date income before income taxes of approximately +/- </font><font style="font-family:inherit;font-size:10pt;">$5.8 million</font><font style="font-family:inherit;font-size:10pt;">, prior to hedging activities.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The objective of the Company's foreign exchange risk management activities is to minimize transaction exposures and the resulting volatility of the Company's earnings. The Company manages this risk by entering into foreign exchange contracts. As of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company has entered into foreign exchange contracts to cover approximately </font><font style="font-family:inherit;font-size:10pt;">68%</font><font style="font-family:inherit;font-size:10pt;"> of its Canadian-U.S. dollar cash flow exposures for the next twelve months.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amount of the Company's Euro denominated debt designated as a hedge against its net investment in its subsidiaries in Austria, The Netherlands, Germany, France and Italy, is </font><font style="font-family:inherit;font-size:10pt;">&#8364;463.1 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">. This hedge was originally designated in March 2014 as a part of the Company's acquisition of manufacturing sites from DSM and is re-designated on a quarterly basis. As of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the balance of the net investment hedge was $</font><font style="font-family:inherit;font-size:10pt;">74.7 million</font><font style="font-family:inherit;font-size:10pt;"> and is included in accumulated other comprehensive income in shareholders' deficit. Any unrealized exchange losses are included in the consolidated statement of operations due to ineffectiveness.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the net investment hedge foreign exchange activity for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> since net investment hedge inception:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange (loss) gain for the period from net investment hedge</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Release of ineffective portion of net investment hedge to consolidated statement of operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) gain to other comprehensive income for the period related to net investment hedge</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Translation gains and losses related to certain foreign currency denominated intercompany loans are included as part of the net investment in certain foreign subsidiaries, and are included in accumulated other comprehensive income in shareholders' deficit.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the foreign currency activity on the intercompany loans that are included as part of the net investment in certain foreign subsidiaries for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> since net investment hedge inception:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange gain for the period from long-term intercompany loan revaluation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Credit risk</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit risk arises from cash and cash equivalents held with banks and financial institutions, derivative financial instruments (foreign exchange contracts with positive fair values), and credit exposure to customers, including outstanding accounts receivable. The maximum exposure to credit risk is equal to the carrying value of the financial assets.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The objective of managing counterparty credit risk is to prevent losses in financial assets. The Company regularly assesses the credit quality of the counterparties, taking into account their financial position, past experience and other factors. Management also regularly monitors the utilization of credit limits. In cases where the credit quality of a customer does not meet the Company's requirements, a cash deposit is received before any services are provided. As of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company held deposits of $</font><font style="font-family:inherit;font-size:10pt;">4.1 million</font><font style="font-family:inherit;font-size:10pt;"> and $</font><font style="font-family:inherit;font-size:10pt;">4.3 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Liquidity risk</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liquidity risk arises when financial obligations exceed financial assets available at a particular point in time. The Company's objective in managing liquidity risk is to maintain sufficient readily available reserves in order to meet its liquidity requirements at all times. The Company mitigates liquidity risk by maintaining cash and cash equivalents on-hand and through the availability of funding from credit facilities. As of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company was holding cash and cash equivalents of $</font><font style="font-family:inherit;font-size:10pt;">92.7 million</font><font style="font-family:inherit;font-size:10pt;"> and had undrawn lines of credit available to it of </font><font style="font-family:inherit;font-size:10pt;">$209.3 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">STOCK BASED COMPENSATION</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of equity based compensation expense recognized during the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> is as follows:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management Equity Incentive Plan (MEIP)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted Stock Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock Options</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock Based Compensation Expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Management Equity Incentive Plan (MEIP)</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to the IPO, the Company was a wholly-owned indirect subsidiary of the Partnership. The Partnership adopted the Management Equity Incentive Plan, or the MEIP, with an effective date of March 11, 2014. The purpose of the MEIP is to provide eligible participants with an opportunity to receive grants of profit interests in the Partnership designated as management units. The award of management units pursuant to this MEIP is intended to compensate employees of the Partnership and its subsidiaries, including the Company. The participants in the MEIP, as a group, are eligible to participate in the gain on the investment earned by JLL and DSM with respect to Patheon once certain specified distribution or return thresholds have been achieved. Upon issuance, MEIP units were subject to certain forfeiture (vesting) provisions which meant that if a holder's employment with Patheon terminated prior to the satisfaction of the applicable provision, the unvested MEIP units would be forfeited and the vested MEIP units could be converted into Class A Units in the Partnership on a cashless basis or by making an additional cash contribution in order to receive additional Class A Units ("Partnership Shares").</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The aggregate number, class and tranche of management units that were issued under the MEIP was determined by the JLL/Delta Patheon GP Ltd., the general partner of the Partnership. The Partnership last issued MEIP units on December 9, 2015. As a result of the IPO and the adoption of the Patheon N.V. 2016 Omnibus Incentive Plan (the &#8220;Omnibus Plan&#8221;) described below, the Partnership will no longer grant awards under the MEIP to our employees.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The granted MEIP units consist of Class B, Class C, Class D, and Class E units. From June 24, 2014 to December 9, 2015, the Partnership granted units under </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> different valuation tranches, with each tranche issued at the most recent quarterly valuation of the Company at the time of the grant.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71.4%</font><font style="font-family:inherit;font-size:10pt;"> of the Class B units have a </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> year service-based component for vesting ("Service-based Class B units") and the remaining Class B units ("Exit Event Class B units") vest if the holder is employed upon the occurrence of an Exit Event. An Exit Event is defined as the earliest to occur of (i) a change of control and (ii) in connection with or following an initial public offering, the sale or disposition by JLL of equity securities such that, immediately following such sale or disposition, JLL and its affiliates either (A) own less than </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> of the equity securities then issued and outstanding, calculated on a fully diluted basis, or (B) have received, in the aggregate, distributions in respect of such sale or distribution (together with any sale or distribution occurring prior thereto) equal to or in excess of </font><font style="font-family:inherit;font-size:10pt;">250%</font><font style="font-family:inherit;font-size:10pt;"> of its aggregate capital contributions made in respect of such equity securities prior to such sale or distribution.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each of the Class C, D, and E units have a performance and service condition related to vesting. These units vest upon the earlier to occur of (i) JLL receiving distributions in the aggregate equal to return on capital thresholds of </font><font style="font-family:inherit;font-size:10pt;">2.0</font><font style="font-family:inherit;font-size:10pt;">x, </font><font style="font-family:inherit;font-size:10pt;">2.5</font><font style="font-family:inherit;font-size:10pt;">x and </font><font style="font-family:inherit;font-size:10pt;">3.0</font><font style="font-family:inherit;font-size:10pt;">x, respectively, or (ii) an Exit Event, as defined above, does not occur prior to the fifth anniversary of an IPO and the return thresholds in (i) are met based on the average price of the Company's publicly traded shares for any twenty day period following the fifth anniversary of an IPO.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If any employee is terminated for any reason prior the achievement of the above vesting conditions, all unvested units in any class are forfeited.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of the MEIP activity for the </font><font style="font-family:inherit;font-size:10pt;">six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> is as follows:</font></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Class B</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Class C</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Class D</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Class E</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted Average Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding as of October 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,290</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,470</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,470</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,470</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">687.27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(288</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(50</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(50</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(50</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(438</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">870.09</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding as of April 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,002</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,420</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,420</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,420</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84,262</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">686.32</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Through the IPO, JLL and DSM received an aggregate return on capital of approximately 2.9x their invested capital, based on the value of ordinary shares of Patheon distributed by the Partnership to JLL and DSM at the IPO price and the value of cash and in-kind distributions made by the Partnership prior to the IPO.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the IPO, a total of </font><font style="font-family:inherit;font-size:10pt;">6,106,540</font><font style="font-family:inherit;font-size:10pt;"> ordinary shares ("MEIP shares") were distributed to the Partnership to be held for the benefit of the MEIP participants until an Exit Event occurs or until MEIP participants are otherwise permitted to transfer such interests in accordance with the terms of the partnership agreement of the Partnership and respective MEIP unit award agreements, at which time MEIP participants will receive their allocable distribution of MEIP shares. These shares represent the value of the MEIP units, in the aggregate, as determined under the MEIP, as a result of the distribution of ordinary shares to the limited partners of the Partnership in connection with the IPO. MEIP shares were issued to the Partnership with respect to Class B, C and D units for the first three valuation tranches as the applicable distribution threshold was achieved. No MEIP shares were allocated to the Partnership with respect to the final two valuation tranches or the Class E units, as the distribution thresholds and the 3.0x capital return threshold, respectively, were not achieved as of the IPO.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Because no additional MEIP awards will be granted and because the ordinary shares were distributed to JLL and DSM prior to an Exit Event, the MEIP awards will not benefit from further appreciation of those shares. As such, the Company issued a total of </font><font style="font-family:inherit;font-size:10pt;">3,388,481</font><font style="font-family:inherit;font-size:10pt;"> Restricted Share Units ("MEIP RSUs") under the Omnibus Plan in order to provide the MEIP participants with the opportunity to participate in the additional appreciation the MEIP awards could have generated if the Partnership had not distributed ordinary shares of the Company to JLL and DSM. MEIP RSUs were issued in relation to all unit classes and valuation tranches.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The MEIP shares issued with respect to the Class B Units remain subject to the same vesting conditions as the Class B Units. As a result, MEIP shares issued in relation to Service-based Class B units are vested to the extent of each original MEIP grant's four year vesting schedule. The MEIP shares issued in relation to Exit Event Class B units are still subject to the defined Exit Event and are not vested. Lastly, the MEIP shares issued in relation to Class C and D units are fully vested due to their respective return thresholds being achieved through the IPO. The fair value of the MEIP shares are </font><font style="font-family:inherit;font-size:10pt;">$21.00</font><font style="font-family:inherit;font-size:10pt;">, the price of the shares at the IPO.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The MEIP RSUs are subject to the same time-based vesting criteria as the original MEIP awards as well as the achievement of performance criteria, which is measured by the Company&#8217;s stock price at the earlier to occur of (i) an Exit Event, as defined above, or (ii) the 5-year anniversary of the IPO, at which time all or a percentage of RSUs would settle based upon the attainment of an share price target, with the remaining percentage of RSUs (if any) forfeited. The share price target is </font><font style="font-family:inherit;font-size:10pt;">$48.47</font><font style="font-family:inherit;font-size:10pt;"> per share, at which 100% of the RSUs would settle on the applicable vesting date with the share price at or above the target. No RSUs would settle on the vesting date with the share price at or below the IPO price of </font><font style="font-family:inherit;font-size:10pt;">$21.00</font><font style="font-family:inherit;font-size:10pt;">, with the settlement amount for a share price between </font><font style="font-family:inherit;font-size:10pt;">$21.00</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$48.47</font><font style="font-family:inherit;font-size:10pt;"> calculated on a pro rata basis. The estimated fair value of the MEIP RSUs are </font><font style="font-family:inherit;font-size:10pt;">$8.41</font><font style="font-family:inherit;font-size:10pt;"> per unit and was estimated using a Monte Carlo simulation model. </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 8, 2016, the Company entered into a separation agreement with a senior officer ("Separation Agreement"). The agreement, in part, replaced the senior officer's </font><font style="font-family:inherit;font-size:10pt;">196,485</font><font style="font-family:inherit;font-size:10pt;"> MEIP RSUs with an equal amount of MEIP RSUs with similar terms but with a provision that the MEIP RSUs will vest, and the performance criteria be measured, on December 31, 2017 (the "Separation Date"). The estimated fair value of these replacement MEIP RSUs was </font><font style="font-family:inherit;font-size:10pt;">$13.87</font><font style="font-family:inherit;font-size:10pt;"> per unit and was estimated using a Monte Carlo simulation model.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Monte Carlo simulation model incorporated the following weighted average assumptions:</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:90%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated years to exit event</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.98</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company previously expensed the service-based Class B units using the graded vesting attribution method and is continuing to do so after the allocation of MEIP shares. In addition, the allocation of MEIP shares and MEIP RSUs in respect to the MEIP units resulted in an increase in fair value from the value attributed to the service-based Class B units at the time of the IPO, which the Company will expense on a straight line basis over the five year period following the IPO date, which represents the requisite service period of the MEIP RSUs. In total, the Company recorded </font><font style="font-family:inherit;font-size:10pt;">$1.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.9 million</font><font style="font-family:inherit;font-size:10pt;"> of compensation expense for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, relating to these units. The Company recorded </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">3.0 million</font><font style="font-family:inherit;font-size:10pt;"> of compensation expense for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively, relating to these units. The total unrecognized compensation expense for the Service-based Class B units is </font><font style="font-family:inherit;font-size:10pt;">$8.5 million</font><font style="font-family:inherit;font-size:10pt;">, which is expected to be recognized through fiscal 2021.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Exit Event Class B units, the allocation of MEIP shares and MEIP RSUs resulted in an increased fair value which will serve as the basis for recognizing compensation expense for these units. The fair value of the MEIP RSUs will be expensed on a straight line basis over </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> years, starting with the IPO date. The Company recognized </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> of compensation expense for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively. The fair value of the MEIP shares issued in respect of the Exit Event Class B units will remain unrecognized until an Exit Event occurs. The total unrecognized compensation expense for the MEIP shares and MEIP RSUs issued in respect of the Exit Event Class B units is </font><font style="font-family:inherit;font-size:10pt;">$31.9 million</font><font style="font-family:inherit;font-size:10pt;">, of which </font><font style="font-family:inherit;font-size:10pt;">$3.4 million</font><font style="font-family:inherit;font-size:10pt;"> is expected to be recognized through fiscal 2021 and the remaining amount expensed on the occurrence of an Exit Event.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the third quarter of fiscal 2016, the Company recorded two one time compensation expenses in relation to the allocation of MEIP shares and MEIP RSUs in respect of the C, D and E units. A </font><font style="font-family:inherit;font-size:10pt;">$9.0 million</font><font style="font-family:inherit;font-size:10pt;"> expense was recorded to account for the fair value of MEIP units that fully vested as a result of their respective return thresholds being met through the IPO. Additionally, a </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;"> expense was recorded to account for the unvested MEIP units that were allocated MEIP RSUs, in which requisite service requirements had already been partially met at the time of the IPO. The Company reversed </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> of these expenses in the second quarter of fiscal 2017 due to the Separation Agreement.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the Company recognized </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> of compensation expense for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, to account for the remaining fair value of the C, D and E MEIP units and the incremental fair value that resulted from the conversion to MEIP shares and MEIP RSUs. These amounts are inclusive of </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> reversed relating to the senior officer's awards that were replaced in the Separation Agreement. The compensation expense will be recorded on a straight line basis over five years. The total unrecognized compensation expense for the C, D, and E units is </font><font style="font-family:inherit;font-size:10pt;">$8.9 million</font><font style="font-family:inherit;font-size:10pt;">, which will be recognized through fiscal 2021.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of the Separation Agreement, the Company recorded </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> of additional expense in the second quarter of fiscal 2017, not including a total of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> in expense reversals, as outlined above. The total unrecognized compensation expense for the replacement awards is </font><font style="font-family:inherit;font-size:10pt;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;">, which will be recognized through the Separation Date.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Patheon N.V. 2016 Omnibus Incentive Plan</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2016, the Company adopted the Omnibus Plan in order to align the long-term financial interests of selected participants with those of our shareholders, strengthen the commitment of such persons to the Company and our affiliates, and attract and retain competent and dedicated persons whose efforts will result in our long-term growth and profitability. The Omnibus Plan provides for the issuance of options, share appreciation rights, restricted shares, restricted shares units, share bonuses, other share-based awards and cash awards to selected officers, employers, non-employee directors and consultants.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Stock Units</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of April 30, 2017, the Company has a total of (i) </font><font style="font-family:inherit;font-size:10pt;">1,366,383</font><font style="font-family:inherit;font-size:10pt;"> restricted stock units outstanding to certain members of management and (ii) </font><font style="font-family:inherit;font-size:10pt;">41,635</font><font style="font-family:inherit;font-size:10pt;"> restricted stock units to non-employee directors (collectively, the "Standard RSUs"), excluding the MEIP RSUs outlined above. The Standard RSUs granted to management vest in equal installments over three years and Standard RSUs granted to non-employee directors vest over one year or at the conclusion of the director's service to the Company. The Standard RSUs are not subject to performance based criteria and have a weighted average fair value of $</font><font style="font-family:inherit;font-size:10pt;">24.79</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the six months ended April 30, 2017, the Company issued </font><font style="font-family:inherit;font-size:10pt;">70,700</font><font style="font-family:inherit;font-size:10pt;"> ordinary shares for vested restricted stock units. To satisfy certain tax withholding requirements, the Company purchased </font><font style="font-family:inherit;font-size:10pt;">8,528</font><font style="font-family:inherit;font-size:10pt;"> of these shares at a weighted average vesting date fair value of </font><font style="font-family:inherit;font-size:10pt;">$27.15</font><font style="font-family:inherit;font-size:10pt;">. These shares are currently being held at cost as treasury shares on the balance sheet.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$4.3 million</font><font style="font-family:inherit;font-size:10pt;"> of stock compensation expense was recognized in relation to the Standard RSUs. As of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, unrecognized stock compensation expense related to Standard RSUs was </font><font style="font-family:inherit;font-size:10pt;">$29.5 million</font><font style="font-family:inherit;font-size:10pt;">, which will be recognized through fiscal 2020.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of Standard RSUs activity for the </font><font style="font-family:inherit;font-size:10pt;">six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> is as follows:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restricted Share Units </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted Average Grant Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding as of October 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">450,184</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,028,534</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.46</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(70,700</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding as of April 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,408,018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.79</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> Standard RSUs have been forfeited.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock Options</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of April 30, 2017, the Company has granted </font><font style="font-family:inherit;font-size:10pt;">1,747,750</font><font style="font-family:inherit;font-size:10pt;"> stock options to certain members of management. The stock options were granted with a weighted average exercise price of </font><font style="font-family:inherit;font-size:10pt;">$23.28</font><font style="font-family:inherit;font-size:10pt;"> per share, with </font><font style="font-family:inherit;font-size:10pt;">1,033,465</font><font style="font-family:inherit;font-size:10pt;"> of the granted stock options ("Regular Options") vesting equally over </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> years. The remaining stock options ("EBITDA Options") were granted to a senior officer and vest based on performance based criteria, using Credit Agreement Adjusted EBITDA as the performance metric. Credit Agreement Adjusted EBITDA is defined as the Company's Adjusted EBITDA, as defined in Note 11, plus pro forma cost savings, synergies and pre-acquisition results.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated weighted average fair value of stock options is </font><font style="font-family:inherit;font-size:10pt;">$9.08</font><font style="font-family:inherit;font-size:10pt;"> per option and was estimated using a Black-Scholes valuation model, using the following weighted average assumptions:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:90%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected life of options (in years)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividend yield</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> of stock compensation expense was recognized in relation to stock options. In the second quarter of fiscal 2017, </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> of stock compensation expense was recognized for the EBITDA Options, due to a portion of the performance based criteria deemed probable as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, total unrecognized compensation expense related to unvested Regular Options was </font><font style="font-family:inherit;font-size:10pt;">$8.1 million</font><font style="font-family:inherit;font-size:10pt;">, which is expected to be recognized through fiscal 2020, and total unrecognized compensation expense for the unvested EBITDA Options was </font><font style="font-family:inherit;font-size:10pt;">$5.6 million</font><font style="font-family:inherit;font-size:10pt;">, which will be recognized over the requisite service period when the performance based criteria is deemed probable to occur.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of stock option activity for the </font><font style="font-family:inherit;font-size:10pt;">six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> is as follows:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock Options </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted Average Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding as of October 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,021,584</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">726,166</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.18</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding as of April 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,747,750</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.08</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> stock options have been forfeited or exercised.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of equity based compensation expense recognized during the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> is as follows:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management Equity Incentive Plan (MEIP)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted Stock Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock Options</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock Based Compensation Expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of Standard RSUs activity for the </font><font style="font-family:inherit;font-size:10pt;">six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> is as follows:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restricted Share Units </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted Average Grant Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding as of October 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">450,184</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,028,534</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.46</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(70,700</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding as of April 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,408,018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.79</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of stock option activity for the </font><font style="font-family:inherit;font-size:10pt;">six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> is as follows:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock Options </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted Average Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding as of October 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,021,584</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">726,166</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.18</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding as of April 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,747,750</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.08</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DISCONTINUED OPERATIONS</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Banner Pharmacaps</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 12, 2015, the Company sold its Banner Pharmacaps entity in Mexico, previously included within the DPS and BLS segments, to the Perrigo Company plc for approximately </font><font style="font-family:inherit;font-size:10pt;">$36.4 million</font><font style="font-family:inherit;font-size:10pt;"> in cash. The Banner Pharmacaps entity in Mexico produced over-the-counter and nutritional products for consumption in Mexico. The Company acquired the entity in fiscal 2012 and subsequent to this acquisition, the Company shifted its business strategy, focusing more on technological innovation and R&amp;D. The Company recognized a gain on sale of $</font><font style="font-family:inherit;font-size:10pt;">2.6 million</font><font style="font-family:inherit;font-size:10pt;">, which included adjustments in the second quarter of 2016 primarily related to working capital adjustments.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Biosolutions Operations in Capua, Italy</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 31, 2015, the Company sold its Biosolutions facility in Capua, Italy, previously included within the Biosolutions segment, for approximately </font><font style="font-family:inherit;font-size:10pt;">&#8364;0.3 million</font><font style="font-family:inherit;font-size:10pt;"> in cash. The sale occurred as a result of a strategic shift in the Company&#8217;s long term business strategy. The Company recognized a loss on sale of $</font><font style="font-family:inherit;font-size:10pt;">24.0 million</font><font style="font-family:inherit;font-size:10pt;">, which included an adjustment in the second quarter of 2016 for future retention bonuses at the facility. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">DPx Fine Chemicals</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 31, 2015, the Company sold its DPx Fine Chemicals ("DFC") division, which previously comprised the DFC operating segment. DFC was sold for a cash purchase price of </font><font style="font-family:inherit;font-size:10pt;">&#8364;179.0 million</font><font style="font-family:inherit;font-size:10pt;">, which included a </font><font style="font-family:inherit;font-size:10pt;">&#8364;3.0 million</font><font style="font-family:inherit;font-size:10pt;"> working capital payment made in the first quarter of 2016. The Company recognized a gain on sale of $</font><font style="font-family:inherit;font-size:10pt;">107.0 million</font><font style="font-family:inherit;font-size:10pt;">, which included an adjustment in the first quarter of 2016 for estimated taxes on the sale. The DPx Fine Chemicals division, which was acquired through the DPP Acquisition, developed chemicals that are not in line with the Company&#8217;s long term business strategy.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The results of the above dispositions have been presented as discontinued operations, the results of which for the three and six months ended April 30, 2016 are as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of goods sold</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on disposals, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange income, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provision for income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company did not record any discontinued operations activity for the three and six months ended April 30, 2017.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EARNINGS (LOSS) PER SHARE</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings (loss) per ordinary share is computed by dividing net income (loss) available to the Company by the weighted-average number of ordinary shares outstanding during the period. Diluted earnings (loss) per ordinary share is computed by dividing net income (loss) available to the Company by the weighted-average number of ordinary shares outstanding adjusted to give effect to potentially dilutive securities.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The details of the computation of basic and diluted earnings (loss) per ordinary share are as follows:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Numerator (in millions):</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss from discontinued operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average number of shares of ordinary shares - basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145,136,214</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115,609,756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145,132,349</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115,609,756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of dilutive securities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,092,951</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,116,435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,963</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,567</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average number of shares of ordinary shares - diluted</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">146,267,128</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115,609,756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">146,276,351</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115,609,756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Earnings (loss) per ordinary share - basic:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.19</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.02</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.39</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From discontinued operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Earnings (loss) per ordinary share - diluted:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.19</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.02</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.38</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From discontinued operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a summary of the financial assets and liabilities that are measured at fair value as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value measurement at April 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value measurement at October 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Assets measured at fair value</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sale securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Held-for-trading securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value measurement at April 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value measurement at October 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Liabilities measured at fair value</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnout liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 1 - Based on quoted market prices in active markets.</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 2 - Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 3 - Unobservable inputs that are not corroborated by market data.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the fair value of the Company's financial instruments and their classifications on the consolidated balance sheets as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Assets as of April 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Assets as of October 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance sheet location</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance sheet location</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sale securities</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Held-for-trade securities</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Liabilities as of April 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Liabilities as of October 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance sheet location</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance sheet location</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts&#160;payable and&#160;accrued&#160;liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts&#160;payable and&#160;accrued&#160;liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnout liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The earnout liability activity is summarized as follows for the </font><font style="font-family:inherit;font-size:10pt;">six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:89%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at October 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at April 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INCOME TAXES </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company accounts for income taxes under FASB ASC 740, Income Taxes ("ASC 740"). The Company calculates its quarterly tax provision consistent with the guidance provided by ASC 740-270, whereby the Company forecasts its estimated annual effective tax rate then applies that rate to its year-to-date pre-tax book (loss) income. The effective tax rate may be subject to fluctuations during the year as new information is obtained, which may affect the assumptions used to estimate the annual effective rate, including factors such as the valuation allowances against deferred tax assets, the recognition or de-recognition of tax benefits related to uncertain tax positions, or changes in or the interpretation of tax laws in jurisdictions where the Company conducts business. The Company has recorded valuation allowances against certain Netherlands and other foreign jurisdictions due to insufficient evidence supporting the Company's ability to use these assets in the future.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;">six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded a benefit from income taxes in continuing operations of $</font><font style="font-family:inherit;font-size:10pt;">22.8 million</font><font style="font-family:inherit;font-size:10pt;"> and $</font><font style="font-family:inherit;font-size:10pt;">0.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The increase in tax benefit for the </font><font style="font-family:inherit;font-size:10pt;">six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> was primarily attributable to changes in the Company&#8217;s jurisdictional combination of pre-tax income, the Company&#8217;s change in tax classification of a United States subsidiary ("US subsidiary") and changes to other discrete tax items, which may have unique tax implications, depending on the nature of the item.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of fiscal 2017, the Company filed an election to change the tax classification of a US subsidiary from a partnership to an association taxable as a corporation. As a result of the change in tax classification, the Company recognized a </font><font style="font-family:inherit;font-size:10pt;">$28.3 million</font><font style="font-family:inherit;font-size:10pt;"> deferred tax benefit related to the change in its deferred tax assets and liabilities. The Company previously accounted for the deferred tax basis difference using outside basis of the partnership's investments. The Company derecognized the deferred tax liability for the outside basis difference and recognized deferred tax assets and liabilities for existing temporary differences between the tax basis and financial reporting basis of the assets and liabilities of the subsidiary.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the second quarter of fiscal 2017, the Company amended prior year federal and state returns, originally filed by a predecessor owner, for a U.S. subsidiary. As a result of the amended returns, the Company recognized a $</font><font style="font-family:inherit;font-size:10pt;">3.5 million</font><font style="font-family:inherit;font-size:10pt;"> deferred tax benefit for an increase in net operating losses.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowances are provided to reduce the related deferred income tax assets to an amount which will, more likely than not, be realized. </font><font style="font-family:inherit;font-size:10pt;">As of April 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company has multiple subsidiaries that continue to maintain either full or a partial valuation allowances on their deferred tax assets as there is not sufficient evidence to support the reversal of all or some portion of these allowances. However, given current and anticipated future earnings in the Company's Austrian subsidiaries, the Company believes that within the next twelve months there is a reasonable possibility positive evidence will become available that would require the release of all or a portion of the valuation allowance recorded at the Company&#8217;s Austrian subsidiaries.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates uncertain tax positions on a quarterly basis and considers various factors, including, but not limited to, changes in tax law, the measurement of tax positions taken or expected to be taken in tax returns, the effective settlement of matters subject to audit, information obtained during in process audit activities and changes in facts or circumstances related to a tax position. The Company also accrues for potential interest and penalties related to unrecognized tax benefits within the provision for income taxes on the consolidated statement operations. </font><font style="font-family:inherit;font-size:10pt;">As of April 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company did not have a material change in the total amount of unrecognized tax positions and does not expect a material change over the next twelve months.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company early adopted ASU No. 2016-09 "Improvements to Employee Share-Based Payment Accounting" during the second quarter of fiscal 2017. ASU 2016-09 eliminates the requirement for additional paid in capital ("APIC") pools and requires excess tax benefits and tax deficiencies to be recorded in the income statement when the awards vest or are settled.&#160; The adoption of ASU 2016-09 had no financial statement impact on the Company.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently adopted accounting pronouncements</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting Standards Update ("ASU")</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Date Adopted </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Improvements to Employee Share-Based Payment Accounting (ASU 2016-09)</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update simplifies several aspects of the accounting for</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities,</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and classification on the statement of cash flows.</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company early-adopted ASU 2016-09 during the second quarter of fiscal 2017, which had no effect on the Company's financial statements.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 1, 2017</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Simplifying the Accounting for Measurement-Period Adjustment (ASU 2015-16) </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update eliminated the requirement to an acquirer in a business combination to retrospectively adjust provisional amounts recognized at the acquisition date with a corresponding adjustment to goodwill. Instead, the update requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The impact will be dependent on future transactions.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Simplifying the Presentation of Debt Issuance Costs (ASU 2015-03)</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The pronouncement requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of the debt liability, consistent</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">with that of debt discounts. The pronouncement is being applied retrospectively and the Company's October 31, 2016 balance sheet has been adjusted. The April 30, 2017 and October 31, 2016 balance sheets were adjusted to decrease the deferred financing cost asset and decrease the long term debt liability by $45.2 million and $50.3 million, respectively.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2016</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently issued accounting pronouncements</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting Standards Update ("ASU")</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Expected Impact</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Effective Date</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (ASU 2017-07)</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update requires that an employer disaggregate the service cost component from the other components of net periodic benefit cost. In addition, only the service cost component will be eligible for capitalization. The amendment is applied retrospectively with earlier application permitted. </font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are assessing the impact to the individual line items to the Statements of Operations. The Company does not expect there to be a material impact to net income.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2018</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Simplifying the Test for Goodwill Impairment (ASU 2017-04) </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update simplified the subsequent measurement of goodwill by eliminating Step 2 of the goodwill impairment test. Instead, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The amendment also eliminated the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. The amendment is applied prospectively with earlier application permitted.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We do not expect to have a material impact on the Company&#8217;s financial statements.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2020</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Clarifying the Definition of a Business (ASU 2017-01)</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update narrows the definition of outputs and aligns it with how outputs are described in Topic 606. The amendment also provides a more robust framework to use in determining when a set of assets and activities is a business. The amendment is applied prospectively with earlier application permitted. </font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The impact on the consolidated financial statements from the adoption of this guidance is dependent on future business combinations. </font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2018</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from Contracts with Customers and related standards (ASU's 2014-09, 2016-08, 2016-10, 2016-12, 2016-20)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This update supersedes the existing revenue recognition guidance and provides a new framework for recognizing revenue. These updates identified practical expedients and clarified various aspects of the new revenue recognition standard outlined in Accounting Standards Update 2014-09. This standard may be adopted using either a retrospective or modified retrospective method. Early adoption is permitted.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are currently in the process of evaluating the impact of this standard. It is still too early in our process to determine the magnitude of the potential impact. However, based on our preliminary assessment, we believe the timing of revenue recognition for commercial and development contracts may differ from our current revenue recognition policies. The Company is determining the magnitude of this potential change. We plan to adopt the standard on November 1, 2018, and we have not yet selected a transition method.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 1, 2018</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date or, in some cases where early adoption is permitted, in advance of the specified effective date. The Company has assessed the recently issued standards that are not yet effective and, unless otherwise discussed above or in our audited consolidated financial statements and notes for fiscal </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, believes these standards will not have a material impact on the Company&#8217;s results of operations, cash flows, or financial position. A more detailed listing of recently issued accounting pronouncements are included in our audited consolidated financial statements and notes for fiscal </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">THE COMPANY</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patheon N.V. (&#8220;Patheon&#8221; or "the Company") was formed on December 24, 2013, as Patheon Co&#246;peratief U.A., a Dutch cooperative with excluded liability for its members (</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">co&#246;perative met uitgesloten aansparkelijkheid</font><font style="font-family:inherit;font-size:10pt;">) and a wholly owned indirect subsidiary of JLL/Delta Patheon Holdings, L.P. (the &#8220;Partnership&#8221;), which in turn is owned </font><font style="font-family:inherit;font-size:10pt;">51%</font><font style="font-family:inherit;font-size:10pt;"> by JLL Patheon Co-Investment Fund L.P. ("JLL") and </font><font style="font-family:inherit;font-size:10pt;">49%</font><font style="font-family:inherit;font-size:10pt;"> by Koninklijke DSM N.V. ("DSM"). On June 3, 2016, the Company was converted into a Dutch limited liability company (</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">naamloze vennootschap</font><font style="font-family:inherit;font-size:10pt;">) and changed its name to Patheon N.V.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 21, 2016, the Company amended its articles of association, resulting in a split of the Company's ordinary shares and a </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> contribution by the Partnership to the Company's equity capital in connection with the share split. This share split and capital contribution resulted in a total of </font><font style="font-family:inherit;font-size:10pt;">115,609,756</font><font style="font-family:inherit;font-size:10pt;"> ordinary shares outstanding at a par value of </font><font style="font-family:inherit;font-size:10pt;">&#8364;0.01</font><font style="font-family:inherit;font-size:10pt;"> per share.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 21, 2016, the Company commenced an initial public offering ("IPO") of an additional </font><font style="font-family:inherit;font-size:10pt;">29,464,286</font><font style="font-family:inherit;font-size:10pt;"> ordinary shares at a public offering price of </font><font style="font-family:inherit;font-size:10pt;">$21.00</font><font style="font-family:inherit;font-size:10pt;"> per share, which included </font><font style="font-family:inherit;font-size:10pt;">4,464,286</font><font style="font-family:inherit;font-size:10pt;"> ordinary shares sold pursuant to the option granted to the underwriters to purchase additional ordinary shares from the Company. As part of the IPO, DSM sold </font><font style="font-family:inherit;font-size:10pt;">4,761,905</font><font style="font-family:inherit;font-size:10pt;"> ordinary shares to the public that were distributed to them in connection to their ownership in the Partnership. A total of </font><font style="font-family:inherit;font-size:10pt;">34,226,191</font><font style="font-family:inherit;font-size:10pt;"> ordinary shares were sold in connection to the IPO. The Company did not receive any proceeds from the ordinary shares sold by DSM. The IPO was completed on July 26, 2016.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company received total net proceeds of approximately </font><font style="font-family:inherit;font-size:10pt;">$584.8 million</font><font style="font-family:inherit;font-size:10pt;"> from the IPO, after deducting underwriting discounts and commissions, but before deducting estimated offering expenses. The shares offered and sold in the IPO were registered under the Securities Act pursuant to the Company's Registration Statement on Form S-1, which was declared effective by the SEC on July 18, 2016. The Company's ordinary shares began trading on the New York Stock Exchange under the symbol "PTHN" as of July 21, 2016.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">145,136,214</font><font style="font-family:inherit;font-size:10pt;"> ordinary shares outstanding with a par value of </font><font style="font-family:inherit;font-size:10pt;">&#8364;0.01</font><font style="font-family:inherit;font-size:10pt;"> per share. Ordinary shares owned by the public constitute approximately </font><font style="font-family:inherit;font-size:10pt;">24%</font><font style="font-family:inherit;font-size:10pt;"> of the outstanding ordinary shares. JLL, DSM and the Partnership own approximately </font><font style="font-family:inherit;font-size:10pt;">38%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">34%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">4%</font><font style="font-family:inherit;font-size:10pt;"> of the Company through their ownership of outstanding ordinary shares, respectively. In accordance with the Company's articles of association, each ordinary share shall have </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> vote in the Company's general meeting. The Partnership's ownership comprises of shares held for the benefit of certain employees. See Note 9 for further discussion.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PENSION AND POST-RETIREMENT BENEFITS</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Employee future benefits</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of net periodic benefit cost from continuing operations for the defined benefit plans and other benefit plans for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Defined&#160;benefit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">pension plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other&#160;benefit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Defined&#160;benefit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">pension plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other&#160;benefit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">plans</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of actuarial loss</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic benefit costs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Defined&#160;benefit<br clear="none"/>pension plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other&#160;benefit<br clear="none"/>plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Defined&#160;benefit<br clear="none"/>pension plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other&#160;benefit<br clear="none"/>plans</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of actuarial loss</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic benefit costs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on current information available from actuarial estimates, the Company anticipates that contributions required under its defined benefit pension plans and other benefit plans for </font><font style="font-family:inherit;font-size:10pt;">fiscal 2017</font><font style="font-family:inherit;font-size:10pt;"> will be approximately $</font><font style="font-family:inherit;font-size:10pt;">3.9 million</font><font style="font-family:inherit;font-size:10pt;"> compared to contributions of </font><font style="font-family:inherit;font-size:10pt;">$5.2 million</font><font style="font-family:inherit;font-size:10pt;"> that were made in </font><font style="font-family:inherit;font-size:10pt;">fiscal 2016</font><font style="font-family:inherit;font-size:10pt;">. The decrease in the expected fiscal 2017 contributions compared to fiscal 2016 are primarily the result of decreased obligations on a pension plan for the Bourgoin, France facility due to a workforce reduction in fiscal 2016. Required contributions to defined benefit pension plans in future years may vary and will be dependent upon a number of variables, including the long-term rate of return on plan assets.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes a termination liability for the Company's Italy operations. In accordance with Italian severance pay statutes, an employee benefit is accrued for service to date and is payable when the employee's employment with the Company ceases. The termination indemnity liability is calculated in accordance with local civil and labor laws based on each employee's length of service, employment category and remuneration. The Italian termination liability is adjusted annually by a cost-of-living index provided by the Italian government. Although there is no vesting period, the Italian government has established private accounts for these benefits and has required the Company to contribute </font><font style="font-family:inherit;font-size:10pt;">$3.9 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$3.4 million</font><font style="font-family:inherit;font-size:10pt;"> in fiscal </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively, to these accounts, with additional contributions in the future. The liability recorded in the consolidated balance sheets is the amount to which the employees would be entitled if their employment with the Company ceased. The related expenses for the </font><font style="font-family:inherit;font-size:10pt;">three months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> was $</font><font style="font-family:inherit;font-size:10pt;">0.9 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, and the related expenses for the </font><font style="font-family:inherit;font-size:10pt;">six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> was $</font><font style="font-family:inherit;font-size:10pt;">1.8 million</font><font style="font-family:inherit;font-size:10pt;"> and $</font><font style="font-family:inherit;font-size:10pt;">1.4 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The employee future benefit expense recorded in continuing operations in connection with defined benefit pension plans, other post-retirement benefit plans and the unfunded termination indemnities for the </font><font style="font-family:inherit;font-size:10pt;">three months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> was $</font><font style="font-family:inherit;font-size:10pt;">2.2 million</font><font style="font-family:inherit;font-size:10pt;"> and $</font><font style="font-family:inherit;font-size:10pt;">1.6 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. For the </font><font style="font-family:inherit;font-size:10pt;">six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, the employee future benefit expense was </font><font style="font-family:inherit;font-size:10pt;">$4.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$3.3 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Below is a reconciliation of Adjusted EBITDA to its most comparable U.S. GAAP measure.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">157.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(61.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(53.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repositioning expenses </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition and integration costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(42.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(59.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(86.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefit from (provision for) income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Refinancing expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operational initiatives related consulting costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">IPO costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition related litigation expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock based compensation expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">FDA remediation costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Environmental remediation costs </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bargain purchase gain</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) from continuing operations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) Repositioning expenses for the three and six months ended April 30, 2017 includes </font><font style="font-family:inherit;font-size:8pt;">$0.4 million</font><font style="font-family:inherit;font-size:8pt;"> and </font><font style="font-family:inherit;font-size:8pt;">$1.1 million</font><font style="font-family:inherit;font-size:8pt;"> of inventory reserves related to the Swindon wind down recorded in cost of goods sold.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RELATED PARTIES</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Related Party Transactions</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">JLL Partners</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a service agreement with JLL Partners Inc. and some JLL Partners affiliates whereby the Company will reimburse the parties for management, consulting, financial, and other business services provided under the agreement. The amounts spent on these services, as well as the amounts payable outstanding in relation to these services, are shown in the tables below.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">DSM</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has transition service agreements ("TSAs") with DSM resulting from the DPP Acquisition whereby DSM performs certain shared service functions on behalf of the Company. Additionally, the Company performs certain services on behalf of DSM. The revenue and expenses relating to these services, as well as the accounts receivable and payable outstanding in relation to these services, are shown in the tables below.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">BLS</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a management service agreement with BLS whereby the Company will provide various management, financial, legal and other business services to BLS. The expenses relating to these services are charged to BLS and the related accounts receivable outstanding in relation to these services are shown in the tables below. We performed production services for BLS in the first quarter of fiscal 2016 before BLS sold their commercial business to a third party.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenues/Expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">JLL Partners Expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DSM Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DSM Expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Banner Life Sciences Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balances as of</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounts Receivable/Payable Balances </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">April&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">October&#160;31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">JLL Partners Accounts Payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DSM Accounts Receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DSM Accounts Payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Banner Life Sciences Accounts Receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Equity Method Investments</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Banner Life Sciences</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2015, the Company invested </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> in Banner Life Sciences. The investment resulted in Banner Life Sciences becoming a variable interest entity, but the entity is not consolidated as the Company does not have the ability to control the entity and therefore does not have the power to direct Banner Life Sciences' activities. The Company's maximum exposure to loss relating to this variable interest entity is limited to the carrying value of the investment. The investment is presented within investments in the consolidated balance sheets. In March 2016, the Company received a </font><font style="font-family:inherit;font-size:10pt;">$2.4 million</font><font style="font-family:inherit;font-size:10pt;"> cash distribution from Banner Life Sciences.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Percivia</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company holds a </font><font style="font-family:inherit;font-size:10pt;">50.0%</font><font style="font-family:inherit;font-size:10pt;"> interest in Percivia, a limited liability company for the purpose of performing research and development activities and licensing certain technology. In February 2016, the Company received a </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> return of capital from Percivia in the form of a cash distribution.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Chemiepark</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company holds a </font><font style="font-family:inherit;font-size:10pt;">47.5%</font><font style="font-family:inherit;font-size:10pt;"> interest in Chemiepark, a company tasked with providing fire protection for the chemicals site in Linz, Austria.</font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Values as of</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Equity Method Investment Values</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">April&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">October&#160;31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Banner Life Sciences</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Percivia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chemiepark</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investment carrying values are presented within investments in the consolidated balance sheets.</font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Equity Method (Loss)/Gain</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Banner Life Sciences</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Percivia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity method earnings are presented within other income in the consolidated statement of operations.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">REPOSITIONING EXPENSES</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company incurred </font><font style="font-family:inherit;font-size:10pt;">$1.8 million</font><font style="font-family:inherit;font-size:10pt;"> and $</font><font style="font-family:inherit;font-size:10pt;">2.4 million</font><font style="font-family:inherit;font-size:10pt;"> in repositioning expenses, respectively, primarily from severance payments resulting from operational initiatives. In addition, the Company recorded inventory reserves of </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> relating to raw material and work in process inventory associated with the final phase of the winding down of the older section of the Swindon facility ("Swindon wind down") to allow us to re-purpose that area, which was expensed through cost of goods sold.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company incurred </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;"> and $</font><font style="font-family:inherit;font-size:10pt;">2.5 million</font><font style="font-family:inherit;font-size:10pt;"> in repositioning expenses, primarily from severance payments resulting from a realignment of DPS operations.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a summary of these expenses and other charges associated with operational improvements as of and for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of and for the three months ended April 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PDS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DSS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total repositioning liability at January 31, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee-related expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repositioning expenses paid</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total repositioning liability at April 30, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of and for the three months ended April 30, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PDS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DSS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total repositioning liability at January 31, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee-related expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consulting, professional and project management costs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repositioning expenses paid</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total repositioning liability at April 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of and for the six months ended April 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PDS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DSS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total repositioning liability at October 31, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee-related expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repositioning expenses paid</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total repositioning liability at April 30, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The balance of repositioning liabilities as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> was recorded in accounts payable and accrued liabilities on the consolidated balance sheet. The Company does not have any long-term repositioning liabilities as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of and for the six months ended April 30, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PDS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DSS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total repositioning liability at October 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee-related expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consulting, professional and project management costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repositioning expenses paid</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total repositioning liability at April 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The balance of repositioning liabilities as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> was recorded in accounts payable and accrued liabilities on the consolidated balance sheet. The Company does not have any long-term repositioning liabilities as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued liabilities consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">April&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">October&#160;31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade payables</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">277.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">279.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued salaries and related expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer deposits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repositioning</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accruals</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">382.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">393.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The revenues and net income from continuing operations from the RCI Acquisition for the period from February 1, 2017 to April 30, 2017 included in the consolidated statement of operations are as follows:</font></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">February 1, 2017 to April 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income from continuing operations </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) Net income from continuing operations includes the $</font><font style="font-family:inherit;font-size:8pt;">26.4 million</font><font style="font-family:inherit;font-size:8pt;"> of the bargain purchase gain</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">As of </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, the fair values and carrying values of the Company&#8217;s long-term debt, including the current portion of long-term debt, are categorized in the table below:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 1</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 2</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 3</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Carrying Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt, including current portion </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,179.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,179.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,134.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the fair values and carrying values of the Company&#8217;s long-term debt, including the current portion of long-term debt, are categorized in the table below:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 1</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 2</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 3</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Carrying Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt, including current portion </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,156.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,156.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,119.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Statements of cash flows non-cash investing and financing activities</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Non-cash financing activities:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assumption of earnout liability from the Partnership </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Treasury stock purchases to satisfy certain tax withholdings </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase in capital lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) Refer to Note 9 for further information</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2) Represents the tax payable held as of April 30, 2017 relating to a second quarter treasury stock purchase.</font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt in the accompanying consolidated balance sheets at </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;"> consists of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:79%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of April 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of October 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">USD Term Loan at LIBOR with a floor of 1% plus 3.25% rate and maturity date of April 20, 2024 (the "Credit Agreement")</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,133.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Euro Term Loan at LIBOR with a floor of 1% plus 3.00% rate and maturity date of April 20, 2024 (the "Credit Agreement")</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">504.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">USD Term Loan with a base rate plus 2.25% or LIBOR with a floor of 1% plus 3.25% rate and maturity date of March 10, 2021 (the "Credit Agreement")</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,138.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Euro Term Loan with a base rate plus 2.50% or LIBOR with a floor of 1% plus 3.50% rate and maturity date of March 10, 2021 (the "Credit Agreement")</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.50% Senior Notes due February 1, 2022 (the "Notes")</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">450.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">450.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Secured Revolving Facility balance at LIBOR plus 3.25% rate and maturity terms on a rolling basis</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government of Austria research and development loans with annual interest rates ranging from 1.56% to 2.00% and maturities through March 2020</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Italian subsidized loan with annual interest rate of 0.5%, and maturity date of June 30, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Italian bank loan with Euribor 6-month + 7.1% rate, and maturity date of June 30, 2020</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital lease obligations </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term debt outstanding</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,146.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,128.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less original issue discount, net of accumulated amortization of $7.1 million and $6.2 million, respectively</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less deferred financing costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(45.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(50.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less current portion</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, end of the period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,069.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,049.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The results of the above dispositions have been presented as discontinued operations, the results of which for the three and six months ended April 30, 2016 are as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of goods sold</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on disposals, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange income, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provision for income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The details of the computation of basic and diluted earnings (loss) per ordinary share are as follows:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Numerator (in millions):</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss from discontinued operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average number of shares of ordinary shares - basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145,136,214</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115,609,756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145,132,349</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115,609,756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of dilutive securities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,092,951</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,116,435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,963</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,567</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average number of shares of ordinary shares - diluted</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">146,267,128</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115,609,756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">146,276,351</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115,609,756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Earnings (loss) per ordinary share - basic:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.19</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.02</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.39</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From discontinued operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Earnings (loss) per ordinary share - diluted:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.19</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.02</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.38</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.16</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From discontinued operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes gross carrying amounts, accumulated amortization, and accumulated impairments related to the Company's identifiable intangible assets as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">Definite-lived intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross carrying value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net carrying value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted Average Useful Life (in Years)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Favorable agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Developed technology</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade secrets and patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">248.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-compete agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subtotal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">310.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(73.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">237.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, end of period</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">233.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the changes in the carrying amount of goodwill for the </font><font style="font-family:inherit;font-size:10pt;">six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:12px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:89%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at October 31, 2016 </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">281.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at April 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">281.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) The opening cumulative goodwill balance is reflective of historical impairment charges of the full value of goodwill.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">Indefinite-lived intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross carrying value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated impairment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net carrying value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research and development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Regulatory permits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subtotal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, end of period</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">April&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">October&#160;31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials, packaging components and spare parts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">228.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">192.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work-in-process</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">451.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">395.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of net periodic benefit cost from continuing operations for the defined benefit plans and other benefit plans for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Defined&#160;benefit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">pension plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other&#160;benefit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Defined&#160;benefit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">pension plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other&#160;benefit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">plans</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of actuarial loss</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic benefit costs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Defined&#160;benefit<br clear="none"/>pension plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other&#160;benefit<br clear="none"/>plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Defined&#160;benefit<br clear="none"/>pension plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other&#160;benefit<br clear="none"/>plans</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of actuarial loss</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic benefit costs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the foreign currency activity on the intercompany loans that are included as part of the net investment in certain foreign subsidiaries for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> since net investment hedge inception:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange gain for the period from long-term intercompany loan revaluation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the net investment hedge foreign exchange activity for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> since net investment hedge inception:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange (loss) gain for the period from net investment hedge</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Release of ineffective portion of net investment hedge to consolidated statement of operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) gain to other comprehensive income for the period related to net investment hedge</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preliminary purchase price allocation for the RCI Acquisition is as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:88%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">155.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total assets acquired </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">165.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total liabilities assumed </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total net assets </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Bargain purchase gain</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total purchase price</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Values as of</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Equity Method Investment Values</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">April&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">October&#160;31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Banner Life Sciences</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Percivia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chemiepark</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The expenses relating to these services are charged to BLS and the related accounts receivable outstanding in relation to these services are shown in the tables below. We performed production services for BLS in the first quarter of fiscal 2016 before BLS sold their commercial business to a third party.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenues/Expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">JLL Partners Expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DSM Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DSM Expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Banner Life Sciences Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balances as of</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounts Receivable/Payable Balances </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">April&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">October&#160;31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">JLL Partners Accounts Payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DSM Accounts Receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DSM Accounts Payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Banner Life Sciences Accounts Receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Equity Method (Loss)/Gain</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Banner Life Sciences</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Percivia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a summary of these expenses and other charges associated with operational improvements as of and for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of and for the three months ended April 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PDS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DSS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total repositioning liability at January 31, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee-related expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repositioning expenses paid</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total repositioning liability at April 30, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of and for the three months ended April 30, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PDS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DSS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total repositioning liability at January 31, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee-related expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consulting, professional and project management costs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repositioning expenses paid</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total repositioning liability at April 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of and for the six months ended April 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PDS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DSS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total repositioning liability at October 31, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee-related expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repositioning expenses paid</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total repositioning liability at April 30, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The balance of repositioning liabilities as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> was recorded in accounts payable and accrued liabilities on the consolidated balance sheet. The Company does not have any long-term repositioning liabilities as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of and for the six months ended April 30, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PDS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DSS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total repositioning liability at October 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee-related expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consulting, professional and project management costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repositioning expenses paid</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total repositioning liability at April 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As illustrated in the table below, revenues are attributed to countries based on the location of the customer's billing address, capital assets are attributed to the country in which they are located and goodwill is attributed to the country in which the entity to which the goodwill pertains is located:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Canada</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">US*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other**</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">483.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*&#160;Includes Puerto Rico</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">** Primarily includes Japan</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Canada</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">US*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other**</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">317.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">124.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">468.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*&#160;Includes Puerto Rico</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">** Primarily includes Japan</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of and for the six months ended April 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Canada</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">US*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other**</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">564.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">320.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">940.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">687.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">367.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,169.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">269.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">281.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*&#160;Includes Puerto Rico</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">** Other revenues primarily include Japan</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of and for the six months ended April 30, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Canada</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">US*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other**</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">589.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">236.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">874.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">487.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">945.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">269.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*&#160;Includes Puerto Rico</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">** Other revenues primarily include Japan</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="17" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PDS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DSS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intersegment Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">297.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">129.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">483.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="17" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PDS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DSS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intersegment Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">287.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">468.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="17" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PDS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DSS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intersegment Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">572.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">259.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">940.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="17" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PDS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DSS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intersegment Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">545.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">226.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">874.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(46.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">157.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of the MEIP activity for the </font><font style="font-family:inherit;font-size:10pt;">six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> is as follows:</font></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Class B</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Class C</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Class D</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Class E</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted Average Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding as of October 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,290</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,470</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,470</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,470</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">687.27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(288</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(50</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(50</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(50</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(438</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">870.09</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding as of April 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,002</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,420</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,420</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,420</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84,262</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">686.32</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated weighted average fair value of stock options is </font><font style="font-family:inherit;font-size:10pt;">$9.08</font><font style="font-family:inherit;font-size:10pt;"> per option and was estimated using a Black-Scholes valuation model, using the following weighted average assumptions:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:90%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected life of options (in years)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividend yield</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Monte Carlo simulation model incorporated the following weighted average assumptions:</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:90%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated years to exit event</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.98</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SEGMENT INFORMATION</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> operating segments are: North America DPS, Europe DPS, PDS and DSS. The North America DPS and Europe DPS operating segments meet the aggregation criteria to be presented as one DPS reportable segment. As a result, the Company has </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> reportable segments: DPS, PDS and DSS. Costs relating to Corporate operations are classified as Other.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The DPS segment includes commercial manufacturing outsourcing services, the PDS segment includes pharmaceutical development services, and the DSS segment includes active pharmaceutical ingredients and pharmaceutical intermediates. Corporate expenses primarily relate to general, administrative and sales and marketing expenses related to the corporate organization. These expenses are centrally directed and controlled and are not included in internal measures of segment operating performance. The CODM does not evaluate its operating segments using discrete asset information.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="17" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PDS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DSS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intersegment Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">297.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">129.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">483.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="17" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PDS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DSS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intersegment Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">287.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">468.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="17" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PDS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DSS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intersegment Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">572.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">259.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">940.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="17" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">PDS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">DSS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intersegment Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">545.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">226.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">874.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(46.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">157.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates the performance of its segments based on segment Adjusted EBITDA. The Company's Adjusted EBITDA is income (loss) from continuing operations before repositioning expenses (including certain product returns and</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">inventory write-offs recorded in gross profit), interest expense, foreign exchange losses reclassified from other comprehensive income (loss), refinancing expenses, acquisition and integration costs (including certain product returns and inventory write-offs recorded in gross profit), gains and losses on sale of capital assets, Biologics earnout income and expense, income taxes, impairment charges, remediation costs, depreciation and amortization, stock-based compensation expense, consulting costs related to our operational initiatives, purchase accounting adjustments, acquisition-related litigation expenses and other income and expenses. Adjusted EBITDA is one of several metrics used to measure segment operating performance and is also used to determine executive compensation. "Adjusted EBITDA margin" is Adjusted EBITDA as a percentage of revenues. The Company's presentation of Adjusted EBITDA may not be comparable to similarly-titled measures used by other companies and is not equivalent to "Consolidated EBITDA" as defined in the Credit Agreement (as discussed in Note 5).</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Below is a reconciliation of Adjusted EBITDA to its most comparable U.S. GAAP measure.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Six months ended April 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">157.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(61.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(53.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repositioning expenses </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition and integration costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(42.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(59.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(86.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefit from (provision for) income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Refinancing expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operational initiatives related consulting costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">IPO costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition related litigation expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock based compensation expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">FDA remediation costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Environmental remediation costs </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bargain purchase gain</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) from continuing operations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) Repositioning expenses for the three and six months ended April 30, 2017 includes </font><font style="font-family:inherit;font-size:8pt;">$0.4 million</font><font style="font-family:inherit;font-size:8pt;"> and </font><font style="font-family:inherit;font-size:8pt;">$1.1 million</font><font style="font-family:inherit;font-size:8pt;"> of inventory reserves related to the Swindon wind down recorded in cost of goods sold.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As illustrated in the table below, revenues are attributed to countries based on the location of the customer's billing address, capital assets are attributed to the country in which they are located and goodwill is attributed to the country in which the entity to which the goodwill pertains is located:</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Canada</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">US*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other**</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">483.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*&#160;Includes Puerto Rico</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">** Primarily includes Japan</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended April 30, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Canada</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">US*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other**</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">317.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">124.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">468.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*&#160;Includes Puerto Rico</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">** Primarily includes Japan</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of and for the six months ended April 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Canada</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">US*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other**</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">564.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">320.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">940.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">687.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">367.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,169.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">269.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">281.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*&#160;Includes Puerto Rico</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">** Other revenues primarily include Japan</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of and for the six months ended April 30, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Canada</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">US*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other**</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">589.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">236.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">874.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">487.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">945.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">269.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*&#160;Includes Puerto Rico</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">** Other revenues primarily include Japan</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment information</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. GAAP requires segmentation based on an entity&#8217;s internal organization and reporting of revenue and operating income (loss) based upon internal accounting methods commonly referred to as the &#8220;management approach.&#8221; Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (&#8220;CODM&#8221;), or decision making group, in deciding how to allocate resources and in assessing performance. The Company&#8217;s CODM is its Chief Executive Officer.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> operating segments are: North America Drug Product Services, or North America DPS, Europe Drug Product Services, or Europe DPS, Pharmaceutical Development Services, or PDS and Drug Substance Services, or DSS. The North America DPS and Europe DPS operating segments meet the aggregation criteria to be presented as </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> reportable segment referred to as DPS. As a result, the Company has determined it has </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> reportable segments: DPS, PDS, and DSS. Corporate is not an individually reportable segment because the quantitative thresholds have not been met and as such has been reported in Other.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SUBSEQUENT EVENTS</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 15, 2017, the Company and Thermo Fisher Scientific Inc. ("Thermo Fisher") and Thermo Fisher (CN) Luxembourg Sarl (the &#8220;Buyer&#8221;) entered into a Purchase Agreement pursuant to which the Buyer will commence a tender offer to all outstanding shares of the Company for </font><font style="font-family:inherit;font-size:10pt;">$35.00</font><font style="font-family:inherit;font-size:10pt;"> per share (the "Offer Consideration"). The transaction represents a purchase price of approximately </font><font style="font-family:inherit;font-size:10pt;">$7.2 billion</font><font style="font-family:inherit;font-size:10pt;">, which includes the assumption of approximately </font><font style="font-family:inherit;font-size:10pt;">$2.0 billion</font><font style="font-family:inherit;font-size:10pt;"> of net debt. The closing of the tender offer (the &#8220;Closing&#8221;) will constitute an Exit Event under the MEIP and the LTIP and, accordingly, (i) all management units under the MEIP that are unvested as of the Closing will vest in full, (ii) the MEIP RSUs will settle in accordance with their terms based on the Offer Consideration; and (iii) all outstanding awards under the LTIP will become payable. All remaining unvested equity awards under the Company's Omnibus Incentive Plan will convert into an equity award of Thermo Fisher with the same value and substantially similar other terms as the existing Company equity award.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SUPPLEMENTAL BALANCE SHEET INFORMATION</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Inventories</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">April&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">October&#160;31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials, packaging components and spare parts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">228.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">192.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work-in-process</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">451.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">395.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounts payable and accrued liabilities</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued liabilities consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">April&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">October&#160;31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade payables</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">277.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">279.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued salaries and related expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer deposits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repositioning</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accruals</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">382.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">393.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible assets</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes gross carrying amounts, accumulated amortization, and accumulated impairments related to the Company's identifiable intangible assets as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">Definite-lived intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross carrying value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net carrying value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted Average Useful Life (in Years)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Favorable agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Developed technology</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade secrets and patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">248.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-compete agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subtotal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">310.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(73.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">237.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, end of period</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">233.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;font-weight:bold;">Indefinite-lived intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross carrying value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated impairment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net carrying value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research and development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Regulatory permits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subtotal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, end of period</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research and development (&#8220;IPR&amp;D&#8221;) is classified as definite-lived or indefinite-lived depending on whether the product has been approved and if commercialization has begun. IPR&amp;D for products that have been approved is classified as a definite-lived intangible asset and is amortized over the life of the asset. IPR&amp;D for products that have not been approved is classified as an indefinite-lived intangible asset and either begins to be amortized upon approval and product commercialization or is written-off if the product is not approved.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of fiscal 2016, the Company sold an IPR&amp;D asset to Banner Life Sciences for cash consideration equal to its net carrying value of </font><font style="font-family:inherit;font-size:10pt;">$3.6 million</font><font style="font-family:inherit;font-size:10pt;">. At the time of the sale, the asset had a gross carrying value of </font><font style="font-family:inherit;font-size:10pt;">$7.9 million</font><font style="font-family:inherit;font-size:10pt;"> and had incurred </font><font style="font-family:inherit;font-size:10pt;">$4.3 million</font><font style="font-family:inherit;font-size:10pt;"> in impairments.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the changes in the carrying amount of goodwill for the </font><font style="font-family:inherit;font-size:10pt;">six months ended April 30, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:12px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:89%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at October 31, 2016 </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">281.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at April 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">281.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) The opening cumulative goodwill balance is reflective of historical impairment charges of the full value of goodwill.</font></div></div> 2 Net of an income tax expense of $0.0 million for the three and six months ended April 30, 2017 and 2016, which is included as a component of provision for income taxes on the consolidated statements of operations. Amounts, gross of tax, have been reclassified to cost of goods sold and selling, general and administrative expenses in the consolidated statements of operations. See Note 7 for further information. 1 Net of an income tax benefit of $0.1 million for the three and six months ended April 30, 2017. Income tax expense is not applicable for the six months ended April 30, 2016 as these amounts are from the Company's Canadian operations which were under a full valuation allowance in the prior period. The valuation allowance was released during the fourth quarter of fiscal 2016. Amounts, gross of tax, have been reclassified to foreign exchange loss, net on the consolidated statements of operations. EX-101.SCH 6 pti-20170430.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2102100 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 2402402 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - BUSINESS COMBINATIONS link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - BUSINESS COMBINATIONS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2403404 - Disclosure - BUSINESS COMBINATIONS - Schedule of Financial Results (Details) link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - BUSINESS COMBINATIONS - Schedule of Preliminary Purchase Price Allocations (Details) link:presentationLink link:calculationLink link:definitionLink 2403405 - Disclosure - BUSINESS COMBINATIONS - Schedule of Unaudited Pro Forma Information (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - BUSINESS COMBINATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - THE COMPANY link:presentationLink link:calculationLink link:definitionLink 2401401 - Disclosure - THE COMPANY - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' DEFICIT (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1003501 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - DISCONTINUED OPERATIONS link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - DISCONTINUED OPERATIONS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - DISCONTINUED OPERATIONS - Schedule of Dispositions (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - DISCONTINUED OPERATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - EARNINGS (LOSS) PER SHARE link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - EARNINGS (LOSS) PER SHARE - Schedule of Basic and Diluted EPS (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT link:presentationLink link:calculationLink link:definitionLink 2409410 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Credit Risk (Details) link:presentationLink link:calculationLink link:definitionLink 2409407 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Earnout Liability Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2409404 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Fair Value Measurements Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2409406 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Foreign Exchange Contracts and Other Arrangements Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2409408 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Foreign Exchange Risk Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2409411 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Liquidity Risk (Details) link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Schedule of Derivative Financial Instruments and Investments Classification on Consolidated Balance Sheet (Details) link:presentationLink link:calculationLink link:definitionLink 2409405 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Schedule of Fair Values and Carrying Values of Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2409409 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Summary of Financial Assets and Liabilities Measured at Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT(Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 2413401 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - LONG-TERM DEBT link:presentationLink link:calculationLink link:definitionLink 2405405 - Disclosure - LONG-TERM DEBT - 2014 Senior Unsecured Notes (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - LONG-TERM DEBT - 2017 Term Loans and Revolving Line (Details) link:presentationLink link:calculationLink link:definitionLink 2405407 - Disclosure - LONG-TERM DEBT - Other Financing Arrangements (Details) link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - LONG-TERM DEBT - Schedule of Long-term Debt in Accompanying balance Sheet (Details) link:presentationLink link:calculationLink link:definitionLink 2405404 - Disclosure - LONG-TERM DEBT - Schedule of Maximum Leverage Ratios (Details) link:presentationLink link:calculationLink link:definitionLink 2405406 - Disclosure - LONG-TERM DEBT - Schedule of Redemption Rates (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - LONG-TERM DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - OTHER INFORMATION link:presentationLink link:calculationLink link:definitionLink 2414404 - Disclosure - OTHER INFORMATION - Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - OTHER INFORMATION - Foreign Exchange (Details) link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - OTHER INFORMATION - Management Incentive Plan (Details) link:presentationLink link:calculationLink link:definitionLink 2414405 - Disclosure - OTHER INFORMATION - Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - OTHER INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - PENSION AND POST-RETIREMENT BENEFITS link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - PENSION AND POST-RETIREMENT BENEFITS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - PENSION AND POST-RETIREMENT BENEFITS - Schedule of Net Periodic Benefit Cost (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - PENSION AND POST-RETIREMENT BENEFITS (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - RELATED PARTIES link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - RELATED PARTIES (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - RELATED PARTIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - REPOSITIONING EXPENSES link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - REPOSITIONING EXPENSES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - REPOSITIONING EXPENSES - Schedule of Repositioning Expenses and Charges (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - REPOSITIONING EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - SEGMENT INFORMATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - SEGMENT INFORMATION - Reconciliation of Adjusted EBITDA (Details) link:presentationLink link:calculationLink link:definitionLink 2410405 - Disclosure - SEGMENT INFORMATION - Schedule of Revenue, Capital Assets and Goodwill, by Country (Details) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - SEGMENT INFORMATION - Segment Results (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - SEGMENT INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - STOCK BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 2408405 - Disclosure - STOCK BASED COMPENSATION - Fair Value Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - STOCK BASED COMPENSATION - Management Equity Incentive Plan (MEIP) (Details) link:presentationLink link:calculationLink link:definitionLink 2408406 - Disclosure - STOCK BASED COMPENSATION - Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - STOCK BASED COMPENSATION - Schedule of Plan Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - STOCK BASED COMPENSATION - Schedule of Share Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2408409 - Disclosure - STOCK BASED COMPENSATION - Schedule of Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 2408408 - Disclosure - STOCK BASED COMPENSATION - Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 2408407 - Disclosure - STOCK BASED COMPENSATION - Summary of Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - STOCK BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2144100 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 2444401 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION - Accounts Payable and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2404404 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION - Finite-Lived Intangible Assets Acquired (Details) link:presentationLink link:calculationLink link:definitionLink 2404407 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2404405 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION - Indefinite-Lived Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2404406 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 pti-20170430_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 pti-20170430_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 pti-20170430_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Debt Disclosure [Abstract] LONG-TERM DEBT Debt Disclosure [Text Block] Discontinued Operations and Disposal Groups [Abstract] Schedule of Results of Discontinued Operations Disposal Groups, Including Discontinued Operations [Table Text Block] Subsequent Events [Abstract] SUBSEQUENT EVENTS Subsequent Events [Text Block] Fair Value Disclosures [Abstract] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Measurement Basis [Axis] Measurement Basis [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement [Member] Portion at Fair Value Measurement [Member] Fair Value Estimate of Fair Value Measurement [Member] Carrying Value Reported Value Measurement [Member] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Level 1 Fair Value, Inputs, Level 1 [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Liabilities: Liabilities, Fair Value Disclosure [Abstract] Long-term debt, including current portion Long-term Debt, Fair Value Income Tax Disclosure [Abstract] Valuation Allowance [Table] Valuation Allowance [Table] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Patheon Biologics LLC Patheon Biologics LLC [Member] Patheon Biologics LLC [Member] Valuation Allowance [Line Items] Valuation Allowance [Line Items] Provision for (benefit from) income taxes Income Tax Expense (Benefit) Deferred income taxes Deferred Income Tax Expense (Benefit) Other Information [Abstract] Other Information [Abstract] Loss Contingencies [Table] Loss Contingencies [Table] Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] Management Long-Term Incentive Plan Management Long-Term Incentive Plan [Member] Management Long-Term Incentive Plan [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Threshold percentage of ownership of equity securities for exit event Deferred Compensation Arrangement with Individual, Threshold Parent Ownership Percentage Resulting in Exit Event Deferred Compensation Arrangement with Individual, Threshold Parent Ownership Percentage Resulting in Exit Event Percentage of excess capital contributions received to trigger an Exit Event Deferred Compensation Arrangement with Individual, Percentage in Excess of Capital Contributions Received by Parent, Resulting in Exit Event Deferred Compensation Arrangement with Individual, Percentage in Excess of Capital Contributions Received by Parent, Resulting in Exit Event Number of days to determine plan details Number of Days after Fiscal Year To Determine Plan Details Number of Days after Fiscal Year To Determine Plan Details Value of LTIP units granted Stock Granted, Value, Share-based Compensation, Gross Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Payments made due to qualified terminations Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Disposal Group Name [Axis] Disposal Group Name [Axis] Disposal Group Name [Domain] Disposal Group Name [Domain] DPx Fine Chemicals DPx Fine Chemicals [Member] DPx Fine Chemicals [Member] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Disposed of by sale Discontinued Operations, Disposed of by Sale [Member] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Revenues Disposal Group, Including Discontinued Operation, Revenue Cost of goods sold Disposal Group, Including Discontinued Operation, Costs of Goods Sold Gross profit Disposal Group, Including Discontinued Operation, Gross Profit (Loss) Selling, general and administrative expenses Disposal Group, Including Discontinued Operation, General and Administrative Expense Loss on disposals, net Disposal Group, including Discontinued Operations, Gain (loss) on Disposal, Net Disposal Group, including Discontinued Operations, Gain (loss) on Disposal, Net Operating loss Disposal Group, Including Discontinued Operation, Operating Income (Loss) Foreign exchange income, net Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses) Loss before income taxes Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax Provision for income taxes Discontinued Operation, Tax Effect of Discontinued Operation Net loss Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Swindon Wind Down Swindon Wind Down [Member] Swindon Wind Down [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Total Adjusted EBITDA Income Loss From Continuing Operations Before Interest Income Expense Income Taxes Depreciation and Amortization Income Loss From Continuing Operations Before Interest Income Expense Income Taxes Depreciation and Amortization Depreciation and amortization Depreciation, Depletion and Amortization Repositioning expenses Restructuring Charges, Including Manual Adjustment Restructuring Charges, Including Manual Adjustment Acquisition and integration costs Business Combination Acquisition and Integration Related Costs, Including Manual Adjustment Business Combination Acquisition and Integration Related Costs, Including Manual Adjustment Interest expense, net Interest Income (Expense), Net Benefit from (provision for) income taxes Refinancing expenses Debt Related Commitment Fees and Debt Issuance Costs Operational initiatives related consulting costs Professional Fees IPO costs Issuance of Common Stock, Initial Public Offering Costs Issuance of Common Stock, Initial Public Offering Costs Acquisition related litigation expenses Legal Fees Stock based compensation expense Allocated Share-based Compensation Expense FDA remediation costs Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, FDA Remediation Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, FDA Remediation Environmental remediation costs Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Environmental Remediation Costs Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Environmental Remediation Costs Bargain purchase gain Business Combination, Bargain Purchase, Gain Recognized, Amount Other Other Adjustments to Net Income (Loss) Other Adjustments to Net Income (Loss) Net income (loss) from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Inventory Write-down Inventory Write-down Income Statement [Abstract] Revenues Revenues Cost of goods sold Cost of Goods Sold Gross profit Gross Profit Selling, general and administrative expenses Selling, General and Administrative Expense Research and development Research and Development Expense Repositioning expenses Restructuring Charges Acquisition and integration costs Business Combination Acquisition and Integration Related Costs Business Combination Acquisition and Integration Related Costs Other operating expense (income) Other Operating Income (Expense), Net Operating income Operating Income (Loss) Interest expense, net Foreign exchange loss, net Foreign Currency Transaction Gain (Loss), before Tax Refinancing expenses Gain (Loss) on Extinguishment of Debt Bargain purchase gain Other loss (income), net Other Nonoperating Income (Expense) Income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (Benefit from) provision for income taxes Net loss from discontinued operations Net income (loss) Net Income (Loss) Attributable to Parent Basic earnings (loss) per ordinary share Earnings Per Share, Basic [Abstract] From continuing operations (in USD per share) Income (Loss) from Continuing Operations, Per Basic Share From discontinued operations (in USD per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Diluted earnings (loss) per ordinary share Earnings Per Share, Diluted [Abstract] From continuing operations (in USD per share) Income (Loss) from Continuing Operations, Per Diluted Share From discontinued operations (in USD per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Average number of ordinary shares outstanding Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Management Equity Incentive Plan DPx Management Equity Incentive Plan [Member] DPx Management Equity Incentive Plan [Member] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Restricted Stock Units Restricted Stock Units (RSUs) [Member] Stock Options Employee Stock Option [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Stock Based Compensation Expense Earnings Per Share [Abstract] EARNINGS (LOSS) PER SHARE Earnings Per Share [Text Block] Banner Acquisition Banner Acquisition [Member] Banner Acquisition [Member] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Softgel Services Softgel Services [Member] Softgel Services [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Service concentration risk Product Concentration Risk [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Sales revenue Sales Revenue, Net [Member] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] Italy ITALY Litigation Case [Axis] Litigation Case [Axis] Litigation Case [Domain] Litigation Case [Domain] Italian client dispute Italian Client Dispute [Member] Italian Client Dispute [Member] Concentration risk, percentage (generally less than) (as percent) Concentration Risk, Percentage Number of plaintiffs Loss Contingency, Number of Plaintiffs Number of plaintiff actions Loss Contingency, Number of Plaintiff Actions Loss Contingency, Number of Plaintiff Actions Number of named plaintiffs Loss Contingency, Number of Named Plaintiffs Loss Contingency, Number of Named Plaintiffs Amount of penalty per day sought by client Loss Contingency, Damages Sought, Value Per Day Loss Contingency, Damages Sought, Value Per Day Accounting Policies [Abstract] New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Accounting Standards Update 2015-03 Accounting Standards Update 2015-03 [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Long-term Debt Long-term Debt [Member] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Number of reportable segments Number of Reportable Segments Number of operating segments Number of Operating Segments DPS reportable segment Number of Reportable Segments, Combined Operating Segments Meeting Aggregation Criteria Number of Reportable Segments, Combined Operating Segments Meeting Aggregation Criteria Deferred finance costs Debt Issuance Costs, Net Supplemental Balance Sheet Information [Abstract] Supplemental Balance Sheet Information [Abstract] Trade payables Accounts Payable, Trade, Current Interest payable Interest Payable, Current Accrued salaries and related expenses Employee-related Liabilities, Current Customer deposits Customer Deposits, Current Repositioning Restructuring Reserve, Current Other accruals Other Accrued Liabilities, Current Balance, end of period Accounts Payable and Accrued Liabilities, Current Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Canada CANADA U.S. UNITED STATES Europe Europe [Member] Other Other Countries [Member] Other Countries [Member] Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Capital Assets Property, Plant and Equipment, Net Goodwill Goodwill Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Class B Common Class B [Member] Class C Common Class C [Member] Class D Common Class D [Member] Common Class D [Member] Class E Common Class E [Member] Common Class E [Member] Common Class C, Class D, Class E Stock Common Class C, Class D, Class E Stock [Member] Common Class C, Class D, Class E Stock [Member] Sale of Stock [Axis] Sale of Stock [Axis] Sale of Stock [Domain] Sale of Stock [Domain] IPO IPO [Member] Stock-based Compensation Stock Compensation Plan [Member] Number of valuation tranches Share-based Compensation Arrangement by Share-based Payment Award, Number of Valuation Tranches Share-based Compensation Arrangement by Share-based Payment Award, Number of Valuation Tranches Percent of service-based units Share-based Compensation Arrangement by Share-based Payment Award, Awards with Vesting Feature, Percentage Share-based Compensation Arrangement by Share-based Payment Award, Awards with Vesting Feature, Percentage Threshold percentage of ownership of equity securities for exit event (less than) Class C, class D, and class E vesting thresholds Share-based Compensation Arrangement by Share-based Payment Award, Return on Capital Threshold Required for Vesting Share-based Compensation Arrangement by Share-based Payment Award, Return on Capital Threshold Required for Vesting Shares distributed to be held for MEIP participants (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Restricted share units under the omnibus Plan (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share price (in USD per share) Share Price Share price target (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Share Price Target Share-based Compensation Arrangement by Share-based Payment Award, Share Price Target Estimated fair value of MEIP RSU's (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Stock-based compensation expense Compensation costs not yet recognized Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Compensation costs not yet recognized, to be recognized before Exit Event Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Expected Capitalized Amount Before Exit Event Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Expected Capitalized Amount Before Exit Event Stock-based compensation expense reversed Allocated Share-based Compensation Expense Reversed As a Result of The Separation Agreement Allocated Share-based Compensation Expense Reversed As a Result of The Separation Agreement Restricted Share Units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Beginning balance (in shares) Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Forfeitures (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Ending balance (in shares) Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Beginning balance (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Granted (in USD per share) Vested (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Ending balance (in USD per share) Restructuring and Related Activities [Abstract] REPOSITIONING EXPENSES Restructuring and Related Activities Disclosure [Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Income (loss) from continuing operations Loss from discontinued operations Weighted-average number of shares of ordinary shares - basic (in shares) Effect of dilutive securities: Dilutive Securities, Effect on Basic Earnings Per Share [Abstract] Dilutive securities (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Weighted-average number of shares of ordinary shares - diluted (in shares) Earnings (loss) per ordinary share - basic: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Earnings (loss) per ordinary share - diluted: Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Subsequent Event [Table] Subsequent Event [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Thermo Fisher Thermo Fisher [Member] Thermo Fisher [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent event Subsequent Event [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Amount of cash and associated inventory and spare parts transferred Business Combination, Consideration Transferred Liability assumed as part of business combination Business Combination, Consideration Transferred, Liabilities Incurred Level 1 Level 2 Level 3 Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Foreign exchange forward contracts Foreign Exchange Forward [Member] Assets measured at fair value Assets, Fair Value Disclosure [Abstract] Available-for-sale securities Available-for-sale Securities Held-for-trading securities Trading Securities Total assets Assets, Fair Value Disclosure Liabilities measured at fair value Foreign exchange forward contracts Derivative Liability Earnout liability Business Combination, Contingent Consideration, Liability Total liabilities Financial and Nonfinancial Liabilities, Fair Value Disclosure Postemployment Benefits [Abstract] Schedule of Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] PENSION AND POST-RETIREMENT BENEFITS Postemployment Benefits Disclosure [Text Block] Schedule of Long-term Debt Schedule of Long-term Debt Instruments [Table Text Block] Schedule of Maximum Leverage Ratio Schedule of Maximum Leverage Ratio [Table Text Block] Schedule of Maximum Leverage Ratio [Member] Schedule of Redemption Prices Debt Instrument Redemption [Table Text Block] Stock Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Beginning balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Ending balance (in shares) Weighted Average Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Beginning balance (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Granted (in USD per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Ending balance (in USD per share) Statements of Cash Flows Non-cash Investing and Financing Activities Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Statement of Cash Flows [Abstract] Operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Net income (loss) from continuing operations Adjustments to reconcile net income to net cash provided by (used in) operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Increase in deferred revenues Increase (Decrease) in Deferred Revenue Amortization of deferred revenues Recognition of Deferred Revenue Non-cash interest Amortization of Debt Issuance Costs Change in other long-term assets and liabilities Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net Deferred income taxes Stock based compensation expense Share-based Compensation Gain on bargain purchase Payment of original issue discount Amortization of Debt Discount (Premium) Return on capital from equity investment Proceeds from Equity Method Investment, Dividends or Distributions Foreign exchange loss on debt Foreign Transaction Gain (Loss) on Debt, Before Tax Foreign Transaction Gain (Loss) on Debt, Before Tax Other Other Noncash Income (Expense) Net change in non-cash working capital balances Increase (Decrease) in Operating Capital, Excluding Deferred Revenue Increase (Decrease) in Operating Capital, Excluding Deferred Revenue Cash provided by (used in) operating activities of continuing operations Net Cash Provided by (Used in) Operating Activities, Continuing Operations Cash used in operating activities of discontinued operations Cash Provided by (Used in) Operating Activities, Discontinued Operations Cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Additions to capital assets Payments to Acquire Property, Plant, and Equipment Acquisitions Payments to Acquire Businesses, Net of Cash Acquired Proceeds from sale of capital assets Proceeds from Sale of Property, Plant, and Equipment Return of capital from equity investment Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital Cash used in investing activities of continuing operations Net Cash Provided by (Used in) Investing Activities, Continuing Operations Cash used in investing activities of discontinued operations Cash Provided by (Used in) Investing Activities, Discontinued Operations Cash used in investing activities Net Cash Provided by (Used in) Investing Activities Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Proceeds from borrowings Proceeds from Issuance of Long-term Debt Repayment of debt Payments of Financing Costs Increase in deferred financing costs Repayments of Long-term Debt Treasury share purchases to satisfy certain tax withholdings Payments for Repurchase of Common Stock Cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents Net change in cash and cash equivalents during the period Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents, beginning of period Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents, end of period Business Combinations [Abstract] Schedule of Preliminary Purchase Price Allocation Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Schedule of Financial Results Schedule of Business Acquisitions, by Acquisition [Table Text Block] Schedule of Unaudited Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Schedule of Segment Results Schedule of Segment Reporting Information, by Segment [Table Text Block] Reconciliation of Adjusted EBITDA Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Schedule of Revenue, Capital Assets and Goodwill, by Country Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Schedule of Other Ownership Interests [Table] Schedule of Other Ownership Interests [Table] JLL Patheon Co-Investment Fund L.P. JLL Patheon Co-Investment Fund L.P. [Member] JLL Patheon Co-Investment Fund L.P. [Member] Koninklijke DSM Koninklijke DSM [Member] Koninklijke DSM [Member] JLL/Delta Patheon Holdings JLL/Delta Patheon Holdings [Member] JLL/Delta Patheon Holdings [Member] Other Ownership Interests [Line Items] Other Ownership Interests [Line Items] Ownership percentage by parent Noncontrolling Interest, Ownership Percentage by Parent Proceeds from partner contribution Proceeds from Partnership Contribution Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Common stock, par value (in euros per share) Common Stock, Par or Stated Value Per Share Issuance of ordinary shares (in shares) Stock Issued During Period, Shares, New Issues IPO price per shares (in USD per share) Shares Issued, Price Per Share Rights to purchase addition ordinary shares (in shares) Stock Issued During Period, Shares, New Issuances Pursuant to Options Granted to IPO Underwriters Stock Issued During Period, Shares, New Issuances Pursuant to Options Granted to IPO Underwriters Total number of ordinary shares sold in connection with IPO (in shares) Stock Issued During Period, Shares, Total of Ordinary Shares Sold In Connection With IPO Stock Issued During Period, Shares, Total of Ordinary Shares Sold In Connection With IPO Proceeds from IPO Proceeds from Issuance Initial Public Offering Percentage of voting stock publicly owned Stock Issued During the Period, Percentage of Voting Stock Publicly Owned Stock Issued During the Period, Percentage of Voting Stock Publicly Owned Number of voting rights Membership Interest Voting Right Number of Votes Membership Interest Voting Right Number of Votes OTHER INFORMATION Other Information [Text Block] Other Information [Text Block] Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] Defined Benefit Plan and Other Postretirement Benefit Plan [Domain] Defined Benefit Plan and Other Postretirement Benefit Plan [Domain] Defined benefit pension plans Pension Plan [Member] Other benefit plans Other Postretirement Benefit Plan [Member] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Service cost Defined Benefit Plan, Service Cost Interest cost Defined Benefit Plan, Interest Cost Expected return on plan assets Defined Benefit Plan, Expected Return on Plan Assets Amortization of actuarial loss Defined Benefit Plan, Amortization of Gains (Losses) Net periodic benefit costs Defined Benefit Plan, Net Periodic Benefit Cost Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Roche Carolina Inc. Roche Carolina Inc. [Member] Roche Carolina Inc. [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Revenues Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual Net income from continuing operations Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual Fair Value, Concentration of Risk [Table] Fair Value, Concentration of Risk [Table] Liquidity risk Liquidity Risk [Member] Liquidity Risk [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Line of credit Line of Credit [Member] Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] Cash and cash equivalents Undrawn lines of credit available Line of Credit Facility, Remaining Borrowing Capacity Related Party Transactions [Abstract] RELATED PARTIES Related Party Transactions Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Ordinary Shares Common Stock [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Treasury Shares Treasury Stock [Member] Accumulated Deficit Retained Earnings [Member] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Stockholders' equity, beginning of period (shares) Shares, Outstanding Stockholders' equity, beginning of period Members' Equity Ordinary share issuances related to stock based compensation (in shares) Stock Issued During Period, Shares, Share-based Compensation, Gross Ordinary share issuances related to stock based compensation Stock Issued During Period, Value, Share-based Compensation, Gross Stock based compensation Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Treasury shares acquired, at cost (in shares) Stock Repurchased During Period, Shares Treasury shares acquired, at cost Stock Repurchased During Period, Value Comprehensive income (loss): Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Net income Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Net gain related to net investment hedge Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax Change in value of derivatives designated as foreign currency cash flow hedges Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax Losses from foreign currency hedges reclassified to consolidated statement of operations Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax Net change in minimum pension liability Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Stockholders' equity, end of period (shares) Stockholders' equity, end of period FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT Derivatives and Fair Value [Text Block] Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract] Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Prepaid expenses and other Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Capital assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract] Accounts payable and accrued liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Deferred revenue Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue Deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Current Total liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Total net assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Total purchase price Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Statement of Financial Position [Abstract] Common stock, shares issued (in shares) Common Stock, Shares, Issued Common stock, shares authorized (in shares) Common Stock, Shares Authorized Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Favorable agreements Favorable Agreements [Member] Favorable Agreements [Member] Trade names Trade Names [Member] Developed technology Developed Technology Rights [Member] Trade secrets and patents Trade Secrets and Patents [Member] Trade Secrets and Patents [Member] Customer relationships Customer Relationships [Member] Non-compete agreements Noncompete Agreements [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Gross carrying value Finite-Lived Intangible Assets, Gross Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Net carrying value Finite-Lived Intangible Assets, Net, Before Translation Adjustments Finite-Lived Intangible Assets, Net, Before Translation Adjustments Foreign exchange Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) Balance, end of period Finite-Lived Intangible Assets, Net Weighted Average Useful Life (in Years) Finite-Lived Intangible Assets, Remaining Amortization Period Banner Pharmacaps Banner Pharmacaps [Member] Banner Pharmacaps [Member] Biosolutions Biosolutions [Member] Biosolutions [Member] Cash purchase price Disposal Group, Including Discontinued Operation, Consideration Gain on disposals Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax Proceeds from working capital Disposal Group Including Discontinued Operation, Proceeds from Working Capital Disposal Group Including Discontinued Operation, Proceeds from Working Capital Goodwill [Roll Forward] Goodwill [Roll Forward] Goodwill, beginning of period Foreign currency translation adjustments Goodwill, Foreign Currency Translation Gain (Loss) Goodwill, end of period SUPPLEMENTAL BALANCE SHEET INFORMATION Supplemental Balance Sheet Disclosures [Text Block] Schedule of Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] Condensed Cash Flow Statement [Table] Condensed Cash Flow Statement [Table] Other Significant Noncash Transaction [Axis] Other Significant Noncash Transaction [Axis] Other Significant Noncash Transaction, Name [Domain] Other Significant Noncash Transaction, Name [Domain] Assumption of earnout liability from the Partnership Assumption of Earnout Liability [Member] Assumption of Earnout Liability [Member] Treasury stock purchases to satisfy certain tax withholdings Treasury Stock Purchases to Satisfy Certain Tax Withholdings [Member] Treasury Stock Purchases to Satisfy Certain Tax Withholdings [Member] Condensed Cash Flow Statements, Captions [Line Items] Condensed Cash Flow Statements, Captions [Line Items] Assumption of earnout liability from the Partnership Other Significant Noncash Transaction, Value of Consideration Given Increase in capital lease obligations Capital Lease Obligations Incurred Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Investments Investments [Member] Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities [Member] Other long-term liabilities Other Noncurrent Liabilities [Member] Foreign exchange forward contracts Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Total assets Foreign exchange forward contracts (Derivative liabilities) Earnout liability Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Total liabilities Financial Liabilities Fair Value Disclosure Assets Assets [Abstract] Current Assets, Current [Abstract] Accounts receivable, net Accounts Receivable, Net, Current Inventories, net Inventory, Net Income taxes receivable Income Taxes Receivable, Current Prepaid expenses and other Prepaid Expense and Other Assets, Current Total current assets Assets, Current Capital assets Intangible assets Intangible Assets, Net (Excluding Goodwill) Deferred tax assets Deferred Tax Assets, Net, Noncurrent Investments Long-term Investments Other long-term assets Other Assets, Noncurrent Total assets Assets Liabilities and shareholders' deficit Liabilities and Equity [Abstract] Current Liabilities, Current [Abstract] Accounts payable and accrued liabilities Income taxes payable Accrued Income Taxes, Current Deferred revenues - current Deferred Revenue, Current Current portion of long-term debt Long-term Debt, Current Maturities Total current liabilities Liabilities, Current Long-term debt Long-term Debt, Excluding Current Maturities Deferred revenues Deferred Revenue, Noncurrent Deferred tax liabilities Deferred Tax Liabilities, Net, Noncurrent Other long-term liabilities Other Liabilities, Noncurrent Total liabilities Liabilities Commitments and contingencies Commitments and Contingencies Shareholders' deficit: Retained Earnings (Accumulated Deficit) [Abstract] Ordinary shares (par value of €0.01 per share, 500,000,000 shares authorized, 145,144,742 and 145,074,042 shares issued as of April 30, 2017 and October 31, 2016, respectively) Common Stock, Value, Issued Additional paid in capital Additional Paid in Capital Treasury shares (at cost, 8,528 ordinary shares as of April 30, 2017) Members' Capital Accumulated deficit Retained Earnings (Accumulated Deficit) Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Total shareholders' deficit Total liabilities and shareholders' deficit Liabilities and Equity Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] In-process research and development In Process Research and Development [Member] BLS Banner Life Sciences [Member] Banner Life Sciences [Member] Spinoff Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Spinoff [Member] Net carrying value Indefinite-Lived Intangible Assets (Excluding Goodwill), Net of Accumulated Impairment, Before Translation Adjustments Indefinite-Lived Intangible Assets (Excluding Goodwill), Net of Accumulated Impairment, Before Translation Adjustments Gross carrying value Indefinite-Lived Intangible Assets Excluding Goodwill, Gross of Accumulated Impairment and Translation Adjustments Indefinite-Lived Intangible Assets Excluding Goodwill, Gross of Accumulated Impairment and Translation Adjustments Impairment losses Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Schedule of Related Party Transactions Schedule of Related Party Transactions [Table Text Block] Basis of presentation Basis of Accounting, Policy [Policy Text Block] Segment information Segment Reporting, Policy [Policy Text Block] Recently adopted and issued accounting pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Operating Segments Operating Segments [Member] Other Corporate, Non-Segment [Member] Intersegment Eliminations Intersegment Eliminations [Member] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] DPS DPS [Member] DPS [Member] PDS PDS [Member] PDS [Member] DSS DSS [Member] DSS [Member] Other Corporate and Other [Member] Adjusted EBITDA Capital expenditures STOCK BASED COMPENSATION Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Schedule of Indefinite-Lived Intangible Assets [Table] Schedule of Indefinite-Lived Intangible Assets [Table] Regulatory permits Regulatory Permits [Member] Regulatory Permits [Member] Indefinite-lived Intangible Assets [Line Items] Indefinite-lived Intangible Assets [Line Items] Accumulated impairment Indefinite-Lived Intangible Assets Excluding Goodwill, Accumulated Impairment Indefinite-Lived Intangible Assets Excluding Goodwill, Accumulated Impairment Net carrying value Foreign exchange Indefinite-lived Intangible Assets, Foreign Currency Translation Gain (Loss) Balance, end of period Indefinite-Lived Intangible Assets (Excluding Goodwill) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Forfeited (in shares) Forfeited (in USD per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price THE COMPANY Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Title of Individual [Axis] Title of Individual [Axis] Relationship to Entity [Domain] Relationship to Entity [Domain] Management Management [Member] Director Director [Member] RSU's granted (in shares) Shares issued during period (in shares) Geographic Concentration Risk Geographic Concentration Risk [Member] Cash receipts from operations in U.S. dollars Cash outflows in U.S. dollars Cash Outflows [Member] Cash Outflows [Member] Foreign credit agreement Foreign Line of Credit [Member] Concentration risk, percentage (as percent) Potential increase/decrease in exchange rate impacting operating income, percentage Exchange Rate Translation Percentage Potential Change In Rate Impacting Operating Income Exchange Rate Translation Percentage Potential Change In Rate Impacting Operating Income Potential increase/decrease in exchange rate impacting operating income, value Exchange Rate Translation Amount Potential Change In Rate Impacting Operating Income Exchange Rate Translation Amount Potential Change In Rate Impacting Operating Income Percent of cash flow exposures covered by hedges Derivative Percent Of Cash Flow Exposure Covered By Hedges Derivative Percent Of Cash Flow Exposure Covered By Hedges Long-term debt, including current portion, carrying value Long-term Debt Cumulative unrealized exchange gains Unrealized Gain on Foreign Currency Derivatives, before Tax SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] Line of Credit Facility [Table] Line of Credit Facility [Table] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Secured revolving credit facility Revolving Credit Facility [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Secured revolving facility due March 2019 Secured Revolving Facility Due March 2019 [Member] Secured Revolving Facility Due March 2019 [Member] Leverage Ratio Levels [Axis] Leverage Ratio Levels [Axis] Leverage Ratio Levels [Axis] Leverage Ratio Levels [Domain] Leverage Ratio Levels [Domain] [Domain] for Leverage Ratio Levels [Axis] April 30, 2014 through October 31, 2014 Leverage Ratio Testing Period Range One [Member] Leverage Ratio Testing Period Range One [Member] November 1, 2014 through October 31, 2015 Leverage Ratio Testing Period Range Two [Member] Leverage Ratio Testing Period Range Two [Member] November 1, 2015 through October 31, 2016 Leverage Ratio Testing Period Range Three [Member] Leverage Ratio Testing Period Range Three [Member] November 1, 2016 through October 31, 2017 Leverage Ratio Testing Period Range Four [Member] Leverage Ratio Testing Period Range Four [Member] November 1, 2017 and thereafter Leverage Ratio Testing Period Range Five [Member] Leverage Ratio Testing Period Range Five [Member] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Maximum leverage ratio (as percent) Debt Instrument, Covenant, Leverage Ratio Debt Instrument, Covenant, Leverage Ratio Statement of Comprehensive Income [Abstract] Losses from foreign currency hedges reclassified to consolidated statement of operations, net of income tax expense Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax Net change in minimum pension liability, net of income tax benefit Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Tax Net income (loss) Other comprehensive income (loss), net of income taxes: Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation adjustments Net (loss) gain related to net investment hedge Net gain on intra-entity foreign currency transactions Other Comprehensive Income (Loss), Intra-Entity Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Other Comprehensive Income (Loss), Intra-Entity Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Change in value of derivatives designated as foreign currency cash flow hedges Losses from foreign currency hedges reclassified to consolidated statement of operations (1) INCOME TAXES Income Tax Disclosure [Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Domestic credit agreement Domestic Line of Credit [Member] Secured term loan Secured Debt [Member] Letter of credit Letter of Credit [Member] USD Term Loan Due April 20, 2024 USD Term Loan Due April 20, 2024 [Member] USD Term Loan Due April 20, 2024 [Member] USD Term Loan Due To Terminate on March 2019 USD Term Loan Due To Terminate on March 11, 2019 [Member] USD Term Loan Due To Terminate on March 11, 2019 [Member] Euro Term Loan Due April 20, 2024 Euro Term Loan Due April 20, 2024 [Member] Euro Term Loan Due April 20, 2024 [Member] Secured Revolving Facility Due April 20, 2024 Secured Revolving Facility Due April 20, 2024 [Member] Secured Revolving Facility Due April 20, 2024 [Member] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] Base rate Base Rate [Member] LIBOR London Interbank Offered Rate (LIBOR) [Member] FIrst Lien Leverage Ratio is less than or equal to 3.00 to 1.00 FIrst Lien Leverage Ratio is less than or equal to 3.00 to 1.00 [Member] FIrst Lien Leverage Ratio is less than or equal to 3.00 to 1.00 [Member] First Lien Leverage Ratio Greater than 4.00 to 1.00 First Lien Leverage Ratio Greater than 4.00 to 1.00 [Member] First Lien Leverage Ratio Greater than 4.00 to 1.00 [Member] First Lien Leverage Ratio Less Than or Equal to 4.00 to 1.00 But Greater Than 3.50 to 1.00 First Lien Leverage Ratio Less Than or Equal to 4.00 to 1.00 But Greater Than 3.50 to 1.00 [Member] First Lien Leverage Ratio Less Than or Equal to 4.00 to 1.00 But Greater Than 3.50 to 1.00 [Member] First Lien Leverage Ratio of Less Than or Equal to 3.50 to 1.00 First Lien Leverage Ratio of Less Than or Equal to 3.50 to 1.00 [Member] First Lien Leverage Ratio of Less Than or Equal to 3.50 to 1.00 [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Amount of debt issued Debt Instrument, Face Amount Basis spread (as percent) Debt Instrument, Basis Spread on Variable Rate Variable interest rate floor (as percent) Debt Instrument, Variable Rate Floor Debt Instrument, Variable Rate Floor Unused capacity, commitment fee percentage (as percent) Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Leverage ratio (as percent) Number of incremental debt instruments Debt Instruments, Number of Instruments, Increase Debt Instruments, Number of Instruments, Increase Amount of borrowings outstanding Long-term Line of Credit Minimum borrowing amount to maintain First Lien Leverage Ratio, percentage Line of Credit Facility, Minimum Borrowing Percentage for Maintaining First Lien Leverage Ratio Line of Credit Facility, Minimum Borrowing Percentage for Maintaining First Lien Leverage Ratio Minimum borrowing amount to maintain First Lien Leverage Ratio Line of Credit Facility, Minimum Borrowing Amount for Maintaining First Lien Leverage Ratio Line of Credit Facility, Minimum Borrowing Amount for Maintaining First Lien Leverage Ratio Prepayment amount of excess cash flows, percentage Debt Instrument, Prepayment Amount From Excess Cash Flows, Percentage Debt Instrument, Prepayment Amount From Excess Cash Flows, Percentage Prepayment amount from net cash proceeds of certain asset sales including insurance and condemnation proceeds, percentage Debt Instrument, Prepayment Amount from Net Cash Proceeds of Certain Asset Sales Including Insurance and Condemnation Proceeds, Percentage Debt Instrument, Prepayment Amount from Net Cash Proceeds of Certain Asset Sales Including Insurance and Condemnation Proceeds, Percentage Prepayment amount from net cash proceeds of issuance of debt obligations, percentage Debt Instrument, Prepayment Amount from Net Cash Proceeds of Issuance of Debt Obligations, Percentage Debt Instrument, Prepayment Amount from Net Cash Proceeds of Issuance of Debt Obligations, Percentage Prepayment amount from excess cash flows, value Debt Instrument, Prepayment Amount From Excess Cash Flows, Value Debt Instrument, Prepayment Amount From Excess Cash Flows, Value Number of business days following deadline to be in compliance with First Lien Leverage Ratio Debt Instrument, Number of Business Days Following Deadline To Be In Compliance with First Lien Leverage Ratio Debt Instrument, Number of Business Days Following Deadline To Be In Compliance with First Lien Leverage Ratio Maximum percentage of consolidated total assets (as percent) Debt Instrument, Covenant Terms, Dividend Distribution, Maximum Consolidated Total Assets, Percentage Debt Instrument, Covenant Terms, Dividend Distribution, Maximum Consolidated Total Assets, Percentage Additional threshold amount for dividend distribution Debt Instrument, Covenant Terms, Dividend Distribution, Maximum Consolidated Total Assets, Amount Debt Instrument, Covenant Terms, Dividend Distribution, Maximum Consolidated Total Assets, Amount Gross unrealized loss Unrealized Loss on Foreign Currency Derivatives, before Tax Gross unrealized gain DPP Acquisition DPP Acquisition [Member] DPP Acquisition [Member] Revenues Net income from continuing operations Impairment expense related to Roche's strategic realignment Business Combination, Pro Forma Information, Impairment Charge since Acquisition Date, Actual Business Combination, Pro Forma Information, Impairment Charge since Acquisition Date, Actual Senior notes Senior Notes [Member] Loan Loans Payable [Member] Capital lease obligations Capital Lease Obligations [Member] USD term loan due March 2021 USD Term Loan Due March 2021 [Member] USD Term Loan Due March 2021 [Member] Euro term loan due March 2021 Euro Term Loan Due March 2021 [Member] Euro Term Loan Due March 2021 [Member] 7.50% senior notes due February 2022 Senior Notes Due February 2022 - 7.50% [Member] Senior Notes Due February 2022 - 7.50% [Member] Seller financing, non-Interest Bearing Loan Due May 2016 Non-Interest Bearing Loan Due May 2016 [Member] Non-Interest Bearing Due Loan May 2016 [Member] Government of Austria research and development loans due March 2020 Government of Austria Research and Development Loans Due March 2019 [Member] Government of Austria Research and Development Loans Due March 2019 [Member] Italian subsidized loan due June 2020 Italian Subsidized Loan Due June 2020 [Member] Italian Subsidized Loan Due June 2020 [Member] Italian bank loan due June 2020 Italian Bank Loan Due June 2020 [Member] Italian Bank Loan Due June 2020 [Member] Euribor rate Euribor 6 month [Member] Euribor 6 month [Member] Total long-term debt outstanding Long-term Debt, Gross Less original issue discount, net of accumulated amortization of $7.1 million and $6.2 million, respectively Debt Instrument, Unamortized Discount Less deferred financing costs Debt Issuance Costs, Gross Less current portion Balance, end of the period Stated rate (as percent) Debt Instrument, Interest Rate, Stated Percentage Accumulated amortization Accumulated Amortization, Unamortized Debt Discount Accumulated Amortization, Unamortized Debt Discount Upfront payment to acquire stock of RCI Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Consideration transferred Business Combination, Consideration Transferred, Other Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Net investment hedge Net Investment Hedging [Member] Foreign exchange contract Foreign Exchange Contract [Member] Intercompany loans Subsidiaries [Member] Foreign exchange (loss) gain for the period from net investment hedge Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax Release of ineffective portion of net investment hedge to consolidated statement of operations Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Release of Ineffective Portion of Derivative Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Release of Ineffective Portion of Derivative Net (loss) gain to other comprehensive income for the period related to net investment hedge Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Net loss to other comprehensive income (loss) for the period related to foreign exchange Adjustment for Long-term Intercompany Transactions, Gross of Tax Raw materials, packaging components and spare parts Inventory, Raw Materials, Net of Reserves Work-in-process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Balance, end of period Other Obligations Notes Payable, Other Payables [Member] Other Commitments [Axis] Other Commitments [Axis] Other Commitments [Domain] Other Commitments [Domain] Investment in Facility Investment in Facility [Member] Investment in Facility [Member] Proceeds from long-term debt Number of semi-annual installments Debt Instrument, Number of Amortization Installments Debt Instrument, Number of Amortization Installments Long-term investment commitment, minimum amount Other Commitment Percentage of property tax payment due (as percent) Debt Payment, Percentage of Property Tax Payment Due Debt Payment, Percentage of Property Tax Payment Due Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] Employee-related expenses Employee Severance [Member] Consulting, professional and project management costs Consulting, Professional and Project Management Costs [Member] Consulting, Professional and Project Management Costs [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Total repositioning liability at beginning of period Restructuring Reserve Repositioning expenses paid Payments for Restructuring Foreign exchange Restructuring Reserve, Foreign Currency Translation Gain (Loss) Total repositioning liability at end of period EBITDA Options EBITDA Options [Member] EBITDA Options [Member] Vesting [Axis] Vesting [Axis] Vesting [Domain] Vesting [Domain] Tranche One Share-based Compensation Award, Tranche One [Member] Stock option grants (in shares) Estimate fair value of stock options (in USD per share)) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Summary of Stock Based Compensation Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Schedule of Plan Activity Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Document and Entity Information [Abstract] Document and Entity Information [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] 2017 Debt Instrument, Redemption, Period Two [Member] 2018 Debt Instrument, Redemption, Period Three [Member] 2019 Debt Instrument, Redemption, Period Four [Member] 2020 and thereafter Debt Instrument, Redemption, Period Five [Member] Redemption price (as percent) Debt Instrument, Redemption Price, Percentage Anticipated contributions required under the defined benefit pension plans and other benefit plans Defined Benefit Plans, Estimated Future Employer Contributions in Current Fiscal Year Contributions made under the defined benefit pension plans and other benefit plans Defined Benefit Plan, Contributions by Employer Deferred compensation arrangement employer contribution Deferred Compensation Arrangement with Individual, Employer Contribution Deferred compensation arrangement employer contribution related expenses Deferred Compensation Arrangement with Individual, Compensation Expense Employee future benefit expense Pension and Other Postretirement Benefit Expense Schedule of Inventories Schedule of Inventory, Current [Table Text Block] Schedule of Accounts Payable and Accrued Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of Finite-Lived Intangible Assets Acquired Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of Indefinite-Lived Intangible Assets Acquired Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Schedule of Goodwill Schedule of Goodwill [Table Text Block] DISCONTINUED OPERATIONS Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Summary of Financial Assets and Liabilities Measured at Fair Value Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Schedule of Derivative Financial Instruments and Investments Classification on Consolidated Balance Sheet Fair Value, by Balance Sheet Grouping [Table Text Block] Schedule of Fair Values and Carrying Values of Long-term Debt Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block] Schedule of Earnout Liability Activity Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block] BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Significant Accounting Policies [Text Block] Deposits held Liability Class [Axis] Liability Class [Axis] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Earnout Earnout [Member] Earnout [Member] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Designated as hedging instruments Designated as Hedging Instrument [Member] Foreign Exchange Forward Issued January 2017 Foreign Exchange Forward Issued January 2017 [Member] Foreign Exchange Forward Issued January 2017 [Member] Position [Axis] Position [Axis] Position [Domain] Position [Domain] Short Short [Member] Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Tranche one Debt, Tranche One [Member] Debt, Tranche One [Member] Tranche two Debt, Tranche Two [Member] Debt, Tranche Two [Member] Tranche three Debt, Tranche Three [Member] Debt, Tranche Three [Member] Aggregate amount to sell Derivative, Notional Amount Average exchange rate Derivative, Average Forward Exchange Rate Unrealized loss recorded in accumulated other comprehensive income in shareholders' deficit, net of associated income tax Derivative Instruments, Loss Recognized in Other Comprehensive Income (Loss), Effective Portion Contingent consideration Capital transaction Distribution Payment Made to Limited Liability Company (LLC) Member Forms Other than Cash or Stock Distribution Payment Made to Limited Liability Company (LLC) Member Forms Other than Cash or Stock Adjusted EBITDA growth rate (as percent) Fair Value Inputs, Adjusted EBITDA Growth Rate Fair Value Inputs, Adjusted EBITDA Growth Rate Maximum payment under Earnout Agreement Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Minimum payment under Earnout Agreement Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low Income recognized from change in fair value in earnout liability Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Number of tranches Debt Instrument, Number of Tranches Debt Instrument, Number of Tranches Consideration transferred Adjusted EBITDA value Fair Value Input, Adjusted EBITDA Value Fair Value Input, Adjusted EBITDA Value Income (expense) recognized from change in fair value earn out liability Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Asset volatility rate (as percent) Fair Value Assumptions, Expected Volatility Rate Asset beta Fair Value Assumptions, Asset Beta Fair Value Assumptions, Asset Beta Change in asset volatility (as percent) Fair Value Assumptions, Change in Asset Volatility Fair Value Assumptions, Change in Asset Volatility Change in liability amount due to asset volatility change Change in Liability Amount Due to Asset Volatility Change Change in Liability Amount Due to Asset Volatility Change Change in asset beta Fair Value Assumptions, Change in Beta Fair Value Assumptions, Change in Beta Change in liability amount due to asset beta change Change in Liability Amount Due to Asset Beta Change Change in Liability Amount Due to Asset Beta Change Other Restructuring Other Restructuring [Member] Inventory Reserve For Three Months Ended Inventory Reserve, First Period [Member] Inventory Reserve, First Period [Member] Inventory Reserve For Six Months Ended Inventory Reserve, Second Period [Member] Inventory Reserve, Second Period [Member] Restructuring Reserve Fair Value Inputs, Liabilities, Quantitative Information [Table] Fair Value Inputs, Liabilities, Quantitative Information [Table] Fair Value Inputs, Liabilities, Quantitative Information [Line Items] Fair Value Inputs, Liabilities, Quantitative Information [Line Items] Fair Value Inputs, Liabilities, Quantitative Information [Roll Forward] Fair Value Inputs, Liabilities, Quantitative Information [Roll Forward] Fair Value Inputs, Liabilities, Quantitative Information [Roll Forward] Earnout liability, beginning balance Change in fair value Earnout liability, ending balance Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Related Party [Axis] Related Party [Axis] Related Party [Domain] Related Party [Domain] Affiliated entity Affiliated Entity [Member] Equity Method Investee Equity Method Investee [Member] Counterparty Name [Axis] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] JLL Partners Inc. and DSM JLL Partners Inc. and DSM [Member] JLL Partners Inc. and DSM [Member] Koninklijke DSM Banner Life Sciences Related Party Transaction [Axis] Related Party Transaction [Axis] Related Party Transaction [Domain] Related Party Transaction [Domain] Business Services Business Services [Member] Business Services [Member] Shared Service Functions Shared Service Functions [Member] Shared Service Functions [Member] Investment, Name [Axis] Investment, Name [Axis] Investment, Name [Domain] Investment, Name [Domain] Percivia Percivia [Member] Percivia [Member] ChemiePark ChemiePark [Member] ChemiePark [Member] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Expenses from transactions with related party Related Party Transaction, Expenses from Transactions with Related Party Revenue for services from related parties Revenue from Related Parties Accounts payable, related parties Accounts Payable, Related Parties Accounts receivable, related parties Accounts Receivable, Related Parties Equity method investment values Equity Method Investments Cash distribution from Banner Life Services Ownership percentage (as percent) Equity Method Investment, Ownership Percentage Return on capital Equity method gain/(loss) Income (Loss) from Equity Method Investments BUSINESS COMBINATIONS Business Combination Disclosure [Text Block] Risk free interest rate (in percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Expected volatility (in percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Estimated years to exit event Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Dividend yield (in percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate EX-101.PRE 10 pti-20170430_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.7.0.1
Document and Entity Information - shares
 6 Months Ended
Apr. 30, 2017
May 31, 2017
Document and Entity Information [Abstract]    
Entity Registrant Name Patheon N.V.  
Entity Central Index Key 0001643848  
Current Fiscal Year End Date --10-31  
Entity Filer Category Non-accelerated Filer  
Document Type 10-Q  
Document Period End Date Apr. 30, 2017  
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Entity Common Stock, Shares Outstanding (in shares)   145,136,214
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Millions
Apr. 30, 2017
Oct. 31, 2016
Current    
Cash and cash equivalents $ 92.7 $ 165.0
Accounts receivable, net 420.9 401.0
Inventories, net 451.6 395.2
Income taxes receivable 14.3 8.7
Prepaid expenses and other 24.1 21.5
Total current assets 1,003.6 991.4
Capital assets 1,169.3 983.6
Intangible assets 235.2 247.6
Deferred tax assets 30.2 29.8
Goodwill 281.4 281.6
Investments 11.2 11.5
Other long-term assets 39.2 44.1
Total assets 2,770.1 2,589.6
Current    
Accounts payable and accrued liabilities 382.2 393.6
Income taxes payable 9.3 6.6
Deferred revenues - current 195.5 154.2
Current portion of long-term debt 19.4 19.5
Total current liabilities 606.4 573.9
Long-term debt 2,069.4 2,049.2
Deferred revenues 132.4 102.3
Deferred tax liabilities 96.7 67.1
Other long-term liabilities 147.7 145.5
Total liabilities 3,052.6 2,938.0
Commitments and contingencies
Shareholders' deficit:    
Ordinary shares (par value of €0.01 per share, 500,000,000 shares authorized, 145,144,742 and 145,074,042 shares issued as of April 30, 2017 and October 31, 2016, respectively) 1.6 1.6
Additional paid in capital 602.4 591.4
Treasury shares (at cost, 8,528 ordinary shares as of April 30, 2017) (0.2) 0.0
Accumulated deficit (786.2) (842.1)
Accumulated other comprehensive loss (100.1) (99.3)
Total shareholders' deficit (282.5) (348.4)
Total liabilities and shareholders' deficit $ 2,770.1 $ 2,589.6
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - € / shares
Apr. 30, 2017
Oct. 31, 2016
Statement of Financial Position [Abstract]    
Common stock, shares issued (in shares) 145,144,742 145,074,042
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, par value (in euros per share) € 0.01 € 0.01
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Income Statement [Abstract]        
Revenues $ 483.4 $ 468.6 $ 940.8 $ 874.5
Cost of goods sold 342.7 330.3 670.4 637.3
Gross profit 140.7 138.3 270.4 237.2
Selling, general and administrative expenses 92.1 74.8 173.2 148.5
Research and development 0.4 0.6 1.1 1.3
Repositioning expenses 1.8 1.3 2.4 2.5
Acquisition and integration costs 8.1 7.6 11.6 10.2
Other operating expense (income) 0.5 1.2 4.1 (3.7)
Operating income 37.8 52.8 78.0 78.4
Interest expense, net 30.8 42.6 59.0 86.4
Foreign exchange loss, net 0.7 7.1 5.5 11.4
Refinancing expenses 6.3 0.0 6.3 0.0
Bargain purchase gain (26.4) 0.0 (26.4) 0.0
Other loss (income), net 0.3 0.5 0.5 (1.3)
Income (loss) before income taxes 26.1 2.6 33.1 (18.1)
(Benefit from) provision for income taxes (1.5) 0.7 (22.8) 0.0
Net income (loss) from continuing operations 27.6 1.9 55.9 (18.1)
Net loss from discontinued operations 0.0 (1.0) 0.0 (3.1)
Net income (loss) $ 27.6 $ 0.9 $ 55.9 $ (21.2)
Basic earnings (loss) per ordinary share        
From continuing operations (in USD per share) $ 0.19 $ 0.02 $ 0.39 $ (0.16)
From discontinued operations (in USD per share) 0.00 (0.01) 0.00 (0.03)
Diluted earnings (loss) per ordinary share        
From continuing operations (in USD per share) 0.19 0.02 0.38 (0.16)
From discontinued operations (in USD per share) $ 0.00 $ (0.01) $ 0.00 $ (0.03)
Average number of ordinary shares outstanding        
Basic (in shares) 145,136,214 115,609,756 145,132,349 115,609,756
Diluted (in shares) 146,267,128 115,609,756 146,276,351 115,609,756
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Statement of Comprehensive Income [Abstract]        
Net income (loss) $ 27.6 $ 0.9 $ 55.9 $ (21.2)
Other comprehensive income (loss), net of income taxes:        
Foreign currency translation adjustments (4.7) 14.3 (7.3) 5.0
Net (loss) gain related to net investment hedge (4.6) (25.8) 4.0 (18.9)
Net gain on intra-entity foreign currency transactions 0.0 3.8 0.0 3.0
Change in value of derivatives designated as foreign currency cash flow hedges (3.4) 6.9 (1.1) (1.0)
Losses from foreign currency hedges reclassified to consolidated statement of operations (1) [1] 0.7 3.5 2.2 8.1
Net change in minimum pension liability [2] 0.7 0.4 1.4 0.8
Comprehensive income (loss) $ 16.3 $ 4.0 $ 55.1 $ (24.2)
[1] 1 Net of an income tax benefit of $0.1 million for the three and six months ended April 30, 2017. Income tax expense is not applicable for the six months ended April 30, 2016 as these amounts are from the Company's Canadian operations which were under a full valuation allowance in the prior period. The valuation allowance was released during the fourth quarter of fiscal 2016. Amounts, gross of tax, have been reclassified to foreign exchange loss, net on the consolidated statements of operations.
[2] 2 Net of an income tax expense of $0.0 million for the three and six months ended April 30, 2017 and 2016, which is included as a component of provision for income taxes on the consolidated statements of operations. Amounts, gross of tax, have been reclassified to cost of goods sold and selling, general and administrative expenses in the consolidated statements of operations. See Note 7 for further information.
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2017
Statement of Comprehensive Income [Abstract]    
Losses from foreign currency hedges reclassified to consolidated statement of operations, net of income tax expense $ 0.1 $ 0.1
Net change in minimum pension liability, net of income tax benefit $ 0.0 $ 0.0
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' DEFICIT (Unaudited) - 6 months ended Apr. 30, 2017 - USD ($)
$ in Millions
Total
Ordinary Shares
Additional Paid-in Capital
Treasury Shares
Accumulated Deficit
Accumulated Other Comprehensive Loss
Stockholders' equity, beginning of period (shares) at Oct. 31, 2016   145,074,042        
Stockholders' equity, beginning of period at Oct. 31, 2016 $ (348.4) $ 1.6 $ 591.4 $ 0.0 $ (842.1) $ (99.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Ordinary share issuances related to stock based compensation 0.0          
Stock based compensation 11.0   11.0      
Treasury shares acquired, at cost (0.2)     (0.2)    
Comprehensive income (loss):            
Net income 55.9       55.9  
Foreign currency translation adjustments (7.3)         (7.3)
Net gain related to net investment hedge 4.0         4.0
Change in value of derivatives designated as foreign currency cash flow hedges (1.1)         (1.1)
Losses from foreign currency hedges reclassified to consolidated statement of operations 2.2 [1]         2.2
Net change in minimum pension liability 1.4 [2]         1.4
Comprehensive income (loss) 55.1       55.9 (0.8)
Stockholders' equity, end of period (shares) at Apr. 30, 2017   145,136,214        
Stockholders' equity, end of period at Apr. 30, 2017 $ (282.5) $ 1.6 $ 602.4 $ (0.2) $ (786.2) $ (100.1)
[1] 1 Net of an income tax benefit of $0.1 million for the three and six months ended April 30, 2017. Income tax expense is not applicable for the six months ended April 30, 2016 as these amounts are from the Company's Canadian operations which were under a full valuation allowance in the prior period. The valuation allowance was released during the fourth quarter of fiscal 2016. Amounts, gross of tax, have been reclassified to foreign exchange loss, net on the consolidated statements of operations.
[2] 2 Net of an income tax expense of $0.0 million for the three and six months ended April 30, 2017 and 2016, which is included as a component of provision for income taxes on the consolidated statements of operations. Amounts, gross of tax, have been reclassified to cost of goods sold and selling, general and administrative expenses in the consolidated statements of operations. See Note 7 for further information.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Operating activities    
Net income (loss) from continuing operations $ 55.9 $ (18.1)
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 61.9 53.5
Increase in deferred revenues 141.1 172.9
Amortization of deferred revenues (137.2) (101.3)
Non-cash interest 9.5 7.6
Change in other long-term assets and liabilities 4.0 2.9
Deferred income taxes (29.7) (0.9)
Stock based compensation expense 11.0 3.0
Gain on bargain purchase (26.4) 0.0
Payment of original issue discount (4.1) 0.0
Return on capital from equity investment 0.0 1.3
Foreign exchange loss on debt 0.0 2.2
Other 4.4 (5.1)
Net change in non-cash working capital balances (69.5) (161.0)
Cash provided by (used in) operating activities of continuing operations 20.9 (43.0)
Cash used in operating activities of discontinued operations 0.0 (2.9)
Cash provided by (used in) operating activities 20.9 (45.9)
Investing activities    
Additions to capital assets (99.2) (95.1)
Acquisitions (10.3) 0.0
Proceeds from sale of capital assets 0.0 0.1
Return of capital from equity investment 0.0 2.3
Cash used in investing activities of continuing operations (109.5) (92.7)
Cash used in investing activities of discontinued operations 0.0 (3.3)
Cash used in investing activities (109.5) (96.0)
Financing activities    
Proceeds from borrowings 30.0 0.7
Repayment of debt (9.6) (9.9)
Increase in deferred financing costs (2.7) 0.0
Treasury share purchases to satisfy certain tax withholdings (0.1) 0.0
Cash provided by (used in) financing activities 17.6 (9.2)
Effect of exchange rate changes on cash and cash equivalents (1.3) 7.1
Net change in cash and cash equivalents during the period (72.3) (144.0)
Cash and cash equivalents, beginning of period 165.0 328.7
Cash and cash equivalents, end of period $ 92.7 $ 184.7
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
THE COMPANY
 6 Months Ended
Apr. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
THE COMPANY
THE COMPANY
Patheon N.V. (“Patheon” or "the Company") was formed on December 24, 2013, as Patheon Coöperatief U.A., a Dutch cooperative with excluded liability for its members (coöperative met uitgesloten aansparkelijkheid) and a wholly owned indirect subsidiary of JLL/Delta Patheon Holdings, L.P. (the “Partnership”), which in turn is owned 51% by JLL Patheon Co-Investment Fund L.P. ("JLL") and 49% by Koninklijke DSM N.V. ("DSM"). On June 3, 2016, the Company was converted into a Dutch limited liability company (naamloze vennootschap) and changed its name to Patheon N.V.
On July 21, 2016, the Company amended its articles of association, resulting in a split of the Company's ordinary shares and a $1.2 million contribution by the Partnership to the Company's equity capital in connection with the share split. This share split and capital contribution resulted in a total of 115,609,756 ordinary shares outstanding at a par value of €0.01 per share.
On July 21, 2016, the Company commenced an initial public offering ("IPO") of an additional 29,464,286 ordinary shares at a public offering price of $21.00 per share, which included 4,464,286 ordinary shares sold pursuant to the option granted to the underwriters to purchase additional ordinary shares from the Company. As part of the IPO, DSM sold 4,761,905 ordinary shares to the public that were distributed to them in connection to their ownership in the Partnership. A total of 34,226,191 ordinary shares were sold in connection to the IPO. The Company did not receive any proceeds from the ordinary shares sold by DSM. The IPO was completed on July 26, 2016.
The Company received total net proceeds of approximately $584.8 million from the IPO, after deducting underwriting discounts and commissions, but before deducting estimated offering expenses. The shares offered and sold in the IPO were registered under the Securities Act pursuant to the Company's Registration Statement on Form S-1, which was declared effective by the SEC on July 18, 2016. The Company's ordinary shares began trading on the New York Stock Exchange under the symbol "PTHN" as of July 21, 2016.
As of April 30, 2017, the Company had 145,136,214 ordinary shares outstanding with a par value of €0.01 per share. Ordinary shares owned by the public constitute approximately 24% of the outstanding ordinary shares. JLL, DSM and the Partnership own approximately 38%, 34% and 4% of the Company through their ownership of outstanding ordinary shares, respectively. In accordance with the Company's articles of association, each ordinary share shall have one vote in the Company's general meeting. The Partnership's ownership comprises of shares held for the benefit of certain employees. See Note 9 for further discussion.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 6 Months Ended
Apr. 30, 2017
Accounting Policies [Abstract]  
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of presentation
Patheon consists of three reportable segments: Drug Product Services ("DPS"), Pharmaceutical Development Services ("PDS"), and Drug Substance Services ("DSS"). Drug Product Services provides manufacturing and packaging for approved prescription, over-the-counter, and nutritional products. Pharmaceutical Development Services provides a wide spectrum of advanced formulation, production, and technical services from the early stages of a product's development to regulatory approval and beyond, as well as for new formulations of approved products for life cycle extension. Drug Substance Services provides development and manufacturing for the biologically active component of a pharmaceutical product from early development through commercial production.
The accompanying unaudited consolidated financial statements have been prepared by the Company in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). Operating results for the three and six months ended April 30, 2017 are not necessarily indicative of the results that may be expected for the fiscal year ending October 31, 2017 ("fiscal 2017"). These consolidated financial statements do not include all the information and footnotes required by U.S. GAAP for annual financial statements and therefore should be read in conjunction with the audited consolidated financial statements and notes for the fiscal year ended October 31, 2016 ("fiscal 2016").
The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions have been eliminated.
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect: the reported amounts of assets and liabilities; the disclosure of contingent assets and liabilities at the date of the consolidated financial statements; and the reported amounts of revenue and expenses in the reporting period. Management believes that the estimates and assumptions used in preparing its consolidated financial statements are reasonable and prudent; however, actual results could differ from those estimates.
Changes in significant accounting policies
As a result of early adopting Accounting Standards Update 2016-09, 'Improvements to Employee Share-Based Payment Accounting', the Company is electing to account for forfeitures on stock based compensation awards as they occur. No adjustment is required to comply with the early adoption. The Company was previously not estimating forfeitures on stock based compensation awards since the impact of potential forfeiture was immaterial to the consolidated financial statements.
Segment information
U.S. GAAP requires segmentation based on an entity’s internal organization and reporting of revenue and operating income (loss) based upon internal accounting methods commonly referred to as the “management approach.” Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (“CODM”), or decision making group, in deciding how to allocate resources and in assessing performance. The Company’s CODM is its Chief Executive Officer.
The Company’s four operating segments are: North America Drug Product Services, or North America DPS, Europe Drug Product Services, or Europe DPS, Pharmaceutical Development Services, or PDS and Drug Substance Services, or DSS. The North America DPS and Europe DPS operating segments meet the aggregation criteria to be presented as one reportable segment referred to as DPS. As a result, the Company has determined it has three reportable segments: DPS, PDS, and DSS. Corporate is not an individually reportable segment because the quantitative thresholds have not been met and as such has been reported in Other.
Recently adopted accounting pronouncements
Accounting Standards Update ("ASU")
Description
Date Adopted
Improvements to Employee Share-Based Payment Accounting (ASU 2016-09)
This update simplifies several aspects of the accounting for
share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities,
and classification on the statement of cash flows.

The Company early-adopted ASU 2016-09 during the second quarter of fiscal 2017, which had no effect on the Company's financial statements.
February 1, 2017
Simplifying the Accounting for Measurement-Period Adjustment (ASU 2015-16)
This update eliminated the requirement to an acquirer in a business combination to retrospectively adjust provisional amounts recognized at the acquisition date with a corresponding adjustment to goodwill. Instead, the update requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The impact will be dependent on future transactions.
November 1, 2016
Simplifying the Presentation of Debt Issuance Costs (ASU 2015-03)
The pronouncement requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of the debt liability, consistent
with that of debt discounts. The pronouncement is being applied retrospectively and the Company's October 31, 2016 balance sheet has been adjusted. The April 30, 2017 and October 31, 2016 balance sheets were adjusted to decrease the deferred financing cost asset and decrease the long term debt liability by $45.2 million and $50.3 million, respectively.
November 1, 2016
Recently issued accounting pronouncements
Accounting Standards Update ("ASU")
Description
Expected Impact
Effective Date
Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (ASU 2017-07)
This update requires that an employer disaggregate the service cost component from the other components of net periodic benefit cost. In addition, only the service cost component will be eligible for capitalization. The amendment is applied retrospectively with earlier application permitted.

We are assessing the impact to the individual line items to the Statements of Operations. The Company does not expect there to be a material impact to net income.
November 1, 2018
Simplifying the Test for Goodwill Impairment (ASU 2017-04)
This update simplified the subsequent measurement of goodwill by eliminating Step 2 of the goodwill impairment test. Instead, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The amendment also eliminated the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. The amendment is applied prospectively with earlier application permitted.
We do not expect to have a material impact on the Company’s financial statements.
November 1, 2020
Clarifying the Definition of a Business (ASU 2017-01)
This update narrows the definition of outputs and aligns it with how outputs are described in Topic 606. The amendment also provides a more robust framework to use in determining when a set of assets and activities is a business. The amendment is applied prospectively with earlier application permitted.
The impact on the consolidated financial statements from the adoption of this guidance is dependent on future business combinations.

November 1, 2018
Revenue from Contracts with Customers and related standards (ASU's 2014-09, 2016-08, 2016-10, 2016-12, 2016-20)
This update supersedes the existing revenue recognition guidance and provides a new framework for recognizing revenue. These updates identified practical expedients and clarified various aspects of the new revenue recognition standard outlined in Accounting Standards Update 2014-09. This standard may be adopted using either a retrospective or modified retrospective method. Early adoption is permitted.
We are currently in the process of evaluating the impact of this standard. It is still too early in our process to determine the magnitude of the potential impact. However, based on our preliminary assessment, we believe the timing of revenue recognition for commercial and development contracts may differ from our current revenue recognition policies. The Company is determining the magnitude of this potential change. We plan to adopt the standard on November 1, 2018, and we have not yet selected a transition method.
November 1, 2018
From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date or, in some cases where early adoption is permitted, in advance of the specified effective date. The Company has assessed the recently issued standards that are not yet effective and, unless otherwise discussed above or in our audited consolidated financial statements and notes for fiscal 2016, believes these standards will not have a material impact on the Company’s results of operations, cash flows, or financial position. A more detailed listing of recently issued accounting pronouncements are included in our audited consolidated financial statements and notes for fiscal 2016.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1
BUSINESS COMBINATIONS
 6 Months Ended
Apr. 30, 2017
Business Combinations [Abstract]  
BUSINESS COMBINATIONS
BUSINESS COMBINATIONS
The acquisition activity referenced below has been accounted for using the acquisition method of accounting in accordance with ASC Subtopic 805-10, "Business Combinations," and the fair value concepts set forth in ASC Subtopic 820-10, "Fair Value Measurements and Disclosures". The total purchase price for each acquisition was allocated to the assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The allocation of the purchase price is based on estimates and assumptions that are subject to change within the measurement period. The excess of the fair values of the assets acquired and liabilities assumed over the consideration transferred was recorded as a bargain purchase gain.
RCI Acquisition
Background
On February 1, 2017, the Company acquired the Roche Carolin, Inc. active pharmaceutical ingredients (API) facility located in Florence, South Carolina ("RCI Acquisition") from Roche Holdings, Inc. (Roche). Through the acquisition, the Company entered into a stock purchase agreement in which Roche provided amounts to satisfy certain capital expenditures and other liabilities of the facility and the Company provided an upfront payment of $1.0 million to acquire the stock of Roche Carolina Inc. (RCI) and approximately $9.3 million to acquire inventory, spare parts, prepaid expense and accounts payable and certain transaction expenses of Roche. The RCI Acquisition is included in the DSS segment.
As part of the transaction, the parties entered into (i) a supply agreement for the production of certain pharmaceutical intermediates by the Company for Roche and (ii) a toll manufacturing agreement where the Company will assume the manufacturing of certain products produced by the facility.
The toll manufacturing agreement has a five-year initial term. During the first four years of the term, Roche is subject to a minimum annual purchasing commitment. The Company will manufacture certain existing Roche products and sell the products back to Roche at fiscal year 2016 standard costs. Annual volumes above the minimum annual commitment will be rolled into the subsequent year. If applicable, Roche will pay true-up payments for amounts below the minimum purchase requirement. A liability from this unfavorable product supply contract has been recognized as deferred revenue in order to reflect this liability at fair value as of the acquisition date.
Purchase Price Allocation
The preliminary purchase price allocation for the RCI Acquisition is as follows:
 
$
Assets
 
Inventories
9.4

Prepaid expenses and other
0.1

Capital assets
155.6

Total assets acquired
165.1

 
 
Liabilities
 
Accounts payable and accrued liabilities
2.0

Deferred revenue
67.0

Deferred tax liabilities
59.4

Total liabilities assumed
128.4

 
 
Total net assets
36.7

Bargain purchase gain
(26.4
)
Total purchase price
10.3


The bargain purchase gain, net of taxes, is reflected in income before taxes in the statements of operations. In late 2015, Roche analyzed strategic alternatives for the facility, including potentially closing or divesting the facility. The cost to close the facility or continue operating an under utilized facility contributed to the bargain purchase gain noted above.
Financial results
The revenues and net income from continuing operations from the RCI Acquisition for the period from February 1, 2017 to April 30, 2017 included in the consolidated statement of operations are as follows:
 
February 1, 2017 to April 30, 2017
 
$
Revenues
8.1

Net income from continuing operations (1)
25.9

(1) Net income from continuing operations includes the $26.4 million of the bargain purchase gain.
Pro forma financial information
The following unaudited supplemental pro forma information presents the financial results as if the acquisition had occurred on November 1, 2015. The unaudited supplemental pro forma information does not purport to be indicative of what would have occurred had the acquisition been completed on November 1, 2015, nor is it indicative of any future results.
 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Revenues
483.4

 
484.0

 
999.1

 
904.9

Net income from continuing operations
1.2

 
(6.0
)
 
11.4

 
(258.8
)
(1) Net income from continuing operations for the six months ended April 30, 2016 includes $257.8 million of impairment expense related to Roche's strategic realignment of the facility. This is not part of the acquisition transaction and as such is not removed from the pro forma financial information.
The unaudited pro forma financial information was prepared using the acquisition method of accounting and is based on the historical financial information of the Company and RCI, reflecting the Company's and RCI's combined results of operations for the three and six months ended April 30, 2017 and 2016. The historical financial information has been adjusted to give effect to the pro forma events that are (i) directly attributable to the RCI Acquisition, (ii) factually supportable and (iii) expected to have a continuing impact on the combined results of the Company and RCI. The unaudited pro forma consolidated results reflect primarily the following pro forma adjustments:
•
additional revenue related to the amortization of deferred revenue on the unfavorable product supply contract;
•
additional cost of goods sold resulting from increases in depreciation expense relating to the fair values of acquired property and equipment;
•
removal of repositioning costs related to the acquisition; and
•
the effect of the bargain purchase gain
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
DISCONTINUED OPERATIONS
 6 Months Ended
Apr. 30, 2017
Discontinued Operations and Disposal Groups [Abstract]  
DISCONTINUED OPERATIONS
DISCONTINUED OPERATIONS
Banner Pharmacaps
On May 12, 2015, the Company sold its Banner Pharmacaps entity in Mexico, previously included within the DPS and BLS segments, to the Perrigo Company plc for approximately $36.4 million in cash. The Banner Pharmacaps entity in Mexico produced over-the-counter and nutritional products for consumption in Mexico. The Company acquired the entity in fiscal 2012 and subsequent to this acquisition, the Company shifted its business strategy, focusing more on technological innovation and R&D. The Company recognized a gain on sale of $2.6 million, which included adjustments in the second quarter of 2016 primarily related to working capital adjustments.
Biosolutions Operations in Capua, Italy
On July 31, 2015, the Company sold its Biosolutions facility in Capua, Italy, previously included within the Biosolutions segment, for approximately €0.3 million in cash. The sale occurred as a result of a strategic shift in the Company’s long term business strategy. The Company recognized a loss on sale of $24.0 million, which included an adjustment in the second quarter of 2016 for future retention bonuses at the facility.
DPx Fine Chemicals
On August 31, 2015, the Company sold its DPx Fine Chemicals ("DFC") division, which previously comprised the DFC operating segment. DFC was sold for a cash purchase price of €179.0 million, which included a €3.0 million working capital payment made in the first quarter of 2016. The Company recognized a gain on sale of $107.0 million, which included an adjustment in the first quarter of 2016 for estimated taxes on the sale. The DPx Fine Chemicals division, which was acquired through the DPP Acquisition, developed chemicals that are not in line with the Company’s long term business strategy.
The results of the above dispositions have been presented as discontinued operations, the results of which for the three and six months ended April 30, 2016 are as follows:
 
Three months ended April 30,
 
Six months ended April 30,
 
2016
 
2016
 
$
 
$
Revenues
—

 
2.1

Cost of goods sold
—

 
1.9

Gross profit
—

 
0.2

Selling, general and administrative expenses
—

 
0.4

Loss on disposals, net
0.9

 
2.8

Operating loss
(0.9
)
 
(3.0
)
Foreign exchange income, net
(0.1
)
 
(0.1
)
Loss before income taxes
(0.8
)
 
(2.9
)
Provision for income taxes
0.2

 
0.2

Net loss
(1.0
)
 
(3.1
)

The Company did not record any discontinued operations activity for the three and six months ended April 30, 2017.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUPPLEMENTAL BALANCE SHEET INFORMATION
 6 Months Ended
Apr. 30, 2017
Supplemental Balance Sheet Information [Abstract]  
SUPPLEMENTAL BALANCE SHEET INFORMATION
SUPPLEMENTAL BALANCE SHEET INFORMATION
Inventories
Inventories consisted of the following:
 
April 30, 2017
 
October 31, 2016
 
$
 
$
Raw materials, packaging components and spare parts
228.7

 
192.1

Work-in-process
92.3

 
80.9

Finished goods
130.6

 
122.2

Balance, end of period
451.6

 
395.2


Accounts payable and accrued liabilities
Accounts payable and accrued liabilities consisted of the following:
 
April 30, 2017
 
October 31, 2016
 
$
 
$
Trade payables
277.1

 
279.3

Interest payable
9.8

 
14.0

Accrued salaries and related expenses
78.8

 
81.8

Customer deposits
4.1

 
4.3

Repositioning
4.9

 
5.4

Other accruals
7.5

 
8.8

Balance, end of period
382.2

 
393.6


Intangible assets
The following table summarizes gross carrying amounts, accumulated amortization, and accumulated impairments related to the Company's identifiable intangible assets as of April 30, 2017:
Definite-lived intangible assets
Gross carrying value
 
Accumulated amortization
 
Net carrying value
 
Weighted Average Useful Life (in Years)
 
$
 
$
 
$
 
 
Favorable agreements
1.0

 
(1.0
)
 
—

 
—

Trade names
1.6

 
(0.9
)
 
0.7

 
5.6

Developed technology
54.1

 
(19.4
)
 
34.7

 
10.8

Trade secrets and patents
2.5

 
(0.4
)
 
2.1

 
14.5

Customer relationships
248.8

 
(49.5
)
 
199.3

 
14.2

Non-compete agreements
2.6

 
(2.2
)
 
0.4

 
3.0

Subtotal
310.6

 
(73.4
)
 
237.2

 
 
Foreign exchange
 
 
 
 
(3.3
)
 
 
Balance, end of period
 
 
 
 
233.9

 
 


Indefinite-lived intangible assets
Gross carrying value
 
Accumulated impairment
 
Net carrying value
 
$
 
$
 
$
In-process research and development
2.2

 
(0.9
)
 
1.3

Regulatory permits
0.2

 
—

 
0.2

Subtotal
2.4

 
(0.9
)
 
1.5

Foreign exchange
 
 
 
 
(0.2
)
Balance, end of period
 
 
 
 
1.3


In-process research and development (“IPR&D”) is classified as definite-lived or indefinite-lived depending on whether the product has been approved and if commercialization has begun. IPR&D for products that have been approved is classified as a definite-lived intangible asset and is amortized over the life of the asset. IPR&D for products that have not been approved is classified as an indefinite-lived intangible asset and either begins to be amortized upon approval and product commercialization or is written-off if the product is not approved.
In the first quarter of fiscal 2016, the Company sold an IPR&D asset to Banner Life Sciences for cash consideration equal to its net carrying value of $3.6 million. At the time of the sale, the asset had a gross carrying value of $7.9 million and had incurred $4.3 million in impairments.
Goodwill
The following table summarizes the changes in the carrying amount of goodwill for the six months ended April 30, 2017:
 
Total
 
$
Balance at October 31, 2016 (1)
281.6

Foreign currency translation adjustments
(0.2
)
Balance at April 30, 2017
281.4


(1) The opening cumulative goodwill balance is reflective of historical impairment charges of the full value of goodwill.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.7.0.1
LONG-TERM DEBT
 6 Months Ended
Apr. 30, 2017
Debt Disclosure [Abstract]  
LONG-TERM DEBT
LONG-TERM DEBT
Long-term debt in the accompanying consolidated balance sheets at April 30, 2017 and October 31, 2016 consists of the following:
 
As of April 30, 2017
 
As of October 31, 2016
 
$
 
$
USD Term Loan at LIBOR with a floor of 1% plus 3.25% rate and maturity date of April 20, 2024 (the "Credit Agreement")
1,133.1

 
—

Euro Term Loan at LIBOR with a floor of 1% plus 3.00% rate and maturity date of April 20, 2024 (the "Credit Agreement")
504.5

 
—

USD Term Loan with a base rate plus 2.25% or LIBOR with a floor of 1% plus 3.25% rate and maturity date of March 10, 2021 (the "Credit Agreement")
—

 
1,138.9

Euro Term Loan with a base rate plus 2.50% or LIBOR with a floor of 1% plus 3.50% rate and maturity date of March 10, 2021 (the "Credit Agreement")
—

 
511.0

7.50% Senior Notes due February 1, 2022 (the "Notes")
450.0

 
450.0

Secured Revolving Facility balance at LIBOR plus 3.25% rate and maturity terms on a rolling basis
50.0

 
20.0

Government of Austria research and development loans with annual interest rates ranging from 1.56% to 2.00% and maturities through March 2020
2.7

 
3.5

Italian subsidized loan with annual interest rate of 0.5%, and maturity date of June 30, 2020
3.6

 
4.1

Italian bank loan with Euribor 6-month + 7.1% rate, and maturity date of June 30, 2020
0.7

 
0.7

Capital lease obligations
1.6

 
0.7

Total long-term debt outstanding
2,146.2

 
2,128.9

Less original issue discount, net of accumulated amortization of $7.1 million and $6.2 million, respectively
(12.2
)
 
(9.9
)
Less deferred financing costs
(45.2
)
 
(50.3
)
Less current portion
(19.4
)
 
(19.5
)
Balance, end of the period
2,069.4

 
2,049.2


2017 Term Loans and Revolving Line
On April 20, 2017, the Company completed the refinancing of its term loans and amended the existing revolving credit facility (the "Refinancing'") by entering into Amendment No. 4 of the original credit facility agreement dated as of March 11, 2014 (the "Credit Facility"). Under Amendment No. 4, the existing term loans were refinanced with new term loans ("Tranche B Term Loans"). The Tranche B Term Loans consisted of (i) Tranche B US Dollar Term Loans in the amount of $1.133 billion and (ii) Tranche B Euro Term Loans in the amount of €463.1 million, or $496.3 million. The Tranche B Term Loans will mature on April 20, 2024.
Under Amendment No. 4, the Company increased the size of the revolver facility (the "Revolving Facility") to $250.0 million, of which up to $75.0 million is available for letters of credit. Of the total revolving commitments, $87.1 million will terminate on March 11, 2019 (the "Tranche A Commitments") and the remaining commitments (the "Tranche B Commitments") will terminate on April 20, 2022.
The US Dollar denominated Tranche B Term Loans bear interest at a rate per annum equal to, at the option of the Company, a base rate plus 2.25% or LIBOR with a floor of 1% plus 3.25%. The margin applied to the base rate will be reduced to 2.0% and the margin applied to LIBOR will be reduced to 3.0% if the Company achieves, and as long as the Company maintains, a B2/Stable credit rating or better from Moody's Inventors Service, Inc.
The Euro denominated Tranche B Term Loans bear interest at a rate per annum equal to LIBOR with a floor of 1% plus 3.00%.
Borrowings under the Revolving Facility bear interest at a rate per annum equal to, at the option of the Company, a base rate plus 2.25% or LIBOR plus an applicable margin of 3.25%. The Company will also pay a commitment fee of 0.50% per annum on the unused portion of the Revolving Facility with a step down to 0.375% when the First Lien Leverage Ratio (as defined below) is less than or equal to 3.00 to 1.00.
As of April 30, 2017, the Company borrowed $50.0 million against the Revolving Facility, which will renew until paid.
Under the Revolving Facility, the Company is required to maintain a First Lien Leverage Ratio below a certain amount for each of the Testing Periods as set forth in the Credit Agreement if the Company has borrowed 25% of the available credit on the Revolving Facility, or $62.5 million. For purposes of the Credit Agreement, a Testing Period means a single period consisting of the most recent four consecutive fiscal quarters ending on the covenant determination date. As of April 30, 2017, the Company was not required to calculate the First Lien Leverage Ratio as the Company has not borrowed 25% or $62.5 million under the Secured Revolving Facility. The following table discloses the maximum First Lien Leverage Ratios permitted under the Credit Agreement:
Testing Period Ending
Maximum Ratio
April 30, 2014 through October 31, 2014
6.75 to 1.00
November 1, 2014 through October 31, 2015
6.50 to 1.00
November 1, 2015 through October 31, 2016
6.25 to 1.00
November 1, 2016 through October 31, 2017
6.00 to 1.00
November 1, 2017 and thereafter
5.75 to 1.00

"First Lien Leverage Ratio" is generally defined in the Credit Agreement as the ratio of (i) the sum of the aggregate principal amount of the Company's and its restricted subsidiaries' indebtedness for borrowed money, principal amount of capital lease obligations and debt obligations evidenced by bonds, promissory notes, debentures or debt securities that is secured by a first priority lien on the collateral minus unrestricted cash and cash equivalents held by the Company and its restricted subsidiaries in each case set forth in the Credit Agreement to (ii) Consolidated EBITDA. Consolidated EBITDA is generally defined in the Credit Agreement as income (loss) from continuing operations before repositioning expenses, interest expense, foreign exchange losses reclassified from other comprehensive income (loss), refinancing expenses, acquisition-related costs, gains and losses on sale of capital assets, income taxes, asset impairment charges, depreciation and amortization, stock-based compensation expense, consulting costs related to the Company's operational initiatives, purchase accounting adjustments, other income and expenses, non-cash charges, expenses related to the DPP Acquisition, pro forma cost savings from operational excellence initiatives and plant consolidations, pro forma synergies from the DPP Acquisition, and proceeds from business interruption insurance, among other adjustments. Consolidated EBITDA is not equivalent to Adjusted EBITDA, which as discussed in Note 11, is the Company's measure of segment performance.
The Company is required to make the following mandatory prepayments in respect of the Tranche B Term Loans: (i) 50% of Excess Cash Flow (as defined in the Credit Agreement) when the Company maintains a First Lien Leverage Ratio of greater than 4.00 to 1.00, with step downs to (a) 25% when the Company maintains a First Lien Leverage Ratio of less than or equal to 4.00 to 1.00 but greater than 3.50 to 1.00 and (b) 0% when the Company maintains a First Lien Leverage Ratio of less than or equal to 3.50 to 1.00; (ii) 100% of the net cash proceeds of certain asset sales (including insurance and condemnation proceeds), subject to thresholds, reinvestment rights and certain other exceptions; and (iii) 100% of the net cash proceeds of issuances of debt obligations, subject to certain exceptions and thresholds. "Excess Cash Flow" is generally defined as Consolidated EBITDA (as defined in the Credit Agreement) plus, (i) decreases in working capital, (ii) extraordinary or nonrecurring income or gains and (iii) certain other adjustments, minus, (a) increases in working capital, (b) cash interest, (c) cash taxes, (d) cash capital expenditures (e) scheduled debt amortization and (f) certain other adjustments. As the Excess Cash Flow calculation is performed annually, no payment is due for the six months ended April 30, 2017. No Excess Cash Flow payment was required for fiscal 2016. The Company may voluntarily repay borrowings under the Credit Facility at any time.
If the Company has failed to maintain the applicable First Lien Leverage Ratio, it may nevertheless avoid a default by (i) repaying outstanding borrowings under the Revolving Facility in an amount sufficient to avoid triggering the First Lien Leverage Ratio for that fiscal quarter or (ii) accepting a cash contribution of qualified equity in an amount which, if treated as Consolidated EBITDA, would bring the Company into compliance with the applicable First Lien Leverage Ratio for that fiscal quarter, in each case during the 11 business days following the deadline for delivery of the Company’s compliance certificate for that fiscal quarter. In addition, maintenance of the First Lien Leverage Ratio is required only with respect to the Revolving Line; the Term Loans do not directly benefit from the financial covenant and, until the Revolving Line is terminated and all outstanding borrowings thereunder are accelerated, will remain unaffected by a default under the Revolving Line that arises from the Company’s failure to maintain the applicable First Lien Coverage Ratio.
The Credit Agreement contains other customary terms, including (i) representations, warranties and affirmative covenants, (ii) negative covenants (in addition to the limitation on distributions and the requirement to maintain the First Lien Leverage Ratio levels as described above), such as limitations on indebtedness, liens, mergers, acquisitions, asset sales, investments, prepayments of subordinated debt, and transactions with affiliates, in each case subject to baskets, thresholds and other exceptions, and (iii) events of default, such as for non-payment, breach of other covenants, misrepresentations, cross default to other debt, change in control, bankruptcy events, ERISA events, unsatisfied judgments and actual or asserted invalidity of guarantees or security documents.
As of April 30, 2017, the Company was in compliance with the covenants in the Credit Facility.
Provided that the Company is in compliance with the First Lien Leverage Ratio test and no default under the Credit Agreement is continuing or would result therefrom, the covenant in the Credit Agreement that limits the Company's ability to pay dividends or make other distributions to its shareholders generally permits (with certain exceptions and qualifications) the Company to pay dividends or make such distributions in an aggregate amount, when taken together with the aggregate amount of any prepayment, repurchase, redemption or defeasance of subordinated indebtedness, not to exceed the greater of (x) 3.00% of Consolidated Total Assets and (y) $65.0 million and (ii) in aggregate amount not to exceed the available amount (as defined in the Credit Agreement) at such time.
The Credit Facility is guaranteed by the Company and certain subsidiaries, and is secured by a first priority pledge on substantially all of the assets of the Company and the subsidiary guarantors, in each case subject to certain exceptions.
2014 Senior Unsecured Notes
In February 2014, the Company issued $450.0 million in aggregate principal amount of 7.50% senior unsecured notes due February 1, 2022 (the "Notes") in a private placement, pursuant to which it entered into an indenture (the “Indenture”) with a commercial bank acting as trustee.
Interest on the Notes accrues at a rate of 7.50% per annum and is payable semiannually in arrears on each February 1 and August 1, commencing on August 1, 2014. Interest is computed on the basis of a 360-day year comprised of twelve 30-day months. The Notes are generally required to be guaranteed by each of the Company’s restricted subsidiaries that guarantees the Credit Facility or that guarantees other material indebtedness of the Company or other Note guarantors.
Except for offers to purchase Notes upon certain asset sales or a change in control of the Company, no mandatory redemption or sinking fund payment is required with respect to the Notes.
On and after February 1, 2017, the Company may redeem all or a portion of the Notes at the applicable redemption prices set forth below (expressed as percentages of principal amount redeemed), plus unpaid interest accruing on the principal amount redeemed to the Redemption Date:
Year
%
2017
105.625
2018
103.750
2019
101.875
2020 and thereafter
100.000

In addition, we may redeem all of the Notes at a redemption price equal to the principal amount redeemed, plus unpaid interest accruing to the Redemption Date, upon certain adverse changes in applicable tax laws.
The Notes are guaranteed by the Company and the Indenture does not require the Company to maintain compliance with any financial covenants. The Indenture does contain customary affirmative and negative covenants, including with respect to mergers, asset sales, restricted payments, restricted investments, issuance of debt and equity, liens, and affiliate transactions, subject to baskets and other exceptions. However, the Company will be exempt from many of the negative covenants if the Notes receive investment grade ratings from both Moody’s and S&P. The Indenture also contains customary events of default, such as for non-payment, breach of other covenants, misrepresentation, cross default to other material debt, bankruptcy events, unsatisfied judgments, and actual or asserted invalidity of guarantees.
As of April 30, 2017, the Company was in compliance with the covenants in the Indenture.
Other Financing Arrangements
During the third quarter of fiscal 2013, the Company received assistance from the Italian government in the form of two loans. One loan is a subsidized loan for approximately €6.0 million, of which the Company received €5.4 million during the third quarter of 2013 and the remaining €0.6 million in the second quarter of 2016. The subsidized loan has an annual interest rate of 0.5%, a maturity date of June 30, 2020 and amortizes in fixed semi-annual installments. The second loan is a bank loan of approximately €0.7 million, of which the Company received €0.6 million during the third quarter of 2013 and the remaining €0.1 million in the second quarter of 2016. The bank loan bears interest at a 6-month Euribor rate plus 7.1%, has a maturity date of June 30, 2020 and amortizes in six variable semi-annual installments beginning in December 2017.
The Company receives research and development loans from the Austrian government. The loans hold various interest rates and have maturity dates through March 31, 2020. The aggregate current balance of these loans as of April 30, 2017 is $2.7 million.
In May 2011, Gallus entered into an agreement with St. Louis County under the county's Chapter 100 program. Under the program, Gallus transferred title of the St. Louis location's buildings and property to St. Louis County in exchange for St. Louis County, Missouri Taxable Industrial Revenue Bonds (Chapter 100 Bonds) of equal value. Gallus then simultaneously leased back the land and facility from St. Louis County. The proceeds of principal and interest on the Chapter 100 Bonds are equal to the lease payment obligations on the Loan. This arrangement was acquired by the Company through the acquisition of Gallus Pharmaceuticals in September 2014.
In August 2015, the agreement with St. Louis County was amended by the Company to extend through December 21, 2029 (originally December 21, 2021), which is consistent with the maturity date of the Chapter 100 Bonds. The Company has determined that it has a legal right of offset for the obligations under the lease agreement with the proceeds receivable from the Chapter 100 Bonds and intends to offset the balance. As a result, the offsetting amounts have not been recorded in the financial statements. The bonds require the Company to maintain a minimum level of employment throughout the term of the loan and an additional investment in the St. Louis facility of at least $47.0 million by December 31, 2019.
In addition to the terms of the bonds indicated above, the Company also entered into an agreement under which it makes "Payments In Lieu Of Taxes" (PILOT) fee payments in lieu of property taxes, which is equal to 50% of the property taxes that would have otherwise been payable on the property. The PILOT fees will increase in years which the Company has not maintained the minimum number of employees as required by the agreement on a prospective basis.
The Company has possessory and equitable title to the property, and at any time can purchase legal title for a nominal fee. In addition, as the holder of the bonds, the Company can waive any default on the lease payments. As the Company retains all benefits of ownership and can take title at any time, at which point the bonds it holds would be redeemed to settle its obligations under the lease agreement, the Company has concluded the land and personal property continue to be assets and are recorded on the consolidated balance sheets.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
PENSION AND POST-RETIREMENT BENEFITS
 6 Months Ended
Apr. 30, 2017
Postemployment Benefits [Abstract]  
PENSION AND POST-RETIREMENT BENEFITS
PENSION AND POST-RETIREMENT BENEFITS
Employee future benefits
The components of net periodic benefit cost from continuing operations for the defined benefit plans and other benefit plans for the three and six months ended April 30, 2017 and 2016 were as follows:
 
Three months ended April 30,
 
2017
 
2016
 
Defined benefit
pension plans
 
Other benefit
plans
 
Defined benefit
pension plans
 
Other benefit
plans
 
$
 
$
 
$
 
$
Service cost
0.6

 
—

 
0.4

 
—

Interest cost
1.0

 
—

 
1.3

 
—

Expected return on plan assets
(1.0
)
 
—

 
(1.2
)
 
—

Amortization of actuarial loss
0.7

 
—

 
0.4

 
—

Net periodic benefit costs
1.3

 
—

 
0.9

 
—

 
Six months ended April 30,
 
2017
 
2016
 
Defined benefit
pension plans
 
Other benefit
plans
 
Defined benefit
pension plans
 
Other benefit
plans
 
$
 
$
 
$
 
$
Service cost
1.2

 
—

 
0.9

 
—

Interest cost
2.0

 
0.1

 
2.6

 
0.1

Expected return on plan assets
(2.0
)
 
—

 
(2.5
)
 
—

Amortization of actuarial loss
1.4

 
—

 
0.8

 
—

Net periodic benefit costs
2.6

 
0.1

 
1.8

 
0.1

Based on current information available from actuarial estimates, the Company anticipates that contributions required under its defined benefit pension plans and other benefit plans for fiscal 2017 will be approximately $3.9 million compared to contributions of $5.2 million that were made in fiscal 2016. The decrease in the expected fiscal 2017 contributions compared to fiscal 2016 are primarily the result of decreased obligations on a pension plan for the Bourgoin, France facility due to a workforce reduction in fiscal 2016. Required contributions to defined benefit pension plans in future years may vary and will be dependent upon a number of variables, including the long-term rate of return on plan assets.
The Company recognizes a termination liability for the Company's Italy operations. In accordance with Italian severance pay statutes, an employee benefit is accrued for service to date and is payable when the employee's employment with the Company ceases. The termination indemnity liability is calculated in accordance with local civil and labor laws based on each employee's length of service, employment category and remuneration. The Italian termination liability is adjusted annually by a cost-of-living index provided by the Italian government. Although there is no vesting period, the Italian government has established private accounts for these benefits and has required the Company to contribute $3.9 million and $3.4 million in fiscal 2017 and 2016, respectively, to these accounts, with additional contributions in the future. The liability recorded in the consolidated balance sheets is the amount to which the employees would be entitled if their employment with the Company ceased. The related expenses for the three months ended April 30, 2017 and 2016 was $0.9 million and $0.7 million, respectively, and the related expenses for the six months ended April 30, 2017 and 2016 was $1.8 million and $1.4 million, respectively.
The employee future benefit expense recorded in continuing operations in connection with defined benefit pension plans, other post-retirement benefit plans and the unfunded termination indemnities for the three months ended April 30, 2017 and 2016 was $2.2 million and $1.6 million, respectively. For the six months ended April 30, 2017 and 2016, the employee future benefit expense was $4.5 million and $3.3 million, respectively.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1
EARNINGS (LOSS) PER SHARE
 6 Months Ended
Apr. 30, 2017
Earnings Per Share [Abstract]  
EARNINGS (LOSS) PER SHARE
EARNINGS (LOSS) PER SHARE
Basic earnings (loss) per ordinary share is computed by dividing net income (loss) available to the Company by the weighted-average number of ordinary shares outstanding during the period. Diluted earnings (loss) per ordinary share is computed by dividing net income (loss) available to the Company by the weighted-average number of ordinary shares outstanding adjusted to give effect to potentially dilutive securities.
The details of the computation of basic and diluted earnings (loss) per ordinary share are as follows:
 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
Numerator (in millions):
 
 
 
 
 
 
 
Income (loss) from continuing operations
$
27.6

 
$
1.9

 
$
55.9

 
$
(18.1
)
Loss from discontinued operations
$
—

 
$
(1.0
)
 
$
—

 
$
(3.1
)
 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted-average number of shares of ordinary shares - basic
145,136,214

 
115,609,756

 
145,132,349

 
115,609,756

Effect of dilutive securities:
 
 
 
 
 
 
 
Restricted stock units
1,092,951

 
—

 
1,116,435

 
—

Stock options
37,963

 
—

 
27,567

 
—

Weighted-average number of shares of ordinary shares - diluted
146,267,128

 
115,609,756

 
146,276,351

 
115,609,756

 
 
 
 
 
 
 
 
Earnings (loss) per ordinary share - basic:
 
 
 
 
 
 
 
From continuing operations
$
0.19

 
$
0.02

 
$
0.39

 
$
(0.16
)
From discontinued operations
$
—

 
$
(0.01
)
 
$
—

 
$
(0.03
)
 
 
 
 
 
 
 
 
Earnings (loss) per ordinary share - diluted:
 
 
 
 
 
 
 
From continuing operations
$
0.19

 
$
0.02

 
$
0.38

 
$
(0.16
)
From discontinued operations
$
—

 
$
(0.01
)
 
$
—

 
$
(0.03
)
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK BASED COMPENSATION
 6 Months Ended
Apr. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK BASED COMPENSATION
STOCK BASED COMPENSATION
A summary of equity based compensation expense recognized during the three and six months ended April 30, 2017 and 2016 is as follows:
 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Management Equity Incentive Plan (MEIP)
1.9

 
2.0

 
4.2

 
3.0

Restricted Stock Units
4.0

 
—

 
5.3

 
—

Stock Options
1.1

 
—

 
1.5

 
—

Stock Based Compensation Expense
7.0

 
2.0

 
11.0

 
3.0


Management Equity Incentive Plan (MEIP)
Prior to the IPO, the Company was a wholly-owned indirect subsidiary of the Partnership. The Partnership adopted the Management Equity Incentive Plan, or the MEIP, with an effective date of March 11, 2014. The purpose of the MEIP is to provide eligible participants with an opportunity to receive grants of profit interests in the Partnership designated as management units. The award of management units pursuant to this MEIP is intended to compensate employees of the Partnership and its subsidiaries, including the Company. The participants in the MEIP, as a group, are eligible to participate in the gain on the investment earned by JLL and DSM with respect to Patheon once certain specified distribution or return thresholds have been achieved. Upon issuance, MEIP units were subject to certain forfeiture (vesting) provisions which meant that if a holder's employment with Patheon terminated prior to the satisfaction of the applicable provision, the unvested MEIP units would be forfeited and the vested MEIP units could be converted into Class A Units in the Partnership on a cashless basis or by making an additional cash contribution in order to receive additional Class A Units ("Partnership Shares").
The aggregate number, class and tranche of management units that were issued under the MEIP was determined by the JLL/Delta Patheon GP Ltd., the general partner of the Partnership. The Partnership last issued MEIP units on December 9, 2015. As a result of the IPO and the adoption of the Patheon N.V. 2016 Omnibus Incentive Plan (the “Omnibus Plan”) described below, the Partnership will no longer grant awards under the MEIP to our employees.
The granted MEIP units consist of Class B, Class C, Class D, and Class E units. From June 24, 2014 to December 9, 2015, the Partnership granted units under five different valuation tranches, with each tranche issued at the most recent quarterly valuation of the Company at the time of the grant.
71.4% of the Class B units have a four year service-based component for vesting ("Service-based Class B units") and the remaining Class B units ("Exit Event Class B units") vest if the holder is employed upon the occurrence of an Exit Event. An Exit Event is defined as the earliest to occur of (i) a change of control and (ii) in connection with or following an initial public offering, the sale or disposition by JLL of equity securities such that, immediately following such sale or disposition, JLL and its affiliates either (A) own less than 20% of the equity securities then issued and outstanding, calculated on a fully diluted basis, or (B) have received, in the aggregate, distributions in respect of such sale or distribution (together with any sale or distribution occurring prior thereto) equal to or in excess of 250% of its aggregate capital contributions made in respect of such equity securities prior to such sale or distribution.
Each of the Class C, D, and E units have a performance and service condition related to vesting. These units vest upon the earlier to occur of (i) JLL receiving distributions in the aggregate equal to return on capital thresholds of 2.0x, 2.5x and 3.0x, respectively, or (ii) an Exit Event, as defined above, does not occur prior to the fifth anniversary of an IPO and the return thresholds in (i) are met based on the average price of the Company's publicly traded shares for any twenty day period following the fifth anniversary of an IPO.
If any employee is terminated for any reason prior the achievement of the above vesting conditions, all unvested units in any class are forfeited.
A summary of the MEIP activity for the six months ended April 30, 2017 is as follows:
 
Class B
Class C
Class D
Class E
Total
 
Weighted Average Fair Value
Outstanding as of October 31, 2016
59,290

8,470

8,470

8,470

84,700

 
$
687.27

Forfeited
(288
)
(50
)
(50
)
(50
)
(438
)
 
$
870.09

Outstanding as of April 30, 2017
59,002

8,420

8,420

8,420

84,262

 
$
686.32


Through the IPO, JLL and DSM received an aggregate return on capital of approximately 2.9x their invested capital, based on the value of ordinary shares of Patheon distributed by the Partnership to JLL and DSM at the IPO price and the value of cash and in-kind distributions made by the Partnership prior to the IPO.
In connection with the IPO, a total of 6,106,540 ordinary shares ("MEIP shares") were distributed to the Partnership to be held for the benefit of the MEIP participants until an Exit Event occurs or until MEIP participants are otherwise permitted to transfer such interests in accordance with the terms of the partnership agreement of the Partnership and respective MEIP unit award agreements, at which time MEIP participants will receive their allocable distribution of MEIP shares. These shares represent the value of the MEIP units, in the aggregate, as determined under the MEIP, as a result of the distribution of ordinary shares to the limited partners of the Partnership in connection with the IPO. MEIP shares were issued to the Partnership with respect to Class B, C and D units for the first three valuation tranches as the applicable distribution threshold was achieved. No MEIP shares were allocated to the Partnership with respect to the final two valuation tranches or the Class E units, as the distribution thresholds and the 3.0x capital return threshold, respectively, were not achieved as of the IPO.
Because no additional MEIP awards will be granted and because the ordinary shares were distributed to JLL and DSM prior to an Exit Event, the MEIP awards will not benefit from further appreciation of those shares. As such, the Company issued a total of 3,388,481 Restricted Share Units ("MEIP RSUs") under the Omnibus Plan in order to provide the MEIP participants with the opportunity to participate in the additional appreciation the MEIP awards could have generated if the Partnership had not distributed ordinary shares of the Company to JLL and DSM. MEIP RSUs were issued in relation to all unit classes and valuation tranches.
The MEIP shares issued with respect to the Class B Units remain subject to the same vesting conditions as the Class B Units. As a result, MEIP shares issued in relation to Service-based Class B units are vested to the extent of each original MEIP grant's four year vesting schedule. The MEIP shares issued in relation to Exit Event Class B units are still subject to the defined Exit Event and are not vested. Lastly, the MEIP shares issued in relation to Class C and D units are fully vested due to their respective return thresholds being achieved through the IPO. The fair value of the MEIP shares are $21.00, the price of the shares at the IPO.
The MEIP RSUs are subject to the same time-based vesting criteria as the original MEIP awards as well as the achievement of performance criteria, which is measured by the Company’s stock price at the earlier to occur of (i) an Exit Event, as defined above, or (ii) the 5-year anniversary of the IPO, at which time all or a percentage of RSUs would settle based upon the attainment of an share price target, with the remaining percentage of RSUs (if any) forfeited. The share price target is $48.47 per share, at which 100% of the RSUs would settle on the applicable vesting date with the share price at or above the target. No RSUs would settle on the vesting date with the share price at or below the IPO price of $21.00, with the settlement amount for a share price between $21.00 and $48.47 calculated on a pro rata basis. The estimated fair value of the MEIP RSUs are $8.41 per unit and was estimated using a Monte Carlo simulation model.
On December 8, 2016, the Company entered into a separation agreement with a senior officer ("Separation Agreement"). The agreement, in part, replaced the senior officer's 196,485 MEIP RSUs with an equal amount of MEIP RSUs with similar terms but with a provision that the MEIP RSUs will vest, and the performance criteria be measured, on December 31, 2017 (the "Separation Date"). The estimated fair value of these replacement MEIP RSUs was $13.87 per unit and was estimated using a Monte Carlo simulation model.
The Monte Carlo simulation model incorporated the following weighted average assumptions:
Risk free interest rate
0.9
%
Expected volatility
41.6
%
Estimated years to exit event
2.98


The Company previously expensed the service-based Class B units using the graded vesting attribution method and is continuing to do so after the allocation of MEIP shares. In addition, the allocation of MEIP shares and MEIP RSUs in respect to the MEIP units resulted in an increase in fair value from the value attributed to the service-based Class B units at the time of the IPO, which the Company will expense on a straight line basis over the five year period following the IPO date, which represents the requisite service period of the MEIP RSUs. In total, the Company recorded $1.4 million and $2.9 million of compensation expense for the three and six months ended April 30, 2017, respectively, relating to these units. The Company recorded $2.0 million and 3.0 million of compensation expense for the three and six months ended April 30, 2016, respectively, relating to these units. The total unrecognized compensation expense for the Service-based Class B units is $8.5 million, which is expected to be recognized through fiscal 2021.
For the Exit Event Class B units, the allocation of MEIP shares and MEIP RSUs resulted in an increased fair value which will serve as the basis for recognizing compensation expense for these units. The fair value of the MEIP RSUs will be expensed on a straight line basis over five years, starting with the IPO date. The Company recognized $0.2 million and $0.4 million of compensation expense for the three and six months ended April 30, 2017, respectively. The fair value of the MEIP shares issued in respect of the Exit Event Class B units will remain unrecognized until an Exit Event occurs. The total unrecognized compensation expense for the MEIP shares and MEIP RSUs issued in respect of the Exit Event Class B units is $31.9 million, of which $3.4 million is expected to be recognized through fiscal 2021 and the remaining amount expensed on the occurrence of an Exit Event.
In the third quarter of fiscal 2016, the Company recorded two one time compensation expenses in relation to the allocation of MEIP shares and MEIP RSUs in respect of the C, D and E units. A $9.0 million expense was recorded to account for the fair value of MEIP units that fully vested as a result of their respective return thresholds being met through the IPO. Additionally, a $1.5 million expense was recorded to account for the unvested MEIP units that were allocated MEIP RSUs, in which requisite service requirements had already been partially met at the time of the IPO. The Company reversed $0.1 million of these expenses in the second quarter of fiscal 2017 due to the Separation Agreement.
In addition, the Company recognized $0.4 million and $1.0 million of compensation expense for the three and six months ended April 30, 2017, respectively, to account for the remaining fair value of the C, D and E MEIP units and the incremental fair value that resulted from the conversion to MEIP shares and MEIP RSUs. These amounts are inclusive of $0.2 million reversed relating to the senior officer's awards that were replaced in the Separation Agreement. The compensation expense will be recorded on a straight line basis over five years. The total unrecognized compensation expense for the C, D, and E units is $8.9 million, which will be recognized through fiscal 2021.
As a result of the Separation Agreement, the Company recorded $1.0 million of additional expense in the second quarter of fiscal 2017, not including a total of $0.3 million in expense reversals, as outlined above. The total unrecognized compensation expense for the replacement awards is $1.7 million, which will be recognized through the Separation Date.
Patheon N.V. 2016 Omnibus Incentive Plan
In July 2016, the Company adopted the Omnibus Plan in order to align the long-term financial interests of selected participants with those of our shareholders, strengthen the commitment of such persons to the Company and our affiliates, and attract and retain competent and dedicated persons whose efforts will result in our long-term growth and profitability. The Omnibus Plan provides for the issuance of options, share appreciation rights, restricted shares, restricted shares units, share bonuses, other share-based awards and cash awards to selected officers, employers, non-employee directors and consultants.
Restricted Stock Units
As of April 30, 2017, the Company has a total of (i) 1,366,383 restricted stock units outstanding to certain members of management and (ii) 41,635 restricted stock units to non-employee directors (collectively, the "Standard RSUs"), excluding the MEIP RSUs outlined above. The Standard RSUs granted to management vest in equal installments over three years and Standard RSUs granted to non-employee directors vest over one year or at the conclusion of the director's service to the Company. The Standard RSUs are not subject to performance based criteria and have a weighted average fair value of $24.79.
In the six months ended April 30, 2017, the Company issued 70,700 ordinary shares for vested restricted stock units. To satisfy certain tax withholding requirements, the Company purchased 8,528 of these shares at a weighted average vesting date fair value of $27.15. These shares are currently being held at cost as treasury shares on the balance sheet.
During the three and six months ended April 30, 2017, $3.0 million and $4.3 million of stock compensation expense was recognized in relation to the Standard RSUs. As of April 30, 2017, unrecognized stock compensation expense related to Standard RSUs was $29.5 million, which will be recognized through fiscal 2020.
A summary of Standard RSUs activity for the six months ended April 30, 2017 is as follows:
 
Restricted Share Units
Weighted Average Grant Date Fair Value
 
 
$
Outstanding as of October 31, 2016
450,184

21.00

Granted
1,028,534

26.46

Vested
(70,700
)
21.00

Outstanding as of April 30, 2017
1,408,018

24.79


As of April 30, 2017, no Standard RSUs have been forfeited.
Stock Options
As of April 30, 2017, the Company has granted 1,747,750 stock options to certain members of management. The stock options were granted with a weighted average exercise price of $23.28 per share, with 1,033,465 of the granted stock options ("Regular Options") vesting equally over three years. The remaining stock options ("EBITDA Options") were granted to a senior officer and vest based on performance based criteria, using Credit Agreement Adjusted EBITDA as the performance metric. Credit Agreement Adjusted EBITDA is defined as the Company's Adjusted EBITDA, as defined in Note 11, plus pro forma cost savings, synergies and pre-acquisition results.
The estimated weighted average fair value of stock options is $9.08 per option and was estimated using a Black-Scholes valuation model, using the following weighted average assumptions:
Risk free interest rate
1.6
%
Expected volatility
38.1
%
Expected life of options (in years)
6.0

Dividend yield
—
%

During the three and six months ended April 30, 2017, $0.8 million and $1.2 million of stock compensation expense was recognized in relation to stock options. In the second quarter of fiscal 2017, $0.3 million of stock compensation expense was recognized for the EBITDA Options, due to a portion of the performance based criteria deemed probable as of April 30, 2017. As of April 30, 2017, total unrecognized compensation expense related to unvested Regular Options was $8.1 million, which is expected to be recognized through fiscal 2020, and total unrecognized compensation expense for the unvested EBITDA Options was $5.6 million, which will be recognized over the requisite service period when the performance based criteria is deemed probable to occur.
A summary of stock option activity for the six months ended April 30, 2017 is as follows:
 
Stock Options
Weighted Average Fair Value
 
 
$
Outstanding as of October 31, 2016
1,021,584

8.29

Granted
726,166

10.18

Outstanding as of April 30, 2017
1,747,750

9.08


As of April 30, 2017, no stock options have been forfeited or exercised.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1
FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT
 6 Months Ended
Apr. 30, 2017
Fair Value Disclosures [Abstract]  
FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT
FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT
The Company has determined the estimated fair values of its financial instruments based on appropriate valuation methodologies; however, considerable judgment is required to develop these estimates. The fair values of the Company's financial instruments are not materially different from their carrying values.
Fair value measurements
The Company classifies and discloses its fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy has the following levels: (a) quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1); (b) inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices) (Level 2); and (c) inputs for the asset or liability that are not based on observable market data (unobservable inputs) (Level 3).
The fair value is principally applied to financial assets and liabilities such as derivative instruments consisting of foreign exchange forward contracts, available-for-sale securities relating to Republic of Austria bonds, held-for-trading securities relating to the Company's U.S. deferred compensation plan, and a liability relating to an earnout payment on future Biologics operating results. The following table provides a summary of the financial assets and liabilities that are measured at fair value as of April 30, 2017 and October 31, 2016:
 
Fair value measurement at April 30, 2017
 
Fair value measurement at October 31, 2016
Assets measured at fair value
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
 
$
 
$
Available-for-sale securities
1.4

 
—

 
—

 
1.4

 
1.4

 
—

 
—

 
1.4

Held-for-trading securities
—

 
1.5

 
—

 
1.5

 
—

 
1.4

 
—

 
1.4

Total assets
1.4

 
1.5

 
—

 
2.9

 
1.4

 
1.4

 
—

 
2.8

 
Fair value measurement at April 30, 2017
 
Fair value measurement at October 31, 2016
Liabilities measured at fair value
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
 
$
 
$
Foreign exchange forward contracts
—

 
1.8

 
—

 
1.8

 
—

 
2.7

 
—

 
2.7

Earnout liability
—

 
—

 
37.9

 
37.9

 
—

 
—

 
33.8

 
33.8

Total liabilities
—

 
1.8

 
37.9

 
39.7

 
—

 
2.7

 
33.8

 
36.5


Level 1 - Based on quoted market prices in active markets.
Level 2 - Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.
Level 3 - Unobservable inputs that are not corroborated by market data.
The following table presents the fair value of the Company's financial instruments and their classifications on the consolidated balance sheets as of April 30, 2017 and October 31, 2016:
 
Assets as of April 30, 2017
 
Assets as of October 31, 2016
 
Balance sheet location
Fair value
 
Balance sheet location
Fair value
 
 
$
 
 
$
Available-for-sale securities
Investments
1.4

 
Investments
1.4

Held-for-trade securities
Investments
1.5

 
Investments
1.4

Total
 
2.9

 
 
2.8

 
Liabilities as of April 30, 2017
 
Liabilities as of October 31, 2016
 
Balance sheet location
Fair value
 
Balance sheet location
Fair value
 
 
$
 
 
$
Foreign exchange forward contracts
Accounts payable and accrued liabilities
1.8

 
Accounts payable and accrued liabilities
2.7

Earnout liability
Other long-term liabilities
37.9

 
Other long-term liabilities
33.8

Total
 
39.7

 
 
36.5


The Company has the option to net settle its derivatives with the counter party under the terms of its contracts and as such any unrealized positions are recorded net. As of April 30, 2017, the Company had gross unrealized losses of $2.0 million and gross unrealized gains of $0.2 million under its derivative contracts. As of October 31, 2016, the Company had gross unrealized losses of $2.7 million and gross unrealized gains of less than $0.1 million under its derivative contracts.
Long-term obligations
As of April 30, 2017, the fair values and carrying values of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:
 
Fair Value
 
 
 
Level 1
Level 2
Level 3
Total
 
Carrying Value
 
$
$
$
$
 
$
Long-term debt, including current portion
—

2,179.3

—

2,179.3

 
2,134.0

As of October 31, 2016, the fair values and carrying values of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:
 
Fair Value
 
 
 
Level 1
Level 2
Level 3
Total
 
Carrying Value
 
$
$
$
$
 
$
Long-term debt, including current portion
—

2,156.8

—

2,156.8

 
2,119.0


The fair value of the Company's long-term debt, including the current portion of long-term debt, is based on the quoted market prices for the same issues or on the current rates offered for debt of similar remaining maturities.
Foreign exchange forward contracts and other arrangements
The Company utilizes financial instruments to manage the risk associated with fluctuations in foreign exchange and interest rates. The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk management objective and strategy for undertaking various hedge transactions.
As of April 30, 2017, the Company's Canadian operations had entered into foreign exchange forward contracts to sell a net aggregate amount of $64.0 million U.S. dollars. These contracts hedge the Canadian operations expected exposure to U.S. dollar denominated receivables and mature at the latest on March 15, 2018, at an average exchange rate of $1.3254 Canadian dollars per U.S. dollar. The mark-to-market value of these financial instruments as of April 30, 2017 was a net unrealized loss of $1.8 million, which has been recorded in accumulated other comprehensive income in shareholders' deficit, net of associated income tax.
The Company acquired a portion of its Biologics business from DSM ("the DPP acquisition") in March 2014. In connection with the DPP acquisition, DSM was entitled to receive certain additional future contingent payments based on the performance of the acquired biologics business (the "earnout"). Under the terms of the original contribution agreement, the earnout only related to the DSM biologics business acquired in March 2014 and the earnout liability was payable by the Partnership, the parent of the Company before the Company's IPO on July 21, 2016. The value of the earnout liability as of January 29, 2016 was $36.0 million.
On January 29, 2016, the Company, the Partnership, JLL, and DSM entered into an agreement (the "Earnout Agreement") whereby the Partnership’s earnout liability was legally assigned to the Company. The assignment of the liability from the Partnership to the Company was deemed a capital transaction with the Partnership of $36.0 million.
Concurrently, the calculation of the earnout consideration was revised to include the future earnings of the Company’s entire biologics business ("Biologics Adjusted EBITDA"), which includes biologics business acquired in connection with a September 2014 acquisition of Gallus Pharmaceuticals. As a result of executing this Earnout Agreement, the Company will pay additional consideration to DSM based on the achievement of certain Biologics Adjusted EBITDA targets, as defined in the Earnout Agreement, of the Company’s biologics business at the conclusion of the 2020 fiscal year. If the Company sells or disposes of the biologics business prior to the end of the 2020 fiscal year, Biologics Adjusted EBITDA will be calculated by applying a 10% compounded annual growth rate through the remaining period ending October 31, 2020 to the Biologics Adjusted EBITDA for the twelve-month period ended on the last day of the month immediately preceding the date of such sale or disposition. The Company's maximum and minimum payments to DSM under the terms of the Earnout Agreement is $60.0 million and $25.0 million, respectively. Using the revised earnout definition, the value of the earnout liability as of January 31, 2016 was $31.1 million and resulted in the Company recognizing income of $4.9 million in the first quarter of fiscal 2016.
The Company estimated the value of the earnout by valuing the three payout tranches. The first tranche of the $25.0 million minimum earnout payment, which is not contingent to Biologics Adjusted EBITDA performance, was estimated by discounting the $25.0 million using cost of debt of the Company. The values of the remaining two tranches, (i) an additional $25.0 million earnout payment which will be realized gradually as Biologics Adjusted EBITDA reaches $98.0 million, and (ii) an additional $10.0 million earnout payment which will be achieved gradually as Biologics Adjusted EBITDA approaches $110.0 million, were estimated using an option pricing framework, where the Company used a modified Black-Scholes model.
The Company adjusted the earnout value to its estimated fair value as of April 30, 2017 to $37.9 million. The Company recorded $0.5 million and $4.1 million of expense in the three and six months ended April 30, 2017, respectively, relating to marking the liability to its estimated fair value. The Company recorded $1.2 million of expense and $3.7 million of income in the three and six months ended April 30, 2016, respectively, relating to marking the liability to its estimated fair value. The April 30, 2017 earnout valuation applies an asset volatility of 30% and an asset beta of 0.9. A 1% change in asset volatility would have an impact on the value of +/- $0.3 million while a 0.1 change in beta would have an impact on the value of +/- $0.3 million. Assumptions are Level 3 in nature.
The earnout liability activity is summarized as follows for the six months ended April 30, 2017:
 
Total
 
$
Balance at October 31, 2016
33.8

Change in fair value
4.1

Balance at April 30, 2017
37.9


The change in fair value relating to the earnout is recorded in other operating income on the consolidated statements of operations.
Risks arising from financial instruments and risk management
The Company's activities expose it to a variety of financial risks: market risk (including foreign exchange and interest rate), credit risk and liquidity risk. The Company's overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the Company's financial performance. The Company uses derivative financial instruments to hedge certain risk exposures. The Company does not purchase any derivative financial instruments for speculative purposes.
Financial risk management is the responsibility of the Company's corporate treasury. The corporate treasury works with the Company's operational personnel to identify, evaluate and, where appropriate, hedge financial risks. The Company's corporate treasury also monitors material risks and discusses them with the Audit Committee of the Board of Directors.
Foreign exchange risk
As of April 30, 2017, the Company operated in Canada, the United States, Italy, France, the United Kingdom, The Netherlands, Australia, Germany, Austria, and Japan. Foreign exchange risk arises because the value of the local currency receivable or payable for transactions denominated in foreign currencies may vary due to changes in exchange rates ("transaction exposures") and because the non-U.S. dollar denominated financial statements of the Company may vary on consolidation into the reporting currency of U.S. dollars ("translation exposures").
The Company's most significant transaction exposure is from its Canadian operations. Approximately 90% of the cash receipts and 15% of the cash outflows relating to Canadian operations are transacted in U.S. dollars. As a result, the Company may experience transaction exposures because of volatility in the exchange rate between the Canadian and U.S. dollar. Based on the Company's current U.S. denominated net inflows, as of April 30, 2017, fluctuations of +/- 10% would, everything else being equal, have an effect on year to date income before income taxes of approximately +/- $5.8 million, prior to hedging activities.
The objective of the Company's foreign exchange risk management activities is to minimize transaction exposures and the resulting volatility of the Company's earnings. The Company manages this risk by entering into foreign exchange contracts. As of April 30, 2017, the Company has entered into foreign exchange contracts to cover approximately 68% of its Canadian-U.S. dollar cash flow exposures for the next twelve months.
The amount of the Company's Euro denominated debt designated as a hedge against its net investment in its subsidiaries in Austria, The Netherlands, Germany, France and Italy, is €463.1 million as of April 30, 2017. This hedge was originally designated in March 2014 as a part of the Company's acquisition of manufacturing sites from DSM and is re-designated on a quarterly basis. As of April 30, 2017, the balance of the net investment hedge was $74.7 million and is included in accumulated other comprehensive income in shareholders' deficit. Any unrealized exchange losses are included in the consolidated statement of operations due to ineffectiveness.
The following table summarizes the net investment hedge foreign exchange activity for the three and six months ended April 30, 2017 and 2016 since net investment hedge inception:
 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Foreign exchange (loss) gain for the period from net investment hedge
(4.6
)
 
(29.0
)
 
4.0

 
(21.0
)
Release of ineffective portion of net investment hedge to consolidated statement of operations
—

 
3.3

 
—

 
2.2

Net (loss) gain to other comprehensive income for the period related to net investment hedge
(4.6
)
 
(25.7
)
 
4.0

 
(18.8
)

Translation gains and losses related to certain foreign currency denominated intercompany loans are included as part of the net investment in certain foreign subsidiaries, and are included in accumulated other comprehensive income in shareholders' deficit.
The following table summarizes the foreign currency activity on the intercompany loans that are included as part of the net investment in certain foreign subsidiaries for the three and six months ended April 30, 2017 and 2016 since net investment hedge inception:
 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Foreign exchange gain for the period from long-term intercompany loan revaluation
—

 
3.8

 
—

 
3.0


Credit risk
Credit risk arises from cash and cash equivalents held with banks and financial institutions, derivative financial instruments (foreign exchange contracts with positive fair values), and credit exposure to customers, including outstanding accounts receivable. The maximum exposure to credit risk is equal to the carrying value of the financial assets.
The objective of managing counterparty credit risk is to prevent losses in financial assets. The Company regularly assesses the credit quality of the counterparties, taking into account their financial position, past experience and other factors. Management also regularly monitors the utilization of credit limits. In cases where the credit quality of a customer does not meet the Company's requirements, a cash deposit is received before any services are provided. As of April 30, 2017 and October 31, 2016, the Company held deposits of $4.1 million and $4.3 million, respectively.
Liquidity risk
Liquidity risk arises when financial obligations exceed financial assets available at a particular point in time. The Company's objective in managing liquidity risk is to maintain sufficient readily available reserves in order to meet its liquidity requirements at all times. The Company mitigates liquidity risk by maintaining cash and cash equivalents on-hand and through the availability of funding from credit facilities. As of April 30, 2017, the Company was holding cash and cash equivalents of $92.7 million and had undrawn lines of credit available to it of $209.3 million.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
SEGMENT INFORMATION
 6 Months Ended
Apr. 30, 2017
Segment Reporting [Abstract]  
SEGMENT INFORMATION
SEGMENT INFORMATION
The Company’s four operating segments are: North America DPS, Europe DPS, PDS and DSS. The North America DPS and Europe DPS operating segments meet the aggregation criteria to be presented as one DPS reportable segment. As a result, the Company has three reportable segments: DPS, PDS and DSS. Costs relating to Corporate operations are classified as Other.
The DPS segment includes commercial manufacturing outsourcing services, the PDS segment includes pharmaceutical development services, and the DSS segment includes active pharmaceutical ingredients and pharmaceutical intermediates. Corporate expenses primarily relate to general, administrative and sales and marketing expenses related to the corporate organization. These expenses are centrally directed and controlled and are not included in internal measures of segment operating performance. The CODM does not evaluate its operating segments using discrete asset information.
 
Three months ended April 30, 2017
 
DPS
 
PDS
 
DSS
 
Other
 
Intersegment Eliminations
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
Revenues
297.2

 
57.8

 
129.2

 
—

 
(0.8
)
 
483.4

Adjusted EBITDA
77.4

 
18.4

 
26.1

 
(27.5
)
 
(0.2
)
 
94.2

Depreciation and amortization
15.4

 
1.9

 
16.1

 
0.9

 
 
 
34.3

Capital expenditures
19.5

 
1.7

 
11.6

 
7.4

 
 
 
40.2


 
Three months ended April 30, 2016
 
DPS
 
PDS
 
DSS
 
Other
 
Intersegment Eliminations
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
Revenues
287.4

 
53.4

 
127.9

 
—

 
(0.1
)
 
468.6

Adjusted EBITDA
72.7

 
16.7

 
30.8

 
(22.2
)
 
 
 
98.0

Depreciation and amortization
14.9

 
1.3

 
10.2

 
0.6

 
 
 
27.0

Capital expenditures
11.7

 
5.9

 
9.0

 
4.3

 
 
 
30.9


 
Six months ended April 30, 2017
 
DPS
 
PDS
 
DSS
 
Other
 
Intersegment Eliminations
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
Revenues
572.4

 
110.1

 
259.1

 
—

 
(0.8
)
 
940.8

Adjusted EBITDA
138.8

 
34.7

 
58.1

 
(54.7
)
 
(0.2
)
 
176.7

Depreciation and amortization
30.7

 
3.7

 
25.8

 
1.7

 
 
 
61.9

Capital expenditures
56.4

 
3.1

 
29.5

 
10.2

 
 
 
99.2


 
Six months ended April 30, 2016
 
DPS
 
PDS
 
DSS
 
Other
 
Intersegment Eliminations
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
Revenues
545.9

 
101.9

 
226.8

 
—

 
(0.1
)
 
874.5

Adjusted EBITDA
127.8

 
30.5

 
45.6

 
(46.9
)
 
 
 
157.0

Depreciation and amortization
29.7

 
2.5

 
20.1

 
1.2

 
 
 
53.5

Capital expenditures
56.7

 
15.6

 
16.3

 
6.5

 
 
 
95.1

The Company evaluates the performance of its segments based on segment Adjusted EBITDA. The Company's Adjusted EBITDA is income (loss) from continuing operations before repositioning expenses (including certain product returns and
inventory write-offs recorded in gross profit), interest expense, foreign exchange losses reclassified from other comprehensive income (loss), refinancing expenses, acquisition and integration costs (including certain product returns and inventory write-offs recorded in gross profit), gains and losses on sale of capital assets, Biologics earnout income and expense, income taxes, impairment charges, remediation costs, depreciation and amortization, stock-based compensation expense, consulting costs related to our operational initiatives, purchase accounting adjustments, acquisition-related litigation expenses and other income and expenses. Adjusted EBITDA is one of several metrics used to measure segment operating performance and is also used to determine executive compensation. "Adjusted EBITDA margin" is Adjusted EBITDA as a percentage of revenues. The Company's presentation of Adjusted EBITDA may not be comparable to similarly-titled measures used by other companies and is not equivalent to "Consolidated EBITDA" as defined in the Credit Agreement (as discussed in Note 5).
Below is a reconciliation of Adjusted EBITDA to its most comparable U.S. GAAP measure.
 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Total Adjusted EBITDA
94.2

 
98.0

 
176.7

 
157.0

Depreciation and amortization
(34.3
)
 
(27.0
)
 
(61.9
)
 
(53.5
)
Repositioning expenses (1)
(2.2
)
 
(1.3
)
 
(3.5
)
 
(2.5
)
Acquisition and integration costs
(8.1
)
 
(7.6
)
 
(11.6
)
 
(10.2
)
Interest expense, net
(30.8
)
 
(42.6
)
 
(59.0
)
 
(86.4
)
Benefit from (provision for) income taxes
1.5

 
(0.7
)
 
22.8

 
—

Refinancing expenses
(6.3
)
 
—

 
(6.3
)
 
—

Operational initiatives related consulting costs
(1.4
)
 
(1.9
)
 
(2.5
)
 
(3.3
)
IPO costs
—

 
(0.4
)
 
—

 
(0.8
)
Acquisition related litigation expenses
(3.7
)
 
(0.9
)
 
(6.0
)
 
(1.9
)
Stock based compensation expense
(7.0
)
 
(2.0
)
 
(11.0
)
 
(3.0
)
FDA remediation costs
—

 
(10.1
)
 
—

 
(18.5
)
Environmental remediation costs
—

 
—

 
(3.7
)
 
—

Bargain purchase gain
26.4

 
—

 
26.4

 
—

Other
(0.7
)
 
(1.6
)
 
(4.5
)
 
5.0

Net income (loss) from continuing operations
27.6

 
1.9

 
55.9

 
(18.1
)

(1) Repositioning expenses for the three and six months ended April 30, 2017 includes $0.4 million and $1.1 million of inventory reserves related to the Swindon wind down recorded in cost of goods sold.
As illustrated in the table below, revenues are attributed to countries based on the location of the customer's billing address, capital assets are attributed to the country in which they are located and goodwill is attributed to the country in which the entity to which the goodwill pertains is located:
 
Three months ended April 30, 2017
 
Canada
 
US*
 
Europe
 
Other**
 
Total
 
$
 
$
 
$
 
$
 
$
Revenues
4.2

 
282.8

 
167.9

 
28.5

 
483.4

* Includes Puerto Rico
** Primarily includes Japan
 
Three months ended April 30, 2016
 
Canada
 
US*
 
Europe
 
Other**
 
Total
 
$
 
$
 
$
 
$
 
$
Revenues
5.1

 
317.6

 
124.8

 
21.1

 
468.6

* Includes Puerto Rico
** Primarily includes Japan
 
As of and for the six months ended April 30, 2017
 
Canada
 
US*
 
Europe
 
Other**
 
Total
 
$
 
$
 
$
 
$
 
$
Revenues
11.2

 
564.7

 
320.7

 
44.2

 
940.8

Capital Assets
100.1

 
687.6

 
367.5

 
14.1

 
1,169.3

Goodwill
2.5

 
269.4

 
7.4

 
2.1

 
281.4


* Includes Puerto Rico
** Other revenues primarily include Japan
 
As of and for the six months ended April 30, 2016
 
Canada
 
US*
 
Europe
 
Other**
 
Total
 
$
 
$
 
$
 
$
 
$
Revenues
12.4

 
589.4

 
236.7

 
36.0

 
874.5

Capital Assets
100.8

 
487.3

 
341.6

 
16.1

 
945.8

Goodwill
2.8

 
269.4

 
7.7

 
2.2

 
282.1


* Includes Puerto Rico
** Other revenues primarily include Japan
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
REPOSITIONING EXPENSES
 6 Months Ended
Apr. 30, 2017
Restructuring and Related Activities [Abstract]  
REPOSITIONING EXPENSES
REPOSITIONING EXPENSES
During the three and six months ended April 30, 2017, the Company incurred $1.8 million and $2.4 million in repositioning expenses, respectively, primarily from severance payments resulting from operational initiatives. In addition, the Company recorded inventory reserves of $0.4 million and $1.1 million for the three and six months ended April 30, 2017 relating to raw material and work in process inventory associated with the final phase of the winding down of the older section of the Swindon facility ("Swindon wind down") to allow us to re-purpose that area, which was expensed through cost of goods sold.
During the three and six months ended April 30, 2016, the Company incurred $1.3 million and $2.5 million in repositioning expenses, primarily from severance payments resulting from a realignment of DPS operations.
The following is a summary of these expenses and other charges associated with operational improvements as of and for the three and six months ended April 30, 2017 and 2016:
 
As of and for the three months ended April 30, 2017
 
DPS
 
PDS
 
DSS
 
Other
 
Total
 
$
 
$
 
$
 
$
 
$
Total repositioning liability at January 31, 2017
 
 
 
 
 
 
 
 
4.6

Employee-related expenses
1.7

 
—

 
—

 
0.1

 
1.8

Repositioning expenses paid
 
 
 
 
 
 
 
 
(1.6
)
Foreign exchange
 
 
 
 
 
 
 
 
0.1

Total repositioning liability at April 30, 2017
 
 
 
 
 
 
 
 
4.9

 
As of and for the three months ended April 30, 2016
 
DPS
 
PDS
 
DSS
 
Other
 
Total
 
$
 
$
 
$
 
$
 
$
Total repositioning liability at January 31, 2016
 
 
 
 
 
 
 
 
4.9

Employee-related expenses
1.6

 
—

 
—

 
—

 
1.6

Consulting, professional and project management costs
(0.3
)
 
—

 
—

 
—

 
(0.3
)
Total expenses
1.3

 
—

 
—

 
—

 
1.3

Repositioning expenses paid
 
 
 
 
 
 
 
 
(3.1
)
Foreign exchange
 
 
 
 
 
 
 
 
0.3

Total repositioning liability at April 30, 2016
 
 
 
 
 
 
 
 
3.4

 
As of and for the six months ended April 30, 2017
 
DPS
 
PDS
 
DSS
 
Other
 
Total
 
$
 
$
 
$
 
$
 
$
Total repositioning liability at October 31, 2016
 
 
 
 
 
 
 
 
5.4

Employee-related expenses
1.9

 
—

 
—

 
0.5

 
2.4

Repositioning expenses paid
 
 
 
 
 
 
 
 
(3.1
)
Foreign exchange
 
 
 
 
 
 
 
 
0.2

Total repositioning liability at April 30, 2017
 
 
 
 
 
 
 
 
4.9

The balance of repositioning liabilities as of April 30, 2017 was recorded in accounts payable and accrued liabilities on the consolidated balance sheet. The Company does not have any long-term repositioning liabilities as of April 30, 2017.
 
As of and for the six months ended April 30, 2016
 
DPS
 
PDS
 
DSS
 
Other
 
Total
 
$
 
$
 
$
 
$
 
$
Total repositioning liability at October 31, 2015
 
 
 
 
 
 
 
 
22.9

Employee-related expenses
2.8

 
—

 
—

 
—

 
2.8

Consulting, professional and project management costs
(0.3
)
 
—

 
—

 
—

 
(0.3
)
Total expenses
2.5

 
—

 
—

 
—

 
2.5

Repositioning expenses paid
 
 
 
 
 
 
 
 
(21.8
)
Foreign exchange
 
 
 
 
 
 
 
 
(0.2
)
Total repositioning liability at April 30, 2016
 
 
 
 
 
 
 
 
3.4


The balance of repositioning liabilities as of April 30, 2016 was recorded in accounts payable and accrued liabilities on the consolidated balance sheet. The Company does not have any long-term repositioning liabilities as of April 30, 2016.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
RELATED PARTIES
 6 Months Ended
Apr. 30, 2017
Related Party Transactions [Abstract]  
RELATED PARTIES
RELATED PARTIES
Related Party Transactions
JLL Partners
The Company has a service agreement with JLL Partners Inc. and some JLL Partners affiliates whereby the Company will reimburse the parties for management, consulting, financial, and other business services provided under the agreement. The amounts spent on these services, as well as the amounts payable outstanding in relation to these services, are shown in the tables below.
DSM
The Company has transition service agreements ("TSAs") with DSM resulting from the DPP Acquisition whereby DSM performs certain shared service functions on behalf of the Company. Additionally, the Company performs certain services on behalf of DSM. The revenue and expenses relating to these services, as well as the accounts receivable and payable outstanding in relation to these services, are shown in the tables below.
BLS
The Company has a management service agreement with BLS whereby the Company will provide various management, financial, legal and other business services to BLS. The expenses relating to these services are charged to BLS and the related accounts receivable outstanding in relation to these services are shown in the tables below. We performed production services for BLS in the first quarter of fiscal 2016 before BLS sold their commercial business to a third party.

 
Three months ended April 30,
 
Six months ended April 30,
Revenues/Expenses
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
JLL Partners Expenses
0.1

 
0.1

 
0.1

 
0.2

 
 
 
 
 
 
 
 
DSM Revenues
0.1

 
0.8

 
0.3

 
0.9

DSM Expenses
1.9

 
2.5

 
5.1

 
5.2

 
 
 
 
 
 
 
 
Banner Life Sciences Revenues
0.7

 
1.4

 
0.7

 
7.9

 
Balances as of
Accounts Receivable/Payable Balances
April 30, 2017
 
October 31, 2016
 
$
 
$
JLL Partners Accounts Payable
0.1

 
—

 
 
 
 
DSM Accounts Receivable
0.1

 
0.4

DSM Accounts Payable
1.7

 
0.2

 
 
 
 
Banner Life Sciences Accounts Receivable
1.2

 
1.1


Equity Method Investments
Banner Life Sciences
In October 2015, the Company invested $5.0 million in Banner Life Sciences. The investment resulted in Banner Life Sciences becoming a variable interest entity, but the entity is not consolidated as the Company does not have the ability to control the entity and therefore does not have the power to direct Banner Life Sciences' activities. The Company's maximum exposure to loss relating to this variable interest entity is limited to the carrying value of the investment. The investment is presented within investments in the consolidated balance sheets. In March 2016, the Company received a $2.4 million cash distribution from Banner Life Sciences.
Percivia
The Company holds a 50.0% interest in Percivia, a limited liability company for the purpose of performing research and development activities and licensing certain technology. In February 2016, the Company received a $1.2 million return of capital from Percivia in the form of a cash distribution.
Chemiepark
The Company holds a 47.5% interest in Chemiepark, a company tasked with providing fire protection for the chemicals site in Linz, Austria.
 
Values as of
Equity Method Investment Values
April 30, 2017
 
October 31, 2016
 
$
 
$
Banner Life Sciences
2.5

 
2.9

Percivia
5.7

 
5.7

Chemiepark
0.1

 
0.1

Total
8.3

 
8.7


Investment carrying values are presented within investments in the consolidated balance sheets.
 
Three months ended April 30,
 
Six months ended April 30,
Equity Method (Loss)/Gain
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Banner Life Sciences
(0.2
)
 
(0.5
)
 
(0.3
)
 
1.3

Percivia
—

 
0.1

 
—

 
0.2

Total
(0.2
)
 
(0.4
)
 
(0.3
)
 
1.5


Equity method earnings are presented within other income in the consolidated statement of operations.
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
INCOME TAXES
 6 Months Ended
Apr. 30, 2017
Income Tax Disclosure [Abstract]  
INCOME TAXES
INCOME TAXES
The Company accounts for income taxes under FASB ASC 740, Income Taxes ("ASC 740"). The Company calculates its quarterly tax provision consistent with the guidance provided by ASC 740-270, whereby the Company forecasts its estimated annual effective tax rate then applies that rate to its year-to-date pre-tax book (loss) income. The effective tax rate may be subject to fluctuations during the year as new information is obtained, which may affect the assumptions used to estimate the annual effective rate, including factors such as the valuation allowances against deferred tax assets, the recognition or de-recognition of tax benefits related to uncertain tax positions, or changes in or the interpretation of tax laws in jurisdictions where the Company conducts business. The Company has recorded valuation allowances against certain Netherlands and other foreign jurisdictions due to insufficient evidence supporting the Company's ability to use these assets in the future.
For the six months ended April 30, 2017 and 2016, the Company recorded a benefit from income taxes in continuing operations of $22.8 million and $0.0 million, respectively. The increase in tax benefit for the six months ended April 30, 2017 was primarily attributable to changes in the Company’s jurisdictional combination of pre-tax income, the Company’s change in tax classification of a United States subsidiary ("US subsidiary") and changes to other discrete tax items, which may have unique tax implications, depending on the nature of the item.
In the first quarter of fiscal 2017, the Company filed an election to change the tax classification of a US subsidiary from a partnership to an association taxable as a corporation. As a result of the change in tax classification, the Company recognized a $28.3 million deferred tax benefit related to the change in its deferred tax assets and liabilities. The Company previously accounted for the deferred tax basis difference using outside basis of the partnership's investments. The Company derecognized the deferred tax liability for the outside basis difference and recognized deferred tax assets and liabilities for existing temporary differences between the tax basis and financial reporting basis of the assets and liabilities of the subsidiary.
In the second quarter of fiscal 2017, the Company amended prior year federal and state returns, originally filed by a predecessor owner, for a U.S. subsidiary. As a result of the amended returns, the Company recognized a $3.5 million deferred tax benefit for an increase in net operating losses.
Valuation allowances are provided to reduce the related deferred income tax assets to an amount which will, more likely than not, be realized. As of April 30, 2017, the Company has multiple subsidiaries that continue to maintain either full or a partial valuation allowances on their deferred tax assets as there is not sufficient evidence to support the reversal of all or some portion of these allowances. However, given current and anticipated future earnings in the Company's Austrian subsidiaries, the Company believes that within the next twelve months there is a reasonable possibility positive evidence will become available that would require the release of all or a portion of the valuation allowance recorded at the Company’s Austrian subsidiaries.
The Company evaluates uncertain tax positions on a quarterly basis and considers various factors, including, but not limited to, changes in tax law, the measurement of tax positions taken or expected to be taken in tax returns, the effective settlement of matters subject to audit, information obtained during in process audit activities and changes in facts or circumstances related to a tax position. The Company also accrues for potential interest and penalties related to unrecognized tax benefits within the provision for income taxes on the consolidated statement operations. As of April 30, 2017, the Company did not have a material change in the total amount of unrecognized tax positions and does not expect a material change over the next twelve months.
The Company early adopted ASU No. 2016-09 "Improvements to Employee Share-Based Payment Accounting" during the second quarter of fiscal 2017. ASU 2016-09 eliminates the requirement for additional paid in capital ("APIC") pools and requires excess tax benefits and tax deficiencies to be recorded in the income statement when the awards vest or are settled.  The adoption of ASU 2016-09 had no financial statement impact on the Company.
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1
OTHER INFORMATION
 6 Months Ended
Apr. 30, 2017
Other Information [Abstract]  
OTHER INFORMATION
OTHER INFORMATION
Foreign exchange
During the three and six months ended April 30, 2017, the Company recorded a foreign exchange loss of $0.7 million and $5.5 million, respectively. These amounts resulted from hedge and operating exposures. During the three and six months ended April 30, 2016, the Company recorded foreign exchange losses of $7.1 million and $11.4 million, respectively
Management Incentive Plan
On March 11, 2014, the Company adopted the Management Long-Term Incentive Plan (the "LTIP") to provide long-term incentives to select key management employees of Patheon and its subsidiaries who have contributed and are expected to contribute materially to the success of the Company, and to reward outstanding performance by such employees. Leadership, key positions or identified key talent may be invited to participate in the LTIP during an identified plan year. Compensation is payable under this plan upon an Exit Event by the controlling investors of the Company (JLL and DSM), if the participant is still employed by the Company, or a qualifying termination, as defined.
An Exit Event is defined as the earlier of: (a) a change of control, and (b) in connection with or following an Initial Public Offering ("IPO"), the sale or disposition by JLL or any of its affiliates of equity securities such that, immediately following such sale or disposition, either (i) JLL and its affiliates own less than 20% of the outstanding equity securities of the Partnership or the Partnership offeror, calculated on a fully-diluted basis, or (ii) JLL and its affiliates have received, in the aggregate, distributions in respect of such sale or disposition (together with any sale or disposition occurring prior thereto) equal to or in excess of 250% of the initial capital contributions and any additional capital contributions made by JLL and its affiliates for all equity securities of the Partnership or the Partnership offeror held by JLL and its affiliates prior to such sale or disposition.
Not later than 90 days following commencement of each applicable Company fiscal year that would end during the term of the LTIP, the compensation committee of the board of directors of the Company (the "Compensation Committee") will determine, in its sole and absolute discretion, with respect to such fiscal year, (i) the Participants (as defined in the LTIP) with respect to that fiscal year, (ii) the EBITDA Target (as defined in the LTIP), and (iii) the targeted amount of each Award. Each award shall be evidenced by a written notice and shall be deemed granted on the first day of the fiscal year with respect to which the Compensation Committee resolves to grant such award (the "Grant Date"). Awards are denominated as a percentage of the Participant’s base salary, with the target percentage based on the Participant’s level within the organization, as determined by the Compensation Committee in its sole and absolute discretion. All awards will be paid in the form of cash, or other property having a value equal to such cash payment, as determined by the Compensation Committee in its sole and absolute discretion.
Under the LTIP, the Company has granted $9.6 million in outstanding awards from March 11, 2014 through April 30, 2017, all of which vest over a five-year period. Through April 30, 2017, the Company has paid out $0.2 million in payments due to qualified terminations. The Company does not accrue for the overall payout as the Exit Event is deemed to not be probable until the actual occurrence of the event.
Contingencies
Procaps Antitrust Matter
On December 10, 2012, Procaps S.A. (‘‘Procaps’’) filed a complaint against the Company in the United States District Court for the Southern District of Florida (the ‘‘District Court’’) (Case No. 12-cv-24356-DLG). The complaint involves the Company’s collaboration agreement with Procaps, pursuant to which both companies agreed to work together with respect to the marketing of a line of certain prescription pharmaceutical soft-gel development and manufacturing services. Procaps alleges that the Company’s acquisition of Banner, a business that historically has generated less than 10% of its revenues from softgel services for prescription pharmaceuticals, transformed the collaboration agreement into an anticompetitive restraint of trade and an agreement between direct competitors to set prices, divide markets and/or allocate geographic territories. Procaps seeks (i) a declaratory judgment that the collaboration agreement must cease and/or terminate; (ii) an injunction requiring that Patheon divest all of Banner’s soft-gel manufacturing capabilities; and (iii) monetary damages under federal and state antitrust and unfair competition laws, including treble damages for violations of the Sherman Act. Patheon subsequently answered Procaps’ complaint and filed its affirmative defenses to the complaint. In July 2014, upon Motion for Summary Judgment by Patheon, the court dismissed Procaps’ unfair competition claims, leaving only the antitrust claims in dispute. In March 2015, the court ordered trial to commence on November 16, 2015.
In October 2015, the court granted Patheon’s motion for summary judgment with respect to all of Procaps’ remaining claims in this matter. In November 2015, Procaps filed a notice of appeal with the United States Court of Appeals for the Eleventh Circuit (the ‘‘11th Circuit Court’’). Procaps filed its initial brief with the 11th Circuit Court in February 2016 and we filed our reply brief in May 2016. Procaps filed its reply to our reply brief in June 2016. The 11th Circuit Court heard oral argument in this matter in November 2016 and in December 2016 affirmed the District Court's decision in favor of Patheon.
In May 2016, Procaps filed a request for arbitration with the International Court of Arbitration of the International Chamber of Commerce. The request for arbitration involves the above-mentioned collaboration agreement. Procaps alleges that (i) Patheon’s acquisition of Banner violated the exclusivity provision of the collaboration agreement, (ii) Patheon failed to return or destroy confidential information of Procaps, (iii) Patheon was unjustly enriched by obtaining the benefit of such confidential information to which it was not entitled, and (iv) Patheon breached implied duties of good faith and fair dealing in carrying out the collaboration agreement. Procaps seeks (i) with respect to the alleged breaches, compensatory damages and (ii) with respect to the claim for unjust enrichment, (a) disgorgement of profits received by Patheon by using any confidential information of Procaps, (b) repayment for all payments made to Patheon pursuant to the collaboration agreement, and (c) payment for the value of any intellectual property associated with the collaboration agreement. The Company filed its answer to the request for arbitration with the International Court of Arbitration of the International Chamber of Commerce in June 2016. The arbitration hearing on the merits in this matter was held in March 2017 and final arguments were heard in May 2017.
The Company has not included any accrual in the consolidated financial statements as of April 30, 2017 related to these matters as a result of its assessment that the likelihood of a material loss in connection with these matters is not probable. However, an adverse outcome in this matter could have a material adverse effect on the Company’s business, results of operations and financial condition.
Oral Contraceptive Litigation
A civil action is pending in the Commonwealth of Pennsylvania against the Company and one of its customers in connection with the recall of certain lots of allegedly defective products manufactured by the Company for the customer. The customer has given the Company notice of its intent to seek indemnification from the Company for all damages, costs and expenses, pursuant to the manufacturing services agreement between the customer and the Company.
The action was filed in Court of Common Pleas of Philadelphia Country, in Philadelphia, Pennsylvania in November 2015 on behalf of 113 plaintiffs who were originally part of a putative class action commenced in state court in Georgia in October 2011 on behalf of 115 plaintiffs and removed by defendants to the United States District Court for the Northern District of Georgia ("Georgia District Court") under the Class Action Fairness Act ("CAFA"). Defendants opposed class certification and class certification was denied. The Georgia action was ordered to proceed as a two-plaintiff action in the Georgia District Court on behalf of the two named plaintiffs, whereupon plaintiffs' lawyers commenced a new action in the Court of Common Pleas in Philadelphia on behalf of the remaining 113 plaintiffs. The two-plaintiff action was dismissed by the Georgia District Court on October 28, 2016 on a motion for summary judgment brought by defendants.
Defendants removed the action to the United States District Court for the Eastern District of Pennsylvania ("Pennsylvania District Court"). In September 2016, the Pennsylvania District Court remanded the action back to the Court of Common Pleas in Philadelphia. Defendants appealed the order of remand and, in February 2017, the United States Court of Appeals for the Third Circuit reversed and vacated the Pennsylvania District Court's remand order and remanded the matter to the Pennsylvania District Court for further proceedings. As the litigation is at an early stage, the Company is unable to estimate the potential damages for which the Company may be directly or indirectly liable.
Italian Client Dispute
In November 2015, the largest client of Patheon Italia S.p.A.’s (‘‘Patheon Italia’’), Ferentino, Italy facility filed a motion for injunctive relief in a Milan court under Article 700 of the Italian Civil Code. The client claims that remediation actions implemented by the Ferentino facility in response to an FDA inspection in May 2015, including, among other things, the use of a third party to certify all production batches for release, caused a significant slowdown in the quality control testing and batch release processes for the client’s product, thereby impairing the client’s ability to supply product in the amounts needed to fulfill the client's needs. The client sought an injunction ordering the Ferentino facility to (i) deliver products set forth in an October 6-7, 2015 release plan discussed by the parties; (ii) transfer products and documentation to the client to enable the client to perform the necessary quality control testing and release the products; and (iii) continue manufacture of the products at the capacity levels set forth in the supply agreement between the parties. The client further asked the court to impose a penalty of €0.2 million per day for every day that the Ferentino facility failed to comply with the order.
On December 7, 2015, Patheon Italia filed a response to the motion, denying all the claims set forth in the client’s motion and asserting several defenses. In particular, Patheon Italia informed the court that the parties had in fact executed an amendment to the existing quality agreement agreeing to transfer the testing and release responsibilities to the client, such amendment was executed prior to the filing of the motion by the client and should have been disclosed to the court in the client’s motion.
On December 10, 2015, the court held a hearing in this matter and on December 18, 2015, denied the client’s motion. The client has filed an appeal to the court's decision, which was heard on February 11, 2016. On February 29, 2016, the appeals court denied the client's appeal. The supply agreement with the client includes an arbitration provision and in its initial motion, the client indicated its intention to file an arbitration claim seeking money damages in this matter. This matter is in the early stages and the Company is unable to estimate the potential damages for which Patheon Italia may be liable if the client files an arbitration claim and prevails in such proceeding.
Statements of cash flows non-cash investing and financing activities
 
Six months ended April 30,
 
2017
 
2016
Non-cash financing activities:
$
 
$
Assumption of earnout liability from the Partnership (1)
—

 
36.0

Treasury stock purchases to satisfy certain tax withholdings (2)
0.1

 
—

Increase in capital lease obligations
1.0

 
—

(1) Refer to Note 9 for further information
(2) Represents the tax payable held as of April 30, 2017 relating to a second quarter treasury stock purchase.
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUBSEQUENT EVENTS
 6 Months Ended
Apr. 30, 2017
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS
On May 15, 2017, the Company and Thermo Fisher Scientific Inc. ("Thermo Fisher") and Thermo Fisher (CN) Luxembourg Sarl (the “Buyer”) entered into a Purchase Agreement pursuant to which the Buyer will commence a tender offer to all outstanding shares of the Company for $35.00 per share (the "Offer Consideration"). The transaction represents a purchase price of approximately $7.2 billion, which includes the assumption of approximately $2.0 billion of net debt. The closing of the tender offer (the “Closing”) will constitute an Exit Event under the MEIP and the LTIP and, accordingly, (i) all management units under the MEIP that are unvested as of the Closing will vest in full, (ii) the MEIP RSUs will settle in accordance with their terms based on the Offer Consideration; and (iii) all outstanding awards under the LTIP will become payable. All remaining unvested equity awards under the Company's Omnibus Incentive Plan will convert into an equity award of Thermo Fisher with the same value and substantially similar other terms as the existing Company equity award.
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 6 Months Ended
Apr. 30, 2017
Accounting Policies [Abstract]  
Basis of presentation
Basis of presentation
Patheon consists of three reportable segments: Drug Product Services ("DPS"), Pharmaceutical Development Services ("PDS"), and Drug Substance Services ("DSS"). Drug Product Services provides manufacturing and packaging for approved prescription, over-the-counter, and nutritional products. Pharmaceutical Development Services provides a wide spectrum of advanced formulation, production, and technical services from the early stages of a product's development to regulatory approval and beyond, as well as for new formulations of approved products for life cycle extension. Drug Substance Services provides development and manufacturing for the biologically active component of a pharmaceutical product from early development through commercial production.
The accompanying unaudited consolidated financial statements have been prepared by the Company in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). Operating results for the three and six months ended April 30, 2017 are not necessarily indicative of the results that may be expected for the fiscal year ending October 31, 2017 ("fiscal 2017"). These consolidated financial statements do not include all the information and footnotes required by U.S. GAAP for annual financial statements and therefore should be read in conjunction with the audited consolidated financial statements and notes for the fiscal year ended October 31, 2016 ("fiscal 2016").
The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions have been eliminated.
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect: the reported amounts of assets and liabilities; the disclosure of contingent assets and liabilities at the date of the consolidated financial statements; and the reported amounts of revenue and expenses in the reporting period. Management believes that the estimates and assumptions used in preparing its consolidated financial statements are reasonable and prudent; however, actual results could differ from those estimates.
Segment information
Segment information
U.S. GAAP requires segmentation based on an entity’s internal organization and reporting of revenue and operating income (loss) based upon internal accounting methods commonly referred to as the “management approach.” Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (“CODM”), or decision making group, in deciding how to allocate resources and in assessing performance. The Company’s CODM is its Chief Executive Officer.
The Company’s four operating segments are: North America Drug Product Services, or North America DPS, Europe Drug Product Services, or Europe DPS, Pharmaceutical Development Services, or PDS and Drug Substance Services, or DSS. The North America DPS and Europe DPS operating segments meet the aggregation criteria to be presented as one reportable segment referred to as DPS. As a result, the Company has determined it has three reportable segments: DPS, PDS, and DSS. Corporate is not an individually reportable segment because the quantitative thresholds have not been met and as such has been reported in Other.
Recently adopted and issued accounting pronouncements
Recently adopted accounting pronouncements
Accounting Standards Update ("ASU")
Description
Date Adopted
Improvements to Employee Share-Based Payment Accounting (ASU 2016-09)
This update simplifies several aspects of the accounting for
share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities,
and classification on the statement of cash flows.

The Company early-adopted ASU 2016-09 during the second quarter of fiscal 2017, which had no effect on the Company's financial statements.
February 1, 2017
Simplifying the Accounting for Measurement-Period Adjustment (ASU 2015-16)
This update eliminated the requirement to an acquirer in a business combination to retrospectively adjust provisional amounts recognized at the acquisition date with a corresponding adjustment to goodwill. Instead, the update requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The impact will be dependent on future transactions.
November 1, 2016
Simplifying the Presentation of Debt Issuance Costs (ASU 2015-03)
The pronouncement requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of the debt liability, consistent
with that of debt discounts. The pronouncement is being applied retrospectively and the Company's October 31, 2016 balance sheet has been adjusted. The April 30, 2017 and October 31, 2016 balance sheets were adjusted to decrease the deferred financing cost asset and decrease the long term debt liability by $45.2 million and $50.3 million, respectively.
November 1, 2016
Recently issued accounting pronouncements
Accounting Standards Update ("ASU")
Description
Expected Impact
Effective Date
Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (ASU 2017-07)
This update requires that an employer disaggregate the service cost component from the other components of net periodic benefit cost. In addition, only the service cost component will be eligible for capitalization. The amendment is applied retrospectively with earlier application permitted.

We are assessing the impact to the individual line items to the Statements of Operations. The Company does not expect there to be a material impact to net income.
November 1, 2018
Simplifying the Test for Goodwill Impairment (ASU 2017-04)
This update simplified the subsequent measurement of goodwill by eliminating Step 2 of the goodwill impairment test. Instead, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The amendment also eliminated the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. The amendment is applied prospectively with earlier application permitted.
We do not expect to have a material impact on the Company’s financial statements.
November 1, 2020
Clarifying the Definition of a Business (ASU 2017-01)
This update narrows the definition of outputs and aligns it with how outputs are described in Topic 606. The amendment also provides a more robust framework to use in determining when a set of assets and activities is a business. The amendment is applied prospectively with earlier application permitted.
The impact on the consolidated financial statements from the adoption of this guidance is dependent on future business combinations.

November 1, 2018
Revenue from Contracts with Customers and related standards (ASU's 2014-09, 2016-08, 2016-10, 2016-12, 2016-20)
This update supersedes the existing revenue recognition guidance and provides a new framework for recognizing revenue. These updates identified practical expedients and clarified various aspects of the new revenue recognition standard outlined in Accounting Standards Update 2014-09. This standard may be adopted using either a retrospective or modified retrospective method. Early adoption is permitted.
We are currently in the process of evaluating the impact of this standard. It is still too early in our process to determine the magnitude of the potential impact. However, based on our preliminary assessment, we believe the timing of revenue recognition for commercial and development contracts may differ from our current revenue recognition policies. The Company is determining the magnitude of this potential change. We plan to adopt the standard on November 1, 2018, and we have not yet selected a transition method.
November 1, 2018
From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date or, in some cases where early adoption is permitted, in advance of the specified effective date. The Company has assessed the recently issued standards that are not yet effective and, unless otherwise discussed above or in our audited consolidated financial statements and notes for fiscal 2016, believes these standards will not have a material impact on the Company’s results of operations, cash flows, or financial position. A more detailed listing of recently issued accounting pronouncements are included in our audited consolidated financial statements and notes for fiscal 2016.
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
BUSINESS COMBINATIONS (Tables)
 6 Months Ended
Apr. 30, 2017
Business Combinations [Abstract]  
Schedule of Preliminary Purchase Price Allocation
The preliminary purchase price allocation for the RCI Acquisition is as follows:
 
$
Assets
 
Inventories
9.4

Prepaid expenses and other
0.1

Capital assets
155.6

Total assets acquired
165.1

 
 
Liabilities
 
Accounts payable and accrued liabilities
2.0

Deferred revenue
67.0

Deferred tax liabilities
59.4

Total liabilities assumed
128.4

 
 
Total net assets
36.7

Bargain purchase gain
(26.4
)
Total purchase price
10.3
Schedule of Financial Results
The revenues and net income from continuing operations from the RCI Acquisition for the period from February 1, 2017 to April 30, 2017 included in the consolidated statement of operations are as follows:
 
February 1, 2017 to April 30, 2017
 
$
Revenues
8.1

Net income from continuing operations (1)
25.9

(1) Net income from continuing operations includes the $26.4 million of the bargain purchase gain
Schedule of Unaudited Pro Forma Information
The following unaudited supplemental pro forma information presents the financial results as if the acquisition had occurred on November 1, 2015. The unaudited supplemental pro forma information does not purport to be indicative of what would have occurred had the acquisition been completed on November 1, 2015, nor is it indicative of any future results.
 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Revenues
483.4

 
484.0

 
999.1

 
904.9

Net income from continuing operations
1.2

 
(6.0
)
 
11.4

 
(258.8
)
(1) Net income from continuing operations for the six months ended April 30, 2016 includes $257.8 million of impairment expense related to Roche's strategic realignment of the facility. This is not part of the acquisition transaction and as such is not removed from the pro forma financial information.
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
DISCONTINUED OPERATIONS (Tables)
 6 Months Ended
Apr. 30, 2017
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Results of Discontinued Operations
The results of the above dispositions have been presented as discontinued operations, the results of which for the three and six months ended April 30, 2016 are as follows:
 
Three months ended April 30,
 
Six months ended April 30,
 
2016
 
2016
 
$
 
$
Revenues
—

 
2.1

Cost of goods sold
—

 
1.9

Gross profit
—

 
0.2

Selling, general and administrative expenses
—

 
0.4

Loss on disposals, net
0.9

 
2.8

Operating loss
(0.9
)
 
(3.0
)
Foreign exchange income, net
(0.1
)
 
(0.1
)
Loss before income taxes
(0.8
)
 
(2.9
)
Provision for income taxes
0.2

 
0.2

Net loss
(1.0
)
 
(3.1
)
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUPPLEMENTAL BALANCE SHEET INFORMATION (Tables)
 6 Months Ended
Apr. 30, 2017
Supplemental Balance Sheet Information [Abstract]  
Schedule of Inventories
Inventories consisted of the following:
 
April 30, 2017
 
October 31, 2016
 
$
 
$
Raw materials, packaging components and spare parts
228.7

 
192.1

Work-in-process
92.3

 
80.9

Finished goods
130.6

 
122.2

Balance, end of period
451.6

 
395.2
Schedule of Accounts Payable and Accrued Liabilities
Accounts payable and accrued liabilities consisted of the following:
 
April 30, 2017
 
October 31, 2016
 
$
 
$
Trade payables
277.1

 
279.3

Interest payable
9.8

 
14.0

Accrued salaries and related expenses
78.8

 
81.8

Customer deposits
4.1

 
4.3

Repositioning
4.9

 
5.4

Other accruals
7.5

 
8.8

Balance, end of period
382.2

 
393.6
Schedule of Finite-Lived Intangible Assets Acquired
The following table summarizes gross carrying amounts, accumulated amortization, and accumulated impairments related to the Company's identifiable intangible assets as of April 30, 2017:
Definite-lived intangible assets
Gross carrying value
 
Accumulated amortization
 
Net carrying value
 
Weighted Average Useful Life (in Years)
 
$
 
$
 
$
 
 
Favorable agreements
1.0

 
(1.0
)
 
—

 
—

Trade names
1.6

 
(0.9
)
 
0.7

 
5.6

Developed technology
54.1

 
(19.4
)
 
34.7

 
10.8

Trade secrets and patents
2.5

 
(0.4
)
 
2.1

 
14.5

Customer relationships
248.8

 
(49.5
)
 
199.3

 
14.2

Non-compete agreements
2.6

 
(2.2
)
 
0.4

 
3.0

Subtotal
310.6

 
(73.4
)
 
237.2

 
 
Foreign exchange
 
 
 
 
(3.3
)
 
 
Balance, end of period
 
 
 
 
233.9

 
 
Schedule of Indefinite-Lived Intangible Assets Acquired
Indefinite-lived intangible assets
Gross carrying value
 
Accumulated impairment
 
Net carrying value
 
$
 
$
 
$
In-process research and development
2.2

 
(0.9
)
 
1.3

Regulatory permits
0.2

 
—

 
0.2

Subtotal
2.4

 
(0.9
)
 
1.5

Foreign exchange
 
 
 
 
(0.2
)
Balance, end of period
 
 
 
 
1.3
Schedule of Goodwill
The following table summarizes the changes in the carrying amount of goodwill for the six months ended April 30, 2017:
 
Total
 
$
Balance at October 31, 2016 (1)
281.6

Foreign currency translation adjustments
(0.2
)
Balance at April 30, 2017
281.4


(1) The opening cumulative goodwill balance is reflective of historical impairment charges of the full value of goodwill.
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
LONG-TERM DEBT (Tables)
 6 Months Ended
Apr. 30, 2017
Debt Disclosure [Abstract]  
Schedule of Long-term Debt
Long-term debt in the accompanying consolidated balance sheets at April 30, 2017 and October 31, 2016 consists of the following:
 
As of April 30, 2017
 
As of October 31, 2016
 
$
 
$
USD Term Loan at LIBOR with a floor of 1% plus 3.25% rate and maturity date of April 20, 2024 (the "Credit Agreement")
1,133.1

 
—

Euro Term Loan at LIBOR with a floor of 1% plus 3.00% rate and maturity date of April 20, 2024 (the "Credit Agreement")
504.5

 
—

USD Term Loan with a base rate plus 2.25% or LIBOR with a floor of 1% plus 3.25% rate and maturity date of March 10, 2021 (the "Credit Agreement")
—

 
1,138.9

Euro Term Loan with a base rate plus 2.50% or LIBOR with a floor of 1% plus 3.50% rate and maturity date of March 10, 2021 (the "Credit Agreement")
—

 
511.0

7.50% Senior Notes due February 1, 2022 (the "Notes")
450.0

 
450.0

Secured Revolving Facility balance at LIBOR plus 3.25% rate and maturity terms on a rolling basis
50.0

 
20.0

Government of Austria research and development loans with annual interest rates ranging from 1.56% to 2.00% and maturities through March 2020
2.7

 
3.5

Italian subsidized loan with annual interest rate of 0.5%, and maturity date of June 30, 2020
3.6

 
4.1

Italian bank loan with Euribor 6-month + 7.1% rate, and maturity date of June 30, 2020
0.7

 
0.7

Capital lease obligations
1.6

 
0.7

Total long-term debt outstanding
2,146.2

 
2,128.9

Less original issue discount, net of accumulated amortization of $7.1 million and $6.2 million, respectively
(12.2
)
 
(9.9
)
Less deferred financing costs
(45.2
)
 
(50.3
)
Less current portion
(19.4
)
 
(19.5
)
Balance, end of the period
2,069.4

 
2,049.2
Schedule of Maximum Leverage Ratio
The following table discloses the maximum First Lien Leverage Ratios permitted under the Credit Agreement:
Testing Period Ending
Maximum Ratio
April 30, 2014 through October 31, 2014
6.75 to 1.00
November 1, 2014 through October 31, 2015
6.50 to 1.00
November 1, 2015 through October 31, 2016
6.25 to 1.00
November 1, 2016 through October 31, 2017
6.00 to 1.00
November 1, 2017 and thereafter
5.75 to 1.00
Schedule of Redemption Prices
On and after February 1, 2017, the Company may redeem all or a portion of the Notes at the applicable redemption prices set forth below (expressed as percentages of principal amount redeemed), plus unpaid interest accruing on the principal amount redeemed to the Redemption Date:
Year
%
2017
105.625
2018
103.750
2019
101.875
2020 and thereafter
100.000
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1
PENSION AND POST-RETIREMENT BENEFITS (Tables)
 6 Months Ended
Apr. 30, 2017
Postemployment Benefits [Abstract]  
Schedule of Net Periodic Benefit Cost
The components of net periodic benefit cost from continuing operations for the defined benefit plans and other benefit plans for the three and six months ended April 30, 2017 and 2016 were as follows:
 
Three months ended April 30,
 
2017
 
2016
 
Defined benefit
pension plans
 
Other benefit
plans
 
Defined benefit
pension plans
 
Other benefit
plans
 
$
 
$
 
$
 
$
Service cost
0.6

 
—

 
0.4

 
—

Interest cost
1.0

 
—

 
1.3

 
—

Expected return on plan assets
(1.0
)
 
—

 
(1.2
)
 
—

Amortization of actuarial loss
0.7

 
—

 
0.4

 
—

Net periodic benefit costs
1.3

 
—

 
0.9

 
—

 
Six months ended April 30,
 
2017
 
2016
 
Defined benefit
pension plans
 
Other benefit
plans
 
Defined benefit
pension plans
 
Other benefit
plans
 
$
 
$
 
$
 
$
Service cost
1.2

 
—

 
0.9

 
—

Interest cost
2.0

 
0.1

 
2.6

 
0.1

Expected return on plan assets
(2.0
)
 
—

 
(2.5
)
 
—

Amortization of actuarial loss
1.4

 
—

 
0.8

 
—

Net periodic benefit costs
2.6

 
0.1

 
1.8

 
0.1
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
EARNINGS (LOSS) PER SHARE (Tables)
 6 Months Ended
Apr. 30, 2017
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The details of the computation of basic and diluted earnings (loss) per ordinary share are as follows:
 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
Numerator (in millions):
 
 
 
 
 
 
 
Income (loss) from continuing operations
$
27.6

 
$
1.9

 
$
55.9

 
$
(18.1
)
Loss from discontinued operations
$
—

 
$
(1.0
)
 
$
—

 
$
(3.1
)
 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted-average number of shares of ordinary shares - basic
145,136,214

 
115,609,756

 
145,132,349

 
115,609,756

Effect of dilutive securities:
 
 
 
 
 
 
 
Restricted stock units
1,092,951

 
—

 
1,116,435

 
—

Stock options
37,963

 
—

 
27,567

 
—

Weighted-average number of shares of ordinary shares - diluted
146,267,128

 
115,609,756

 
146,276,351

 
115,609,756

 
 
 
 
 
 
 
 
Earnings (loss) per ordinary share - basic:
 
 
 
 
 
 
 
From continuing operations
$
0.19

 
$
0.02

 
$
0.39

 
$
(0.16
)
From discontinued operations
$
—

 
$
(0.01
)
 
$
—

 
$
(0.03
)
 
 
 
 
 
 
 
 
Earnings (loss) per ordinary share - diluted:
 
 
 
 
 
 
 
From continuing operations
$
0.19

 
$
0.02

 
$
0.38

 
$
(0.16
)
From discontinued operations
$
—

 
$
(0.01
)
 
$
—

 
$
(0.03
)
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK BASED COMPENSATION (Tables)
 6 Months Ended
Apr. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Stock Based Compensation
A summary of equity based compensation expense recognized during the three and six months ended April 30, 2017 and 2016 is as follows:
 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Management Equity Incentive Plan (MEIP)
1.9

 
2.0

 
4.2

 
3.0

Restricted Stock Units
4.0

 
—

 
5.3

 
—

Stock Options
1.1

 
—

 
1.5

 
—

Stock Based Compensation Expense
7.0

 
2.0

 
11.0

 
3.0

A summary of Standard RSUs activity for the six months ended April 30, 2017 is as follows:
 
Restricted Share Units
Weighted Average Grant Date Fair Value
 
 
$
Outstanding as of October 31, 2016
450,184

21.00

Granted
1,028,534

26.46

Vested
(70,700
)
21.00

Outstanding as of April 30, 2017
1,408,018

24.79

A summary of stock option activity for the six months ended April 30, 2017 is as follows:
 
Stock Options
Weighted Average Fair Value
 
 
$
Outstanding as of October 31, 2016
1,021,584

8.29

Granted
726,166

10.18

Outstanding as of April 30, 2017
1,747,750

9.08
Schedule of Plan Activity
A summary of the MEIP activity for the six months ended April 30, 2017 is as follows:
 
Class B
Class C
Class D
Class E
Total
 
Weighted Average Fair Value
Outstanding as of October 31, 2016
59,290

8,470

8,470

8,470

84,700

 
$
687.27

Forfeited
(288
)
(50
)
(50
)
(50
)
(438
)
 
$
870.09

Outstanding as of April 30, 2017
59,002

8,420

8,420

8,420

84,262

 
$
686.32
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The estimated weighted average fair value of stock options is $9.08 per option and was estimated using a Black-Scholes valuation model, using the following weighted average assumptions:
Risk free interest rate
1.6
%
Expected volatility
38.1
%
Expected life of options (in years)
6.0

Dividend yield
—
%
The Monte Carlo simulation model incorporated the following weighted average assumptions:
Risk free interest rate
0.9
%
Expected volatility
41.6
%
Estimated years to exit event
2.98
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1
FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT(Tables)
 6 Months Ended
Apr. 30, 2017
Fair Value Disclosures [Abstract]  
Summary of Financial Assets and Liabilities Measured at Fair Value
The following table provides a summary of the financial assets and liabilities that are measured at fair value as of April 30, 2017 and October 31, 2016:
 
Fair value measurement at April 30, 2017
 
Fair value measurement at October 31, 2016
Assets measured at fair value
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
 
$
 
$
Available-for-sale securities
1.4

 
—

 
—

 
1.4

 
1.4

 
—

 
—

 
1.4

Held-for-trading securities
—

 
1.5

 
—

 
1.5

 
—

 
1.4

 
—

 
1.4

Total assets
1.4

 
1.5

 
—

 
2.9

 
1.4

 
1.4

 
—

 
2.8

 
Fair value measurement at April 30, 2017
 
Fair value measurement at October 31, 2016
Liabilities measured at fair value
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
 
$
 
$
Foreign exchange forward contracts
—

 
1.8

 
—

 
1.8

 
—

 
2.7

 
—

 
2.7

Earnout liability
—

 
—

 
37.9

 
37.9

 
—

 
—

 
33.8

 
33.8

Total liabilities
—

 
1.8

 
37.9

 
39.7

 
—

 
2.7

 
33.8

 
36.5


Level 1 - Based on quoted market prices in active markets.
Level 2 - Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.
Level 3 - Unobservable inputs that are not corroborated by market data.
Schedule of Derivative Financial Instruments and Investments Classification on Consolidated Balance Sheet
The following table presents the fair value of the Company's financial instruments and their classifications on the consolidated balance sheets as of April 30, 2017 and October 31, 2016:
 
Assets as of April 30, 2017
 
Assets as of October 31, 2016
 
Balance sheet location
Fair value
 
Balance sheet location
Fair value
 
 
$
 
 
$
Available-for-sale securities
Investments
1.4

 
Investments
1.4

Held-for-trade securities
Investments
1.5

 
Investments
1.4

Total
 
2.9

 
 
2.8

 
Liabilities as of April 30, 2017
 
Liabilities as of October 31, 2016
 
Balance sheet location
Fair value
 
Balance sheet location
Fair value
 
 
$
 
 
$
Foreign exchange forward contracts
Accounts payable and accrued liabilities
1.8

 
Accounts payable and accrued liabilities
2.7

Earnout liability
Other long-term liabilities
37.9

 
Other long-term liabilities
33.8

Total
 
39.7

 
 
36.5
Schedule of Fair Values and Carrying Values of Long-term Debt
As of April 30, 2017, the fair values and carrying values of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:
 
Fair Value
 
 
 
Level 1
Level 2
Level 3
Total
 
Carrying Value
 
$
$
$
$
 
$
Long-term debt, including current portion
—

2,179.3

—

2,179.3

 
2,134.0

As of October 31, 2016, the fair values and carrying values of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:
 
Fair Value
 
 
 
Level 1
Level 2
Level 3
Total
 
Carrying Value
 
$
$
$
$
 
$
Long-term debt, including current portion
—

2,156.8

—

2,156.8

 
2,119.0
Schedule of Earnout Liability Activity
The earnout liability activity is summarized as follows for the six months ended April 30, 2017:
 
Total
 
$
Balance at October 31, 2016
33.8

Change in fair value
4.1

Balance at April 30, 2017
37.9
Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)
The following table summarizes the foreign currency activity on the intercompany loans that are included as part of the net investment in certain foreign subsidiaries for the three and six months ended April 30, 2017 and 2016 since net investment hedge inception:
 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Foreign exchange gain for the period from long-term intercompany loan revaluation
—

 
3.8

 
—

 
3.0

The following table summarizes the net investment hedge foreign exchange activity for the three and six months ended April 30, 2017 and 2016 since net investment hedge inception:
 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Foreign exchange (loss) gain for the period from net investment hedge
(4.6
)
 
(29.0
)
 
4.0

 
(21.0
)
Release of ineffective portion of net investment hedge to consolidated statement of operations
—

 
3.3

 
—

 
2.2

Net (loss) gain to other comprehensive income for the period related to net investment hedge
(4.6
)
 
(25.7
)
 
4.0

 
(18.8
)
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1
SEGMENT INFORMATION (Tables)
 6 Months Ended
Apr. 30, 2017
Segment Reporting [Abstract]  
Schedule of Segment Results
 
Three months ended April 30, 2017
 
DPS
 
PDS
 
DSS
 
Other
 
Intersegment Eliminations
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
Revenues
297.2

 
57.8

 
129.2

 
—

 
(0.8
)
 
483.4

Adjusted EBITDA
77.4

 
18.4

 
26.1

 
(27.5
)
 
(0.2
)
 
94.2

Depreciation and amortization
15.4

 
1.9

 
16.1

 
0.9

 
 
 
34.3

Capital expenditures
19.5

 
1.7

 
11.6

 
7.4

 
 
 
40.2


 
Three months ended April 30, 2016
 
DPS
 
PDS
 
DSS
 
Other
 
Intersegment Eliminations
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
Revenues
287.4

 
53.4

 
127.9

 
—

 
(0.1
)
 
468.6

Adjusted EBITDA
72.7

 
16.7

 
30.8

 
(22.2
)
 
 
 
98.0

Depreciation and amortization
14.9

 
1.3

 
10.2

 
0.6

 
 
 
27.0

Capital expenditures
11.7

 
5.9

 
9.0

 
4.3

 
 
 
30.9


 
Six months ended April 30, 2017
 
DPS
 
PDS
 
DSS
 
Other
 
Intersegment Eliminations
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
Revenues
572.4

 
110.1

 
259.1

 
—

 
(0.8
)
 
940.8

Adjusted EBITDA
138.8

 
34.7

 
58.1

 
(54.7
)
 
(0.2
)
 
176.7

Depreciation and amortization
30.7

 
3.7

 
25.8

 
1.7

 
 
 
61.9

Capital expenditures
56.4

 
3.1

 
29.5

 
10.2

 
 
 
99.2


 
Six months ended April 30, 2016
 
DPS
 
PDS
 
DSS
 
Other
 
Intersegment Eliminations
 
Total
 
$
 
$
 
$
 
$
 
$
 
$
Revenues
545.9

 
101.9

 
226.8

 
—

 
(0.1
)
 
874.5

Adjusted EBITDA
127.8

 
30.5

 
45.6

 
(46.9
)
 
 
 
157.0

Depreciation and amortization
29.7

 
2.5

 
20.1

 
1.2

 
 
 
53.5

Capital expenditures
56.7

 
15.6

 
16.3

 
6.5

 
 
 
95.1
Reconciliation of Adjusted EBITDA
Below is a reconciliation of Adjusted EBITDA to its most comparable U.S. GAAP measure.
 
Three months ended April 30,
 
Six months ended April 30,
 
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Total Adjusted EBITDA
94.2

 
98.0

 
176.7

 
157.0

Depreciation and amortization
(34.3
)
 
(27.0
)
 
(61.9
)
 
(53.5
)
Repositioning expenses (1)
(2.2
)
 
(1.3
)
 
(3.5
)
 
(2.5
)
Acquisition and integration costs
(8.1
)
 
(7.6
)
 
(11.6
)
 
(10.2
)
Interest expense, net
(30.8
)
 
(42.6
)
 
(59.0
)
 
(86.4
)
Benefit from (provision for) income taxes
1.5

 
(0.7
)
 
22.8

 
—

Refinancing expenses
(6.3
)
 
—

 
(6.3
)
 
—

Operational initiatives related consulting costs
(1.4
)
 
(1.9
)
 
(2.5
)
 
(3.3
)
IPO costs
—

 
(0.4
)
 
—

 
(0.8
)
Acquisition related litigation expenses
(3.7
)
 
(0.9
)
 
(6.0
)
 
(1.9
)
Stock based compensation expense
(7.0
)
 
(2.0
)
 
(11.0
)
 
(3.0
)
FDA remediation costs
—

 
(10.1
)
 
—

 
(18.5
)
Environmental remediation costs
—

 
—

 
(3.7
)
 
—

Bargain purchase gain
26.4

 
—

 
26.4

 
—

Other
(0.7
)
 
(1.6
)
 
(4.5
)
 
5.0

Net income (loss) from continuing operations
27.6

 
1.9

 
55.9

 
(18.1
)

(1) Repositioning expenses for the three and six months ended April 30, 2017 includes $0.4 million and $1.1 million of inventory reserves related to the Swindon wind down recorded in cost of goods sold.
Schedule of Revenue, Capital Assets and Goodwill, by Country
As illustrated in the table below, revenues are attributed to countries based on the location of the customer's billing address, capital assets are attributed to the country in which they are located and goodwill is attributed to the country in which the entity to which the goodwill pertains is located:
 
Three months ended April 30, 2017
 
Canada
 
US*
 
Europe
 
Other**
 
Total
 
$
 
$
 
$
 
$
 
$
Revenues
4.2

 
282.8

 
167.9

 
28.5

 
483.4

* Includes Puerto Rico
** Primarily includes Japan
 
Three months ended April 30, 2016
 
Canada
 
US*
 
Europe
 
Other**
 
Total
 
$
 
$
 
$
 
$
 
$
Revenues
5.1

 
317.6

 
124.8

 
21.1

 
468.6

* Includes Puerto Rico
** Primarily includes Japan
 
As of and for the six months ended April 30, 2017
 
Canada
 
US*
 
Europe
 
Other**
 
Total
 
$
 
$
 
$
 
$
 
$
Revenues
11.2

 
564.7

 
320.7

 
44.2

 
940.8

Capital Assets
100.1

 
687.6

 
367.5

 
14.1

 
1,169.3

Goodwill
2.5

 
269.4

 
7.4

 
2.1

 
281.4


* Includes Puerto Rico
** Other revenues primarily include Japan
 
As of and for the six months ended April 30, 2016
 
Canada
 
US*
 
Europe
 
Other**
 
Total
 
$
 
$
 
$
 
$
 
$
Revenues
12.4

 
589.4

 
236.7

 
36.0

 
874.5

Capital Assets
100.8

 
487.3

 
341.6

 
16.1

 
945.8

Goodwill
2.8

 
269.4

 
7.7

 
2.2

 
282.1


* Includes Puerto Rico
** Other revenues primarily include Japan
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
REPOSITIONING EXPENSES (Tables)
 6 Months Ended
Apr. 30, 2017
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Related Costs
The following is a summary of these expenses and other charges associated with operational improvements as of and for the three and six months ended April 30, 2017 and 2016:
 
As of and for the three months ended April 30, 2017
 
DPS
 
PDS
 
DSS
 
Other
 
Total
 
$
 
$
 
$
 
$
 
$
Total repositioning liability at January 31, 2017
 
 
 
 
 
 
 
 
4.6

Employee-related expenses
1.7

 
—

 
—

 
0.1

 
1.8

Repositioning expenses paid
 
 
 
 
 
 
 
 
(1.6
)
Foreign exchange
 
 
 
 
 
 
 
 
0.1

Total repositioning liability at April 30, 2017
 
 
 
 
 
 
 
 
4.9

 
As of and for the three months ended April 30, 2016
 
DPS
 
PDS
 
DSS
 
Other
 
Total
 
$
 
$
 
$
 
$
 
$
Total repositioning liability at January 31, 2016
 
 
 
 
 
 
 
 
4.9

Employee-related expenses
1.6

 
—

 
—

 
—

 
1.6

Consulting, professional and project management costs
(0.3
)
 
—

 
—

 
—

 
(0.3
)
Total expenses
1.3

 
—

 
—

 
—

 
1.3

Repositioning expenses paid
 
 
 
 
 
 
 
 
(3.1
)
Foreign exchange
 
 
 
 
 
 
 
 
0.3

Total repositioning liability at April 30, 2016
 
 
 
 
 
 
 
 
3.4

 
As of and for the six months ended April 30, 2017
 
DPS
 
PDS
 
DSS
 
Other
 
Total
 
$
 
$
 
$
 
$
 
$
Total repositioning liability at October 31, 2016
 
 
 
 
 
 
 
 
5.4

Employee-related expenses
1.9

 
—

 
—

 
0.5

 
2.4

Repositioning expenses paid
 
 
 
 
 
 
 
 
(3.1
)
Foreign exchange
 
 
 
 
 
 
 
 
0.2

Total repositioning liability at April 30, 2017
 
 
 
 
 
 
 
 
4.9

The balance of repositioning liabilities as of April 30, 2017 was recorded in accounts payable and accrued liabilities on the consolidated balance sheet. The Company does not have any long-term repositioning liabilities as of April 30, 2017.
 
As of and for the six months ended April 30, 2016
 
DPS
 
PDS
 
DSS
 
Other
 
Total
 
$
 
$
 
$
 
$
 
$
Total repositioning liability at October 31, 2015
 
 
 
 
 
 
 
 
22.9

Employee-related expenses
2.8

 
—

 
—

 
—

 
2.8

Consulting, professional and project management costs
(0.3
)
 
—

 
—

 
—

 
(0.3
)
Total expenses
2.5

 
—

 
—

 
—

 
2.5

Repositioning expenses paid
 
 
 
 
 
 
 
 
(21.8
)
Foreign exchange
 
 
 
 
 
 
 
 
(0.2
)
Total repositioning liability at April 30, 2016
 
 
 
 
 
 
 
 
3.4
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.7.0.1
RELATED PARTIES (Tables)
 6 Months Ended
Apr. 30, 2017
Related Party Transactions [Abstract]  
Schedule of Related Party Transactions
 
Values as of
Equity Method Investment Values
April 30, 2017
 
October 31, 2016
 
$
 
$
Banner Life Sciences
2.5

 
2.9

Percivia
5.7

 
5.7

Chemiepark
0.1

 
0.1

Total
8.3

 
8.7

The expenses relating to these services are charged to BLS and the related accounts receivable outstanding in relation to these services are shown in the tables below. We performed production services for BLS in the first quarter of fiscal 2016 before BLS sold their commercial business to a third party.

 
Three months ended April 30,
 
Six months ended April 30,
Revenues/Expenses
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
JLL Partners Expenses
0.1

 
0.1

 
0.1

 
0.2

 
 
 
 
 
 
 
 
DSM Revenues
0.1

 
0.8

 
0.3

 
0.9

DSM Expenses
1.9

 
2.5

 
5.1

 
5.2

 
 
 
 
 
 
 
 
Banner Life Sciences Revenues
0.7

 
1.4

 
0.7

 
7.9

 
Balances as of
Accounts Receivable/Payable Balances
April 30, 2017
 
October 31, 2016
 
$
 
$
JLL Partners Accounts Payable
0.1

 
—

 
 
 
 
DSM Accounts Receivable
0.1

 
0.4

DSM Accounts Payable
1.7

 
0.2

 
 
 
 
Banner Life Sciences Accounts Receivable
1.2

 
1.1

 
Three months ended April 30,
 
Six months ended April 30,
Equity Method (Loss)/Gain
2017
 
2016
 
2017
 
2016
 
$
 
$
 
$
 
$
Banner Life Sciences
(0.2
)
 
(0.5
)
 
(0.3
)
 
1.3

Percivia
—

 
0.1

 
—

 
0.2

Total
(0.2
)
 
(0.4
)
 
(0.3
)
 
1.5
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1
OTHER INFORMATION (Tables)
 6 Months Ended
Apr. 30, 2017
Other Information [Abstract]  
Statements of Cash Flows Non-cash Investing and Financing Activities
Statements of cash flows non-cash investing and financing activities
 
Six months ended April 30,
 
2017
 
2016
Non-cash financing activities:
$
 
$
Assumption of earnout liability from the Partnership (1)
—

 
36.0

Treasury stock purchases to satisfy certain tax withholdings (2)
0.1

 
—

Increase in capital lease obligations
1.0

 
—

(1) Refer to Note 9 for further information
(2) Represents the tax payable held as of April 30, 2017 relating to a second quarter treasury stock purchase.
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.7.0.1
THE COMPANY - Narrative (Details)
$ / shares in Units, $ in Millions
Jul. 26, 2016
USD ($)
Jul. 21, 2016
USD ($)
shares
Apr. 30, 2017
vote
€ / shares
shares
Oct. 31, 2016
€ / shares
Jul. 21, 2016
€ / shares
shares
Jul. 21, 2016
$ / shares
shares
Dec. 24, 2013
Other Ownership Interests [Line Items]              
Proceeds from partner contribution | $   $ 1.2          
Common stock, shares outstanding (in shares)     145,136,214   115,609,756 115,609,756  
Common stock, par value (in euros per share) | € / shares     € 0.01 € 0.01 € 0.01    
Proceeds from IPO | $ $ 584.8            
Number of voting rights | vote     1        
JLL Patheon Co-Investment Fund L.P.              
Other Ownership Interests [Line Items]              
Ownership percentage by parent 38.00%           51.00%
Koninklijke DSM              
Other Ownership Interests [Line Items]              
Ownership percentage by parent 34.00%           49.00%
JLL/Delta Patheon Holdings              
Other Ownership Interests [Line Items]              
Ownership percentage by parent 4.00%            
IPO              
Other Ownership Interests [Line Items]              
Issuance of ordinary shares (in shares)   29,464,286          
IPO price per shares (in USD per share) | $ / shares           $ 21.00  
Rights to purchase addition ordinary shares (in shares)   4,464,286          
Total number of ordinary shares sold in connection with IPO (in shares)   34,226,191          
Percentage of voting stock publicly owned 24.00%            
IPO | Koninklijke DSM              
Other Ownership Interests [Line Items]              
Issuance of ordinary shares (in shares)   4,761,905          
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.7.0.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)
$ in Millions
 6 Months Ended
Apr. 30, 2017
USD ($)
segment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Number of reportable segments 3
Number of operating segments 4
DPS reportable segment 1
Deferred finance costs | $ $ 45.2
Accounting Standards Update 2015-03 | Long-term Debt  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Deferred finance costs | $ $ (50.3)
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.7.0.1
BUSINESS COMBINATIONS - Narrative (Details) - Roche Carolina Inc.
$ in Millions
Feb. 01, 2017
USD ($)
Business Acquisition [Line Items]  
Upfront payment to acquire stock of RCI $ 1.0
Consideration transferred $ 9.3
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.7.0.1
DISCONTINUED OPERATIONS - Narrative (Details) - Disposed of by sale
€ in Millions, $ in Millions
 3 Months Ended
Jul. 31, 2015
USD ($)
May 12, 2015
USD ($)
Apr. 30, 2016
EUR (€)
Apr. 30, 2016
USD ($)
Aug. 31, 2015
EUR (€)
Jul. 31, 2015
EUR (€)
Banner Pharmacaps            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Cash purchase price   $ 36.4        
Gain on disposals   $ 2.6        
Biosolutions            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Cash purchase price | €           € 0.3
Gain on disposals $ (24.0)          
DPx Fine Chemicals            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Cash purchase price | €         € 179.0  
Gain on disposals       $ 107.0    
Proceeds from working capital | €     € 3.0      
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.7.0.1
BUSINESS COMBINATIONS - Schedule of Preliminary Purchase Price Allocations (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Feb. 01, 2017
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Mar. 31, 2015
Liabilities            
Gain on bargain purchase   $ (26.4) $ 0.0 $ (26.4) $ 0.0  
Roche Carolina Inc.            
Assets            
Inventories $ 9.4          
Prepaid expenses and other 0.1          
Capital assets 155.6          
Total assets acquired 165.1          
Liabilities            
Accounts payable and accrued liabilities 2.0          
Deferred revenue 67.0          
Deferred tax liabilities 59.4          
Total liabilities assumed 128.4          
Total net assets 36.7          
Gain on bargain purchase $ (26.4)          
Total purchase price           $ 10.3
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.7.0.1
DISCONTINUED OPERATIONS - Schedule of Dispositions (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Net loss $ 0.0 $ (1.0) $ 0.0 $ (3.1)
DPx Fine Chemicals | Disposed of by sale        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Revenues   0.0   2.1
Cost of goods sold   0.0   1.9
Gross profit   0.0   0.2
Selling, general and administrative expenses   0.0   0.4
Loss on disposals, net   0.9   2.8
Operating loss   (0.9)   (3.0)
Foreign exchange income, net   (0.1)   (0.1)
Loss before income taxes   (0.8)   (2.9)
Provision for income taxes   0.2   0.2
Net loss   $ (1.0)   $ (3.1)
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.7.0.1
BUSINESS COMBINATIONS - Schedule of Financial Results (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Feb. 01, 2017
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Business Acquisition [Line Items]          
Bargain purchase gain   $ (26.4) $ 0.0 $ (26.4) $ 0.0
Roche Carolina Inc.          
Business Acquisition [Line Items]          
Revenues   8.1      
Net income from continuing operations   $ 25.9      
Bargain purchase gain $ (26.4)        
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.7.0.1
BUSINESS COMBINATIONS - Schedule of Unaudited Pro Forma Information (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
DPP Acquisition        
Business Acquisition [Line Items]        
Revenues $ 483.4 $ 484.0 $ 999.1 $ 904.9
Net income from continuing operations 1.2 $ (6.0) $ 11.4 (258.8)
Roche Carolina Inc.        
Business Acquisition [Line Items]        
Revenues 8.1      
Net income from continuing operations $ 25.9      
Impairment expense related to Roche's strategic realignment       $ 257.8
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUPPLEMENTAL BALANCE SHEET INFORMATION - Inventories (Details) - USD ($)
$ in Millions
Apr. 30, 2017
Oct. 31, 2016
Supplemental Balance Sheet Information [Abstract]    
Raw materials, packaging components and spare parts $ 228.7 $ 192.1
Work-in-process 92.3 80.9
Finished goods 130.6 122.2
Balance, end of period $ 451.6 $ 395.2
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUPPLEMENTAL BALANCE SHEET INFORMATION - Accounts Payable and Accrued Liabilities (Details) - USD ($)
$ in Millions
Apr. 30, 2017
Oct. 31, 2016
Supplemental Balance Sheet Information [Abstract]    
Trade payables $ 277.1 $ 279.3
Interest payable 9.8 14.0
Accrued salaries and related expenses 78.8 81.8
Customer deposits 4.1 4.3
Repositioning 4.9 5.4
Other accruals 7.5 8.8
Balance, end of period $ 382.2 $ 393.6
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUPPLEMENTAL BALANCE SHEET INFORMATION - Finite-Lived Intangible Assets Acquired (Details)
$ in Millions
 6 Months Ended
Apr. 30, 2017
USD ($)
Finite-Lived Intangible Assets [Line Items]  
Gross carrying value $ 310.6
Accumulated amortization (73.4)
Net carrying value 237.2
Foreign exchange (3.3)
Balance, end of period 233.9
Favorable agreements  
Finite-Lived Intangible Assets [Line Items]  
Gross carrying value 1.0
Accumulated amortization (1.0)
Net carrying value $ 0.0
Weighted Average Useful Life (in Years) 0 years
Trade names  
Finite-Lived Intangible Assets [Line Items]  
Gross carrying value $ 1.6
Accumulated amortization (0.9)
Net carrying value $ 0.7
Weighted Average Useful Life (in Years) 5 years 7 months 6 days
Developed technology  
Finite-Lived Intangible Assets [Line Items]  
Gross carrying value $ 54.1
Accumulated amortization (19.4)
Net carrying value $ 34.7
Weighted Average Useful Life (in Years) 10 years 9 months 18 days
Trade secrets and patents  
Finite-Lived Intangible Assets [Line Items]  
Gross carrying value $ 2.5
Accumulated amortization (0.4)
Net carrying value $ 2.1
Weighted Average Useful Life (in Years) 14 years 6 months
Customer relationships  
Finite-Lived Intangible Assets [Line Items]  
Gross carrying value $ 248.8
Accumulated amortization (49.5)
Net carrying value $ 199.3
Weighted Average Useful Life (in Years) 14 years 2 months 12 days
Non-compete agreements  
Finite-Lived Intangible Assets [Line Items]  
Gross carrying value $ 2.6
Accumulated amortization (2.2)
Net carrying value $ 0.4
Weighted Average Useful Life (in Years) 3 years
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUPPLEMENTAL BALANCE SHEET INFORMATION - Indefinite-Lived Intangible Assets (Details)
$ in Millions
 6 Months Ended
Apr. 30, 2017
USD ($)
Indefinite-lived Intangible Assets [Line Items]  
Gross carrying value $ 2.4
Accumulated impairment (0.9)
Net carrying value 1.5
Foreign exchange (0.2)
Balance, end of period 1.3
In-process research and development  
Indefinite-lived Intangible Assets [Line Items]  
Gross carrying value 2.2
Accumulated impairment (0.9)
Net carrying value 1.3
Regulatory permits  
Indefinite-lived Intangible Assets [Line Items]  
Gross carrying value 0.2
Accumulated impairment 0.0
Net carrying value $ 0.2
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUPPLEMENTAL BALANCE SHEET INFORMATION - Narrative (Details) - USD ($)
$ in Millions
 6 Months Ended
Apr. 30, 2016
Apr. 30, 2017
Jan. 31, 2016
Finite-Lived Intangible Assets [Line Items]      
Net carrying value   $ 1.5  
Gross carrying value   2.4  
In-process research and development      
Finite-Lived Intangible Assets [Line Items]      
Net carrying value   1.3  
Gross carrying value   $ 2.2  
In-process research and development | BLS | Spinoff      
Finite-Lived Intangible Assets [Line Items]      
Net carrying value     $ 3.6
Gross carrying value     $ 7.9
Impairment losses $ 4.3    
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUPPLEMENTAL BALANCE SHEET INFORMATION - Goodwill (Details)
$ in Millions
 6 Months Ended
Apr. 30, 2017
USD ($)
Goodwill [Roll Forward]  
Goodwill, beginning of period $ 281.6
Foreign currency translation adjustments (0.2)
Goodwill, end of period $ 281.4
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.7.0.1
LONG-TERM DEBT - Schedule of Long-term Debt in Accompanying balance Sheet (Details) - USD ($)
$ in Millions
 3 Months Ended
Apr. 20, 2017
Apr. 30, 2017
Jul. 31, 2013
Oct. 31, 2016
Oct. 31, 2015
Feb. 28, 2014
Debt Instrument [Line Items]            
Total long-term debt outstanding   $ 2,146.2   $ 2,128.9    
Less original issue discount, net of accumulated amortization of $7.1 million and $6.2 million, respectively   (12.2)   (9.9)    
Less deferred financing costs   (45.2)   (50.3)    
Less current portion   (19.4)   (19.5)    
Balance, end of the period   2,069.4   2,049.2    
Accumulated amortization   7.1     $ 6.2  
Domestic credit agreement | USD Term Loan Due April 20, 2024            
Debt Instrument [Line Items]            
Total long-term debt outstanding   $ 1,133.1   0.0    
Domestic credit agreement | USD Term Loan Due April 20, 2024 | LIBOR            
Debt Instrument [Line Items]            
Basis spread (as percent)   3.25%        
Variable interest rate floor (as percent)   1.00%        
Domestic credit agreement | USD term loan due March 2021            
Debt Instrument [Line Items]            
Total long-term debt outstanding   $ 0.0   1,138.9    
Domestic credit agreement | USD term loan due March 2021 | Base rate            
Debt Instrument [Line Items]            
Basis spread (as percent)   2.25%        
Domestic credit agreement | USD term loan due March 2021 | LIBOR            
Debt Instrument [Line Items]            
Basis spread (as percent)   3.25%        
Variable interest rate floor (as percent)   1.00%        
Foreign credit agreement | Euro Term Loan Due April 20, 2024            
Debt Instrument [Line Items]            
Total long-term debt outstanding   $ 504.5   0.0    
Foreign credit agreement | Euro Term Loan Due April 20, 2024 | LIBOR            
Debt Instrument [Line Items]            
Basis spread (as percent)   3.00%        
Variable interest rate floor (as percent)   1.00%        
Foreign credit agreement | Euro term loan due March 2021            
Debt Instrument [Line Items]            
Total long-term debt outstanding   $ 0.0   511.0    
Foreign credit agreement | Euro term loan due March 2021 | Base rate            
Debt Instrument [Line Items]            
Basis spread (as percent)   2.50%        
Foreign credit agreement | Euro term loan due March 2021 | LIBOR            
Debt Instrument [Line Items]            
Basis spread (as percent)   3.50%        
Variable interest rate floor (as percent)   1.00%        
Senior notes | 7.50% senior notes due February 2022            
Debt Instrument [Line Items]            
Total long-term debt outstanding   $ 450.0   450.0    
Stated rate (as percent)   7.50%       7.50%
Loan | Government of Austria research and development loans due March 2020            
Debt Instrument [Line Items]            
Total long-term debt outstanding   $ 2.7   3.5    
Loan | Italian subsidized loan due June 2020            
Debt Instrument [Line Items]            
Total long-term debt outstanding   $ 3.6   4.1    
Stated rate (as percent)   0.50% 0.50%      
Loan | Italian bank loan due June 2020            
Debt Instrument [Line Items]            
Total long-term debt outstanding   $ 0.7   0.7    
Loan | Italian bank loan due June 2020 | Euribor rate            
Debt Instrument [Line Items]            
Basis spread (as percent)   7.10% 7.10%      
Capital lease obligations            
Debt Instrument [Line Items]            
Total long-term debt outstanding   $ 1.6   0.7    
Minimum | Government of Austria research and development loans due March 2020            
Debt Instrument [Line Items]            
Stated rate (as percent)   1.56%        
Maximum | Government of Austria research and development loans due March 2020            
Debt Instrument [Line Items]            
Stated rate (as percent)   2.00%        
Secured revolving credit facility | Seller financing, non-Interest Bearing Loan Due May 2016            
Debt Instrument [Line Items]            
Total long-term debt outstanding   $ 50.0   $ 20.0    
Basis spread (as percent)   3.25%        
Secured revolving credit facility | Domestic credit agreement | USD Term Loan Due April 20, 2024 | Base rate            
Debt Instrument [Line Items]            
Basis spread (as percent) 2.25%          
Secured revolving credit facility | Domestic credit agreement | USD Term Loan Due April 20, 2024 | LIBOR            
Debt Instrument [Line Items]            
Basis spread (as percent) 3.25%          
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.7.0.1
LONG-TERM DEBT - 2017 Term Loans and Revolving Line (Details)
 3 Months Ended
Apr. 20, 2017
USD ($)
Apr. 30, 2017
USD ($)
Apr. 20, 2017
EUR (€)
Apr. 20, 2017
USD ($)
Line of credit        
Debt Instrument [Line Items]        
Maximum percentage of consolidated total assets (as percent) 3.00%      
Additional threshold amount for dividend distribution $ 65,000,000.0      
Line of credit | Secured term loan        
Debt Instrument [Line Items]        
Prepayment amount from net cash proceeds of certain asset sales including insurance and condemnation proceeds, percentage 100.00%      
Prepayment amount from net cash proceeds of issuance of debt obligations, percentage 100.00%      
Prepayment amount from excess cash flows, value   $ 0    
Line of credit | Secured term loan | First Lien Leverage Ratio Greater than 4.00 to 1.00        
Debt Instrument [Line Items]        
Leverage ratio (as percent)     4.00 4.00
Prepayment amount of excess cash flows, percentage 50.00%      
Line of credit | Secured term loan | First Lien Leverage Ratio Less Than or Equal to 4.00 to 1.00 But Greater Than 3.50 to 1.00        
Debt Instrument [Line Items]        
Prepayment amount of excess cash flows, percentage 25.00%      
Line of credit | Secured term loan | First Lien Leverage Ratio Less Than or Equal to 4.00 to 1.00 But Greater Than 3.50 to 1.00 | Minimum        
Debt Instrument [Line Items]        
Leverage ratio (as percent)     3.50 3.50
Line of credit | Secured term loan | First Lien Leverage Ratio Less Than or Equal to 4.00 to 1.00 But Greater Than 3.50 to 1.00 | Maximum        
Debt Instrument [Line Items]        
Leverage ratio (as percent)     4.00 4.00
Line of credit | Secured term loan | First Lien Leverage Ratio of Less Than or Equal to 3.50 to 1.00        
Debt Instrument [Line Items]        
Leverage ratio (as percent)     3.50 3.50
Prepayment amount of excess cash flows, percentage 0.00%      
Line of credit | Secured revolving credit facility        
Debt Instrument [Line Items]        
Number of business days following deadline to be in compliance with First Lien Leverage Ratio 11 days      
Line of credit | Secured revolving credit facility | Secured Revolving Facility Due April 20, 2024        
Debt Instrument [Line Items]        
Unused capacity, commitment fee percentage (as percent) 0.50%      
Minimum borrowing amount to maintain First Lien Leverage Ratio, percentage   25.00% 25.00% 25.00%
Minimum borrowing amount to maintain First Lien Leverage Ratio   $ 62,500,000.0   $ 62,500,000.0
Line of credit | Secured revolving credit facility | Secured Revolving Facility Due April 20, 2024 | FIrst Lien Leverage Ratio is less than or equal to 3.00 to 1.00        
Debt Instrument [Line Items]        
Unused capacity, commitment fee percentage (as percent) 0.375%      
Leverage ratio (as percent)     3.00 3.00
Domestic credit agreement | USD Term Loan Due April 20, 2024 | LIBOR        
Debt Instrument [Line Items]        
Basis spread (as percent)   3.25%    
Variable interest rate floor (as percent)   1.00%    
Domestic credit agreement | Secured term loan        
Debt Instrument [Line Items]        
Amount of borrowings outstanding   $ 50,000,000    
Domestic credit agreement | Secured term loan | USD Term Loan Due April 20, 2024        
Debt Instrument [Line Items]        
Amount of debt issued       $ 1,133,000,000.000
Domestic credit agreement | Secured term loan | USD Term Loan Due April 20, 2024 | Base rate        
Debt Instrument [Line Items]        
Basis spread (as percent) 2.25%      
Domestic credit agreement | Secured term loan | USD Term Loan Due April 20, 2024 | Base rate | Minimum        
Debt Instrument [Line Items]        
Basis spread (as percent) 2.00%      
Domestic credit agreement | Secured term loan | USD Term Loan Due April 20, 2024 | LIBOR        
Debt Instrument [Line Items]        
Basis spread (as percent) 3.25%      
Domestic credit agreement | Secured term loan | USD Term Loan Due April 20, 2024 | LIBOR | Minimum        
Debt Instrument [Line Items]        
Basis spread (as percent) 3.00%      
Variable interest rate floor (as percent) 1.00%      
Domestic credit agreement | Secured revolving credit facility | USD Term Loan Due April 20, 2024        
Debt Instrument [Line Items]        
Amount of debt issued       250,000,000.0
Domestic credit agreement | Secured revolving credit facility | USD Term Loan Due April 20, 2024 | Base rate        
Debt Instrument [Line Items]        
Basis spread (as percent) 2.25%      
Domestic credit agreement | Secured revolving credit facility | USD Term Loan Due April 20, 2024 | LIBOR        
Debt Instrument [Line Items]        
Basis spread (as percent) 3.25%      
Domestic credit agreement | Secured revolving credit facility | USD Term Loan Due To Terminate on March 2019        
Debt Instrument [Line Items]        
Amount of debt issued       87,100,000.0
Domestic credit agreement | Letter of credit | USD Term Loan Due April 20, 2024        
Debt Instrument [Line Items]        
Amount of debt issued       75,000,000.0
Foreign credit agreement | Euro Term Loan Due April 20, 2024 | LIBOR        
Debt Instrument [Line Items]        
Basis spread (as percent)   3.00%    
Variable interest rate floor (as percent)   1.00%    
Foreign credit agreement | Secured term loan | Euro Term Loan Due April 20, 2024        
Debt Instrument [Line Items]        
Amount of debt issued     € 463,100,000.0 $ 496,300,000.0
Foreign credit agreement | Secured term loan | Euro Term Loan Due April 20, 2024 | LIBOR        
Debt Instrument [Line Items]        
Basis spread (as percent) 3.00%      
Foreign credit agreement | Secured term loan | Euro Term Loan Due April 20, 2024 | LIBOR | Minimum        
Debt Instrument [Line Items]        
Variable interest rate floor (as percent) 1.00%      
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.7.0.1
LONG-TERM DEBT - Schedule of Maximum Leverage Ratios (Details) - Line of credit - Secured revolving credit facility - Secured revolving facility due March 2019
Mar. 11, 2014
April 30, 2014 through October 31, 2014  
Line of Credit Facility [Line Items]  
Maximum leverage ratio (as percent) 6.75
November 1, 2014 through October 31, 2015  
Line of Credit Facility [Line Items]  
Maximum leverage ratio (as percent) 6.50
November 1, 2015 through October 31, 2016  
Line of Credit Facility [Line Items]  
Maximum leverage ratio (as percent) 6.25
November 1, 2016 through October 31, 2017  
Line of Credit Facility [Line Items]  
Maximum leverage ratio (as percent) 6.00
November 1, 2017 and thereafter  
Line of Credit Facility [Line Items]  
Maximum leverage ratio (as percent) 5.75
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.7.0.1
LONG-TERM DEBT - 2014 Senior Unsecured Notes (Details) - Senior notes - 7.50% senior notes due February 2022 - USD ($)
Apr. 30, 2017
Feb. 28, 2014
Debt Instrument [Line Items]    
Amount of debt issued   $ 450,000,000.0
Stated rate (as percent) 7.50% 7.50%
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.7.0.1
LONG-TERM DEBT - Schedule of Redemption Rates (Details) - Senior notes - 7.50% senior notes due February 2022
 1 Months Ended
Feb. 28, 2014
2017  
Debt Instrument [Line Items]  
Redemption price (as percent) 105.625%
2018  
Debt Instrument [Line Items]  
Redemption price (as percent) 103.75%
2019  
Debt Instrument [Line Items]  
Redemption price (as percent) 101.875%
2020 and thereafter  
Debt Instrument [Line Items]  
Redemption price (as percent) 100.00%
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.7.0.1
LONG-TERM DEBT - Other Financing Arrangements (Details)
€ in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
USD ($)
Apr. 30, 2016
EUR (€)
Jul. 31, 2013
EUR (€)
payment
debt_instrument
Apr. 30, 2017
USD ($)
Apr. 30, 2016
USD ($)
Oct. 31, 2016
USD ($)
Aug. 31, 2015
USD ($)
Debt Instrument [Line Items]              
Proceeds from long-term debt       $ 30.0 $ 0.7    
Total long-term debt outstanding $ 2,146.2     $ 2,146.2   $ 2,128.9  
Investment in Facility              
Debt Instrument [Line Items]              
Long-term investment commitment, minimum amount             $ 47.0
Loan              
Debt Instrument [Line Items]              
Number of incremental debt instruments | debt_instrument     2        
Loan | Italian subsidized loan due June 2020              
Debt Instrument [Line Items]              
Amount of debt issued | €     € 6.0        
Proceeds from long-term debt | €   € 0.6 € 5.4        
Stated rate (as percent) 0.50%   0.50% 0.50%      
Total long-term debt outstanding $ 3.6     $ 3.6   4.1  
Loan | Italian bank loan due June 2020              
Debt Instrument [Line Items]              
Amount of debt issued | €     € 0.7        
Proceeds from long-term debt | €   € 0.1 € 0.6        
Number of semi-annual installments | payment     6        
Total long-term debt outstanding $ 0.7     0.7   0.7  
Loan | Italian bank loan due June 2020 | Euribor rate              
Debt Instrument [Line Items]              
Basis spread (as percent) 7.10%   7.10%        
Loan | Government of Austria research and development loans due March 2020              
Debt Instrument [Line Items]              
Total long-term debt outstanding $ 2.7     $ 2.7   $ 3.5  
Other Obligations              
Debt Instrument [Line Items]              
Percentage of property tax payment due (as percent)             50.00%
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.7.0.1
PENSION AND POST-RETIREMENT BENEFITS - Schedule of Net Periodic Benefit Cost (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Defined benefit pension plans        
Defined Benefit Plan Disclosure [Line Items]        
Service cost $ 0.6 $ 0.4 $ 1.2 $ 0.9
Interest cost 1.0 1.3 2.0 2.6
Expected return on plan assets (1.0) (1.2) (2.0) (2.5)
Amortization of actuarial loss 0.7 0.4 1.4 0.8
Net periodic benefit costs 1.3 0.9 2.6 1.8
Other benefit plans        
Defined Benefit Plan Disclosure [Line Items]        
Service cost 0.0 0.0 0.0 0.0
Interest cost 0.0 0.0 0.1 0.1
Expected return on plan assets 0.0 0.0 0.0 0.0
Amortization of actuarial loss 0.0 0.0 0.0 0.0
Net periodic benefit costs $ 0.0 $ 0.0 $ 0.1 $ 0.1
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.7.0.1
PENSION AND POST-RETIREMENT BENEFITS - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended 12 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Oct. 31, 2016
Defined Benefit Plan Disclosure [Line Items]          
Anticipated contributions required under the defined benefit pension plans and other benefit plans     $ 3.9    
Contributions made under the defined benefit pension plans and other benefit plans         $ 5.2
Employee future benefit expense $ 2.2 $ 1.6 4.5 $ 3.3  
Italy          
Defined Benefit Plan Disclosure [Line Items]          
Deferred compensation arrangement employer contribution     3.9   $ 3.4
Deferred compensation arrangement employer contribution related expenses $ 0.9 $ 0.7 $ 1.8 $ 1.4  
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.7.0.1
EARNINGS (LOSS) PER SHARE - Schedule of Basic and Diluted EPS (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Income (loss) from continuing operations $ 27.6 $ 1.9 $ 55.9 $ (18.1)
Loss from discontinued operations $ 0.0 $ (1.0) $ 0.0 $ (3.1)
Weighted-average number of shares of ordinary shares - basic (in shares) 145,136,214 115,609,756 145,132,349 115,609,756
Effect of dilutive securities:        
Weighted-average number of shares of ordinary shares - diluted (in shares) 146,267,128 115,609,756 146,276,351 115,609,756
Earnings (loss) per ordinary share - basic:        
From continuing operations (in USD per share) $ 0.19 $ 0.02 $ 0.39 $ (0.16)
From discontinued operations (in USD per share) 0.00 (0.01) 0.00 (0.03)
Earnings (loss) per ordinary share - diluted:        
From continuing operations (in USD per share) 0.19 0.02 0.38 (0.16)
From discontinued operations (in USD per share) $ 0.00 $ (0.01) $ 0.00 $ (0.03)
Restricted Stock Units        
Effect of dilutive securities:        
Dilutive securities (in shares) 1,092,951 0 1,116,435 0
Stock Options        
Effect of dilutive securities:        
Dilutive securities (in shares) 37,963 0 27,567 0
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK BASED COMPENSATION - Schedule of Share Based Compensation Expense (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock Based Compensation Expense $ 7.0 $ 2.0 $ 11.0 $ 3.0
Restricted Stock Units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock Based Compensation Expense 4.0 0.0 5.3 0.0
Stock Options        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock Based Compensation Expense 1.1 $ 0.0 1.5 $ 0.0
Management Equity Incentive Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock Based Compensation Expense 1.9   $ 4.2  
Management Equity Incentive Plan | Restricted Stock Units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock Based Compensation Expense $ 1.0      
XML 72 R62.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK BASED COMPENSATION - Management Equity Incentive Plan (MEIP) (Details)
$ / shares in Units, $ in Millions
 3 Months Ended 6 Months Ended
Dec. 08, 2016
USD ($)
$ / shares
shares
Apr. 30, 2017
USD ($)
$ / shares
shares
Apr. 30, 2016
USD ($)
Apr. 30, 2017
USD ($)
tranche
$ / shares
shares
Apr. 30, 2016
USD ($)
Oct. 31, 2016
shares
Jul. 26, 2016
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based compensation expense   $ 7.0 $ 2.0 $ 11.0 $ 3.0    
Restricted Stock Units              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Restricted share units under the omnibus Plan (in shares) | shares   1,408,018   1,408,018   450,184  
Estimated fair value of MEIP RSU's (in USD per share) | $ / shares       $ 26.46      
Stock-based compensation expense   $ 4.0 0.0 $ 5.3 0.0    
IPO | Restricted Stock Units              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Share price (in USD per share) | $ / shares             $ 24.79
Management Equity Incentive Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of valuation tranches | tranche       5      
Stock-based compensation expense   $ 1.9   $ 4.2      
Management Equity Incentive Plan | Stock-based Compensation              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Shares distributed to be held for MEIP participants (in shares) | shares             6,106,540
Stock-based compensation expense     $ 2.0   $ 3.0    
Management Equity Incentive Plan | Restricted Stock Units              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period       5 years      
Restricted share units under the omnibus Plan (in shares) | shares 196,485           3,388,481
Share price target (in USD per share) | $ / shares   $ 48.47   $ 48.47      
Estimated fair value of MEIP RSU's (in USD per share) | $ / shares $ 13.87 $ 8.41          
Stock-based compensation expense   $ 1.0          
Compensation costs not yet recognized $ 1.7            
Stock-based compensation expense reversed   $ 0.3          
Management Equity Incentive Plan | IPO | Stock-based Compensation              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Share price (in USD per share) | $ / shares             $ 21.00
Management Equity Incentive Plan | Class B              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Threshold percentage of ownership of equity securities for exit event (less than)       20.00%      
Percentage of excess capital contributions received to trigger an Exit Event   250.00%   250.00%      
Compensation costs not yet recognized   $ 31.9   $ 31.9      
Compensation costs not yet recognized, to be recognized before Exit Event       $ 3.4      
Management Equity Incentive Plan | Class B | Stock-based Compensation              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Percent of service-based units       71.40%      
Vesting period       4 years      
Stock-based compensation expense   1.4   $ 2.9      
Compensation costs not yet recognized   8.5   8.5      
Management Equity Incentive Plan | Class B | Restricted Stock Units              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based compensation expense   0.2   $ 0.4      
Management Equity Incentive Plan | Class C              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Class C, class D, and class E vesting thresholds       200.00%      
Management Equity Incentive Plan | Class D              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Class C, class D, and class E vesting thresholds       250.00%      
Management Equity Incentive Plan | Class E              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Class C, class D, and class E vesting thresholds       300.00%      
Management Equity Incentive Plan | Common Class C, Class D, Class E Stock              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based compensation expense   0.4   $ 1.0      
Compensation costs not yet recognized   8.9   8.9      
Stock-based compensation expense reversed   0.1   $ 0.2      
Management Equity Incentive Plan | Common Class C, Class D, Class E Stock | Stock-based Compensation              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based compensation expense   9.0          
Management Equity Incentive Plan | Common Class C, Class D, Class E Stock | Restricted Stock Units              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based compensation expense   $ 1.5          
XML 73 R63.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK BASED COMPENSATION - Schedule of Plan Activity (Details) - Stock-based Compensation - Management Equity Incentive Plan
 6 Months Ended
Apr. 30, 2017
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Beginning balance (in shares) 84,700
Forfeited (in shares) (438)
Ending balance (in shares) 84,262
Weighted Average Fair Value  
Beginning balance (in USD per share) | $ / shares $ 687.27
Forfeited (in USD per share) | $ / shares 870.09
Ending balance (in USD per share) | $ / shares $ 686.32
Class B  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Beginning balance (in shares) 59,290
Forfeited (in shares) (288)
Ending balance (in shares) 59,002
Class C  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Beginning balance (in shares) 8,470
Forfeited (in shares) (50)
Ending balance (in shares) 8,420
Class D  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Beginning balance (in shares) 8,470
Forfeited (in shares) (50)
Ending balance (in shares) 8,420
Class E  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Beginning balance (in shares) 8,470
Forfeited (in shares) (50)
Ending balance (in shares) 8,420
XML 74 R64.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK BASED COMPENSATION - Fair Value Assumptions (Details) - Management Equity Incentive Plan
 6 Months Ended
Apr. 30, 2017
Stock-based Compensation  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Risk free interest rate (in percent) 0.90%
Expected volatility (in percent) 41.60%
Estimated years to exit event 2 years 357 days
Stock Options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Risk free interest rate (in percent) 1.60%
Expected volatility (in percent) 38.10%
Estimated years to exit event 6 years
Dividend yield (in percent) 0.00%
XML 75 R65.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK BASED COMPENSATION - Restricted Stock Units (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Jul. 26, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based compensation expense $ 7.0 $ 2.0 $ 11.0 $ 3.0  
Restricted Stock Units          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
RSU's granted (in shares)     1,028,534    
Stock-based compensation expense $ 4.0 $ 0.0 $ 5.3 $ 0.0  
IPO | Restricted Stock Units          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share price (in USD per share)         $ 24.79
Management | IPO | Restricted Stock Units          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
RSU's granted (in shares)     1,366,383    
Director | IPO | Restricted Stock Units          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
RSU's granted (in shares)     41,635    
Ordinary Shares | Restricted Stock Units          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share price (in USD per share) $ 27.15   $ 27.15    
Shares issued during period (in shares)     70,700    
Treasury shares acquired, at cost (in shares)     (8,528)    
Stock-based compensation expense $ 3.0   $ 4.3    
Compensation costs not yet recognized $ 29.5   $ 29.5    
XML 76 R66.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK BASED COMPENSATION - Summary of Restricted Stock Units (Details) - Restricted Stock Units
 6 Months Ended
Apr. 30, 2017
$ / shares
shares
Restricted Share Units  
Beginning balance (in shares) 450,184
Granted (in shares) 1,028,534
Vested (in shares) (70,700)
Forfeitures (in shares) 0
Ending balance (in shares) 1,408,018
Weighted Average Grant Date Fair Value  
Beginning balance (in USD per share) | $ / shares $ 21.00
Granted (in USD per share) | $ / shares 26.46
Vested (in USD per share) | $ / shares 21.00
Ending balance (in USD per share) | $ / shares $ 24.79
XML 77 R67.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK BASED COMPENSATION - Stock Options (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 6 Months Ended
Jul. 26, 2016
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based compensation expense   $ 7.0 $ 2.0 $ 11.0 $ 3.0
Stock Options          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock option grants (in shares)       726,166  
Stock-based compensation expense   1.1 $ 0.0 $ 1.5 $ 0.0
Compensation costs not yet recognized   8.1   8.1  
Stock Options | EBITDA Options          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based compensation expense   0.3      
Compensation costs not yet recognized   5.6   5.6  
IPO | Stock Options          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock option grants (in shares) 1,747,750        
Share price (in USD per share) $ 23.28        
Estimate fair value of stock options (in USD per share)) $ 9.08        
Stock-based compensation expense   $ 0.8   $ 1.2  
IPO | Stock Options | Tranche One          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock option grants (in shares) 1,033,465        
Vesting period 3 years        
XML 78 R68.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK BASED COMPENSATION - Schedule of Stock Options (Details) - Stock Options
 6 Months Ended
Apr. 30, 2017
$ / shares
shares
Stock Options  
Beginning balance (in shares) 1,021,584
Granted (in shares) 726,166
Forfeited (in shares) 0
Exercised (in shares) 0
Ending balance (in shares) 1,747,750
Weighted Average Fair Value  
Beginning balance (in USD per share) | $ / shares $ 8.29
Granted (in USD per share) | $ / shares 10.18
Ending balance (in USD per share) | $ / shares $ 9.08
XML 79 R69.htm IDEA: XBRL DOCUMENT v3.7.0.1
FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Summary of Financial Assets and Liabilities Measured at Fair Value (Details) - USD ($)
$ in Millions
Apr. 30, 2017
Oct. 31, 2016
Jan. 31, 2016
Jan. 29, 2016
Assets measured at fair value        
Available-for-sale securities $ 1.4 $ 1.4    
Held-for-trading securities 1.5 1.4    
Total assets 2.9 2.8    
Liabilities measured at fair value        
Earnout liability 37.9 33.8 $ 31.1 $ 36.0
Total liabilities 39.7 36.5    
Foreign exchange forward contracts        
Liabilities measured at fair value        
Foreign exchange forward contracts 1.8 2.7    
Level 1        
Assets measured at fair value        
Available-for-sale securities 1.4 1.4    
Held-for-trading securities 0.0 0.0    
Total assets 1.4 1.4    
Liabilities measured at fair value        
Earnout liability 0.0 0.0    
Total liabilities 0.0 0.0    
Level 1 | Foreign exchange forward contracts        
Liabilities measured at fair value        
Foreign exchange forward contracts 0.0 0.0    
Level 2        
Assets measured at fair value        
Available-for-sale securities 0.0 0.0    
Held-for-trading securities 1.5 1.4    
Total assets 1.5 1.4    
Liabilities measured at fair value        
Earnout liability 0.0 0.0    
Total liabilities 1.8 2.7    
Level 2 | Foreign exchange forward contracts        
Liabilities measured at fair value        
Foreign exchange forward contracts 1.8 2.7    
Level 3        
Assets measured at fair value        
Available-for-sale securities 0.0 0.0    
Held-for-trading securities 0.0 0.0    
Total assets 0.0 0.0    
Liabilities measured at fair value        
Earnout liability 37.9 33.8    
Total liabilities 37.9 33.8    
Level 3 | Foreign exchange forward contracts        
Liabilities measured at fair value        
Foreign exchange forward contracts $ 0.0 $ 0.0    
XML 80 R70.htm IDEA: XBRL DOCUMENT v3.7.0.1
FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Schedule of Derivative Financial Instruments and Investments Classification on Consolidated Balance Sheet (Details) - USD ($)
$ in Millions
Apr. 30, 2017
Oct. 31, 2016
Derivatives, Fair Value [Line Items]    
Available-for-sale securities $ 1.4 $ 1.4
Held-for-trading securities 1.5 1.4
Total assets 2.9 2.8
Total liabilities 39.7 36.5
Foreign exchange forward contracts    
Derivatives, Fair Value [Line Items]    
Foreign exchange forward contracts (Derivative liabilities) 1.8 2.7
Investments    
Derivatives, Fair Value [Line Items]    
Available-for-sale securities 1.4 1.4
Held-for-trading securities 1.5 1.4
Accounts payable and accrued liabilities | Foreign exchange forward contracts    
Derivatives, Fair Value [Line Items]    
Foreign exchange forward contracts (Derivative liabilities) 1.8 2.7
Other long-term liabilities    
Derivatives, Fair Value [Line Items]    
Earnout liability $ 37.9 $ 33.8
XML 81 R71.htm IDEA: XBRL DOCUMENT v3.7.0.1
FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Fair Value Measurements Narrative (Details) - USD ($)
$ in Millions
 6 Months Ended 12 Months Ended
Apr. 30, 2017
Oct. 31, 2016
Fair Value Disclosures [Abstract]    
Gross unrealized loss $ 2.0 $ 2.7
Gross unrealized gain $ 0.2 $ 0.1
XML 82 R72.htm IDEA: XBRL DOCUMENT v3.7.0.1
FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Schedule of Fair Values and Carrying Values of Long-term Debt (Details) - USD ($)
$ in Millions
Apr. 30, 2017
Oct. 31, 2016
Fair Value    
Liabilities:    
Long-term debt, including current portion $ 2,179.3 $ 2,156.8
Fair Value | Level 1    
Liabilities:    
Long-term debt, including current portion 0.0 0.0
Fair Value | Level 2    
Liabilities:    
Long-term debt, including current portion 2,179.3 2,156.8
Fair Value | Level 3    
Liabilities:    
Long-term debt, including current portion 0.0 0.0
Carrying Value    
Liabilities:    
Long-term debt, including current portion $ 2,134.0 $ 2,119.0
XML 83 R73.htm IDEA: XBRL DOCUMENT v3.7.0.1
FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Foreign Exchange Contracts and Other Arrangements Narrative (Details)
$ in Millions
 3 Months Ended 6 Months Ended
Jan. 29, 2016
USD ($)
tranche
Apr. 30, 2017
USD ($)
CAD / $
Apr. 30, 2016
USD ($)
Apr. 30, 2017
USD ($)
CAD / $
Apr. 30, 2016
USD ($)
Oct. 31, 2016
USD ($)
Jan. 31, 2016
USD ($)
Derivatives, Fair Value [Line Items]              
Contingent consideration $ 36.0 $ 37.9   $ 37.9   $ 33.8 $ 31.1
Capital transaction 36.0            
Adjusted EBITDA growth rate (as percent)       10.00%      
Maximum payment under Earnout Agreement 60.0            
Minimum payment under Earnout Agreement $ 25.0            
Income recognized from change in fair value in earnout liability     $ 4.9        
Number of tranches | tranche 3            
Level 3              
Derivatives, Fair Value [Line Items]              
Contingent consideration   $ 37.9   $ 37.9   33.8  
Tranche one              
Derivatives, Fair Value [Line Items]              
Consideration transferred $ 25.0            
Tranche two              
Derivatives, Fair Value [Line Items]              
Contingent consideration 25.0            
Adjusted EBITDA value 98.0            
Tranche three              
Derivatives, Fair Value [Line Items]              
Contingent consideration 10.0            
Adjusted EBITDA value $ 110.0            
Designated as hedging instruments | Foreign Exchange Forward Issued January 2017 | Canada              
Derivatives, Fair Value [Line Items]              
Average exchange rate | CAD / $   1.3254   1.3254      
Unrealized loss recorded in accumulated other comprehensive income in shareholders' deficit, net of associated income tax   $ (1.8)          
Designated as hedging instruments | Foreign Exchange Forward Issued January 2017 | Canada | Short              
Derivatives, Fair Value [Line Items]              
Aggregate amount to sell   64.0   $ 64.0      
Earnout | Level 3              
Derivatives, Fair Value [Line Items]              
Earnout liability   37.9   37.9   $ 33.8  
Income (expense) recognized from change in fair value earn out liability   $ (0.5) $ (1.2) $ (4.1) $ 3.7    
Asset volatility rate (as percent)       30.00%      
Asset beta       0.9      
Change in asset volatility (as percent)       1.00%      
Change in liability amount due to asset volatility change       $ 0.3      
Change in asset beta       0.1      
Change in liability amount due to asset beta change       $ 0.3      
XML 84 R74.htm IDEA: XBRL DOCUMENT v3.7.0.1
FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Earnout Liability Activity (Details) - Level 3 - Earnout - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Fair Value Inputs, Liabilities, Quantitative Information [Roll Forward]        
Earnout liability, beginning balance     $ 33.8  
Change in fair value $ 0.5 $ 1.2 4.1 $ (3.7)
Earnout liability, ending balance $ 37.9   $ 37.9  
XML 85 R75.htm IDEA: XBRL DOCUMENT v3.7.0.1
FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Foreign Exchange Risk Narrative (Details)
€ in Millions, $ in Millions
 6 Months Ended 12 Months Ended
Apr. 30, 2017
USD ($)
Oct. 31, 2016
USD ($)
Apr. 30, 2017
EUR (€)
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]      
Cumulative unrealized exchange gains $ 0.2 $ 0.1  
Foreign credit agreement      
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]      
Long-term debt, including current portion, carrying value | €     € 463.1
Cumulative unrealized exchange gains $ 74.7    
Canada      
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]      
Potential increase/decrease in exchange rate impacting operating income, percentage 10.00%    
Potential increase/decrease in exchange rate impacting operating income, value $ 5.8    
Percent of cash flow exposures covered by hedges     68.00%
Geographic Concentration Risk | Canada | Cash receipts from operations in U.S. dollars      
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]      
Concentration risk, percentage (as percent) 90.00%    
Geographic Concentration Risk | Canada | Cash outflows in U.S. dollars      
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]      
Concentration risk, percentage (as percent) 15.00%    
XML 86 R76.htm IDEA: XBRL DOCUMENT v3.7.0.1
FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) (Details) - Net investment hedge - Foreign exchange contract - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Foreign exchange (loss) gain for the period from net investment hedge $ (4.6) $ (29.0) $ 4.0 $ (21.0)
Release of ineffective portion of net investment hedge to consolidated statement of operations 0.0 3.3 0.0 2.2
Net (loss) gain to other comprehensive income for the period related to net investment hedge (4.6) (25.7) 4.0 (18.8)
Intercompany loans        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Net loss to other comprehensive income (loss) for the period related to foreign exchange $ 0.0 $ 3.8 $ 0.0 $ 3.0
XML 87 R77.htm IDEA: XBRL DOCUMENT v3.7.0.1
FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Credit Risk (Details) - USD ($)
$ in Millions
Apr. 30, 2017
Oct. 31, 2016
Fair Value Disclosures [Abstract]    
Deposits held $ 4.1 $ 4.3
XML 88 R78.htm IDEA: XBRL DOCUMENT v3.7.0.1
FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Liquidity Risk (Details) - USD ($)
$ in Millions
Apr. 30, 2017
Oct. 31, 2016
Apr. 30, 2016
Oct. 31, 2015
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]        
Cash and cash equivalents $ 92.7 $ 165.0 $ 184.7 $ 328.7
Liquidity risk        
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]        
Cash and cash equivalents 92.7      
Liquidity risk | Line of credit        
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]        
Undrawn lines of credit available $ 209.3      
XML 89 R79.htm IDEA: XBRL DOCUMENT v3.7.0.1
SEGMENT INFORMATION - Narrative (Details)
 6 Months Ended
Apr. 30, 2017
segment
Segment Reporting [Abstract]  
Number of operating segments 4
Number of reportable segments 3
XML 90 R80.htm IDEA: XBRL DOCUMENT v3.7.0.1
SEGMENT INFORMATION - Segment Results (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Segment Reporting Information [Line Items]        
Revenues $ 483.4 $ 468.6 $ 940.8 $ 874.5
Adjusted EBITDA 94.2 98.0 176.7 157.0
Depreciation and amortization 34.3 27.0 61.9 53.5
Capital expenditures 40.2 30.9 99.2 95.1
Operating Segments | DPS        
Segment Reporting Information [Line Items]        
Revenues 297.2 287.4 572.4 545.9
Adjusted EBITDA 77.4 72.7 138.8 127.8
Depreciation and amortization 15.4 14.9 30.7 29.7
Capital expenditures 19.5 11.7 56.4 56.7
Operating Segments | PDS        
Segment Reporting Information [Line Items]        
Revenues 57.8 53.4 110.1 101.9
Adjusted EBITDA 18.4 16.7 34.7 30.5
Depreciation and amortization 1.9 1.3 3.7 2.5
Capital expenditures 1.7 5.9 3.1 15.6
Operating Segments | DSS        
Segment Reporting Information [Line Items]        
Revenues 129.2 127.9 259.1 226.8
Adjusted EBITDA 26.1 30.8 58.1 45.6
Depreciation and amortization 16.1 10.2 25.8 20.1
Capital expenditures 11.6 9.0 29.5 16.3
Other | Other        
Segment Reporting Information [Line Items]        
Revenues 0.0 0.0 0.0 0.0
Adjusted EBITDA (27.5) (22.2) (54.7) (46.9)
Depreciation and amortization 0.9 0.6 1.7 1.2
Capital expenditures 7.4 4.3 10.2 6.5
Intersegment Eliminations        
Segment Reporting Information [Line Items]        
Revenues (0.8) $ (0.1) (0.8) $ (0.1)
Adjusted EBITDA $ (0.2)   $ (0.2)  
XML 91 R81.htm IDEA: XBRL DOCUMENT v3.7.0.1
SEGMENT INFORMATION - Reconciliation of Adjusted EBITDA (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Segment Reporting Information [Line Items]        
Total Adjusted EBITDA $ 94.2 $ 98.0 $ 176.7 $ 157.0
Depreciation and amortization (34.3) (27.0) (61.9) (53.5)
Repositioning expenses (2.2) (1.3) (3.5) (2.5)
Acquisition and integration costs (8.1) (7.6) (11.6) (10.2)
Interest expense, net (30.8) (42.6) (59.0) (86.4)
Benefit from (provision for) income taxes 1.5 (0.7) 22.8 0.0
Refinancing expenses (6.3) 0.0 (6.3) 0.0
Operational initiatives related consulting costs (1.4) (1.9) (2.5) (3.3)
IPO costs 0.0 (0.4) 0.0 (0.8)
Acquisition related litigation expenses (3.7) (0.9) (6.0) (1.9)
Stock based compensation expense (7.0) (2.0) (11.0) (3.0)
FDA remediation costs 0.0 (10.1) 0.0 (18.5)
Environmental remediation costs 0.0 0.0 (3.7) 0.0
Bargain purchase gain 26.4 0.0 26.4 0.0
Other (0.7) (1.6) (4.5) 5.0
Net income (loss) from continuing operations 27.6 $ 1.9 55.9 $ (18.1)
Swindon Wind Down        
Segment Reporting Information [Line Items]        
Inventory Write-down $ 0.4   $ 1.1  
XML 92 R82.htm IDEA: XBRL DOCUMENT v3.7.0.1
SEGMENT INFORMATION - Schedule of Revenue, Capital Assets and Goodwill, by Country (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Oct. 31, 2016
Revenues from External Customers and Long-Lived Assets [Line Items]          
Revenues $ 483.4 $ 468.6 $ 940.8 $ 874.5  
Capital Assets 1,169.3 945.8 1,169.3 945.8 $ 983.6
Goodwill 281.4 282.1 281.4 282.1 $ 281.6
Canada          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Revenues 4.2 5.1 11.2 12.4  
Capital Assets 100.1 100.8 100.1 100.8  
Goodwill 2.5 2.8 2.5 2.8  
U.S.          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Revenues 282.8 317.6 564.7 589.4  
Capital Assets 687.6 487.3 687.6 487.3  
Goodwill 269.4 269.4 269.4 269.4  
Europe          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Revenues 167.9 124.8 320.7 236.7  
Capital Assets 367.5 341.6 367.5 341.6  
Goodwill 7.4 7.7 7.4 7.7  
Other          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Revenues 28.5 21.1 44.2 36.0  
Capital Assets 14.1 16.1 14.1 16.1  
Goodwill $ 2.1 $ 2.2 $ 2.1 $ 2.2  
XML 93 R83.htm IDEA: XBRL DOCUMENT v3.7.0.1
REPOSITIONING EXPENSES - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Jan. 31, 2017
Oct. 31, 2016
Jan. 31, 2016
Oct. 31, 2015
Restructuring Cost and Reserve [Line Items]                
Repositioning expenses $ 1.8 $ 1.3 $ 2.4 $ 2.5        
Restructuring Reserve 4.9 $ 3.4 4.9 $ 3.4 $ 4.6 $ 5.4 $ 4.9 $ 22.9
Other Restructuring                
Restructuring Cost and Reserve [Line Items]                
Repositioning expenses 1.8              
Inventory Reserve For Three Months Ended | Swindon Wind Down                
Restructuring Cost and Reserve [Line Items]                
Restructuring Reserve 0.4   0.4          
Inventory Reserve For Six Months Ended | Swindon Wind Down                
Restructuring Cost and Reserve [Line Items]                
Restructuring Reserve $ 1.1   $ 1.1          
XML 94 R84.htm IDEA: XBRL DOCUMENT v3.7.0.1
REPOSITIONING EXPENSES - Schedule of Repositioning Expenses and Charges (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Restructuring Reserve [Roll Forward]        
Total repositioning liability at beginning of period $ 4.6 $ 4.9 $ 5.4 $ 22.9
Repositioning expenses 1.8 1.3 2.4 2.5
Repositioning expenses paid (1.6) (3.1) (3.1) (21.8)
Foreign exchange 0.1 0.3 0.2 (0.2)
Total repositioning liability at end of period 4.9 3.4 4.9 3.4
Employee-related expenses        
Restructuring Reserve [Roll Forward]        
Repositioning expenses 1.8 1.6 2.4 2.8
Consulting, professional and project management costs        
Restructuring Reserve [Roll Forward]        
Repositioning expenses   (0.3)   (0.3)
Operating Segments | DPS        
Restructuring Reserve [Roll Forward]        
Repositioning expenses   1.3   2.5
Operating Segments | DPS | Employee-related expenses        
Restructuring Reserve [Roll Forward]        
Repositioning expenses 1.7 1.6 1.9 2.8
Operating Segments | DPS | Consulting, professional and project management costs        
Restructuring Reserve [Roll Forward]        
Repositioning expenses   (0.3)   (0.3)
Operating Segments | PDS        
Restructuring Reserve [Roll Forward]        
Repositioning expenses   0.0   0.0
Operating Segments | PDS | Employee-related expenses        
Restructuring Reserve [Roll Forward]        
Repositioning expenses 0.0 0.0 0.0 0.0
Operating Segments | PDS | Consulting, professional and project management costs        
Restructuring Reserve [Roll Forward]        
Repositioning expenses   0.0   0.0
Operating Segments | DSS        
Restructuring Reserve [Roll Forward]        
Repositioning expenses   0.0   0.0
Operating Segments | DSS | Employee-related expenses        
Restructuring Reserve [Roll Forward]        
Repositioning expenses 0.0 0.0 0.0 0.0
Operating Segments | DSS | Consulting, professional and project management costs        
Restructuring Reserve [Roll Forward]        
Repositioning expenses   0.0   0.0
Other | Other        
Restructuring Reserve [Roll Forward]        
Repositioning expenses   0.0   0.0
Other | Other | Employee-related expenses        
Restructuring Reserve [Roll Forward]        
Repositioning expenses $ 0.1 0.0 $ 0.5 0.0
Other | Other | Consulting, professional and project management costs        
Restructuring Reserve [Roll Forward]        
Repositioning expenses   $ 0.0   $ 0.0
XML 95 R85.htm IDEA: XBRL DOCUMENT v3.7.0.1
RELATED PARTIES (Details) - USD ($)
$ in Millions
 1 Months Ended 3 Months Ended 6 Months Ended
Mar. 31, 2016
Feb. 29, 2016
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Oct. 31, 2016
Oct. 31, 2015
Related Party Transaction [Line Items]                
Cash distribution from Banner Life Services         $ 0.0 $ 1.3    
Return on capital         0.0 2.3    
Affiliated entity | JLL Partners Inc. and DSM | Business Services                
Related Party Transaction [Line Items]                
Expenses from transactions with related party     $ 0.1 $ 0.1 0.1 0.2    
Accounts payable, related parties     0.1   0.1   $ 0.0  
Affiliated entity | Koninklijke DSM | Shared Service Functions                
Related Party Transaction [Line Items]                
Expenses from transactions with related party     1.9 2.5 5.1 5.2    
Revenue for services from related parties     0.1 0.8 0.3 0.9    
Accounts payable, related parties     1.7   1.7   0.2  
Accounts receivable, related parties     0.1   0.1   0.4  
Affiliated entity | Banner Life Sciences | Shared Service Functions                
Related Party Transaction [Line Items]                
Revenue for services from related parties     0.7 1.4 0.7 7.9    
Accounts receivable, related parties     1.2   1.2   1.1  
Equity Method Investee                
Related Party Transaction [Line Items]                
Equity method investment values     8.3   8.3   8.7  
Equity method gain/(loss)     (0.2) (0.4) (0.3) 1.5    
Equity Method Investee | Banner Life Sciences                
Related Party Transaction [Line Items]                
Equity method investment values     2.5   2.5   2.9 $ 5.0
Cash distribution from Banner Life Services $ 2.4              
Equity method gain/(loss)     (0.2) (0.5) (0.3) 1.3    
Equity Method Investee | Percivia                
Related Party Transaction [Line Items]                
Equity method investment values     $ 5.7   $ 5.7   5.7  
Ownership percentage (as percent)     50.00%   50.00%      
Return on capital   $ 1.2            
Equity method gain/(loss)     $ 0.0 $ 0.1 $ 0.0 $ 0.2    
Equity Method Investee | ChemiePark                
Related Party Transaction [Line Items]                
Equity method investment values     $ 0.1   $ 0.1   $ 0.1  
Ownership percentage (as percent)     47.50%   47.50%      
XML 96 R86.htm IDEA: XBRL DOCUMENT v3.7.0.1
INCOME TAXES (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Jan. 31, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Valuation Allowance [Line Items]          
Provision for (benefit from) income taxes $ (1.5)   $ 0.7 $ (22.8) $ 0.0
Deferred income taxes       $ 29.7 $ 0.9
Patheon Biologics LLC          
Valuation Allowance [Line Items]          
Deferred income taxes $ 3.5 $ 28.3      
XML 97 R87.htm IDEA: XBRL DOCUMENT v3.7.0.1
OTHER INFORMATION - Foreign Exchange (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Other Information [Abstract]        
Foreign exchange loss, net $ 0.7 $ 7.1 $ 5.5 $ 11.4
XML 98 R88.htm IDEA: XBRL DOCUMENT v3.7.0.1
OTHER INFORMATION - Management Incentive Plan (Details) - Management Long-Term Incentive Plan - USD ($)
$ in Millions
 38 Months Ended
Mar. 11, 2014
Apr. 30, 2017
Loss Contingencies [Line Items]    
Threshold percentage of ownership of equity securities for exit event 20.00%  
Percentage of excess capital contributions received to trigger an Exit Event 250.00%  
Number of days to determine plan details 90 days  
Value of LTIP units granted   $ 9.6
Vesting period   5 years
Payments made due to qualified terminations   $ 0.2
XML 99 R89.htm IDEA: XBRL DOCUMENT v3.7.0.1
OTHER INFORMATION - Contingencies (Details)
€ in Millions
 1 Months Ended 6 Months Ended
Nov. 30, 2015
EUR (€)
plaintiff
Oct. 31, 2011
plaintiff
Apr. 30, 2017
Loss Contingencies [Line Items]      
Number of plaintiffs 113 115  
Number of plaintiff actions   2  
Number of named plaintiffs   2  
Italy | Italian client dispute      
Loss Contingencies [Line Items]      
Amount of penalty per day sought by client | € € 0.2    
Banner Acquisition | Softgel Services | Service concentration risk | Sales revenue      
Loss Contingencies [Line Items]      
Concentration risk, percentage (generally less than) (as percent)     10.00%
XML 100 R90.htm IDEA: XBRL DOCUMENT v3.7.0.1
OTHER INFORMATION - Supplemental Cash Flow Information (Details) - USD ($)
$ in Millions
 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Condensed Cash Flow Statements, Captions [Line Items]    
Increase in capital lease obligations $ 1.0 $ 0.0
Assumption of earnout liability from the Partnership    
Condensed Cash Flow Statements, Captions [Line Items]    
Assumption of earnout liability from the Partnership 0.0 36.0
Treasury stock purchases to satisfy certain tax withholdings    
Condensed Cash Flow Statements, Captions [Line Items]    
Assumption of earnout liability from the Partnership $ 0.1 $ 0.0
XML 101 R91.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUBSEQUENT EVENTS (Details) - Thermo Fisher - Subsequent event
$ / shares in Units, $ in Billions
May 15, 2017
USD ($)
$ / shares
Subsequent Event [Line Items]  
Share price (in USD per share) | $ / shares $ 35.00
Amount of cash and associated inventory and spare parts transferred $ 7.2
Liability assumed as part of business combination $ 2.0
EXCEL 102 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 103 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 104 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 106 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 433 361 1 true 147 0 false 13 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.patheon.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://www.patheon.com/role/ConsolidatedBalanceSheetsUnaudited CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 1001501 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://www.patheon.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://www.patheon.com/role/ConsolidatedStatementsOfOperationsUnaudited CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 1003000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) Sheet http://www.patheon.com/role/ConsolidatedStatementsOfComprehensiveIncomeLossUnaudited CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) Statements 5 false false R6.htm 1003501 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical) Sheet http://www.patheon.com/role/ConsolidatedStatementsOfComprehensiveIncomeLossUnauditedParenthetical CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical) Statements 6 false false R7.htm 1004000 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' DEFICIT (Unaudited) Sheet http://www.patheon.com/role/ConsolidatedStatementOfChangesInShareholdersDeficitUnaudited CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' DEFICIT (Unaudited) Statements 7 false false R8.htm 1005000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://www.patheon.com/role/ConsolidatedStatementsOfCashFlowsUnaudited CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 8 false false R9.htm 2101100 - Disclosure - THE COMPANY Sheet http://www.patheon.com/role/Company THE COMPANY Notes 9 false false R10.htm 2102100 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.patheon.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 2103100 - Disclosure - BUSINESS COMBINATIONS Sheet http://www.patheon.com/role/BusinessCombinations BUSINESS COMBINATIONS Notes 11 false false R12.htm 2103100 - Disclosure - DISCONTINUED OPERATIONS Sheet http://www.patheon.com/role/DiscontinuedOperations DISCONTINUED OPERATIONS Notes 12 false false R13.htm 2104100 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION Sheet http://www.patheon.com/role/SupplementalBalanceSheetInformation SUPPLEMENTAL BALANCE SHEET INFORMATION Notes 13 false false R14.htm 2105100 - Disclosure - LONG-TERM DEBT Sheet http://www.patheon.com/role/LongTermDebt LONG-TERM DEBT Notes 14 false false R15.htm 2106100 - Disclosure - PENSION AND POST-RETIREMENT BENEFITS Sheet http://www.patheon.com/role/PensionAndPostRetirementBenefits PENSION AND POST-RETIREMENT BENEFITS Notes 15 false false R16.htm 2107100 - Disclosure - EARNINGS (LOSS) PER SHARE Sheet http://www.patheon.com/role/EarningsLossPerShare EARNINGS (LOSS) PER SHARE Notes 16 false false R17.htm 2108100 - Disclosure - STOCK BASED COMPENSATION Sheet http://www.patheon.com/role/StockBasedCompensation STOCK BASED COMPENSATION Notes 17 false false R18.htm 2109100 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT Sheet http://www.patheon.com/role/FinancialInstrumentsFairValueAndRiskManagement FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT Notes 18 false false R19.htm 2110100 - Disclosure - SEGMENT INFORMATION Sheet http://www.patheon.com/role/SegmentInformation SEGMENT INFORMATION Notes 19 false false R20.htm 2111100 - Disclosure - REPOSITIONING EXPENSES Sheet http://www.patheon.com/role/RepositioningExpenses REPOSITIONING EXPENSES Notes 20 false false R21.htm 2112100 - Disclosure - RELATED PARTIES Sheet http://www.patheon.com/role/RelatedParties RELATED PARTIES Notes 21 false false R22.htm 2113100 - Disclosure - INCOME TAXES Sheet http://www.patheon.com/role/IncomeTaxes INCOME TAXES Notes 22 false false R23.htm 2114100 - Disclosure - OTHER INFORMATION Sheet http://www.patheon.com/role/OtherInformation OTHER INFORMATION Notes 23 false false R24.htm 2144100 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.patheon.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 24 false false R25.htm 2202201 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.patheon.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 25 false false R26.htm 2303301 - Disclosure - BUSINESS COMBINATIONS (Tables) Sheet http://www.patheon.com/role/BusinessCombinationsTables BUSINESS COMBINATIONS (Tables) Tables http://www.patheon.com/role/BusinessCombinations 26 false false R27.htm 2303301 - Disclosure - DISCONTINUED OPERATIONS (Tables) Sheet http://www.patheon.com/role/DiscontinuedOperationsTables DISCONTINUED OPERATIONS (Tables) Tables http://www.patheon.com/role/DiscontinuedOperations 27 false false R28.htm 2304301 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION (Tables) Sheet http://www.patheon.com/role/SupplementalBalanceSheetInformationTables SUPPLEMENTAL BALANCE SHEET INFORMATION (Tables) Tables http://www.patheon.com/role/SupplementalBalanceSheetInformation 28 false false R29.htm 2305301 - Disclosure - LONG-TERM DEBT (Tables) Sheet http://www.patheon.com/role/LongTermDebtTables LONG-TERM DEBT (Tables) Tables http://www.patheon.com/role/LongTermDebt 29 false false R30.htm 2306301 - Disclosure - PENSION AND POST-RETIREMENT BENEFITS (Tables) Sheet http://www.patheon.com/role/PensionAndPostRetirementBenefitsTables PENSION AND POST-RETIREMENT BENEFITS (Tables) Tables http://www.patheon.com/role/PensionAndPostRetirementBenefits 30 false false R31.htm 2307301 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables) Sheet http://www.patheon.com/role/EarningsLossPerShareTables EARNINGS (LOSS) PER SHARE (Tables) Tables http://www.patheon.com/role/EarningsLossPerShare 31 false false R32.htm 2308301 - Disclosure - STOCK BASED COMPENSATION (Tables) Sheet http://www.patheon.com/role/StockBasedCompensationTables STOCK BASED COMPENSATION (Tables) Tables http://www.patheon.com/role/StockBasedCompensation 32 false false R33.htm 2309301 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT(Tables) Sheet http://www.patheon.com/role/FinancialInstrumentsFairValueAndRiskManagementtables FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT(Tables) Tables http://www.patheon.com/role/FinancialInstrumentsFairValueAndRiskManagement 33 false false R34.htm 2310301 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://www.patheon.com/role/SegmentInformationTables SEGMENT INFORMATION (Tables) Tables http://www.patheon.com/role/SegmentInformation 34 false false R35.htm 2311301 - Disclosure - REPOSITIONING EXPENSES (Tables) Sheet http://www.patheon.com/role/RepositioningExpensesTables REPOSITIONING EXPENSES (Tables) Tables http://www.patheon.com/role/RepositioningExpenses 35 false false R36.htm 2312301 - Disclosure - RELATED PARTIES (Tables) Sheet http://www.patheon.com/role/RelatedPartiesTables RELATED PARTIES (Tables) Tables http://www.patheon.com/role/RelatedParties 36 false false R37.htm 2314301 - Disclosure - OTHER INFORMATION (Tables) Sheet http://www.patheon.com/role/OtherInformationTables OTHER INFORMATION (Tables) Tables http://www.patheon.com/role/OtherInformation 37 false false R38.htm 2401401 - Disclosure - THE COMPANY - Narrative (Details) Sheet http://www.patheon.com/role/CompanyNarrativeDetails THE COMPANY - Narrative (Details) Details 38 false false R39.htm 2402402 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Sheet http://www.patheon.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Details http://www.patheon.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies 39 false false R40.htm 2403402 - Disclosure - BUSINESS COMBINATIONS - Narrative (Details) Sheet http://www.patheon.com/role/BusinessCombinationsNarrativeDetails BUSINESS COMBINATIONS - Narrative (Details) Details 40 false false R41.htm 2403402 - Disclosure - DISCONTINUED OPERATIONS - Narrative (Details) Sheet http://www.patheon.com/role/DiscontinuedOperationsNarrativeDetails DISCONTINUED OPERATIONS - Narrative (Details) Details 41 false false R42.htm 2403403 - Disclosure - BUSINESS COMBINATIONS - Schedule of Preliminary Purchase Price Allocations (Details) Sheet http://www.patheon.com/role/BusinessCombinationsScheduleOfPreliminaryPurchasePriceAllocationsDetails BUSINESS COMBINATIONS - Schedule of Preliminary Purchase Price Allocations (Details) Details 42 false false R43.htm 2403403 - Disclosure - DISCONTINUED OPERATIONS - Schedule of Dispositions (Details) Sheet http://www.patheon.com/role/DiscontinuedOperationsScheduleOfDispositionsDetails DISCONTINUED OPERATIONS - Schedule of Dispositions (Details) Details 43 false false R44.htm 2403404 - Disclosure - BUSINESS COMBINATIONS - Schedule of Financial Results (Details) Sheet http://www.patheon.com/role/BusinessCombinationsScheduleOfFinancialResultsDetails BUSINESS COMBINATIONS - Schedule of Financial Results (Details) Details 44 false false R45.htm 2403405 - Disclosure - BUSINESS COMBINATIONS - Schedule of Unaudited Pro Forma Information (Details) Sheet http://www.patheon.com/role/BusinessCombinationsScheduleOfUnauditedProFormaInformationDetails BUSINESS COMBINATIONS - Schedule of Unaudited Pro Forma Information (Details) Details 45 false false R46.htm 2404402 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION - Inventories (Details) Sheet http://www.patheon.com/role/SupplementalBalanceSheetInformationInventoriesDetails SUPPLEMENTAL BALANCE SHEET INFORMATION - Inventories (Details) Details 46 false false R47.htm 2404403 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION - Accounts Payable and Accrued Liabilities (Details) Sheet http://www.patheon.com/role/SupplementalBalanceSheetInformationAccountsPayableAndAccruedLiabilitiesDetails SUPPLEMENTAL BALANCE SHEET INFORMATION - Accounts Payable and Accrued Liabilities (Details) Details 47 false false R48.htm 2404404 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION - Finite-Lived Intangible Assets Acquired (Details) Sheet http://www.patheon.com/role/SupplementalBalanceSheetInformationFiniteLivedIntangibleAssetsAcquiredDetails SUPPLEMENTAL BALANCE SHEET INFORMATION - Finite-Lived Intangible Assets Acquired (Details) Details 48 false false R49.htm 2404405 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION - Indefinite-Lived Intangible Assets (Details) Sheet http://www.patheon.com/role/SupplementalBalanceSheetInformationIndefiniteLivedIntangibleAssetsDetails SUPPLEMENTAL BALANCE SHEET INFORMATION - Indefinite-Lived Intangible Assets (Details) Details 49 false false R50.htm 2404406 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION - Narrative (Details) Sheet http://www.patheon.com/role/SupplementalBalanceSheetInformationNarrativeDetails SUPPLEMENTAL BALANCE SHEET INFORMATION - Narrative (Details) Details 50 false false R51.htm 2404407 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION - Goodwill (Details) Sheet http://www.patheon.com/role/SupplementalBalanceSheetInformationGoodwillDetails SUPPLEMENTAL BALANCE SHEET INFORMATION - Goodwill (Details) Details 51 false false R52.htm 2405402 - Disclosure - LONG-TERM DEBT - Schedule of Long-term Debt in Accompanying balance Sheet (Details) Sheet http://www.patheon.com/role/LongTermDebtScheduleOfLongTermDebtInAccompanyingBalanceSheetDetails LONG-TERM DEBT - Schedule of Long-term Debt in Accompanying balance Sheet (Details) Details 52 false false R53.htm 2405403 - Disclosure - LONG-TERM DEBT - 2017 Term Loans and Revolving Line (Details) Sheet http://www.patheon.com/role/LongTermDebt2017TermLoansAndRevolvingLineDetails LONG-TERM DEBT - 2017 Term Loans and Revolving Line (Details) Details 53 false false R54.htm 2405404 - Disclosure - LONG-TERM DEBT - Schedule of Maximum Leverage Ratios (Details) Sheet http://www.patheon.com/role/LongTermDebtScheduleOfMaximumLeverageRatiosDetails LONG-TERM DEBT - Schedule of Maximum Leverage Ratios (Details) Details 54 false false R55.htm 2405405 - Disclosure - LONG-TERM DEBT - 2014 Senior Unsecured Notes (Details) Notes http://www.patheon.com/role/LongTermDebt2014SeniorUnsecuredNotesDetails LONG-TERM DEBT - 2014 Senior Unsecured Notes (Details) Details 55 false false R56.htm 2405406 - Disclosure - LONG-TERM DEBT - Schedule of Redemption Rates (Details) Sheet http://www.patheon.com/role/LongTermDebtScheduleOfRedemptionRatesDetails LONG-TERM DEBT - Schedule of Redemption Rates (Details) Details 56 false false R57.htm 2405407 - Disclosure - LONG-TERM DEBT - Other Financing Arrangements (Details) Sheet http://www.patheon.com/role/LongTermDebtOtherFinancingArrangementsDetails LONG-TERM DEBT - Other Financing Arrangements (Details) Details 57 false false R58.htm 2406402 - Disclosure - PENSION AND POST-RETIREMENT BENEFITS - Schedule of Net Periodic Benefit Cost (Details) Sheet http://www.patheon.com/role/PensionAndPostRetirementBenefitsScheduleOfNetPeriodicBenefitCostDetails PENSION AND POST-RETIREMENT BENEFITS - Schedule of Net Periodic Benefit Cost (Details) Details 58 false false R59.htm 2406403 - Disclosure - PENSION AND POST-RETIREMENT BENEFITS - Narrative (Details) Sheet http://www.patheon.com/role/PensionAndPostRetirementBenefitsNarrativeDetails PENSION AND POST-RETIREMENT BENEFITS - Narrative (Details) Details 59 false false R60.htm 2407402 - Disclosure - EARNINGS (LOSS) PER SHARE - Schedule of Basic and Diluted EPS (Details) Sheet http://www.patheon.com/role/EarningsLossPerShareScheduleOfBasicAndDilutedEpsDetails EARNINGS (LOSS) PER SHARE - Schedule of Basic and Diluted EPS (Details) Details http://www.patheon.com/role/EarningsLossPerShareTables 60 false false R61.htm 2408402 - Disclosure - STOCK BASED COMPENSATION - Schedule of Share Based Compensation Expense (Details) Sheet http://www.patheon.com/role/StockBasedCompensationScheduleOfShareBasedCompensationExpenseDetails STOCK BASED COMPENSATION - Schedule of Share Based Compensation Expense (Details) Details 61 false false R62.htm 2408403 - Disclosure - STOCK BASED COMPENSATION - Management Equity Incentive Plan (MEIP) (Details) Sheet http://www.patheon.com/role/StockBasedCompensationManagementEquityIncentivePlanMeipDetails STOCK BASED COMPENSATION - Management Equity Incentive Plan (MEIP) (Details) Details 62 false false R63.htm 2408404 - Disclosure - STOCK BASED COMPENSATION - Schedule of Plan Activity (Details) Sheet http://www.patheon.com/role/StockBasedCompensationScheduleOfPlanActivityDetails STOCK BASED COMPENSATION - Schedule of Plan Activity (Details) Details 63 false false R64.htm 2408405 - Disclosure - STOCK BASED COMPENSATION - Fair Value Assumptions (Details) Sheet http://www.patheon.com/role/StockBasedCompensationFairValueAssumptionsDetails STOCK BASED COMPENSATION - Fair Value Assumptions (Details) Details 64 false false R65.htm 2408406 - Disclosure - STOCK BASED COMPENSATION - Restricted Stock Units (Details) Sheet http://www.patheon.com/role/StockBasedCompensationRestrictedStockUnitsDetails STOCK BASED COMPENSATION - Restricted Stock Units (Details) Details 65 false false R66.htm 2408407 - Disclosure - STOCK BASED COMPENSATION - Summary of Restricted Stock Units (Details) Sheet http://www.patheon.com/role/StockBasedCompensationSummaryOfRestrictedStockUnitsDetails STOCK BASED COMPENSATION - Summary of Restricted Stock Units (Details) Details 66 false false R67.htm 2408408 - Disclosure - STOCK BASED COMPENSATION - Stock Options (Details) Sheet http://www.patheon.com/role/StockBasedCompensationStockOptionsDetails STOCK BASED COMPENSATION - Stock Options (Details) Details 67 false false R68.htm 2408409 - Disclosure - STOCK BASED COMPENSATION - Schedule of Stock Options (Details) Sheet http://www.patheon.com/role/StockBasedCompensationScheduleOfStockOptionsDetails STOCK BASED COMPENSATION - Schedule of Stock Options (Details) Details 68 false false R69.htm 2409402 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Summary of Financial Assets and Liabilities Measured at Fair Value (Details) Sheet http://www.patheon.com/role/FinancialInstrumentsFairValueAndRiskManagementSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueDetails FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Summary of Financial Assets and Liabilities Measured at Fair Value (Details) Details 69 false false R70.htm 2409403 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Schedule of Derivative Financial Instruments and Investments Classification on Consolidated Balance Sheet (Details) Sheet http://www.patheon.com/role/FinancialInstrumentsFairValueAndRiskManagementScheduleOfDerivativeFinancialInstrumentsAndInvestmentsClassificationOnConsolidatedBalanceSheetDetails FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Schedule of Derivative Financial Instruments and Investments Classification on Consolidated Balance Sheet (Details) Details 70 false false R71.htm 2409404 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Fair Value Measurements Narrative (Details) Sheet http://www.patheon.com/role/FinancialInstrumentsFairValueAndRiskManagementFairValueMeasurementsNarrativeDetails FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Fair Value Measurements Narrative (Details) Details 71 false false R72.htm 2409405 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Schedule of Fair Values and Carrying Values of Long-term Debt (Details) Sheet http://www.patheon.com/role/FinancialInstrumentsFairValueAndRiskManagementScheduleOfFairValuesAndCarryingValuesOfLongTermDebtDetails FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Schedule of Fair Values and Carrying Values of Long-term Debt (Details) Details 72 false false R73.htm 2409406 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Foreign Exchange Contracts and Other Arrangements Narrative (Details) Sheet http://www.patheon.com/role/FinancialInstrumentsFairValueAndRiskManagementForeignExchangeContractsAndOtherArrangementsNarrativeDetails FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Foreign Exchange Contracts and Other Arrangements Narrative (Details) Details 73 false false R74.htm 2409407 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Earnout Liability Activity (Details) Sheet http://www.patheon.com/role/FinancialInstrumentsFairValueAndRiskManagementEarnoutLiabilityActivityDetails FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Earnout Liability Activity (Details) Details 74 false false R75.htm 2409408 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Foreign Exchange Risk Narrative (Details) Sheet http://www.patheon.com/role/FinancialInstrumentsFairValueAndRiskManagementForeignExchangeRiskNarrativeDetails FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Foreign Exchange Risk Narrative (Details) Details 75 false false R76.htm 2409409 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) (Details) Sheet http://www.patheon.com/role/FinancialInstrumentsFairValueAndRiskManagementScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossDetails FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) (Details) Details 76 false false R77.htm 2409410 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Credit Risk (Details) Sheet http://www.patheon.com/role/FinancialInstrumentsFairValueAndRiskManagementCreditRiskDetails FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Credit Risk (Details) Details 77 false false R78.htm 2409411 - Disclosure - FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Liquidity Risk (Details) Sheet http://www.patheon.com/role/FinancialInstrumentsFairValueAndRiskManagementLiquidityRiskDetails FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT - Liquidity Risk (Details) Details 78 false false R79.htm 2410402 - Disclosure - SEGMENT INFORMATION - Narrative (Details) Sheet http://www.patheon.com/role/SegmentInformationNarrativeDetails SEGMENT INFORMATION - Narrative (Details) Details 79 false false R80.htm 2410403 - Disclosure - SEGMENT INFORMATION - Segment Results (Details) Sheet http://www.patheon.com/role/SegmentInformationSegmentResultsDetails SEGMENT INFORMATION - Segment Results (Details) Details 80 false false R81.htm 2410404 - Disclosure - SEGMENT INFORMATION - Reconciliation of Adjusted EBITDA (Details) Sheet http://www.patheon.com/role/SegmentInformationReconciliationOfAdjustedEbitdaDetails SEGMENT INFORMATION - Reconciliation of Adjusted EBITDA (Details) Details 81 false false R82.htm 2410405 - Disclosure - SEGMENT INFORMATION - Schedule of Revenue, Capital Assets and Goodwill, by Country (Details) Sheet http://www.patheon.com/role/SegmentInformationScheduleOfRevenueCapitalAssetsAndGoodwillByCountryDetails SEGMENT INFORMATION - Schedule of Revenue, Capital Assets and Goodwill, by Country (Details) Details 82 false false R83.htm 2411402 - Disclosure - REPOSITIONING EXPENSES - Narrative (Details) Sheet http://www.patheon.com/role/RepositioningExpensesNarrativeDetails REPOSITIONING EXPENSES - Narrative (Details) Details 83 false false R84.htm 2411403 - Disclosure - REPOSITIONING EXPENSES - Schedule of Repositioning Expenses and Charges (Details) Sheet http://www.patheon.com/role/RepositioningExpensesScheduleOfRepositioningExpensesAndChargesDetails REPOSITIONING EXPENSES - Schedule of Repositioning Expenses and Charges (Details) Details 84 false false R85.htm 2412402 - Disclosure - RELATED PARTIES (Details) Sheet http://www.patheon.com/role/RelatedPartiesDetails RELATED PARTIES (Details) Details http://www.patheon.com/role/RelatedPartiesTables 85 false false R86.htm 2413401 - Disclosure - INCOME TAXES (Details) Sheet http://www.patheon.com/role/IncomeTaxesDetails INCOME TAXES (Details) Details http://www.patheon.com/role/IncomeTaxes 86 false false R87.htm 2414402 - Disclosure - OTHER INFORMATION - Foreign Exchange (Details) Sheet http://www.patheon.com/role/OtherInformationForeignExchangeDetails OTHER INFORMATION - Foreign Exchange (Details) Details 87 false false R88.htm 2414403 - Disclosure - OTHER INFORMATION - Management Incentive Plan (Details) Sheet http://www.patheon.com/role/OtherInformationManagementIncentivePlanDetails OTHER INFORMATION - Management Incentive Plan (Details) Details 88 false false R89.htm 2414404 - Disclosure - OTHER INFORMATION - Contingencies (Details) Sheet http://www.patheon.com/role/OtherInformationContingenciesDetails OTHER INFORMATION - Contingencies (Details) Details 89 false false R90.htm 2414405 - Disclosure - OTHER INFORMATION - Supplemental Cash Flow Information (Details) Sheet http://www.patheon.com/role/OtherInformationSupplementalCashFlowInformationDetails OTHER INFORMATION - Supplemental Cash Flow Information (Details) Details 90 false false R91.htm 2444401 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.patheon.com/role/SubsequentEventsDetails SUBSEQUENT EVENTS (Details) Details http://www.patheon.com/role/SubsequentEvents 91 false false All Reports Book All Reports pti-20170430.xml pti-20170430.xsd pti-20170430_cal.xml pti-20170430_def.xml pti-20170430_lab.xml pti-20170430_pre.xml true true ZIP 108 0001643848-17-000028-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001643848-17-000028-xbrl.zip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

  •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�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�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end